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Abstract: An investigation into the existence of Cyprinid 
herpesvirus 3 encoded microRNAs 
 
Cyprinid herpesvirus 3 (CyHV-3), a member of the Alloherpesviridae family, is a 
cause of mass mortalities in carp (Cyprinus carpio carpio) and koi (Cyprinus carpio 
koi) worldwide. It is difficult to detect the low levels of viral genomic DNA present 
in latently infected (carrier) fish. Recent evidence shows that latent herpesviral gene 
transcription is often confined to non-protein-coding genes including microRNAs 
(miRNAs). This study set out to determine if CyHV-3 encoded its own miRNAs and 
to investigate their suitability as biomarkers for the diagnosis of latent CyHV-3 
infections. Extensive bioinformatic analysis of the CyHV-3 genome suggested the 
presence of non-conserved precursor-miRNA (pre-miRNA) genes. High throughput 
deep RNA sequencing of size-selected small RNA fractions from in vitro CyHV-3 
lytic infections resulted in the identification of potential miRNAs, associated isomiRs 
and miRNA–offset RNA (moRNAs), a new functional class of small RNAs related 
to miRNAs. DNA microarray analysis, northern blotting and stem-loop RT-qPCR 
were used to definitively identify some of these as novel viral miRNAs.  In all, seven 
CyHV-3 pre-miRNAs were identified and three of these were conclusively detected 
in vivo by stem-loop RT-qPCR. Tentative CyHV-3 mRNA targets for some of these 
miRNAs were also identified, thus offering insights into the possible role of these 
novel viral genes during infection. Potential homologues of some of these CyHV-3 
pre-miRNAs were identified in the two closely related viruses CyHV-1 and -2, 
indicating that other members of the Alloherpesviridae family may also encode 
miRNAs. This is the first report of miRNA and miRNA-offset-RNAs being produced 
by a member of the Alloherpesviridae family. Collectively, these findings may help 
further our understanding of the biology of these economically important viruses and 
they may also serve as biomarkers for the identification of latently infected fish. 
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1 Introduction 
1.1 Herpesvirales  
The order Herpesvirales is a large group of disease-causing viruses that are widely 
distributed in nature. Members of this order are commonly referred to as 
herpesviruses (HVs) and can give rise to both lytic and latent infections in animal 
hosts. The name comes from the Greek work “herpin” meaning “to creep” in 
reference to the reoccurring nature of the diseases caused by these viruses. This 
ability to establish long-term latent infections is undoubtedly a significant factor that 
has enabled HVs to become some of the most prevalent viral pathogens known. To 
date, over 200 have been identified in mammalian, avian, reptilian, piscine, 
amphibian and bivalve hosts, with each virus being highly evolved to replicate within 
a specific or narrow range of host species (Davison, 2002; Roizmann, 2001). These 
highly adapted and ubiquitous pathogens significantly affect human health (Arvin et 
al., 2007). Although in most cases, both long term latent infections and periodic lytic 
reactivation can be relatively benign (at worst, undesirable), in some circumstances 
human HVs can cause life threatening disease, particularly in the case of 
immunocompromised individuals (Ljungman, 1993). Some non-human HVs are 
much more pathogenic, causing highly contagious disease resulting in acute mass 
mortality among susceptible hosts. Viral latency presents a huge problem in this 
context as it allows these pathogens to persist in populations for long periods in the 
absence of any symptoms and results in significant economic loss upon reactivation. 
Such viruses are a major problem for certain sectors of the agriculture and 
aquaculture industries (Atkins et al., 2011; Bowland and Shewen, 2000; Pokorova et 
al., 2005) and for these reasons have been the main focus of research in terms of non-
human HVs.  
 
Due to substantial phylogenetic differences, Herpesvirales is split into 3 families: (i) 
Herpesviridae, consisting of mammalian, avian and reptilian herpesviruses (ii) 
Alloherpesviridae consisting of piscine and amphibian herpesviruses and (iii) 
Malacoherpesviridae consisting of two known bivalve herpesviruses. Despite the 
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significant phylogenetic distance between these families (Davison et al., 2009) all 
HVs retain common distinctive features that differentiates them from other viral 
orders (Ackermann, 2004). All HVs include a linear double-stranded DNA genome 
from 120-295 kbp in size (Aoki et al., 2007; Davison et al., 2009). Reports suggest 
that this may in fact be arranged into the shape of a torus (Zhou et al., 1999). The 
nucleic acid is surrounded by (and associated with) a distinct T=16 icosahedral 
capsid of ~100 nm in diameter consisting of different types of capsomers (major 
capsid proteins, triplex proteins and small capsomer interacting proteins). Capsids 
also feature a small portal located at one vertex for HV DNA entry and exit (Cardone 
et al., 2007; Rochat et al., 2011). The capsid is surrounded by a proteinaceous matrix 
called the tegument. This is surrounded by a viral envelope containing glycoproteins. 
These glycoproteins are shorter and much more numerous than those present on 
many other enveloped viruses (Wildy and Watson, 1962). Mature enveloped virons 
range from 120-260 nm with size depending on tegument thickness, which can vary 
depending on where the viron is in the infected cell (Falke et al., 1959) (Figure 1.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Diagram of typical herpesvirus viron structure  
Left: cross-section of viron on the left showing all of the layers described in Section 1.1. Right: 
illustration of a T=16 icosahedral capsid structure. Figure from expasy.org (2013) 
  
 
In addition to these distinct morphological attributes HVs also share 4 distinctive 
biological traits: (i) They encode a large array of genes involved in nucleic acid 
metabolism and synthesis e.g. thymidine kinase, thymidylate synthase, dUTPase, 
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ribonucleotide reductase, DNA polymerase, primase and helicase; (ii) Viral DNA 
replication and capsid assembly occurs in the nucleus with further processing to yield 
mature virons occuring in the cytoplasm; (iii) Viral replication and the release of new 
infective viral progeny results in destruction of the host cell; (iv) All HVs can also 
establish latent infections although this only occurs in specific types of cells 
(Roizmann, 2001).  
 
The exact types of cells in which specific HVs can establish latent infections (tissue 
tropism) is important and can be indicative of their general biology. This aspect of 
HV biology has been best studied in members of the Herpesviridae family, 
particularly in human in HVs. In broad terms, these HVs display 3 distinct types of 
tissue tropism during latency and accordingly members of the Herpesviridae are split 
into 3 subfamilies on this basis. Members of the Alphaherpesvirinae subfamily 
establish latent infections primarily in sensory ganglia. Typically these HVs also 
have shorter lytic replication cycles than other HVs, causing fast efficient destruction 
of infected cells with rapid spread. It is difficult for these reasons to establish in vitro 
models of latency for these viruses, whereas in contrast latency is established quite 
readily in the case of in vivo models (Cohrs and Gilden, 2001). HVs of the 
Betaherpesvirinae subfamily are maintained in lymphoreticular cells, kidney, 
secretory glands, and other tissues. Notably these viruses display relatively slow 
replication cycles in vitro. The in vitro cytopatic effects (CPE) associated with these 
viruses includes a notable cellular enlargement (cytomegalia) before lysis (Roizmann 
2001). Members of the Gammaherpesvirinae subfamily establish latency in the 
lymphoid tissue. In vivo, these viruses usually infect either T or B lymphocytes and 
are capable of transforming such cells (Küppers, 2003). In contrast to members of the 
alphaherpesvirinae and Betaherpesvirinae groups, the establishment of a latent 
infection is almost always the default pathway in vitro (Speck and Ganem, 2010). A 
summary of all human HVs as categorized by subfamily is given in Table 1.1.  
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Table 1.1 Summary of human HVs and their tissue tropism 
Viruses that are also the prototype for their respective families are marked in bold. Table adapted from 
Penkert and Kalejta (2011) 
 
Family Virus Productive (Lytic) Replication Site of Latency 
Herpes Simplex 1 (HSV-1) Epithelial and keratinocyte Neurons 
Herpes Simplex 2 (HSV-2) Epithelial and keratinocyte Neurons 
 
  
Varicella zoster virus (VSV) 
Epithelial, keratinocyte, T 
cell, sebocyte, monocyte, 
endothelial, Langerhans and 
peripheral blood 
mononuclear cells 
Neurons 
Human cytomegalovirus 
(HCMV) 
Macrophage, dendritic, 
endothelial, smooth muscle, 
epithelial and fibroblast cells 
CD34+ hematopoietic 
stem cell and 
monocytes 
Human herpesvirus 6 
(HHV-6) T cells T cells 
 
  
Human herpesvirus 7 
(HHV-7) T cells T cells 
Epstein–Barr virus (EBV) B cell and epithelial cells B cells 
 Kaposi's sarcoma-
associated herpesvirus 
(KSHV) 
Lymphocytes B cells 
 
1.2 Herpesvirus life cycle  
Every HV studied to date has the ability to establish both lytic and latent infections 
and the factors that dictate what kind of infection takes place vary for each HV. 
These include host cell type, host cell differentiation status and host cell interaction 
with elements of the immune system. These factors and the general characteristics of 
the HV life cycle are described below. 
 
1.2.1 Lytic replication 
The lytic replication strategies of members of the three Herpesviridae subfamilies all 
display common characteristics (Johnson and Baines, 2011). The infection process 
begins with attachment to the host cell surface. Glycoproteins in the viral envelope 
(of which there are usually about a dozen per HV) bind to cell surface molecules. At 
least 3 types of conserved HV glycoproteins appear to be essential for this process in 
Herpesviridae, namely glycoproteins B, H and L (gB, gH, and gL). Additional 
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glycoproteins involved in cell surface interaction vary between HVs and may be the 
determinants of host cell specificity. On this note, gD and gO have been found to 
play specific roles in the Alphaherpesvirinae (Ligas and Johnson, 1988) and 
Betaherpesvirinae (Huber and Compton, 1998) respectively. Most HVs primarily 
bind weakly (and reversibly) to heparan sulphate glycosaminoglycans (GAG) on cell 
surfaces (Shukla and Spear, 2001), a notable exception to this is EBV which 
analogously binds to complement receptor 2 (CR2) on the surface of its host cells 
(Szakonyi et al., 2006). All HVs enter host cells through fusion between the viral 
envelope and the cell membrane. Although the initial nature of cell surface 
interaction varies between HVs, they all rely on very similar mechanisms involving 
viral gB, gH and gL (Heldwein and Krummenacher, 2008) of which the latter form a 
gH/gL dimer (Peng et al., 1998).  Fusion results in the introduction of the viral capsid 
to the cytoplasm. Capsids are then guided towards the nucleus by latching onto a 
network of microtubules (Granzow et al., 1997). Upon binding to a nuclear pore, the 
viral genome is injected from the capsid into the nucleus. If conditions are 
permissible for lytic replication, the synthesis of new infective viral particles begins 
(alternatively a latent infection is established at this stage, with subsequent lytic 
infections occurring upon reactivation see Section 1.2.2). This process proceeds in a 
coordinated manner. During lytic replication, viral gene expression occurs as a 
classic regulatory cascade that is conserved across all HVs. This involves the initial 
expression of immediate early (IE) genes which mainly encode gene trans-activators. 
This is followed by early (E) genes, whose expression is dependent on expression of 
IE trans-activator genes. In the final phase, late (L) genes that code for structural 
proteins involved in assembly of new viron components i.e. capsids, tegument and 
envelope glycoproteins. In the case of most HVs, transcription of IE genes relies on 
ready made IE trans-activators that were incorporated into the tegument and also 
released into the cell upon viral entry (Penkert and Kalejta, 2011; Roizmann, 2001) 
(for more detail see Section 1.2.2.). Genome replication takes place in the early 
stages of lytic replication. This occurs by a rolling-circle mechanism that results in 
long head-to-tail genome concatemers (Jacob et al., 1979). Concatemerized genomes 
are separated by cleavage based on specific signals at the genomic termini and then 
packaged into newly formed capsids via the portal vertex (Cardone et al., 2007; 
Johnson and Baines, 2011; Rochat et al., 2011). While in the nucleus, capsids are 
coated with an initial tegument layer. In order to continue the process of viron 
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maturation, immature virons must exit the nucleus and access the cytoplasm. Nuclear 
egress takes place in two steps. Firstly the inner nuclear membrane (INM) is partially 
dismantled allowing immature virons to become enveloped in the INM as they enter 
the perinuclear space (Scott and O’Hare, 2001). Fusion of this temporary viral 
envelope with the outer nuclear layer results in de-envelopment and release of non-
enveloped immature virons into the cytoplasm. Once in the cytoplasm, additional 
layers of tegument are acquired, after which the viron enters the Golgi and trans-
Golgi-network by budding and becoming re-enveloped in the process. Newly 
enveloped virons are then transported to the cell membrane in cytoplasmic vesicles. 
These vesicles fuse with the plasma membrane releasing the mature enveloped 
virons. Several subtly different models of this maturation process have been 
proposed however the model described here is supported by a significant amount of 
independent experimental data (Johnson and Baines, 2011; Roizmann, 2001). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Model of herpesvirus egress  
Figure from Johnson and Baines (2011). 
 
1.2.2 Latency 
Latency refers to a type of infection where the HVs go dormant or silent within the 
host. This results in the establishment life-long infections, from which lytic 
infections may periodically reactivate under permissive conditions. During this stage 
HV genomes are maintained in the nucleus as non-integrated closed circular 
episomes, however low frequency chromosomal integration has been observed in 
some HVs (Morissette and Flamand, 2010). During latency, genes involved in lytic 
replication are turned off; instead viral gene expression is limited to a specific subset 
of genes involved in the long-term maintenance of latency. This takes place through 
tight regulation of other viral genes, immune-evasion and periodic viral genome 
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replication and partitioning where necessary. The fact that these latent genomes still 
retain the capacity to undergo productive lytic replication is an important aspect of 
latency that makes it distinct from abortive infections. However reactivation may 
may never result in illness or any detectable symptoms. This occurs when a small 
subset of latently infected cells undergo lytic reactivation resulting in asymptomatic 
shedding of low levels of active viral particles (stimulating an on-going immune 
response) and it is something that has been observed in all 3 Herpesviridae 
subfamilies (Hadinoto et al., 2009; Ling et al., 2003; Tronstein E, 2011). Latency is 
typically described as having 3 phases: establishment, maintenance, and reactivation. 
A fourth distinctive phase occurring between latency and reactivation, termed 
“animation”, has been proposed to describe the key event that causes the transition 
between latency and reactivation (Penkert and Kalejta, 2011). Some of the main 
molecular events corresponding to these stages of latency have been described (even 
if not fully understood). These processes have been best studied in the prototypical 
members of each of the Herpesviridae subfamilies (indicated in Table 1.1). The 
molecular basis of latency in each type of HV is slightly different, although gene 
regulation through remodelling of chromatin appears to be a common feature in 
Herpesviridae (Bloom et al., 2010; Sinclair, 2010; Tempera and Lieberman, 2010). 
Using the prototype as a representative, the following section gives a brief 
description of the molecular basis of latency (establishment, maintenance, animation 
and reactivation) in each Herpesviridae subfamily.  
 
1.2.2.1 Alphaherpesvirinae: HSV-1 
It is believed that HSV-1 enters latency as a consequence of IE genes not being 
expressed. These genes are normally activated by the viral trans-activator VP16. Its 
presence does not rely on any initial viral gene expression as it is a component of the 
tegument layer (O’Hare and Goding, 1988; Stern et al., 1989). Activation of IE genes 
requires the entry of VP16 into the nucleus and is facilitated by the host protein HCF 
(La Boissiere et al., 1999). However, in neurons, HCF is sequestered in the 
cytoplasm due to association with the protein Zhangfei which is selectively 
expressed in neurons (Akhova et al., 2005). As a result, VP16 is prevented from 
entering the nucleus in neurons, HSV-1 IE genes are not activated and latency is 
established. As HSV-1 establishes latency in non-dividing cells, it does not need to 
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undergo genome replication or partitioning. Transcription during latency is almost 
exclusively limited to a no non-coding transcript called LAT which is responsible for 
the maintenance of latent infections (Stroop et al., 1984). This transcript has been 
associated with cell survival through the blocking of apoptosis (Perng et al., 2000). It 
also functions as a primary microRNA (pri-miRNA) giving rise to several mature 
microRNAs (miRNAs)  one of which silences spurious expression of the IE gene 
ICP0  (Umbach and Cullen, 2010). In vivo, latency may also be maintained through 
extra-cellular factors such as CD8+ T-cell mediated inhibition of HSV-1 reactivation. 
CD8+ T-cells surround latently infected neurons and release of cytotoxic granuales 
into these cells. These granales contain several proteases, one of which, granzyme B 
(GrB), can directly cleave the HSV-1 IE protein IPC4 which is essential for initiation 
of the lytic stage. In vivo experiments suggest that VP16 is implicated in both 
animation and reactivation phases and that this process is triggered by cellular stress. 
However, the cellular changes that occur to facilitate VP16 transcription and 
(presumably) disassociation of HCF from Zhangfei are unknown (Thompson et al., 
2009). 
 
1.2.2.2 Betaherpesvirinae: HCMV 
HCMV latency is established following repression of the major immediate-early 
enhancer-promoter (MIEP) by the host cell proteins Daxx and HDACs coupled with 
an enigmatic DAC-independent mechanism, which together create and maintain a 
transcriptionally repressive chromatin structure on the HCMV genome (Saffert et al., 
2010; Woodhall et al., 2006). In the establishment of lytic infections, this intrinsic 
cellular defense mechanism mediated by Daxx, is normally overcome by HCMV 
tegument-derived IE gene trans-activator phosphoprotein-71 (pp71) (Hofmann et al., 
2002; Saffert and Kalejta, 2006). However, during latency this process is inhibited by 
Natural Killer (NK) cells which introduce granzyme-M (GrM) into infected cells (in 
a similar manner to the role of CD8+ T-cells during HSV-1 infections, see Section 
1.2.2.1). Once introduced to infected cells, GrM directly cleaves pp71 after Leu439, 
thus this process is likley to facilite both establishment and maintenance of latency 
(Domselaar et al., 2010). The maintenance of latency is aided by immunosuppression 
through the expression of a HCMV-encoded functional homologue of the cytokine 
interleukin-10 (IL-10) (Jenkins et al., 2008). This acts to down-regulate 
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Although it has been shown that this can aid the establishment and maintenance of 
latency, it is not essential (Cheung et al., 2009). Also, it is not known if latently 
infected cells divide, thus it is unclear if latent HCMV undergoes genome replication 
or if partitioning is required during latency. It has been suggested that miRNAs may 
be also involved in the maintenance of latency, but so far HCMV miRNA expression 
has only been investigated during lytic infections (Meshesha et al., 2012). 
Reactivation is known to be dependent on cellular differentiation (Hertel et al., 2003; 
Söderberg-Nauclér et al., 2001) and although the underlying molecular events 
corresponding to this are unknown, both animation and reactivation phases may take 
place as a result of the cessation of pp71 cleavage by GrM (Domselaar et al., 2010) 
allowing pp71 to counteract the effects of Daxx. However, studies have been unable 
to detect de novo expression of pp71 prior to IE gene expression during reactivation 
(Reeves and Sinclair, 2010).   
 
1.2.2.3 Gammaherpesvirinae: EBV 
Here, and unlike HSV-1 and HCMV, where inhibition of IE gene expression is a key 
element in the establishment of latent infections, the expression of IE genes is 
actually required for the establishment of EBV latency. Latency is the default fate of 
EBV upon infection of primary B lymphocytes, transforming them into proliferating 
immortalized lymphoblastoid cell lines (LCLs) (Speck and Ganem, 2010). As with 
HSV-1 and HCMV, viral IE expression may be initiated by EBV tegument proteins 
(although in the case of HSV-1 and HCMV it is for the purposes of establishing lytic 
infections). The EBV tegument protein BNRF1 has been shown to disrupt repressive 
Daxx-mediated chromatin remodeling on the EBV genome allowing expression of 
the IE genes required for the establishment of latency (Tsai et al., 2011). Up to 11 
gene products contribute to this transformation process. In particular, 2 EBV genes 
BALF1 and BHRF1 (both viral homologues of a human anti-apoptotic gene B-cell 
lymphoma-2), have been shown to be vital to the initiation of this process, although 
they are not involved in long-term maintenance (Altmann and Hammerschmidt, 
2005). Z protein, a product of the IE gene BZLF1 (and a homologue of human AP-1) 
has been directly implicated in the proliferation of host cells (Kalla et al., 2010) 
(although it is not apparent how Z avoids repression by cellular protein Zeb at this 
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stage). As latently infected cells proliferate, DNA replication and partitioning is 
required during EBV latency. Both of these processes are mediated by the EBV 
protein EBNA-1 (Sears et al., 2004). Non-coding RNAs also play a role in 
maintaining latency. For example miRNAs from the 3’ UTR of the BHRF1 locus 
have been shown to inhibit apoptosis and promote cell proliferation (Seto et al., 
2010). EBERs allow latently infected cells to be resistant to PKR-mediated apoptosis 
(Iwakiri and Takada, 2010) and miRNAs derived from the BART transcript are 
involved in regulation of EBV Latent membrane Protein-1 (LMP-1) expression 
which itself is implicated in inducing cell growth (Lo et al., 2007). EBV lytic 
reactivation occurs when memory B cells differentiate into plasma cells as a result of 
immunogenic stimulation (Amon and Farrell, 2005; Laichalk and Thorley-Lawson, 
2005). At a molecular level, EBV genome methylation and host cell factors appear to 
be two key elements in the transition from latent to lytic EBV infections. During 
latency, the EBV genome becomes extensively methylated (Kalla et al., 2010), with 
the exception of loci involved in latency (Chau and Lieberman, 2004). Despite the 
fact that loci associated with lytic reactivation become methylated, they can still be 
activated by the EBV protein Z, which preferentially activates methylated loci 
(Bhende et al., 2004; Kalla et al., 2010). However, in order for this to occur it 
requires the down-regulation of Zeb, a cellular repressor of the Z-protein (Kraus et 
al., 2003; Yu et al., 2007). It has been postulated that this down-regulation of Zeb 
happens during memory B cell differentiation (Penkert and Kalejta, 2011) and is the 
animation step required for reactivation of a lytic infection.   
 
1.3 Herpesviruses that infect fish  
Members of the Alloherpesviridae family infect fish and amphibians. Currently, 
there are 14 known members of the Alloherpesviridae family that infect fish. The 
majority of known fish HVs have been identified in economically important fish 
species such as salmon, carp, catfish, sturgeon, eel and cod (Table 1.2). Some of 
these can be highly pathogenic e.g. CyHV-3 (Pokorova et al., 2005) and IcHV-1 
(Wolf and Darlington, 1971) although others are less pathogenic (depending on host 
age) causing tumour-like proliferations e.g. CyHV-1 (Sano et al., 1991). A 
phylogenetic comparison of these fish HVs using full-length terminase gene 
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sequences suggested the existence of two separate clades within the 
Alloherpesviridae family (Waltzek et al., 2009). On the basis of phylogenetic 
similarity, ten of these HVs that infect fish have been tentatively assigned to three 
distinct genera Cyprinivirus, Ictalurivirus and Salmonivirus (ICTV, 2013). Details of 
the fourteen Alloherpesviridae that infect fish, their clades, genera, hosts and effects 
are given in Table 1.2. In addition to these HVs, electron microscopy of diseased fish 
tissues has resulted in the identification of many more viruses that have been 
tentatively described as HVs. This is mainly on the basis of HV-like morphological 
features and such viruses need to be further characterized before being classified as 
members of the Alloherpesviridae family (Hanson et al (2011). 
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Table 1.2 List of known HVs that infect fish 
Table adapted from Hanson et al (2011) 
 
Virus name Clade  Genus Alternative 
name(s) Host(s) Disease 
Anguillid 
herpesvirus 1 
(AngHV-1)* 
1 Cyprinivirus HV anguillae (HVA) 
Japanese eel  
(Anguilla japonica), 
European eel 
(Anguilla Anguilla) 
Hemorrhages of skin, fins, 
gills, liver 
Cyprinid 
herpesvirus 1 
(CyHV-1) 
1 Cyprinivirus 
HV cyprini, 
carp pox HV, 
carp HV (CHV) 
Common 
carp (Cyprinus 
carpio carpio), Koi 
(C. Caroio koi) 
High losses in fry- 
exopthalmia hemorrhages, 
survivors have papillomas 
Cyprinid 
herpesvirus 2 
(CyHV-2) 
1 Cyprinivirus 
Goldfish 
hematopoietic 
necrosis virus 
(GFHNV) 
Goldfish (Carassius 
auratus) 
High mortality all ages. 
Necrosis of hematopoietic 
tissue, spleen, pancreas, 
intestine 
Cyprinid 
herpesvirus 3 
(CyHV-3) 
1 Cyprinivirus 
Koi HV (KHV), 
carp nephritis 
and gill 
necrosis virus 
(CNGV) 
Common carp (C. 
carpio carpio), Koi 
(C. Caroio koi) 
Gill inflammation, 
hyperplasia, and necrosis, 
hematopoietic tissue 
necrosis, high mortality,18–
26 °C, all ages 
Ictalurid 
herpesvirus 1 
(IcHV-1) 
2 Ictalurivirus 
Channel 
catfish virus 
(CCV), 
Channel 
catfish 
herpesvirus 
Channel 
catfish (Ictalurus 
punctatus) 
Kidney, liver and intestinal 
necrosis, hemorrhages, 
high mortality in young fish 
at above 27 °C 
Ictalurid 
herpesvirus 2 
(IcHV-2) 
2 Ictalurivirus Ictalurus melas HV (IcmHV) 
Black 
bullhead (Ameiurus 
melas) 
Kidney necrosis, 
hemorrhages, high mortality 
all ages 
Acipenserid 
herpesvirus 1 
(AciHV-1) 
2 Not Assigned White sturgeon HV 1 
White 
sturgeon (Acipenser 
transmontanus) 
diffuse dermatitis, high 
losses in juveniles 
Acipenserid 
herpesvirus 2 
(AciHV-2) 
2 Ictalurivirus White sturgeon HV 2 White sturgeon  Epithelial hyperplasia 
Salmonid 
herpesvirus 1 
(SalHV-1) 
2 Salmonivirus 
HV salmonis 
(HPV) 
Steelhead 
herpesvirus 
(SHV) 
Rainbow 
trout (Oncorhynchus 
mykiss) 
Mild disease low losses at 
10 °C. Adults- Virus 
shedding in ovarian fluid. 
No signs of disease. 
Salmonid 
herpesvirus 2 
(SalHV-2) 
2 Salmonivirus 
Oncorhynchus 
masou virus 
(OMV) 
Cherry salmon (O. 
masou), Coho 
salmon (O. kisutch), 
Sockeye salmon (O. 
nerka), chum 
salmon (O. keta), 
rainbow trout, 
Viremia, external 
hemorrhages expthalmia, 
hepatic necrosis with high 
losses in young. Survivors 
oral papillomas, virus shed 
in ovaran fluid 
Salmonid 
herpesvirus 3 
(SalHV-3) 
2 Salmonivirus 
Epizootic 
epitheliotropic 
disease virus 
(EEDV) 
Lake 
trout (Salvelinus 
namaycush), lake 
trout × brook 
trout (S. 
fontinalis) hybrids 
Epithelial hyperplasia, 
hypertrophy, hemorrhages 
on eye and jaw. High losses 
in juveniles at 6–15 °C 
Gadid herpesvirus 
1 (GaHV-1) 
Not 
Assigned 
Not Assigned Atlantic cod 
herpesvirus 
(ACHV) 
Atlantic cod (Gadus 
morhua) 
Hypertophy of cells in gills. 
High losses in adults. 
Pilchard 
herpesvirus 
Not 
Assigned 
Not Assigned 
  
Australian 
pilchard (Sardinops 
sagax) 
Acute losses with gill 
inflammation, epithelial 
hyperplasia and 
hypertrophy 
Percid herpesvirus 
1 (PeHV-1) 
Not 
Assigned 
Not Assigned HV vitreum, 
walleye HV 
Walleye (Stizostedio
n vitreum) 
diffuse epidermal 
hyperplasia 
*Genus classification for AngHV-1 updated from Hanson et al  (2011) based on data from van 
Beurden et al (2012; 2010) 
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Members of the Alloherpesviridae family are only distantly related to those of the 
Herpesviridae family. In fact there is only one gene (terminase, involved in genome 
packaging) that is convincingly conserved among all known members of the order 
Herpesvirales (Davison, 2002; Roizmann, 2001). As more complete genomes 
become available for members of the Alloherpesviridae family, it has become ever 
more apparent that it represents a much more divergent family when compared to the 
Herpesviridae. In the Herpesviridae family there are 43 genes conserved among all 
members. These genes are referred to as core genes and are essential to the 
fundamental biological processes of these HVs (Davison et al., 2002). By contrast, 
only 12 core genes have been identified as being in some way conserved among 
members of the Alloherpesviridae family (Davison et al., 2012). Yet, remarkably 
HVs from both the Herpesviridae and Alloherpesviridae families share the same 
distinctive structural, biological and biochemical characteristics described in Section 
1.1 (Hanson et al., 2011). All fish HVs have virons that are morphologically similar 
(in terms of capsid architecture, the presence of a tegument and virion envelope) to 
that of Herpesviridae. The use of mass spectrometry to catalogue the structural 
proteins present in mature virons of IcHV-1 (Davison and Davison, 1995), CyHV-3 
(Michel et al., 2010b) and AngHV-1 (Van Beurden et al., 2011) have revealed that 
the  types of structural proteins present in Alloherpesviridae virons are similar to 
those of the Herpesviridae. The complete genomes of five fish HVs have been 
sequenced: these include IcHV-1 (Davison, 1992), CyHV-3 (Aoki et al., 2007), 
AngHV-1 (Van Beurden et al., 2010), CyHV-1 and CyHV-2 (Davison et al., 2012). 
All of these viruses have genome structures that are the same as Herpesviridae Type 
A, consisting of 1 unique region flanked by direct terminal repeats.  However, as 
with members of the Herpesviridae family, not all members of the Alloherpesviridae 
family have the same genomic structure. Although not fully sequenced yet, the 
genome structure of SalHV-1 is different, but does resemble a Herpesviridae-type D 
structure (Davison, 1998), consisting of two unique regions (one long and one short) 
with the short unique region flanked by inverted repeats (Figure 1.3). 
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Figure 1.3 Herpesvirus genome structures Types A and D 
Type A consists of 1 unique region (U) flanked by direct terminal repeats (TR). Type D consists of 
two unique regions, one long (UL) and one short (US) where the short unique region is flanked by two 
inverted repeat regions, one internal (IR) and one terminal (TR)  
 
For members of the Herpesviridae family, gene expression takes place in a temporal 
fashion during productive infections. To date, the gene expression kinetics of 3 
members of the Alloherpesviridae family have been investigated, these include 
IcHV-1 (Huang and Hanson, 1998; Stingley and Gray, 2000), CyHV-3 (Ilouze et al., 
2012a) and AngHV-1 (Van Beurden et al., 2013). These studies have all shown that 
gene expression in these viruses follows a similar temporal expression pattern. Like 
all HVs, members of the Alloherpesviridae family have been shown to establish 
latent (or at least latent-like) infections. The exact molecular basis of this has not 
been thoroughly investigated for any member of this family. Preliminary molecular 
characterisation of latency has involved the detection of viral DNA in healthy 
survivors of viral challenge. This has been demonstrated with CyHV-3 (Eide et al., 
2011b; Gilad et al., 2004) IcHV-1 (Boyle and Blackwell, 1991; Gray et al., 1999) 
and CyHV-1 (Sano et al., 1993). In addition, viral reactivation has been convincingly 
demonstrated in the case CyHV-3 (St-Hilaire et al., 2005).    
 
Unlike HVs of homeothermic hosts (i.e. mammals and birds) HVs infecting 
poikilothermic hosts (i.e. fish) experience radical temperature changes. Temperature 
fluctuation can cause significant changes in host fish for many reasons e.g. natural 
adaptive response to seasonal change, physiological stress in response to unseasonal 
temperatures (either too low or too high). As described in section 1.2.2 the viral-host 
interaction is an important factor that dictates the lifecycle of HVs. Changes in host 
cells or to host systems that interact with them may have important consequences 
with respect to viral life cycle. Viruses with narrow host ranges like HVs are highly 
evolved to live with their hosts. If hosts are pre-disposed to being affected by 
temperature changes encountered in their natural habitats, it is likely that HVs 
TR TR 
IR TR 
U 
UL US 
Type A 
Type D 
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infecting them will have life cycles that respond to this also. On this note, rather 
unsurprisingly, temperature is an important factor in the pathogenicity of these HVs. 
Some members of the Alloherpesviridae will only cause mortality at relatively warm 
temperatures, such as CyHV-3 which has a permissive water temperature range of 
16-28°C  (Gilad et al., 2003) and IcHV1 which has a slightly higher temperature 
range of 25-33 °C (Wolf and Darlington, 1971). By comparison, disease associated 
with other Alloherpesviridae members occurs at much lower temperatures e.g. 
SalHV-1 (5-10 °C) (Wolf et al., 1978) and CyHV1 (<15°C) (Roberts, 2011). Outside 
of these permissive temperature ranges, some of these viruses have been shown to 
persist by establishing latent infections, which subsequently reactivate when 
permissive temperatures are encountered again. This kind of response to temperature 
is something that has been best studied in CyHV3 (Gilad et al., 2004; St-Hilaire et 
al., 2005),  although work into the underlying molecular  processes involved is still in 
its infancy (Section 1.4.10.2) 
 
1.4 Cyprinid herpesvirus 3 (CyHV-3)  
Cyprinid herpesvirus 3 (CyHV-3) is a highly contagious virus that causes acute mass 
mortalities in populations of common carp (Cyprinus carpio carpio) and ornamental 
koi (Cyprinus carpio koi). The virus is also commonly referred to as Koi Herpesvirus 
(KHV) and for a period of time it was referred to as carp interstitial nephritis and gill 
necrosis virus (CNGV) in publications from certain research groups (Pikarsky et al., 
2004; Ronen et al., 2003). During a typical outbreak, mortality rates among affected 
fish populations are usually over 80% (Haenen et al., 2004; Hedrick et al., 2000; 
Ilouze et al., 2006; Perelberg et al., 2003). Described by R.P. Hendrick as “the worst 
and most rapidly spreading” fish virus he had ever encountered, CyHV-3 is now 
recognized as a significant problem for both the common carp and koi culture 
industries (Pearson, 2004).  
1.4.1 Discovery, spread and current global distribution 
The first confirmed outbreaks of CyHV-3 occurred in 1998. The first of these began 
in May of that year on several carp farms in north-western Israel. This was followed 
by a separate outbreak three months later in an ornamental koi retail facility in 
eastern USA. In both cases, fish of all ages were affected in water temperatures of 
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22-23°C and the same causative agent (morphologically similar to HVs) was isolated 
from infected tissue samples from both locations (Hedrick et al., 2000). The vast 
geographical distance between the locations of these two principle outbreaks 
suggested that the virus had already spread to many more regions prior to its initial 
description by Hedrick et al. (2000). Indeed, retrospective analysis of archived 
samples suggested that the same virus may have been encountered in the UK as far 
back as 1996 (Haenen et al., 2004; Walster, 1999; Way, 2008; Way et al., 2004a) and 
in Germany in 1997 (Bretzinger et al., 1999).  
 
By 2001, CyHV-3 outbreaks were reported in 90% of carp farms in Israel (Perelberg 
et al., 2003). Since these initial epizootics, additional outbreaks of the virus have 
been confirmed worldwide (Pokorova et al., 2005). The fast global spread of CyHV-
3 is more than likely heavily connected with the worldwide fish trade, specifically 
the unregulated transport and trading of koi (Pokorova et al., 2005; Way, 2012; 
Whittington and Chong, 2007). As of 2012, CyHV-3 outbreaks have been confirmed 
in 28 countries (see Table 1.3). It is possible that outbreaks have occurred in many 
more regions but remain unreported or undetected. Two isolated cases of CyHV-3 
infections have been confirmed in the Republic of Ireland. The first occurred in 
imported koi, and was restricted to a single domestic pond. The second was 
identified through a routine health inspection on a consignment of imported koi by 
the resident border inspection patrol (McCleary et al., 2011). In both cases, all fish 
associated with these batches were culled and the virus was contained. Effective 
management of these two cases ensured that no outbreak occurred. As a result, the 
Republic of Ireland retains a CyHV-3 free status and as such is not listed in Table 
1.3. 
 
Apart from Israel, some of the most severe outbreaks to date have occurred in Japan 
and Indonesia (Bondad-Reantaso et al., 2007; Lio-Po, 2011; Sano et al., 2004; Way, 
2008). The spread of CyHV-3 has had major economic impact with devastating 
losses reported in both intensive and extensive carp and koi culture facilities. 
However cases have not been confined to aquaculture, with many outbreaks also 
reported in wild populations (Denham, 2003; Garver et al., 2010; Grimmett et al., 
2006; Kempter and Bergmann, 2007; Uchii et al., 2009) and fisheries (Taylor et al., 
2010; Way, 2008). The emergence of CyHV-3 is an important issue for cyprinid 
  17
aquaculture. Consequently, the World Organisation for Animal Health or Office 
International des Epizooties (OIE), as it is more commonly refferred to as, has listed 
CyHV-3 as a notifiable disease and outbreaks must be reported to this organisation. 
Within the European Union, CyHV-3 is now listed as a non-exotic disease. Under the 
Aquatic Animal Health Directive (2006/88/EC) each EU member state is required to 
follow the appropriate diagnostic methods and ensure appropriate controls are in 
place to minimise the spread of CyHV-3 to, or within their respective jurisdictions. If 
the disease status of a country is unknown, extensive surveillance programs must be 
implemented before it can be declared free of CyHV-3. As of yet there are no 
vaccines approved for use within the EU. Currently, attempts to monitor for CyHV-3 
involve the use of several highly sensitive and robust PCR (Bercovier et al., 2005; 
Gilad et al., 2004) and serological-based diagnostic techniques (Adkison et al., 2005) 
in order to confirm the presence of KHV during or after high-mortality outbreak, 
allowing appropriate action to be taken. 
 
Table 1.3 List of countries with confirmed CyHV-3 outbreaks 
Based on a combination of information available in Pokorova et al. (2005) and Way  (2012) 
 
Europe Asia America Africa 
Austria Indonesia USA South Africa 
Belgium Israel Canada   
Denmark Japan     
England Taiwan     
France Thailand     
Germany China     
Italy South Korea     
Luxemburg Malaysia     
The Netherlands Singapore     
Switzerland       
Poland       
Czech Republic       
Romania       
Slovenia       
Spain       
Sweden       
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1.4.2 Hosts 
 
1.4.2.1 Susceptible fish species and economic impact 
CyHV-3 primarily causes acute mass mortality among common carp and koi. These 
are two very economically important fish species. The popular hobby of keeping and 
trading high value ornamental koi represents a significant portion of a global 
ornamental fish industry (Balon, 1995; David et al., 2004), which is itself estimated 
to be indirectly worth around US$15 billion (fao.org, 2013a). Common carp 
(Cyprinus carpio carpio) is one of the most widely cultivated fish species for human 
consumption, with an estimated 3.4 million metric tonnes being produced annually. 
As of 2010, this industry was valued at over US$4.5 billion (fao.org, 2010). As of 
2002, common carp represented nearly 14% of global fresh water aquaculture output, 
with most (~70%) production occurring in China (fao.org, 2013b). In many Asian 
regions, farmed carp represents an important source of protein for many low-income 
families. Carp aquaculture provides both direct and indirect employment in the same 
regions. As with other farmed fish species, threats to the long-term feasibility of carp 
aquaculture are becoming ever more relevant in the context of global food security 
(Liao and Chao, 2009). 
 
Ghost carp (hybrids of common carp and koi) are also susceptible to the disease. 
Hybrids of common carp and koi with non-susceptible cyprinid species have shown 
mixed results in terms of resistance. Goldfish-koi hybrids show reduced mortality 
rates (35-42%) compared to crucian carp (Carassius carassius)-koi hybrids (100%) 
(Bergmann et al., 2010). Furthermore, Goldfish (Carassius auratus )-common carp 
hybrids were shown to be quite resistant to CyHV-3 infection with mortality rates of 
~5% under permissive conditions. PCR showed that ~50% of them remained positive 
for CyHV-3 DNA for up to 25 days following infection, however it is not clear if 
viral replication was occurring in these survivors (Hedrick et al., 2006). 
 
1.4.2.2 Vector Species  
It is possible that other aquatic species, that are not susceptible to CyHV-3, play 
important roles in transmission. 
 
  19
1.4.2.2.1 Fish vector species 
Goldfish co-habited with CyHV-3 infected koi have been shown to be resistant to the 
virus yet test positive for CyHV-3 DNA (Sadler et al., 2008). In addition to goldfish, 
CyHV-3 DNA has also been detected in other cyprinid species such as ide (Leuciscus 
idus) and grass carp (Ctenopharyngodon idella) (Bergmann et al., 2009) and non-
cyprinid species such as ornamental catfish (Ancistrus sp.) (Bergmann et al., 2009), 
Russian sturgeon (Acipenser gueldenstaedtii) and Atlantic sturgeon (A. oxyrinchus) 
(Kempter et al., 2009). In addition the transmission of CyHV-3 to naïve carp 
(without the development of disease) from several wild species (gudgeon, pike, rudd, 
ruffe, and tench) previously co-habited with suspected latently infected carp has been 
observed (Fabian et al., 2013). 
 
1.4.2.2.2 Invertebrate vector species 
It is known that filter feeding aquatic invertebrates can accumulate bacterial and viral 
particles without suffering any adverse effects. In some cases viral particles 
accumulated in this way remain infectious for long periods e.g. norovirus in oysters 
(Lowther et al., 2008). CyHV-3 DNA has been detected in swan mussels, (Anodonta 
cygnea) in Poland (Kielpinski et al., 2010) and in lake plankton, specifically Rotifera 
sp. in Japan (Minamoto et al., 2011). Both of these observations suggest that natural 
mechanisms exist within habitats that may result in the concentration of virus before 
contact with carp or koi. It is unclear how concentration of the virus in these vector 
species affects the stability of viral particles outside the host, how long they remain 
infective or if vector species facilitate viral replication.  
 
1.4.3 Clinical signs and mortality   
During a typical outbreak, morbidity among infected populations is usually ~100%. 
Clinically infected fish exhibit general lethargy and appetite loss. At later stages fish 
may also show loss of equilibrium. One of the principal external signs of clinical 
infection is swollen, pale or patchy gills showing severe necrotic damage. Other 
variable non-specific external signs can include skin lesions, mucus hypersecretion, 
enophthalmia (sunken eyes), hyperemia (increased blood flow to specific tissues), 
hemorrhaging of the epidermis and fins and fin erosion. Examples of these are 
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displayed in Figure 1.4. Internally, severe nephritis can be one of the most prominent 
internal pathological changes. Organs such as liver, spleen, gastro-intestinal tract 
show necrosis, numerous microscopic lesions and other forms of histopathological 
damage (Figure 1.5) thus demonstrating the systemic nature of CyHV-3 infection 
(Hedrick et al., 2005, 2000; Miyazaki et al., 2008a; Walster, 1999). The course of 
disease is quite rapid and mortality can occur in as little as 7-12 days following 
exposure under ideal conditions (Pikarsky et al., 2004). Under such optimum 
conditions mortality rates are usually >80% and 100% mortality is not uncommon 
(Haenen et al., 2004; Hedrick et al., 2000; Ilouze et al., 2006; Perelberg et al., 2003). 
 
 
 
  
 
 
 
  
 
 
 
Figure 1.4 Examples of some common clinical signs associated with disease caused by CyHV-3 
(a) Gills displaying varying degrees of necrosis Lio-Po (2011), (b) hyperemia occurring at the base of 
the caudal fin from Michel et al. (2010a) (c) widespread epidermal hemorrhageing from Garver et al 
(2010), (d) herpetic lesions and erosion of fins Michel et al. (2010a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
(b) 
(c) 
(d) 
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Figure 1.5 Examples of visible pathology from microscopic lesions  
(a) Hyperplasia in gill, (b) nuclei with intranuclear inclusions in kidney, (c) nuclei with intranuclear 
inclusions in branchial epithelium, (d) chromatin margination of spleen stromal cell. Images are from 
Hedrick et al. (2000). 
 
1.4.4 Factors in the emergence of disease  
The disease caused by CyHV-3 (mostly referred to as KHV-disease or KHVD) is 
highly virulent and contagious, resulting in acute mass mortality amongst the host 
species. Despite its virulence, high mortality outbreaks can only occur within a 
permissive water temperature range of 16-28oC with an optimum range of 22-25oC 
(Gilad et al., 2004, 2003; Hedrick et al., 2000; Perelberg et al., 2003; St-Hilaire et al., 
2005; Way, 2007). As a result, in some climates clinical signs of the disease and 
mass mortality only occur in spring and summer. This also coincides with the time of 
year when fish gather for spawning, which occurs when water temperatures reach 17-
18°C (fao.org, 2013b). Outside the permissive temperature, symptoms appear to 
subside and mortality decreases. Despite this, viral DNA can still be detected while 
fish are kept at low temperatures (Gilad et al., 2004; St-Hilaire et al., 2005). 
Furthermore, clinical signs and mortality can resume once fish are exposed to 
permissive temperatures again (St-Hilaire et al., 2005). CyHV-3 can cause disease in 
both juvenile and adult fish (Bretzinger et al., 1999; Hedrick et al., 2000; Sano et al., 
2004; Terhune et al., 2004). Carp have been shown to remain unaffected while at the 
larval sage (Ito et al., 2007). However, they do become susceptible once they mature 
past this stage to become fry. In fact, co-habitation studies have shown that at this 
stage (fry: 1-3 months, 2.5-6 g) carp are more susceptible to disease caused by 
CyHV-3 than any other stage of their development (Perelberg et al., 2003). Other 
(a) 
(b) 
(c) 
(d) 
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factors such as population density and stress (due to infections with other pathogens, 
poor water quality, transport etc.) may also contribute towards the development of 
disease associated with CyHV-3.   
 
1.4.5 Transmission 
The main mode of transmission is horizontal with virulent virus being shed from 
infected fish, through faeces, urine and gill and skin mucous (Pokorova et al., 2005). 
Fish become infected through encountering waterborne virus or though direct 
physical contact with infected fish. Virus shed via faeces is more likely to 
accumulate in the sediment. Plankton vectors that concentrate virus may also settle in 
the sediment when they become inactive or die. This accumulation of virus in the 
sediment can result in there being up to 1000 times more viral load in the sediment 
when compared to water in the same location (Honjo et al., 2012) and may result in 
fish becoming infected while stirring or burrowing in the sediment as part of their 
normal feeding behaviour. Also, the indiscriminate filter feeding mechanisms of 
bivalves (e.g. swan muscles) may concentrate both viral particles and plankton 
vectors themselves (Minamoto et al., 2011). Thus carp may become infected through 
feeding on such vector species.  
 
Virus shed into water remains infective in water for at least 4 hours at permissive 
temperatures of 22-25°C, explaining the highly contagious nature of the disease 
(Perelberg et al., 2003). At lower temperatures of 15°C, viral infectivity can persist in 
river water for three days and for at least seven days in sterile river water. This 
suggests that the local microbial ecosystem has an effect on viral stability and 
transmission (Shimizu et al., 2006). It is also possible that other factors may act to 
keep the virus stable in the environment. Active viral particles may be preserved in 
faeces for long periods of time (Dishon et al., 2005) meaning that it is plausible that 
faecal-borne viral particles that have accumulated in sediment are preserved for long 
periods after outbreaks during non-permissive temperatures. The extent to which 
virus that has accumulated in sediment or bivalve vectors contributes to overall 
transmission has not been established. It is likely that most transmission occurs 
through direct contact with infected fish or water-borne virus. No cases of vertical 
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transmission from infected parents to eggs have been observed but such events 
cannot be ruled out.  
 
Transmission of CyHV-3 from clinically infected fish during outbreaks may not be 
the only way in which the virus is spread. In one case, viral DNA was detected in a 
Japanese river up to 4 months prior to an outbreak while temperatures (9-11°C) were 
far too low for the virus to cause disease (Haramoto et al., 2007), however the 
infectivity of the virus detected is unknown. The presence of viral DNA in river 
water long before an outbreak during non-permissive temperatures may occur as a 
result of the virus being shed by other fish vector species (Section 1.4.2.2 ) or by 
latently infected carp that may periodically shed low levels of virus, as is 
characteristic of latency with other HVs (Section 1.2.2). From studies of carp 
populations in Japan, researchers have suggested that the presence of anti-CyHV-3 
antibody in healthy carp long after disease outbreaks (Uchii et al., 2009), may be 
caused by such periodic low-level reactivation of latent virus continuously boosting 
the animal’s immune response. This may also result in these fish acting as reservoirs 
for infectious virus particles at low non-permissive temperatures (<16°C) without 
developing disease themselves. At such temperatures, naive carp that subsequently 
become infected would not immediately develop disease either.  
 
The same study by Uchii et al. (2009) also provided an interesting insight into factors 
affecting the transmission and persistence of CyHV-3 in the wild. In this study, the 
authors investigated the distribution of CyHV-3 among wild carp populations in a 
Japanese lake two years after a high mortality CyHV-3 outbreak (two sporadic low 
level mortality outbreaks had occurred in the two intervening years). It was found 
that CyHV-3 DNA could be detected in only 6% of small fish (300 mm) but at 31% 
of fish greater than 300 mm. Also, a significant number of carp tested positive for 
antibodies to CyHV-3. Of these antibody-positive fish, 45% tested negative for viral 
DNA by PCR suggesting that viral load was reduced beyond the limit of detection 
for the assay used. Furthermore, 11% of fish (one of which was <300 mm) tested 
positive by PCR but showed no sign of antibodies. This suggested that it was not 
long since these fish were infected as it had previously been shown in carp that the 
antibody response to CyHV-3 only begins to rise to detectable levels after 14 days 
following exposure, reaching a peak at 21 days after which it plateaus for at least a 
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year (Adkison et al., 2005). In summary, fish greater than 300 mm were more likely 
to be: (i) infected (possibly latently) on the basis of testing positive for CyHV-3 
DNA and anti-CyHV-3 antibody and (ii) recently infected on the basis of testing 
positive for CyHV-3 DNA and negative for anti-CyHV-3 antibody. A possible 
reason for greater prevalence among fish larger than 300 mm and in particular among 
fish greater than 400 mm (which accounted for 69% of those positive for anti-CyHV-
3 antibody) may be because of spawning activity. Carp first start to spawn at a size of 
~360 mm. this suggests that, in the wild, it is generally sexually mature carp that are 
more likely to become infected because of more frequent interactions with a high 
number of other individuals. 
 
1.4.6 Viral entry and replication 
The virus may enter its host through many routes. Early studies suggested that gills 
may be the initial point of entry into the hosts (Gilad et al., 2004; Miyazaki et al., 
2008a; Pikarsky et al., 2004). This was based on a the high levels of CyHV-3 found 
in gills at the early stages of infection and the fact that the disease is mainly 
characterised by the presence of gill lesions and gill necrosis. However later studies 
showed that the virus can easily enter hosts via the skin and that this may indeed be 
the predominant portal of entry and that the virus can also replicate in the skin 
(Costes et al., 2009). Paradoxically, further studies showed that the epidermal mucus 
layer prevents viral entry through the skin (Raj et al., 2011) but suggested that 
localized inconsistencies or loss of mucus layers may facilitate viral entry. Recent 
evidence suggests that fish may also become infected following feeding on 
contaminated material via infection of the pharyngeal periodontal mucosa (Fournier 
et al., 2012).  
 
Once in its host cell, electron microscopy has revealed that CyHV-3 replication takes 
place in a similar manner to other HVs and that it involves two distinct envelopments 
(Miwa et al., 2007; Miyazaki et al., 2008a). Viron replication and maturation is 
consistent with the general HV model (described earlier in Section 1.2.1.). Infected 
cells generally show intranuclear inclusion bodies, marginal hyperchromatosis and 
an increase in filamentous nucleoproteins  (Miyazaki et al., 2008a) 
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CyHV-3 can be detected by PCR in various organs (gill, liver, gut, spleen, kidney 
and brain) and mucus as early as one day after initial exposure (Gilad et al., 2004). 
Interestingly, a recent study showed that CyHV-3 replication in the intestine 
upregulates the expression of claudin-2, -3c, -11, and -23 (Syakuri et al., 2013). The 
virus replicates most efficiently in the kidneys where it induces the most prominent 
pathological changes. These changes can be observed in as little as 2 days following 
initial exposure (Pikarsky et al., 2004). The quick systematic spread of the virus 
makes it difficult to resolve a clear picture of the sequential spread from the initial 
sites of infection. The rapid transfer to the kidneys and subsequent localisation of 
CyHV-3 in white blood cells may then allow the virus to quickly spread to other 
organs. Rapid replication in the gills and release into the water may promote the 
transmission of CyHV-3 in a fashion that is analogous to that of mammalian 
respiratory viruses (Ilouze et al., 2011; Pikarsky et al., 2004). It has been suggested 
that the pathological damage sustained to the gill, kidneys and gut during infection 
results in loss of osmoregulatory functions in these organs, ultimately leading to 
death (Gilad et al., 2004). 
 
 
1.4.7 Diagnostic methods  
 
1.4.7.1 Cell culture 
CyHV-3 can replicate in several established cell lines.  Cell lines from host species 
include, koi fin cells (KF-1) (Hedrick et al., 2000), KF-101 (Lin et al., 2013) and 
common carp brain cells (CCB) (Neukirch et al., 1999). Interestingly, CyHV-3 has 
been shown to replicate in cell lines derived from resistant cyprinid species such as 
silver carp (Hypophthalmichthys molitrix) (Tol/FL cells) and Goldfish (Au cells) 
(Davidovich et al., 2007). However, other cell lines derived from common carp have 
been shown to be somewhat restrictive to CyHV-3 growth. Epithelioma papulosum 
cyprinid cells (EPC cells) were initially reported to be resistant to CyHV-3 
(Davidovich et al., 2007). Later the same group reported that CyHV-3 does replicate 
in these cells but that this only occurs three weeks post-inoculation and leads only to 
low titres of virus (their unpublished results; Ilouze et al., 2011). These results 
indicate that CyHV-3 can replicate in host species other than carp and koi and 
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suggest that it is possible for CyHV-3 to infect other cyprinid hosts. Based on the 
restrictiveness of EPCs, additional factors other than the presence of appropriate host 
cell receptors may dictate whether or not CyHV-3 will replicate in specific cells. 
Such additional factors may include the types of innate immune responses in cells. 
While in vitro culture of CyHV-3 on susceptible cell lines presents a useful way to 
study the virus, these methods are not sensitive or reliable enough for routine use in 
screening for or diagnosis of CyHV-3 in fish tissue. In addition, virus cultivation 
cannot be used as a confirmatory method (Haenen et al., 2004; Way, 2012). 
 
1.4.7.2 Antibody detection 
Anti-CyHV-3 antibodies produced by hosts in response to CyHV-3 challenge can be 
detected using an enzyme linked immunosorbent assay (ELISA) developed by 
Adkison et al (2005). As expected, the ability to produce high levels of anti-CyHV-3 
antibodies does result in protection against CyHV-3 infection, especially fish that 
have survived CyHV-3 exposure (Perelberg et al., 2008). This is quite useful as it 
allows the identification of healthy fish that have been exposed to CyHV-3 at some 
point and which have more than likely survived as carriers. Due to insufficient 
knowledge of the immune response in carp (especially in relation to how long anti-
CyHV-3 antibodies remain at detectable levels), it is difficult to definitively evaluate 
the potential usefulness of targeting anti-CyHV-3 antibodies as part of routine 
screening programs for CyHV-3 infection. There is some preliminary data available 
regarding this: for example it has been shown that in 15–50g fish the anti-CyHV-3 
antibody levels remain detectable for 280 days (Perelberg et al., 2008) and in larger 
fish ranging from 100-200g anti-CyHV-3 antibodies were shown to remain at 
detectable levels for at least a year after exposure (Adkison et al., 2005). However, as 
there are many more variables (water temperature, length of time exposed to specific 
temperature, viral titre used etc) that will affect the magnitude and length of immune 
response, it is hard to directly compare results from different controlled experiments. 
The analysis of antibody responses to CyHV-3 in wild populations has also given 
mixed results, but these results suggest that a long-term response is possible. Carp 
tested in fisheries in the UK were still positive for anti-CyHV-3 antibody up to one 
year following large outbreaks (Taylor et al., 2010) and wild carp in Japan have 
tested positive up to two years after outbreaks (Uchii et al., 2009). However, in all 
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cases it is not known if the anti-CyHV-3 antibodies detected are present as a result of 
the initial exposure to CyHV-3 or the result of a later immune response to low level 
CyHV-3 reactivation and shedding. In cases where anti-CyHV-3 antibodies have 
declined beyond detection since initial viral exposure, fish still remain resistant to the 
virus, most likely due to the rapid response of memory B-cells. For this reason the 
absence of detectable antibodies does not mean that fish have not been previously 
exposed or are not harbouring latent virus. In this way, testing for the presence of 
anti-CyHV-3 antibodies might result in false negatives. In addition, due to the 
presence of shared antigens, anti-CyHV-3 antibodies are known to cross-react with 
anti-CyHV-1 antibodies (Adkison et al., 2005) thus potentially leading to false 
positive results.  
 
1.4.7.3 Antigen Detection 
ELISA methods to detect CyHV-3 antigens have also been developed (Dishon et al., 
2005; Pikarsky et al., 2004). These assays may be suitable for detecting of CyHV-3 
during clinical infections when there are high levels of virus but may not be sensitive 
enough to enable screening for carriers in healthy populations (Way, 2012). 
Furthermore, if no viral proteins are expressed during latency (or if protein 
expression is restricted), antigen detection methods would not be suitable.  
 
1.4.7.4 Polymerase Chain reaction (PCR) 
There have been several conventional and real-time PCR methods used to detect 
CyHV-3. The most widely used and sensitive conventional PCR methods include 
those developed by Bercovier et al. (2005) and Yuasa et al (2005). The most widely 
used real-time PCR method is the method developed by Gilad et al. (2004). These 
are the most sensitive methods used to diagnose and confirm CyHV-3 clinical 
infections. Because of their higher sensitivity they are also ideal for screening 
healthy populations for latent carriers.  
 
1.4.7.5 Most reliable method for screening for CyHV-3 carriers 
It appears that assaying for anti-CyHV-3 antibodies or CyHV-3 DNA are the most 
suitable methods for screening healthy fish in order to detect potential latent carriers. 
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However it is not clear which of these approaches is most appropriate. There have 
been cases where anti-CyHV-3 antibodies have been detected in healthy fish in the 
absence of any CyHV-3 DNA (Uchii et al., 2009). Conversely there have been cases 
where CyHV-3 DNA has been detected in the absence of any anti-CyHV-3 
antibodies (Eide et al., 2011b; Uchii et al., 2009). Ideally both tests should be used in 
unison, however the extra advantages offered by PCR in terms of reduced labour, 
higher sensitivity, increased specificity and the ability to verify results with southern 
blotting and/or DNA sequencing has resulted in PCR being the most popular 
approach. It is for these reasons also that PCR it is the method recommended by the 
OIE when screening for CyHV-3 carriers (Way, 2012). 
  
1.4.8 Control 
 
1.4.8.1 Vaccination 
There has been some work done regarding the vaccination of carp against CyHV-3-
related disease. The first approach to this involved creating “ naturally resistant”  fish. 
This was done by first exposing carp to CyHV-3 at a permissive temperature for 3-5 
days and then moving them to a non-permissive temperature at or above 30oC for 30 
days to promote survival. When these fish were subsequently transferred to open-air 
ponds (where water temperatures fell within the permissive temperature range) and 
re-challenged with CyHV-3 the mortality rate was reduced to 39% compared to a 
control group (kept at 22oC and not exposed to the virus) which showed 82% 
mortality. These “ naturally resistant”  fish also showed high levels of anti-CyHV-3 
antibody and remained resistant for periods of at least 6-12 months. In addition the 
fish showed no sign of viral DNA or infectious virus. Despite its simplicity and 
effectiveness, this approach still resulted in ~40% mortality. The high cost 
(especially in cold climates) involved in raising water temperatures to 30oC for long 
periods of time and the fact that it increases the risk of other disease makes this 
approach quite impractical to execute on a routine basis. In addition, there is a 
possibility these fish could become latently infected as a result of the initial exposure 
and that this may reactivate at a later date during permissive temperatures. No latent 
CyHV-3 has not been detected in such fish to date, although this possibility needs to 
be investigated further (Ronen et al., 2003).  
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Other studies have focused on generating live attenuated CyHV-3 strains for the 
purpose of inducing host immunity (Perelberg et al., 2005). In these experiments, it 
was found that if carp were exposed to the attenuated strain (by bathing) and kept at 
a permissive temperature, this resulted in near 100% resistance to subsequent 
challenge with non-attenuated strains. This method of vaccination conferred 
resistance to CyHV-3 for up to 8 months (Perelberg et al., 2008).  Other approaches 
such as oral vaccines have also been developed. These consist of formalin-
inactivated CyHV-3 (at that stage, CyHV-3 antigens) entrapped in liposomes. This 
approach has been shown to work reasonably well resulting in lower mortality rates 
ranging from 23% to 35% (Miyazaki et al., 2008b; Yasumoto et al., 2006). More 
recently, work has also commenced on a DNA vaccine using a CyHV-3 glycoprotein 
to stimulate an immune response. The use of this vaccine has been reported to result 
in a reduced mortality rate of 3.3% (Nuryati et al., 2012).  
 
1.4.8.2 Resistance breeding 
As an alternative way to control CyHV-3, some studies have focused on the selection 
of CyHV-3-resistant carp strains for crossbreeding with CyHV-3-sensitive 
domesticated strains in order to evaluate the resistance of the resulting progeny 
(Shapira et al., 2005; Zak et al., 2007). Interestingly, Shapira et al (2005) found that 
crossing the domesticated strain Dor-70 (D) with a the wild-type Sassan (S) resulted 
in progeny that showed a 60% survival rate when challenged with CyHV-3. Other 
research into genetic factors likely to influence resistance to CyHV-3 include the 
identification of carp SNPs associated with the innate immune response (Kongchum 
et al., 2010) and the identification of different polymorphisms in the carp major 
histocompatibility (MH) class II B gene that are associated with both susceptibility 
and resistance to CyHV-3 (Rakus et al., 2009). 
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1.4.9 Characterisation of CyHV-3 
 
1.4.9.1 Morphology 
Initial investigations of KHV outbreaks revealed a virus with characteristics 
consistent with HVs. Similar morphological characteristics included an inner capsid 
displaying icosahedral symmetry surrounded by a thread-like tegument and an 
additional host derived viral envelope on mature virons, giving an overall diameter of 
170-230nm (Hedrick et al., 2000). Further morphological characterization supported 
these findings and showed the presence of two distinct envelopments (Miwa et al., 
2007) (Figure 1.6) consistent with morphology and replication of other HVs 
(described earlier in Section 1.1 and 1.2.1, respectively). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Electron micrograph of mature CyHV-3 virons in an infected carp cell   
The main features of the mature viron (the core, capsid, tegument and envelope) are indicated in the 
bottom left of the image. An example of a mature viron with a second envelope can be seen in the top 
right corner of the image. This is more than likely to be a cytoplasmic vesicle involved in the transport 
of mature virons to the cell membrane for release. This image was taken from Ilouze et al. (2011) 
 
1.4.9.2 Phylogenetic Analysis 
Early phylogenetic analysis based on limited sequence data showed little evidence 
that CyHV-3 was related to mammalian or avian herpesviruses (HVs). Strangely, 
amino acid sequences for some putative genes showed more similarity to genes from 
other distantly related dsDNA viruses from the Poxviridae, Adenoviridae 
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and Baculoviridae families (Hutoran et al., 2005). Due to a perceived lack of 
compelling phylogenetic evidence to suggest its inclusion as a member of the 
Herpesviridae family, the virus was sometimes just referred to as carp interstitial 
nephritis and gill necrosis virus or CNGV (based on the principal clinical signs) 
rather than Koi herpesvirus (KHV) (as it was more commonly known at the time). 
Subsequently, sequencing of the most phylogenetically relevant genes (terminase 
sub-unit and DNA polymerase) from this virus and other lower vertebrate HVs, 
(particularly CyHV-1 and CyHV-2) allowed more meaningful phylogenetic analyses 
be carried out. This showed that the virus was not closely related to mammalian and 
avian HVs but was more closely related to the other known Cyprinid HVs (CyHV-1 
and CyHV-2) and (albeit much more distantly) to other lower vertebrate viruses such 
as IcHV-1 and ranid HV-1 (RaHV-1) (Waltzek et al., 2005). Thus, the classification 
issue was resolved and it was confirmed that the initial description of the virus by 
Hedrick et al. (2000) as a member of the Herpesviridae family (as it was known then 
before re-structuring, see Section 1.3 for details) was correct, prompting the proposal 
for its inclusion in this family under the formal name CyHV-3 (Waltzek et al., 2005; 
Way et al., 2004b). Subsequent sequencing of the entire CyHV-3 genome (Aoki et 
al., 2007) and other genomes such as CyHV-1, CyHV-2 (Davison et al., 2012) and 
Ang-HV1 (Van Beurden et al., 2010) has since confirmed the initial findings that 
CyHV-1, -2 and -3 are all closely related and in addition that all of them are more 
closely related to AngHV-1 than to any other member of the Alloherpesviridae 
family.  
 
Hutoran et al (2005) originally observed that CyHV-3 contained some genes that 
were more closely related to distantly related dsDNA viruses outside the order 
Herpesvirales. Further analysis of the protein-coding sequences of several genes 
such as ribonucleotide reductase (RNR) thymidine kinase (TK) showed that these 
were more similar to the same genes present in the Poxviridae family (Ilouze et al., 
2006). A thymidylate monophosphate kinase (TmpK) gene encoded by CyHV-3 but 
not found in any other HVs was also most closely related to a TmpK gene found in 
the Poxviridae family. In addition, CyHV-3 was also found to encode a form of 
Serpin (or serine protease inhibitor) that is very similar to B22R which is found 
exclusively in members of the Poxviridae family. It was speculated that the presence 
of these genes in the CyHV-3 genome may be the result of gene acquisition through 
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horizontal gene transfer. It us unclear how thi scould have occurred as both types of 
viruses replicate within different cellular compartments, i.e Poxviruses replicate in 
the cytoplasm and HVs replicate in the nucleus. However, in rare occasions where 
host cells may be co-infected with both types of virus, breakdown of the nuclear 
membrane (during mytosis or due to the effects of viral infecton) may bring these 
different viruses into close contact during replication. These results have also 
prompted speculation that CyHV-3 may be an ancestor of a particularly ancient viral 
family from which several other viral families evolved, including the Herpesvirales 
order and the Poxviridae family (Ilouze et al., 2006). Interestingly, sequencing of the 
genomes for CyHV-1 and CyHV- 2 revealed that of the non-HV genes, TmpK 
(ORF140 in CyHV-3) was found in both these viruses but B22R (ORF139 in CyHV-
3) was not present in CyHV-1 (Davison et al., 2012). 
 
1.4.9.3 Genome and genes 
Sequencing of the CyHV-3 genome also confirmed earlier estimates of the large 
genome size (Hutoran et al., 2005), showing that it was 295 kb in size and therefore 
larger than any other known HV genome (Aoki et al., 2007). This large genome size 
makes CyHV-3 an ideal model for mutagenesis of large DNA viruses and this has 
been demonstrated by Costes et al (2008). The genome contains one unique region 
flanked by direct terminal repeats (each ~22 kb in length), resembling a Type-A 
structure (Section 1.3). Aoki et al (2007) also predicted the existence of 156 protein-
coding genes, which includes 5 gene families (Figure 1.7), all of which have now 
been shown to be transcribed into mRNA (Ilouze et al., 2012a). Of these 156 genes, 
120 have orthologues in CyHV-1 and CyHV-2 and 55 have orthologues in AngHV-
1. In addition, twelve of them (referred to as core genes) are conserved across all 
members of the Alloherpesviridae family (Figure 1.7) (Davison et al., 2012). 
Interestingly all three CyHVs contain telomere-like repeats (based on the element 
TTAGGG). These are located close to the ends of the terminal repeats on the three 
viral genomes. Telomere-like repeats are also present in other HVs such as Mareks 
disease virus (MDV-1) and HHV-6A, HHV-6B and HHV-7 and may be involved in 
the integration of these viral genomes into the telomere regions of host genomes 
(Arbuckle et al., 2010; Kaufer et al., 2011; Morissette and Flamand, 2010). 
 
  33
During lytic replication, CyHV-3 genes are expressed in a coordinated manner 
similar to other herpesviruses (Section 1.2.1). Analysis of CyHV-3 gene expression 
in the early stages of in vitro infections has resulted in the identification of 15 
immediate early (IE) genes, 112 early (E) genes and 22 late (L) genes. Seven of the 
156 ORFs remain unclassified and require additional analysis to determine at what 
stage of the process they are expressed (Ilouze et al., 2012a). Using liquid 
chromatography tandem mass spectrometry-based approaches to analyze the protein 
composition of mature CyHV-3 virons, Michel et al (2010b) identified 40 CyHV-3 
genes that encode structural proteins. Using bioinformatic methods, 17 of these 
structural proteins were sub-classified into 3 capsid, 2 tegument and 13 envelope 
proteins. The sequences of 2 of these envelope proteins (ORF25 and ORF65) and a 
predicted CyHV-3 membrane protein (ORF 116) have been compared between four 
CyHV-3 strains (U, I, J and K) and found to contain several significant deletions and 
insertions in some strains, most notably in the K strain (Han et al., 2013). Some 
individual CyHV-3 genes and gene products have been characterised in more detail. 
These include TK (Bercovier et al., 2005; Costes et al., 2008), viral IL-10 homologue 
(Sunarto et al., 2012), ORF112 (Tomé et al., 2013) and ORF81 (Rosenkranz et al., 
2008). To date no non-coding CyHV-3 genes have been identified. 
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Figure 1.7 CyHV-3 genome map showing all predicted ORFs, gene families and 
Alloherpesviridae core genes  
Diagram taken from Davison et al (2012) (updated version of map provided by Aoki et al (2007)). 
 
1.4.10 Latency  
Like other HVs, it is likely that CyHV-3 also establishes long-term latent infections 
that may reactivate under the appropriate conditions. Experimental infection studies 
and field investigations suggest that CyHV-3 latency is temperature-dependent. 
Outside the permissive temperature range, mortality associated with outbreaks 
decreases but low levels of CyHV-3 DNA can still be found in healthy survivors 
long after initial exposure (Gilad et al., 2004). CyHV-3 can be found even in the 
absence of any apparent outbreaks (Pokorova et al., 2007). In addition, despite the 
presence of CyHV-3 DNA in many organs of healthy fish (and reminiscent latent 
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infections established by other HVs), infectious virus cannot be isolated from the 
same tissues (Eide et al., 2011a, 2011b). Furthermore, lytic infections can be 
reactivated in latent carriers (causing mortality) by introducing them to temperatures 
within the CyHV-3 permissive temperature range. CyHV-3 reactivation has been 
demonstrated in this manner in both common carp (St-Hilaire et al., 2005) and koi 
(Eide et al., 2011b). A detailed description of some of the experiments that have 
shown that CyHV-3 can establish a latent infection is given below.  
 
1.4.10.1 Experimental evidence CyHV-3 latency and reactivation 
There has been several large-scale in vivo infection experiments conducted since 
2000. The results of these experiments have revealed a lot about the possible nature 
of CyHV-3 and especially the significance of water temperature on mortality rates. 
Thus the optimum water temperature range for a CyHV-3 infection to take hold has 
been established to be 16-28oC. However it is experiments involving infection 
outside this optimum temperature range that have yielded the most interesting results 
and have given a greater insight into the possible nature of CyHV-3 latency. 
 
One such study has shown that bath exposure to the virus at lower non-permissive 
temperatures such as 13oC results in no symptoms or mortality. Subsequent transfer 
of the same fish to a permissive temperature of 23oC, 30 days after initial exposure, 
resulted in acute death and high mortality (~80%). However the same study showed 
that fish kept at extended periods of time (64 days in this case) at 13oC do not 
experience any mortality when moved to a permissive temperature of 23oC (Gilad et 
al., 2003). In a separate study by  St-Hilaire et al. (2005), fish were initially exposed 
to CyHV-3 at a permissive temperature of 22oC for just 2 hours before being 
transferred to non-permissive water temperatures of 12oC for 125 days. Unlike the 
results reported by Gilad, et al. (2003) above, in this case transferring the fish to a 
permissive temperature of 23oC after a prolonged period at the non-permissive 
temperature did result in mortality of these fish (although mortality was reduced to 
~50%) and 100% mortality among naïve fish that were cohabited with these fish at 
23oC. This suggested that the introduction of a short initial exposure to CyHV-3 (2h 
in this case) at the permissive temperature before extended periods at a non-
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permissive temperature was enough for the virus to establish an infection capable of 
remaining dormant at low temperatures and reactivating at permissive temperatures.   
 
Also in the same study, exposure to CyHV-3 at permissive temperatures for long 
periods (21oC for 15 days) resulted in high mortality outbreaks (95%) with a small 
number of fish surviving due to subsequent lowering of the temperature to 12oC (to 
promote survival). These fish showed no reactivation of the virus or infection of 
cohabiting naive fish that were introduced as the temperature was raised to 23oC. 
This was in spite of the fact that the fish were also stressed by injections of the stress 
hormone cortisol. One of the survivor fish from the original outbreak did test positive 
for anti-CyHV-3 antibodies. A similar experiment was later conducted where fish 
were exposed to virus leading to another relatively high mortality outbreak, this time 
at an initial temperature of 18oC for 20 days (later lowered to 11oC to promote 
survival). Survivors were split into 2 groups in separate tanks and the temperature 
was raised to 23oC. Reactivation of CyHV-3 in response to the raised temperature 
only occurred in one of these groups. Failure of clinical signs to reappear did not 
necessarily mean that the virus was not present, as interestingly in the group where 
no reactivation occurred, anti-CyHV-3 antibody was detected in one of the naïve fish 
that co-habited with the survivors. The only possible source of CyHV-3 in this tank 
would have been the co-habiting survivors of the previous outbreak. This suggested 
that the virus may have been actively shed by the survivor fish in the absence of 
clinical symptoms i.e. the hallmarks of a persistent/latent infection. The use of a re-
circulation system in this tank may have helped retain any virus particles shed, 
increasing the chances of contact with naïve fish. Despite the fact that this took place 
at a permissive temperature, it did not result in a high mortality outbreak among 
naïve fish that had picked up the virus. This evidence certainly suggests that 
survivors may act as asymptomatic carriers and shed active virus particles that are at 
least capable of causing an immune response in naïve fish as shown by the 
production of anti-CyHV-3 antibodies. 
 
The experimental studies on described above on CyHV-3 reactivation were done 
using carp. Reactivation has also been demonstrated in koi under similar 
circumstances. In this case six koi known to have had previous CyHV-3 infections or 
exposure, were re-introduced to CyHV-3 at permissive temperatures. CyHV-3 DNA 
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could be detected in the faecal secretions and gill swabs from these fish only when 
the temperature was raised but not beforehand. In addition, infectious virus could be 
isolated from the same sources only after the temperature was raised. This 
reactivation of CyHV-3 resulted in two mortalities. Interestingly, one these 
mortalities had been a survivor of both a suspected CyHV-outbreak in 1998 and 
confirmed CyHV-3 outbreak in 2003 (10 years prior to reactivation) (Eide et al., 
2011b). 
 
It has been shown that virus remains viable in water for approximately 4 hours 
(Perelberg et al., 2003). Hence in the experiments mentioned above, the clinical signs 
that appeared in fish, following the switch to a permissive temperature, were not 
caused by virus particles remaining in the immediate environment after the initial 
exposure, as in all cases a switch to the permissive temperature occurred long after 4 
hours. In fact of the studies mentioned, the least time that had elapsed before a switch 
to the permissive temperature was 30 days (Gilad et al., 2003). Therefore it can be 
concluded from these studies that keeping fish at low temperatures after or during 
initial exposure must result in an infection of some kind at this stage, albeit in the 
absence or reduction of mortality and clinical signs. It is this initial dormant infection 
that can be the only source of reactivated virus at the permissive temperature later on. 
As shown, clinical signs may or may not re-appear and cause repeat outbreaks when 
transferred to permissive temperatures. These studies suggest that this may depend 
on the nature of the initial exposure with respect to temperature and time. It is highly 
unlikely that exposed fish survive better at lower temperatures due to temporary 
suppression of the virus by the adaptive immune response as it is well documented 
that the immune response in carp is at its lowest at these temperatures. The necessary 
magnitude of response required to fight off infection is much more likely to happen 
at higher temperatures (Le Morvan et al., 1998, 1996). 
 
Whether or not the survival of CyHV-3 infected fish at low temperatures represents 
some form of temporary latency in response to low temperatures is something that 
has yet to be confirmed. Initiation of latency during cold temperatures may be an 
advantageous evolutionary adaptation for successful viruses of poikilothermic hosts 
whose immune system declines in response to cold temperatures. The establishment 
of a dormant infection at this stage would act to prevent the virus completely killing 
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off its immuno-suppressed host, allowing the host to survive the winter and act as a 
reservoir for infectious virus particles and emergence of the virus in spring when 
hosts start to interact in high numbers during spawning.  
 
In vivo studies conducted at the other end of the non-permissive temperature scale 
(i.e. >28oC) also show interesting results. As mentioned in Section 1.4.8.1 studies 
have shown that vaccination of fish can be achieved through exposure to CyHV-3 at 
a permissive temperature followed by transfer to a non-permissive temperature of 
30oC for 30 days. Resistant fish generated in this manner showed no sign of viral 
DNA or infectious virus at permissive temperatures. In addition cohabitation of 
“ naturally resistant”  fish with naïve fish did not lead to disease transmission (Ronen 
et al., 2003). Whether or not the virus remains present in some capacity in these 
“ naturally resistant”  fish is something that remains to be seen. The immune response 
in carp is at its most potent during such high temperatures (Le Morvan et al., 1998). 
This correlates with a decrease in CyHV-3 mortality above ~25oC. It would be an 
advantage for a virus to go silent at high temperatures and stopping viral gene 
expression would prevent the display of viral antigens on infected cells and would 
act as a way of evading detection by the host’ s immune system while it is at its peak.  
 
Dishon et al. (2007) produced an excellent in vitro simulation of the conditions used 
to create “ naturally resistant”  fish. Their study showed that a dormant persistent 
infection in the common carp brain cell line (CCBs) can be maintained at the higher 
non-permissive temperature of 30oC. No viral replication occurred at this 
temperature. Importantly this study showed that virus was not destroyed at the non-
permissive temperatures but instead reactivated again once cultures were reverted to 
permissive temperatures. However, the ability to reactivate virus ceased following 70 
days at 30oC indicating the infection may have become abortive at this point. It is 
unclear if an abortive infection (i.e. an infection where no viral DNA synthesis or 
new viral particles are produced) could occur in vivo, under similar conditions, in the 
case of “ naturally resistant”  fish.  
 
This study by Dishon et al. (2007) presented an interesting in vitro model that may 
have facilitated the study of CyHV-3 latency/persistence. However, attempts to 
replicate this experiment in the manner described in this publication in our laboratory 
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and in our collaborating lab (Cefas, UK) did not show the same results. Instead CPE 
progressed at a much slowere rate and in some cases the negative control cells began 
to detach from the flask surface, indicating that the even in the absence of viral 
infection the cells were not well suited to culture at this elevated temperature. This in 
vitro model was not utilised in any other study until it was reproduced again by the 
same group for a follow-up study on gene expression (Ilouze et al., 2012b). Notably 
in this second study, and based on some further evidence presented therein, the 
infection established at 30oC was now explicitly described as an abortive infection 
rather than a persistent infection as described in the first study.  
 
It is clear from both the in vitro and in vivo studies described above that the 
characteristics of CyHV-3 infection do change in response to non-permissive 
temperatures, resulting in the establishment of a dormant infection involving the 
cessation of viral replication. During this stage, although viral genomic DNA can be 
detected, no infectious virus can be isolated. Furthermore, in some cases lytic 
replication can be reactivated upon re-exposure to permissive temperatures. This is 
certainly not unlike the pattern of behaviour displayed by other HVs during latent 
infections. CyHV-3 can therefore be described as a virus that is capable of 
establishing latent infection and that both establishment and reactivation are 
temperature-dependent. The molecular basis of these observations remains to be 
elucidated however. 
 
1.4.10.2 CyHV-3 gene expression during latency 
Genes involved in lytic infections are switched off during latency. Instead, the virus 
relies on a subset of genes involved in the long-term maintenance of latent infections. 
There is not much information on CyHV-3 gene expression during latency but from 
the small volume of work that has been done in this area it is clear that the 
temperature changes described above also cause dramatic changes to CyHV-3 gene 
expression (most notably the down-regulation of genes involved in lytic replication) 
Some of these observations are outlined in this section.  
 
In addition to establishing an apparent in vitro model of a CyHV-3 latent/persistent 
infection by incubating cells at 30oC Dishon et al. (2007) (refer to Section 1.4.10.1) 
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also monitored the expression levels of viral genes throughout this infection. Initially 
20 genes were monitored and all were found to be down-regulated to undetectable 
levels. In a later study another similar infection was set up at 30oC and gene 
expression monitoring was expanded to include all 156 genes (Ilouze et al., 2012b) 
(at this point the infection was described as an abortive infection). The results 
showed that viral transcription patterns changed as a result of transfer to the non-
permissive temperature. Some genes that had earlier been reported to be expressed 
during lytic replication (Ilouze et al., 2012a) were not expressed at all and the 
expression of other viral genes gradually decreased beyond the limit of detection. 
Not all genes were down-regulated at the same rate, and some genes (notably 
ORF115 and ORF116) were expressed for a longer time than any of the others. 
However as this infection was described as an abortive infection its relevance to 
CyHV-3 latency is unclear at this stage. 
 
In terms of CyHV-3 gene expression (or lack of) during latency in vivo, Eide et al 
(2011b) showed that at lower permissive temperatures, while CyHV-3 DNA could be 
found in leucocytes from healthy fish, the same samples were negative for mRNA 
for the viral DNA polymerase and major capsid protein (MCP). This suggested that 
the CyHV-3 genome present was not undergoing replication. In another recent study, 
the expression of the same two genes along with those encoding helicase, IL-10 
homologue and intercapsomeric triplex protein (ITP) were also monitored. Gene 
expression was monitored during lytic replication, latency and reactivation of CyHV-
3 in vivo (Sunarto et al., 2012). All genes were expressed at high levels during lytic 
replication and at moderate levels during reactivation. Like Eide et al (2011b), this 
study found that the genes encoding the viral DNA polymerase, MCP and helicase 
were not expressed during latency. However, mRNAs from the IL-10 homologue and 
ITP were present at low levels during latency. It is unclear what role the CyHV-3 late 
gene ITP would play during latency and it is not known if it is even translated at that 
stage. The presence of the CyHV-3 IL-10 homologue may facilitate immune evasion 
during latency, in the same way as the HCMV IL-10 homologue although its 
expression is not essential for latency in HCMV (Section 1.2.2). It should be noted 
that not all HV IL-10 homologs are expressed in this manner e.g. the EBV IL-10 
homologue is only expressed during lytic infections (Hsu et al., 1990). With this in 
mind it is also possible that these transcripts were just down regulated at a slower 
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rate than the other three transcripts assessed in this study and if fish were kept at 
11ºC for longer than 24 days before sampling it is possible that expression of these 
genes would not be detected. Nevertheless, to date mRNA for ITP and IL-10 are the 
only CyHV-3 genes found to be transcribed during latency in vivo. In addition, based 
on the role of its homologue in HCMV it is plausible that CyHV-3 IL-10 plays an 
active role in helping to facilitate the maintenance of CyHV-3 latency.   
 
1.4.10.3 Tissue tropism 
CyHV-3 DNA can be routinely detected in healthy hosts by PCR. If this DNA 
represents latent genome, the results do not point to any particular tissue tropism 
during latency as viral genome has been reported in a wide variety of organs in 
healthy survivors including brain, eye, spleen, gills hematopoietic kidney, trunk 
kidney, and intestine (Eide et al., 2011a; Gilad et al., 2004). In addition some studies 
suggest that CyHV-3 DNA may persist in the brain longer than any other organs 
(Gilad et al., 2004; Yuasa and Sano, 2009).  Apart from organs, CyHV-3  DNA can 
also be found in leukocytes. In addition to being non-lethal, recent studies suggest 
that testing leucocytes may in fact be the most reliable and sensitive way to detect 
latent CyHV-3 in both carp and koi (Eide et al., 2011a, 2011b; Xu et al., 2013).  
 
1.4.10.4 Viral levels during latency 
In all cases CyHV-3 DNA can only be detected at low levels in healthy carriers (Eide 
et al., 2011b; Gilad et al., 2004). However this low level of virus is consistent with 
the levels of other HVs during latency (Sawtell et al., 1998; Wang et al., 2005a). 
Even in leucocytes, the estimated level of latent genomes ranged from only 2-150 
copies per microgram of total DNA (Eide et al., 2011b).   
 
1.4.10.5 Difficulties associated with diagnosing latent CyHV-3 infections 
Assaying for viral DNA is considered the most reliable/sensitive method for 
detecting latent CyHV-3 carriers (see Section 1.4.7). Experimental infection studies 
have shown it to be very likely that the low level CyHV-3 DNA detected in long 
term healthy survivors is indeed latent viral genome. Although such findings 
certainly support the idea that CyHV-3 can establish a latent infection, it is the 
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additional evidence such as reactivation of disease or the production of infectious 
viral particles upon introduction to permissive temperatures that prove that viral 
DNA initially detected at non-permissive temperatures represents latent viral 
genome. While CyHV-3 DNA likely to represent latent genome can be detected in 
survivors, currently there is no way to conclusively distinguish between latency and 
an abortive infection without reactivating infectious virus. Therefore in the strictest 
sense, the detection of low level viral DNA alone cannot be used to confirm latency. 
In addition, because the CyHV-3 genome is present in such low levels (as with latent 
infections of HVs) and because the levels of CyHV-3 genome detected in the organs 
of survivors tend to decrease over time after initial exposure (Gilad et al., 2004) there 
is a possibility that PCR could give false negatives when testing carrier fish. 
Therefore, although PCR is currently the most suitable method available assaying for 
latent CyHV-3, it may not always be reliable.  
 
1.4.10.6 An alternative diagnostic target: Viral RNA transcripts  
Analysis of CyHV-3 gene transcription during in vitro and in vivo infections at high 
and low non-permissive temperatures has shown a complete absence of or gradual 
down-regulation of known viral protein-coding genes (Dishon et al., 2007; Eide et 
al., 2011b; Ilouze et al., 2012b; Sunarto et al., 2012). Although two CyHV-3 genes, 
namely the viral Il-10 homologue and ITP, have been identified as being potentially 
expressed during latency (Sunarto et al., 2012), it is not clear whether their 
expression is gradually down-regulated (like all other CyHV-3 protein-coding genes) 
or if they both remain stably expressed during latency. 
 
The identification of more genes likely to be expressed during CyHV-3 latency 
would not only be quite useful in terms of the molecular characterisation of this stage 
of the viral life cycle but might also be useful targets for the diagnosis of latent 
carriers. Currently the most reliable method to identify potential latent carriers of 
CyHV-3 is the detection of viral genomic DNA. However as outlined in Section 
1.4.10.5, detection of viral DNA alone cannot confirm latency. If viral gene 
expression could be detected it would imply that the virus is still active in some 
capacity and capable of reactivation unlike an abortive infection. In addition to 
allowing confirmation of latency (as opposed to an abortive infection) targeting RNA 
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transcripts (instead of DNA) may make for more sensitive assays. In theory RNA 
transcripts from genes expressed during latency should be much more abundant than 
the low levels of viral genome from which they are transcribed. Being present in 
higher copy numbers, these RNA transcripts should be much more easily detectable 
and might reduce the occurrences of false positives.  
 
There are several examples of protein-coding genes being expressed by HVs during 
latency e.g. EBNAs by EBV and a homologue of the cytokine interleukin-10 (IL-10) 
by HCMV (although not essential for latency). Usually however, HVs also express 
non-coding transcripts during this stage (or sometimes only non-coding transcripts at 
this stage e.g. HSV-1). These are sometimes just referred to as latency-associated 
transcripts (or LATs) and these are involved in the regulation of other genes. 
Examples include the LAT transcript in HSV-1 (Stroop et al., 1984) EBERs in EBV 
(Lerner et al., 1981).  
 
One particular class of LATs that are particularly prominent during HV latency are 
miRNAs. They are involved in the regulation of both viral and host genes and 
provide an ideal way for the virus to maintain a cellular homeostasis that facilitates 
latency without using (or limiting the use of) potentially immunogenic viral proteins. 
Unsurprisingly most HV miRNAs identified to date have been found in latently 
infected cells although many are also expressed during lytic infections (although 
mainly with different expression levels). These non-coding transcripts are described 
in more detail in Section 1.5 
 
1.5 MiRNAs 
In recent years many HVs have been shown to encode miRNAs. MiRNAs are short 
non-coding RNA transcripts of typically ~22 nucleotides (nt) in length. They were 
first discovered in Caenorhabditis elegans (Lee et al., 1993) and were subsequently 
shown to have important roles in gene regulation through targeted cleavage or 
translational repression of specific mRNAs (Ambros, 2001; Lagos-Quintana et al., 
2001; Lau et al., 2001; Lee and Ambros, 2001). These transcripts are mostly encoded 
in intergenic regions, although they can occur antisense to protein-coding genes, 
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within 3’  and 5’  UTRs, introns or in rare cases overlapping with protein-coding 
sequences (Cai et al., 2005).  
 
1.5.1 Biogenesis  
MiRNAs are derived from a series of cleavage steps from much longer primary 
miRNA transcripts (pri-miRNAs) (Lee et al., 2002). Pri-miRNAs are usually 
transcribed by RNA polymerase II. The terminals of these primary transcripts are 
modified by the addition of 5’  7-methyl guanylate cap and 3’  polyA tail (Cai et al., 
2004; Lee et al., 2004). Certain parts of the pri-miRNA form distinct hairpin 
secondary structures, these structures are recognised and cleaved by the RNAse III 
enzyme Drosha and its co-factor DGCR8 (collectively referred to as the 
microprocessor complex). Cleavage occurs ~20-30 nt from the hairpin terminal loop, 
releasing a precursor-miRNA hairpin (pre-miRNA) that is typically ~60-70 nt in 
length and displays a characteristic 2 nt 3’  overhang (Fukunaga et al., 2012; Lee et 
al., 2003) (Figure 1.8). These are then transported to the cytoplasm by Exportin-5 (Yi 
et al., 2003). Once in the cytoplasm, pre-miRNAs are cleaved near the terminal loop 
by another RNase III enzyme called Dicer that works in association with TRBP. This 
second cleavage step results in the release of a mature miRNA duplex present on the 
stem of the precursor, again this usually results in a 2 nt 3’ overhang (Chendrimada et 
al., 2005; Ji, 2008; Koscianska et al., 2011).  
 
Both of these strands from the mature duplex can become incorporated into a multi-
protein complex known as the RNA-induced silencing complex (RISC), a key 
component of which is the Argonaute protein. In addition to facilitating miRNA 
processing, TRBP also recruits Argonaute 2 (Ago2) to the mature miRNAs bound by 
Dicer (Chendrimada et al., 2005). Usually one of these strands becomes stably 
incorporated in the RISC more frequently than the other with preference given to the 
strand with the lowest 5' terminus base-pairing stability (Khvorova et al., 2003; 
Schwarz et al., 2003; Tomari et al., 2007). This strand is referred to as the mature 
miRNA, guide strand or major form while the other strand that is not usually 
incorporated is known as the mature miRNA* (pronounced “ miRNA star” ), 
passenger strand or minor form. These strands will be referred to as the major form 
and minor form respectively from this point onwards. Once incorporated into the 
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RISC the miRNA can then carry out targeted mRNA silencing. This biogenesis 
pathway is illustrated in Figure 1.8 (a). Although most miRNA biogenesis occurs in 
this fashion, non-canonical miRNA biogenesis pathways have been discovered. Most 
notably, some pre-miRNA-hairpins occurring in introns can be processed 
independently of Drosha through the combined action of splicing machinery and 
lariat-debranching enzyme. Pre-miRNA hairpins that are processed in this fashion 
are referred to as “ mirtrons”  (Okamura et al., 2007). Less abundant variations of 
miRNAs are also normally present; these share the same core sequence as the 
miRNAs but display varying degrees of terminal heterogeneity, these are classed as 
isomiRs (Morin et al., 2008). These may occur as a result of inconsistencies in Dicer 
and Drosha processing of mature miRNAs from the pre-miRNAs (Ruby et al., 2007, 
2006; Wu et al., 2009) and the nature of the heterogeneity may be influenced by pre-
miRNA structural features (Starega-Roslan et al., 2011). These transcripts can also 
be incorporated into the RISC. In some cases they may be present at physiologically 
relevant levels and thus may also contribute significantly to gene silencing (Cloonan 
et al., 2011). 
 
1.5.2 Mode of gene silencing 
Once incorporated into the RISC, mature miRNAs can carry out gene specific 
silencing. Because gene silencing occurs through complementary base pairing 
between the miRNAs and specific regions on target mRNAs, each miRNA is capable 
of post-transcriptional regulation of a specific subset of mRNAs. These specific 
mRNA regions are referred to as target sites. This base pairing does not need to be 
fully complementary although in plants, miRNAs generally display a high degree of 
complementary base pairing with target sites, which are usually within the ORFs of 
these mRNAs (Voinnet, 2009). By contrast, perfect or near perfect base pairing 
between animal miRNAs and their target miRNAs are rare. In addition animal 
miRNA target sites are usually located within 3’  UTRs as opposed to ORFs. In this 
case, mRNA target sites are generally perfectly complementary to positions 2-7 on 
the miRNA. This is known as the seed region and it is the primary determinant of 
animal miRNA target specificity. Additional base pairing between the target site and 
miRNA at positions 13-16 on the miRNA is also sometimes important and this acts 
to supplement or compensate for weak seed pairing stability (Garcia et al., 2011; 
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Grimson et al., 2007). These and other factors that are important for target specificity 
are described later in Section 1.8. 
 
Ultimately target mRNAs are silenced through action of various components of 
RISC. This occurs by either endonucleolytic cleavage or mRNA repression 
(enhanced mRNA degredation/turnover or translational inhibition). Endonucleolytic 
cleavage occurs when miRNAs are complementary to mRNA targets and is carried 
out by Ago2. MRNA repression occurs when there is only a match to the seed region 
(normally the case in animal cells). This can be carried out by any of the several 
other Argonaute proteins (Gu and Kay, 2010; Su et al., 2009). Often mRNA 
repression involves the aggregation of RISC bound mRNA into translationally 
inactive cellular processing bodies (p-bodies) leading to degradation (Beckham and 
Parker, 2008; Eulalio et al., 2008; Huntzinger and Izaurralde, 2011).  
 
1.5.3 MiRBase 
MiRBase is an online database of all published miRNA sequences. Each miRNA 
entry is represented by its precursor name. Details of mature miRNAs derived from 
each pre-miRNA, a summary caption and associated publications are available for 
each pre-miRNA entry. Recent versions of miRBase have also included details of 
isomiRs, alignment signatures (alignments of miRNAs and isomiRs and their 
respective positions on pre-miRNAs) and read counts from deep sequencing 
experiments, although these details are usually only available for widely researched 
miRNA entries (Kozomara and Griffiths-Jones, 2011). Each miRBase entry is named 
according to a specific naming system. All pre-miRNAs start with a 3-4 letter 
abbreviation of the species of origin, followed by “ -mir-”  followed by a number, 
ascending in order of genome position or in order of discovery (sometimes this 
number may be preceded by a letter). MiRNAs use the same name as the precursor 
they are processed from except “ -mir-”  is replaced with “ -miR-”  Where the two 
miRNAs are annotated on a given pre-miRNA, both miRNA names end with either -
5p or -3p depending on the arm from which they are derived. For example the first 
miRNAs discovered from HSV-1 are in miRBase under the precursor name hsv-mir-
H1 and the miRNAs are named hsv-miR-H1-5p and hsv-miR-H1-3p.  Exceptions to 
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these rules include miRNAs named prior to establishment of the nomenclature 
system, e.g. let-7a.  
 
1.6 Viral miRNAs 
Many eukaryotic miRNAs are involved in fundamental cellular processes and hence 
have been found to be heavily evolutionarily conserved across many distantly related 
metazoans (Lee et al., 2007; Wheeler et al., 2009). Viruses of these organisms are 
often found to encode homologues of host genes as a result of horizontal gene 
acquisition events during their evolution. Considering the ubiquitous presence of 
miRNAs in metazoan genomes, it is unsurprising that many viruses have also 
acquired this method of post-transcriptional regulation. Since their first discovery on 
viral genomes (Pfeffer et al., 2004) miRNA-coding genes have been found in 30 
different viruses. Details of all currently known viral miRNAs are given in Table 1.4   
 
1.6.1 Differences to eukaryotic miRNAs   
Most viral miRNAs have been found to be no different from cellular miRNAs in 
their biogenesis and in the processes by which they carry out gene regulation and as 
such, they rely entirely on the use of host cell miRNA biogenesis and silencing 
machinery to function. Despite the many similarities to host miRNAs there are some 
differences that have given further insights into the biology of miRNAs in terms of 
biogenesis, evolution and the extent of their prevalence outside metazoans. 
 
1.6.1.1 Biogenesis of viral miRNAs 
All known viral miRNAs are processed using cellular RNA processing machinery. 
However some viruses deviate from the canonical miRNA biogenesis pathway 
outlined earlier in Section 1.5.1. Most pri-miRNAs are transcribed by RNA 
polymerase II, although some viral pre-miRNAs have been shown to be transcribed 
by RNA polymerase III. Examples include, pri-miRNAs from murine -herpesvirus 
68 (MHV-68) which are transcribed alongside viral tRNA-like transcripts (Bogerd et 
al., 2010; Reese et al., 2010) and miRNAs from Bovine leukaemia virus (BLV) 
(Kincaid et al., 2012). Furthermore, in both these cases the processing of pre-
miRNAs from these pri-miRNAs takes place in a non-canonical fashion that is 
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independent of Drosha cleavage. In the case of MHV68, pre-miRNAs are processed 
from tRNA-like transcripts by host tRNase Z. In BLV, pri-miRNAs do not require 
processing by Drosha and are directly processed by Dicer i.e. the pri-miRNAs also 
function as pre-miRNAs without a need for prior Drosha processing. In addition, 
Herpesvirus saimiri (HVS) encodes pre-miRNAs on the 3’  ends of other non-coding 
RNAs called HSURs. Mature HSURs and pre-miRNAs are processed from the same 
primary transcript by the host cell Integrator-Complex (Cazalla et al., 2011). All of 
the biogenesis pathways described here are shown in Figure 1.8.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 Canonical and non- canonical viral miRNA biogenesis pathways   
The nucleus is represented by the dark grey shape on the left. It is surrounded by the cytoplasm in 
light grey. (a) The canonical miRNA biogenesis pathway used by most cellular and viral miRNAs is 
described in Section 1.5 (b) HVS pre-miRNA forming after 3’  box on primary HSUR transcript and 
processed by cellular integrator complex (c) MHV68 pre-miRNA forming on the 3’  end of a viral 
tRNA-like transcript (transcribed by RNA polymerase III) and processed by tRNase Z (d) BLV pre-
miRNA (pri-miRNA) directly transcribed as a short discrete transcriptional unit by RNA polymerase 
III (e) Export of pre-miRNA from nucleus by Exprotin5 (XPO5), Dicer processing releasing mature 
miRNA duplex (with 3’  overhangs) and incorporation into RISC (f) Targeted regulation of specific 
mRNAs. Top: imperfect complementary pairing to target site leading to translational repression of 
target mRNA, Bottom: perfect complementary base pairing to target site leading to cleavage of target 
mRNA. The diagram was adapted from Kincaid and Sullivan (2012).  
 
 
(a) 
(b) 
(c) 
(d) 
(e) 
(f) 
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1.6.1.2 Prevalence among viral families 
Even though miRNAs are ubiquitous among eukaryotic organisms, current 
knowledge suggests that they may not be equally prevalent among all viral families. 
Most known viral miRNAs occur in dsDNA viruses (Table 1.4). There may be 
several reasons why this is the case. Firstly, in theory, miRNA genes encoded in an 
ssRNA + sense genome may form the appropriate pre-miRNA hairpin structures 
without a need for transcription, allowing parts of the genome to act as substrate for 
Drosha. Thus, the presence of miRNA genes in RNA viral genomes may result in 
genome cleavage and may be disadvantageous for such viruses. Secondly most RNA 
viruses replicate in the cytoplasm (some exceptions include Orthomyxoviridae and 
Retroviridae) and therefore do not have access to the microprocessor complex 
involved in canonical miRNA biogenesis pathways as these are housed in the nuclei 
of host cells. Unlike most RNA viruses retroviruses replicate in the nucleus and in 
addition they also have a DNA stage, thus these are the only RNA viruses that have 
been shown to produce miRNAs (Kincaid et al., 2012; Ouellet et al., 2008). As 
outlined in Section 1.6.1.1 BLV pre-miRNAs are directly transcribed by RNA 
Polymerase III. In this case the correct pre-miRNA structure is only formed in this 
context. The same sequence does not fold into the same hairpin in the setting of the 
full genome or when present in longer RNA polymerase II transcribed mRNAs, thus 
allowing BLV to circumvent cleavage of the viral genome while still at its RNA 
stage and cleavage of overlapping mRNAs. It has been demonstrated that the 
insertion of a miRNA gene into influenza A virus - a member of the 
Orthomyxoviridae family, results in efficient miRNA processing and expression 
(Varble et al., 2010). In another interesting experiment, an EBV pre-miRNA was 
inserted into the genome of tick-borne encephalitis virus (TBEV), a member of the 
Flaviviridae family. Despite the fact that TBEV is an RNA virus that replicates in the 
cytoplasm, it was demonstrated that it was possible for miRNAs to be processed 
from the pre-miRNA, but at a low level (Rouha et al., 2010). This process did 
involve Drosha and the observed inefficiency of miRNA processing may be caused 
by the separation of the miRNA from the microprocessor components in the nucleus. 
It is possible that low level miRNA processing did occur as a result of breakdown of 
the nuclear membrane during mitosis, thus allowing temporary access to the miRNA 
processing machinery.  
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Despite the fact that it is possible for some RNA viruses to encode miRNAs, they 
seem to be much more prevalent in dsDNA viruses, such as members of the 
Polyomaviridae family and HVs in particular. In fact the majority of all known viral 
miRNAs occur in HVs. This may be due to the fact that they have larger genomes, 
but it should also be noted that most of them occur as part of miRNA gene clusters 
that occupy only short stretches of their respective genomes, meaning that the 
presence of multiple miRNA genes is not necessarily a result of their having larger 
genomes. One of the main reasons for the high prevalence of miRNAs among HVs 
may be latency. All known HVs have the ability to establish latent infections 
(Roizmann, 2001). MiRNAs appear to be closely associated with latency and this is 
reflected in the fact that the majority of known HV miRNAs have initially been 
indentified in latently infected cells. Latency represents a unique transcriptional state 
for the HVs, where they only rely on a subset of genes in order to maintain latency 
on a long-term basis. It is thought that the utilization of miRNAs during latency in 
particular is an evolutionary adaption of herpesviruses most likely driven by the fact 
that miRNAs provide an ideal way for the virus to maintain a cellular homeostasis 
that facilitates latency without using (or limiting the use of) potentially immunogenic 
viral proteins. This idea of miRNAs being connected with HV latency seems quite 
plausible. However, studies on HV genomes have concluded that 3 human HVs, 
HHV-3, HHV-6 and HHV-7 are not likely to encode miRNAs. These viruses all 
establish latent infections and it remains unclear why they would have not adapted 
similar methods of gene regulation (Pfeffer et al., 2005b). Indeed deep sequencing of 
small RNAs from HHV-3 latently infected ganglia failed to identify any potential 
HHV-3 miRNAs (Umbach et al., 2009a). Contrary to predictions however, a recent 
study was able to identify a low number of HHV-6B encoded miRNAs in latently 
infected cell cultures (Tuddenham et al., 2012) although these have been removed 
from latest Release of miRBase (Table 1.4). Many viral miRNAs expressed during 
latency are also expressed (albeit at different levels) during lytic infections (Cai et 
al., 2006, 2005; Cui et al., 2006; Pfeffer et al., 2005b; Reese et al., 2010; Umbach 
and Cullen, 2010; Zhu et al., 2010b). The biological relevance of this is not clear and 
this may just occur as a consequence of an overall increase in the levels transcription 
from viral genomes or read-through transcripts during lytic infections. Indeed, many 
viral miRNAs do have specific roles during lytic infections (Section 1.6.3).  
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Table 1.4 Details of all viral miRNA entries in the current release of miRBase (Release 20 – June 
2013) 
All virus families represented in this table are dsDNA viruses with the exception of Retroviridae. N.I. 
= Not Investigated. 
 
aHHV-6B entry changed from “ 4”  pre-miRNAs in miRBase Release 19 to “ 0”  pre-miRNAs in 
Release 20 (the reason for this change was not disclosed). bPyV miRNAs not submitted to miRBase 
taken from Sullivan et al (2009), cSA12 miRNAs not submitted to miRBase taken from Cantalupo et 
al (2005), dHVaV miRNAs not submitted to miRBase taken from Hussain et al. (2008) eTwo HIV 
miRNA entries may be deleted from future releases of miRBase due to lack of sufficient experimental 
evidence 
 
1.6.2 Evolutionary conservation  
In contrast to eukaryotic miRNAs, most viral miRNAs show no evolutionary 
conservation with host or other viral miRNAs. This is true even where the genomic 
location is conserved between related viruses e.g. the miRNA clusters in Kaposi’ s 
sarcoma-associated herpesvirus (KSHV) and related rhesus rhadinovirus (RRV) 
Infection 
Family Virus 
Known 
Pre-
miRNAs 
Known 
miRNAs Lytic  Latent 
Anatid herpesvirus 1 (AHV-1) 24 33 Yes N.I 
Bovine herpesvirus 1 (BoHV-1) 10 12 Yes N.I. 
Herpes B virus (HBV) 3 3 Yes N.I. 
Herpes Simplex Virus 1 (HSV-1)  17 26 Yes Yes 
Herpes Simplex Virus 2  (HSV-2) 18 24 Yes Yes 
HV of turkeys (HVT) 17 28 Yes N.I. 
Infectious laryngotracheitis virus (ILHV)  7 10 Yes N.I. 
Marek’s disease virus type 1 (MDV-1) 14 26 Yes Yes 
Marek’s disease virus type 2 (MDV-2) 18 36 Yes Yes 
Alphaherpesvirinae  
Pseudorabies virus (PSV) 13 13 Yes N.I. 
Human cytomegalovirus (HCMV) 11 17 Yes N.I. 
Human herpesvirus 6B (HHV-6B)a 4 8 Yes N.I. Betaherpesvirinae  
Mouse cytomegalovirus (MCHV) 18 29 Yes N.I. 
Epstein-Barr virus (EBV) 25 44 Yes Yes 
Herpesvirus saimiri strain A11 (HSV)  3 6 N.I. Yes 
Kaposi sarcoma-associated HV (KHSV)  13 25 Yes Yes 
Mouse gammaherpesvirus 68 (MHV68) 15 28 Yes Yes 
Rhesus lymphocryptovirus  (rLCV) 36 68 N.I. Yes 
Gammaherpesvirinae  
Rhesus monkey rhadinovirus  (RRV) 7 11 Yes Yes 
BK polyomavirus (BKV)  1 2 Yes N.I. 
JC polyomavirus (JCV) 1 2 Yes N.I. 
Merkel cell polyomavirus (MCV) 1 2 Yes N.I. 
Simian virus 40 (SV40) 1 2 Yes N.I. 
Murine polyomavirus (PyV)b 1 2 Yes N.I. 
Polyomaviridae 
Simian agent 12 (SA12)c 1 2 Yes N.I. 
Bandicoot papillomatosis carcinomatosis 
virus type 1 (BPCV-1) 1 1 Yes N.I. 
Unclassified: Related 
to both 
Polyomaviridae and 
Papillomaviridae 
Bandicoot papillomatosis carcinomatosis 
virus type 2 (BPCV-2) 1 1 Yes N.I. 
Ascoviridae Heliothis virescens ascovirus (HvAV)d 1 1 Yes N.I. 
Bovine leukemia virus (BLV)  5 8 Persistent Retroviridae 
Human immunodeficiency virus 1 (HIV-1)e 3 4 Persistent 
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(Walz et al., 2010) and miRNAs in Marek’ s disease viruses-1 and -2 (Grey et al., 
2008; Yao et al., 2007). Notable exceptions appear to only be limited to very closely 
related viruses e.g. 22 miRNAs shared between EBV and rLCV (Riley et al., 2010) 
and 9 pre-miRNAs shared between RRV and Japanese macaque herpesvirus (JMHV) 
(Walz et al., 2010). There are several miRNAs from HSV-1 and HSV-2 that show 
conservation in genomic location and significant sequence homology particularly in 
their seed regions but no identical miRNAs (Jurak et al., 2010). Sequence 
conservation seems to be more prevalent in the Polyomaviridae family with miRNAs 
shared between BKV and JCV (Seo et al., 2008) and BPCV-1 and BPCV-2 (Chen et 
al., 2011) respectively. Although some miRNAs are conserved, this does not 
necessarily imply that their respective pre-miRNA sequences (Figure 1.9) are 
conserved suggesting that in these cases it is only the miRNAs themselves that are 
under selective pressure (Takane and Kanai, 2011). 
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Figure 1.9 Examples of miRNAs conserved between different viruses or that are present in 
different pre-miRNAs in the same virus 
Conserved miRNAs are highlighted in bold on their respective pre-miRNAs. All miRNAs are named 
following the system described in 1.5.3. For each miRNA the virus of origin is stated in the prefix e.g. 
ebv-miR-BART-1-3p is from Epstein-Barr Virus. (A) Conserved miRNA between JCV and BKV (B) 
Conserved miRNA between EBV and rLCV (C) MiRNA present on 2 different pre-miRNAs on the 
HVT genome (D) Conserved miRNA between BPCV-1 and BPCV-2. Diagram adapted from Tankane 
and Kanai (2011). 
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1.6.3 Functions of viral miRNAs 
The functions of most viral miRNAs are either unknown or have only been 
tentatively predicted. Some have been investigated however, in particular in the case 
of miRNAs from EBV, HSV-1 and KSHV. In the context of both lytic and latent 
infections, viral miRNAs have been found to carry out three main types of functions 
(i) promotion of cell survival (ii) viral immune evasion, (iii) to control or limit lytic 
replication. Viral miRNAs carry out these functions through the regulation of both 
host and viral protein-coding genes. While this is comprehensively reviewed 
elsewhere (Grundhoff and Sullivan, 2011; Kincaid and Sullivan, 2012; Skalsky and 
Cullen, 2010), a few key examples illustrating the general functions of viral miRNAs 
are outlined below. 
 
Cell survival is important for the establishment and maintenance of long-term latent 
infections and usually involves viral regulation of host cell factors that promote cell 
death. For example, during EBV latency, ebv-mir-BART-5 down-regulates the host 
cell pro-apoptotic protein (PUMA)  (Choy et al., 2008) and other EBV miRNAs from 
the BART cluster target the cellular Bim gene which encodes a Bcl-2 interacting 
mediator of cell death. KSHV miRNAs have also been shown to promote cell 
survival by targeting the apoptosis initiator TWEAKR (Abend et al., 2010) and late 
apoptotic caspase 3 (Suffert et al., 2011).  MiRNAs from KSHV, EBV and HCMV 
have all been shown to regulate the pro-apoptotic gene BCLAF1. This is interesting 
as none of these viral miRNAs are conserved between these three viruses. Instead 
this may represent a case of convergent evolution indicting that the regulation of this 
gene is important in the lifecycle of all three viruses (Lee et al., 2012; Riley et al., 
2012; Ziegelbauer et al., 2009).  
 
The use of miRNAs to suppress viral proteins capable of eliciting an immune 
response during latency is advantageous to viruses (Sullivan, 2008). This can also be 
useful during productive lytic infections. All members of the Polyomaviridae family 
(investigated so far) have been found to express a single miRNA that is antisense to a 
viral early gene encoding a protein called T-antigen (Cantalupo et al., 2005; Seo et 
al., 2009, 2008; Sullivan et al., 2009, 2005). It is hypothesized that down-regulation 
of this gene helps evade cytotoxic T-cell-mediated cell lysis. While this was shown 
to be the case in SV40 (Sullivan et al., 2005),  down-regulation of the T antigen by 
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PyV miRNA did not enhance cytotoxic T-cell evasion under the experimental 
conditions used (Sullivan et al., 2009). In a similar case to the one mentioned earlier, 
there is yet more evidence of convergent evolution in the function of miRNAs from 
EBV, KSHV and HCMV. A set of miRNAs from these 3 viruses has been shown to 
down-regulate the major histocompatibility complex class I-related chain B (MICB) 
mRNA. This encodes a ligand for natural killer (NK) cells and its down-regulation in 
infected cells leads to reduced NK mediated destruction of infected cells (Nachmani 
et al., 2009; Stern-Ginossar et al., 2007).  
 
As well as evading the immune response viral miRNAs can also act to prolong the 
longevity of infected cells and limit the lytic cycle. Many viral miRNAs that are 
expressed during latency have been shown to suppress viral genes that are involved 
in lytic infections and therefore act to maintain latency by preventing lytic cycle 
initiation. Some examples of HSV-1 and EBV miRNAs that function in this manner 
were described in Section 1.2.2. Expression of the HSV-1IE early gene ICP0 is 
prevented by the miRNA hsv1-miR-H2-5p. This HSV-1 miRNA is unusual as it is 
situated antisense to the ICP0 ORF in the HSV genome; as a result, the miRNA is 
perfectly complementary to a target site within the ICP0 coding region. Such an 
occurrence is rare in animal cells but is more common in viruses and may be a 
consequence of their small genome size. A homologue of this miRNA also exists in 
HSV-2. This was originally designated HSV-2-miR-III but for convenience is now 
designated hsv2-miR-H2-5p in line with its homologue in HSV-1. Although this 
miRNA is slightly divergent in sequence, its genomic location is conserved, hence it 
also targets the HSV-2 ICP0 homologue (Jurak et al., 2010). KSHV also uses 
miRNAs to maintain latency, for example the miRNA miR-K12-9-5p targets the 3’  
UTR of an mRNA for the KSHV 
	


 protein 
(RTA), reducing the occurrence of spontaneous lytic reactivation in latently infected 
cells (Bellare and Ganem, 2009; David, 2010). EBV miRNA miR-BART2 down-
regulates the viral DNA polymerase BALF5 during latency, presumably acting to 
inhibit the transition to lytic replication (Barth et al., 2008). As well as regulating 
lytic genes during latency, viral miRNAs can also regulate lytic genes during lytic 
infections. During HCMV lytic infections the miRNA miR-UL112-1 regulates the 
viral trans-activator gene IE-72 (interestingly it has 2 target sites in its 3’  UTR). It is 
likely the regulation of this gene late in lytic replication is necessary to ensure the 
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correct temporal sequence of viral gene expression during this process (Grey et al., 
2007). Notably this is the same HCMV miRNA that targets the MICB gene 
(mentioned earlier) and is a good example of a miRNA that regulates both cellular 
and viral genes. 
 
Some viral miRNAs have been shown to possess the exact same seed regions as 
cellular miRNAs and are therefore capable of regulating at least some of the same 
transcripts. This is the case for oncogenic viruses such as MDV-1, KSHV and BLV. 
MDV-1 and KSHV encode orthologues of miR-155 and BLV encodes a mir-29 
orthologue. In all cases the viral miRNA seed regions are exact matches to the 
cellular miRNAs, implying that they have the same targets (Boss et al., 2011; 
Kincaid et al., 2012; Zhao et al., 2011). Strikingly, these particular cellular miRNAs 
are known to directly contribute to oncogenesis when over-expressed and 
unsurprisingly all of the viral orthologues mentioned have been shown to 
independently contribute to the same process.  
 
1.7 Identification of novel viral miRNAs 
Given their roles in the regulation of other genes, the identification of novel miRNA 
genes (either conserved or non-conserved) can significantly contribute to or change 
our understanding of the molecular basis of many biological processes. The 
identification of novel miRNAs usually involves a mixture of bioinformatics and 
experimental work. In the following section these approaches are described and 
critically evaluated in the context of this study. 
 
1.7.1 Prediction of novel viral miRNAs 
The use of bioinformatics to predict novel miRNAs in genomes can be very useful 
and if approached properly, the predictions can serve as a solid basis from which to 
proceed with experimental approaches to novel miRNA identification. The approach 
to novel miRNA prediction depends on the nature of the organism in question and 
the objectives of the study, but broadly speaking the methods used are dictated by 
whether the study requires the identification of conserved or non-conserved 
miRNAs.  
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1.7.1.1 De Novo prediction of non-evolutionarily conserved miRNAs 
Based on observations in other viruses (Section 1.6) it is more likely that most novel 
viral miRNAs are species-specific, and in such cases de novo approaches to novel 
miRNA prediction are the most appropriate approached to use. De novo miRNA 
prediction does not rely on any evolutionary conservation and involves searching for 
miRNAs in a more indirect manner. This usually involves scanning genomes and 
predicting the occurrence of RNA secondary structures that loosely resemble pre-
miRNAs. However, genomes produce many random RNA hairpin structures for 
many reasons and only a small number of these may function as pre-miRNAs, it is 
therefore important that these can be distinguished from non-pre-miRNA hairpins in 
some way. Unfortunately, the structural properties of bone fide pre-miRNAs are 
difficult to define in a manner that would allow them to be definitively distinguished 
from non-pre-miRNA-like hairpins or pseudo-pre-miRNAs. This means that 
unfortunately it is not currently possible to develop a “ perfect”  algorithm that would 
allow definitive distinction of real pre-mRNAs from background noise. Thus, 
approaches to de novo pre-miRNA prediction could be largely described as being 
based on a “ loose”  form of pattern recognition. These are generally rule-based 
approaches that take into account general structural properties of known pre-
miRNAs. In the development of such prediction methods, the ideal structural 
properties of pre-miRNAs are usually defined through analysis of sets of bone fide 
pre-miRNAs, referred to as ‘training data’ . Properties analysed include hairpin 
length, terminal-loop size, minimum free energy, the extent of base-pairing in stems, 
bulge frequency, bulge size and bulge location, sequence composition, sequence 
complexity, repeat elements and internal and inverted repeats and other biologically 
relevant features (Bentwich, 2005). The exact composition of the training data used 
to develop methods may have some effect on performance or suitability in certain 
circumstances. This is important as training data can vary considerably in content, 
size and organisms of origin. Hence methods may only be as useful as the quality 
and suitability of the training data that is used as part of their respective development 
processes. Once pre-miRNA structural properties are defined in a way that allows 
bone fide miRNAs to be distinguished from non-pre-miRNA-like hairpins to an 
acceptable degree (checked by using appropriate negative training data), algorithms 
are developed to carryout high throughput analysis of the same properties among 
predicted hairpins. To distinguish between low and high likelihood pre-miRNA 
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predictions, each candidate is usually scored. Scores are usually determined by 
assigning values to each structural property based on a predefined scoring system. 
This is where most de novo prediction methods differ from one another. Different 
methods commonly assign different weights to different structural properties. An 
ideal way to ascertain the significance scores for given hairpins is to impose cut-off 
values, allowing elimination of low likelihood pre-miRNA predictions. The 
establishment and implementation of cut-off values relevant to specific studies is 
important in order to ensure correct interpretation of the significance of given 
predictions. The use of cut-off values is a delicate balance between increasing 
accuracy (lowering false positive rates) and maintaining sensitivity (not eliminating 
real pre-miRNAs from predictions), and it is best to have some acceptable way of 
measuring of the effects of various cut-off values on both of these aspects. Several 
methods that allow high throughput de novo prediction of pre-miRNAs in genomes 
have been developed. Details of several of these methods are given in Table 1.5.   
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Table 1.5 List of methods used for de novo prediction of miRNAs in genomes 
 
 
The programs listed in Table 1.5 mainly consist of a series of algorithms (a pipeline) 
that predicts hairpins in a genome followed by scoring of these hairpins in terms of 
their structural consistency with bone-fide pre-miRNAs. Two of these methods, 
Pfeffer-SVM-Method and VMir have been successfully used to predict viral pre-
miRNAs, however Pfeffer-SVM-Method is not publically available. The Bentwich-
Method also seems quite suitable to viral miRNA prediction although like the 
Pfeffer-SVM method, it is not publically available and for the reasons described 
above SSC profiler and, miRANK are not suitable (Table 1.5). 
 
VMir was specifically designed for the prediction of novel pre-miRNAs in viral 
genomes. It also generates particularly useful graphical and raw data output that can 
be easily utilised by other downstream methods in the novel miRNA identification 
process. It works by sliding an analysis window of predefined size over sections of 
genome. This window advances along the genome in predefined increments. All 
RNA secondary structures formed by the sequence in each window are predicted 
using the in-built RNAfold algorithm. Any hairpins that form are identified and 
Method Description Reference 
Bentwich-Method 
Involves, predicting hairpins in genomes, 
filtering predicted hairpins based on overlap 
with other known RNA transcripts and 
scoring based on stability and structure 
(Not publically available) 
Bentwich et al 
(2005) 
Pfeffer-SVM-Method 
Uses a support- vector machine (SVM) 
learning algorithm to predict pre-miRNAs in 
genomes (Not publically available)  
Pfeffer et al (2005b) 
VMir  
 
Predicts pre-miRNAs in viral genomes, 
assigns scores to hairpins based on 
structural consistency with pre-miRNAs and 
stability.  
Grundhoff et al  
(2006) 
MiRank  
Predicts hairpins using RNAfold. Uses 
random-walk machine learning algorithm to 
assess hairpins. Requires a small amount 
of known miRNAs from the genome in 
question in order to predict novel miRNAs 
Xu et al (2008) 
SSC Profiler 
Scans genomes for hairpins. Uses a 
Hidden Markov Model based method to 
assess hairpins. Only for available for use 
with human genome. 
Oulas et al (2009) 
NOVOMIR   
Searches for hairpins in genomes using 
RNAfold. Evaluates and scores predicted 
precursors based on consistency with plant 
miRNAs. 
Teune and Steger 
(2010) 
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scored. The scoring system is based on structural features and similarity to bone fide 
pre-miRNA structures (see Grundhoff et al. (2006) for a more detailed account of 
this scoring system). Hairpins from different analysis windows are compared and 
classified as main, subsidiary or repeated Hairpins (MHPs, SHPs, or RHPs, 
respectively). They are then grouped into local and/or repeat families. Local families 
consist of 2 or more hairpins forming at the same location and sharing the same core 
loop sequence but differing in stem length. These are simply variations of essentially 
the same hairpin that have formed differently in separate analysis windows. These 
differences in the predicted structure occur due to slight changes in the flanking 
sequences available for folding calculations in each analysis window. Within each 
local family, the longest hairpin is designated as the MHP and shorter variations of 
this hairpin (identified in different analysis windows) are designated SHPs. Repeat 
groups consist of hairpins located at different parts of the genome that have the same 
sequence and structure. Within these repeat groups, the hairpin located nearest to the 
5’  end of the genome (based on the forward strand) is designated as the MHP of the 
group and all other repeats of this are designated RHPs. Individual hairpins that are 
not part of local or repeat groups are by default classified as MHPs. Each MHP is 
assigned an individual alphanumerical ID e.g. MD*** for regions on the forward 
strand and MR*** for regions on the reverse strand.  
 
The graphical output consists of a chart indicating the position of each predicted 
MHP (as a representative of each local hairpin family). Genome position is 
represented on the X-axis and the VMir score of each MHP is represented by the Y-
axis. Selecting individual MHPs will bring up a graphical representation of its 
structure in a window on the right hand side and includes information such as score, 
rank, window counts, SHPs, hairpin lengths, RNA sequence and individual hairpin 
structures in dot bracket-notation and in plain text format. To improve the quality of 
predictions VMir also allows results to be filtered based on several parameters: 
 
• Score: The higher the score, the more pre-miRNA-like the hairpin. Setting the 
score filters high eliminates non-pre-miRNA-like hairpins from the results 
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• Min/Max Hairpin Size: A lot of results fall outside the sizes ranges of bone 
fide pre-miRNA molecules. Setting appropriate size filters can get rid of 
these. 
 
• Window Count (WC): This is the number of windows in which a specific 
MHP or SHP was detected in during analysis. Adjacent windows will fold 
differently due to differing base composition at the beginning and ends of the 
sequence being analysed. A higher WC gives more confidence that the 
hairpin represents a stable structure within its specific local sequence context. 
The WC of a specific MHP or SHP is known as the absolute-WC. The 
combined values for absolute-WC for the MHP and all SHPs in a local HP 
family is known as the relative-WC and this acts as an indication of the 
overall stability of a given MHP site. Results can be filtered based on 
relative-WC, thus removing any unstable HPs on the basis that pre-miRNAs 
should be more stable than random HPs from other RNA transcripts. 
 
A significant advantage in using VMir is the fact that it also has integrated array 
design tool that will generate user specified probes (and control probes) to detect 
potential miRNAs derived from pre-miRNAs that it has predicted, thus aiding high 
throughput experimental evaluation of its predictions. In addition it will also accept 
imports of raw fluorescence data from subsequent DNA microarray experiments and 
carry out automated analysis of the data in order to identify positive signals for 
miRNAs from predicted precursors. 
 
1.7.1.2 Pre-miRNA classifiers 
Some methods of miRNA prediction concentrate on the classification of proposed 
pre-miRNAs that have been predicted by other means i.e. high throughput hairpin 
prediction in genomes (as described in section 1.7.1.1 ) or experimentally identified 
pre-miRNA candidates. Although classifiers do not predict pre-miRNAs themselves 
they do provide a useful way to filter prediction results. This is important sometimes 
because while most de novo prediction methods score hairpins, usually they do not 
classify them as pre-miRNAs or pseudo-pre-miRNAs, whereas classifiers will do this 
and in addition will usually provide associated probability scores. As expected, pre-
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miRNAs classified as having a high probability of being bone-fide pre-miRNAs  also 
score highly using de novo prediction methods, although classifiers generally analyse 
proposed pre-miRNAs in a much more thorough manner and also employ statistical 
methods. Pre-miRNA classifiers are ideal methods to use to support conclusions 
from de novo pre-miRNA prediction programs or experimentally identified pre-
miRNAs. Details of several of pre-miRNA classifiers are given in Table 1.6. 
 
Table 1.6 List of pre-miRNA classifier methods 
 
Method Description Reference 
Triplet-SVM See text below (Xue et al., 2005) 
MiPred See text below (Jiang et al., 2007) 
miPred 
SVM (support vector machine) based 
approach where classification based on 23 
global and intrinsic features of pre-miRNAs 
(Ng and Mishra, 
2007) 
microPred SVM based approach similar to miPred but 
used much higher quality training data sets 
(Batuwita and 
Palade, 2009) 
CSHMM-Method 
Uses of a context-sensitive-hidden-Markov-
model to estimate the probability that a 
given hairpin is a real pre-miRNA. 
(Agarwal et al., 2010) 
miRD  
Uses 2 strategies to (A) to classify multi-
stem pre-miRNA and (B) to classify 
standard single-stem pre-miRNAs using 59 
features based on sequence and structural 
composition  
(Zhang et al., 2011b) 
                                                                                                                                                                                                                                                                                                                                                                                                                            
 
In theory, any of these are suitable for classification of viral pre-miRNA candidates. 
However some of these methods have been directly compared to each other in terms 
of performance and the results of these comparisons may be useful when it comes to 
selecting what method(s) are most suitable for particular studies. A comparison of 
MiPred and Triplet-SVM showed that MiPred performed better at identifying 
pseudo-pre-miRNAs, correctly classifying 96% of them compared to Triplet-SVM 
(86%) (Sinha et al., 2009). MiPred takes advantage of a novel machine learning 
algorithm known as ‘Random Forest’  that takes into account local contiguous 
structure-sequence composition. This is based on earlier observations that the local 
sequence and structural features (especially the stem) are important pre-miRNA for 
distinguishing between genuine pre-miRNAs and random hairpins. There appears to 
be a subtle pattern to the type and frequency of sub-structures and sequence motifs 
that are most likely to be present in pre-miRNA stems. In addition these features will 
have a tendency to make pre-miRNAs more stable than other types of hairpins 
(Bonnet et al., 2004b). Before Jiang et al, (2007) developed MiPred, Xue et al, 
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(2005) had developed a triplet-SVM to analyse local contiguous sequence structure 
composition of pre-miRNAs. The approach involved structural analysis of hairpins 
by focusing on 3 adjacent stem nucleotides at a time, referring to these as triplets. 
Each triplet was described in terms of its sequence and structure, with the sequence 
defined by the middle nucleotide and the structure defined as either "(((", "((.", "(..", 
"(.(", ".((", ".(.", "..(" or "..." with "." meaning unpaired and "(" meaning paired. As 
there are 4 different middle nucleotide possibilities there are 32 possible sequence-
structure triplets denoted as “ A(((“  “ C(((“  etc…  In this case a type of machine 
learning algorithm known as a ‘support-vector-machine’  was used to study a training 
data set consisting of bone-fide pre-miRNAs and pseudo-pre-miRNAs and take into 
account patterns of triplets present. This was the basis of the triplet-SVM method 
(Xue et al., 2005). To develop MiPred, Jiang et al, (2007) further built on the idea 
behind triplet-SVM by using an improved machine learning method known as 
Random-Forest (introduced already). This was also combined with the use of p-value 
of randomisation tests to assess the statistical significance of the low minimum free 
energy (MFE) displayed by potential pre-miRNAs. This involves randomly shuffling 
the sequence 1000 times, measuring the MFE of new structures formed and 
analysing the distribution of MFE values to assign a p-value to the MFE of proposed 
pre-miRNAs. The output from MiPred consists of classification of a predicted pre-
miRNA as “ pre-miRNA” , “ pseudo-pre-miRNA”  or not a “ pre-miRNA”  with an 
associated percent confidence and a p-value of randomisation. Interestingly Jiang et 
al, (2007) also showed this p-value of randomisation to be the most important feature 
for distinguishing between real and pseudo pre-miRNAs. 
 
A separate performance comparison between the CSHMM-Method and miPred (not 
to be confused with MiPred) showed that the CSHMM-method performed slightly 
better at identifying pseudo-pre-miRNAs (98% vs. 98.4%) (Agarwal et al., 2010). In 
the CSHMM-method, classification is based on the use of a context-sensitive-hidden-
Markov-model to estimate the probability that a given hairpin is a real pre-miRNA. 
Its output consists of the predicted pre-miRNA structure and probability score. This 
is very different the Random-Forest machine learning approach used by MiPred, 
although both methods appear to be able to adequately differentiate between real and 
pseudo pre-miRNAs and may be best used in combination for identifying genuine 
viral pre miRNAs.  
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1.7.2 Experimental detection of novel viral miRNAs. 
Ultimately, conclusive evidence of the existence of predicted miRNA genes can only 
be found through experimental evaluation. Common approaches to this are described 
below.  
 
1.7.2.1 Small RNA Sequencing 
Sequencing of small RNAs from cells or tissue has provided an ideal way to identify 
novel non-conserved miRNAs. MiRNAs make up a very small percentage of total 
RNA (Masotti et al., 2009). Therefore, in order to improve the coverage of small 
RNAs and reduce background noise attributed to non-miRNA transcripts, samples 
are generally specifically enriched for miRNAs before sequencing. This is done by 
size fractionation through PAGE, where generally only RNA within the miRNA size 
range (17-25nt) is isolated.  
 
Sample preparation involves an initial step to convert unknown single-stranded RNA 
(ssRNA) transcripts into a double-stranded DNA (dsDNA) sequencing library. This 
can be done in a number of steps regardless of the sequence of the ssRNAs present in 
the sample. It involves the ligation of specific adaptors to the 5’  and 3’  ends of all 
ssRNA species followed by RT-PCR using primers specific to the adaptors. T4 RNA 
ligase 1 is commonly used to carry out ligation of these adaptors. It will readily ligate 
ssRNA strands in the presence of Adenosine triphosphate (ATP) provided one strand 
has a 3’  hydroxyl group (OH) (acceptor) and the other has a 5’  phosphate group 
(PO4) (donor). T4 RNA ligase 1 becomes adenylated by ATP resulting in the 
covalent attachment of adenosine monophosphate (AMP) to the enzyme. This AMP 
is then transferred to the PO4 group of the donor. T4 ligase 1 then catalyses the attack 
of the adenylated donor by the OH group of the acceptor, resulting in the formation 
of a new phosphodiester bond and release of the AMP (Ho et al., 2004). For correct 
sample preparation it is vital that adaptor ligation occurs correctly, i.e. specific 
ligation of 5’  and 3’  adaptors to their respective ends only, without 
concatamerization or circularisation. The key to achieving this is through selective, 
reversible blocking of adaptor/RNA terminals (making them refractory to ligation). 
There are two approaches to this. Both involve carrying out 5’  and 3’  adaptor ligation 
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separately and are described by Pfeffer et al (2005a). The first approach, referred to 
as the Basic Protocol, involves dephosphorylation of ssRNA with alkaline 
phosphatase to remove 5’  donor groups and then carrying out 3’ adaptor ligation 
using an adaptor with a blocked 3’  OH group. The resulting products (only 
consisting of ssRNA with 3’  ends ligated to 3’  adaptors) are then separated from 
non-ligated adaptors, the 5’  donor group is re-introduced to the ssRNA through 
phosphorylation using T4 polynucleotide kinase and then 5’  adaptor ligation takes 
place using an adaptor containing no 5’ donor group. This results in ligation of the 5’  
ends of ssRNA to 5’  adaptors only. The second protocol, referred to as the Alternate 
Protocol, involves 3’  adaptor ligation in the absence of ATP using a 5’  pre-
adenylated 3’  adaptor (again with a blocked OH group on the 3’  end). As the adapter 
is pre-adenylated there is no need for ATP and the 3’  adaptor can only ligate to the 3’  
end of the ssRNA. This circumvents the need for dephosphorylation and re-
phosphorylation of the ssRNA. This process in outlined in Figure 1.10. 
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Figure 1.10 Sequencing Library preparation 
Diagram taken from Pfeffer et al (2005a) 
 
Although this can be done using T4 RNA ligase, a mutant of T4 RNA ligase, known 
as ‘T4-Rnl2-truncated’ , is much more efficient at joining 5’  pre-adenylated adaptors 
to 3’  ends of ssRNA and in addition, unlike T4 RNA ligase 1, it does not have a 
tendency to adenylate the 5’  end of ssRNA and therefore largely eliminates 
unwanted low-level ligation of 3’  adaptors to 5’  ends of ssRNA species (Viollet et 
al., 2011). 
 
Small RNA sequences can be determined following their conversion to double-
stranded cDNA. Initially, cloning of such products followed by low throughput dye 
terminator sequencing was a popular approach to miRNA discovery and it was 
through this approach that the first viral miRNAs were discovered (Pfeffer et al., 
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2004). In recent times, high throughput deep sequencing has become the favoured 
approach to novel miRNA discovery due to the shear depth of coverage that it offers. 
It allows and unprecedented sensitivity in the profiling of RNA transcripts making it 
theoretically possible to detect every RNA species present in a given sample within a 
short time period. There are three main deep sequencing technologies in widespread 
use: the Illumina Genome Analyzer, the Applied Biosystems SOLiD Sequencer and 
the Roche/454 FLX Pyrosequencer These are comprehensively reviewed elsewhere 
(Mardis, 2008). The most popular technology used for miRNA discovery is Illumina 
Genome Analyzer (Bentley et al., 2008). This offers very high coverage of approx 
20-25 million reads per sample lane and has been extensively used to identify novel 
herpesvirus miRNAs from infected cells (Glazov et al., 2010; Jurak et al., 2010; 
Meshesha et al., 2012; Reese et al., 2010; Riley et al., 2010; Umbach and Cullen, 
2010; Umbach et al., 2010). Using Illumina technology for miRNA sequencing, 
samples are prepared in a similar manner to that described by Pfeffer et al (2005a) 
(using the Alternate protocol). The sequences flanking the small RNAs in the 
resulting dsDNA sequencing libraries are highly specific and facilitate the 
subsequent process of high throughput sequencing. This process is outlined in Figure 
1.11. 
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(a) 
(b) 
(c) 
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 Figure 1.11 Illumina sequencing process 
(a) Sequencing libraries are denatured and one end of individual ssDNA molecules becomes bound 
randomly all over the surface of the flow cell. The flow cell surface is also coated with a dense lawn 
of primers (also bound to flow cell on one end) of which they are 2 types, each complementary to one 
of the adaptor sequences. (b) The ssDNA template strands are allowed to anneal to these flow cell 
primers, and then these primers are extended through PCR to create a complementary strand. This is 
known as “ bridge-amplification”  and this process continues until the area immediately around the 
original template strand becomes populated with millions of double-stranded copies of this molecule 
to form a cluster. At the same time, millions of other individual clusters (representing other template 
strands with different sequences) are also formed all over the flow cell surface. (c) All complementary 
strands are removed by chemical cleavage of one flow cell primer (in this diagram it is the blue one). 
Then a sequencing primer (complementary to the remaining portion of the blue adaptor on the 
unbound end of the template strands) is added. Sequencing occurs through the extension of this 
sequencing primer with the incorporation of labelled nucleotides. Each nucleotide has a reversible 
terminator, so extension stops after one nucleotide is inserted at which point a high resolution image 
of the flow cell is taken. Each cluster gives a fluorescent signal corresponding to the base being added 
thus allowing identification of the first base added in each cluster. The terminator dyes are then 
removed allowing the addition of another fluorescent nucleotide and the flow cell is imaged again 
allowing the identification of the next base in each cluster. This process continues resulting in the 
generation of a series of images, each recording what base was incorporated in each cluster at each 
extension step. ‘Basecalling’  is done using an algorithm that monitors the change in emission colour 
from each cluster in each image/extension step, revealing the sequence of the ssDNA molecule that is 
generated in each cluster. Diagrams adapted from Illumina.com (2010) 
 
 
1.7.2.2 Analysis of Deep sequencing data 
Once small RNAs are sequenced they are mapped to a genome, using high 
throughput mapping software. Novel non-conserved miRNAs can then be identified 
by checking for the presence of predicted pre-miRNAs overlapping the same 
genomic loci as these small RNAs in the absence of any overlap with any other RNA 
species such as mRNAs, rRNAs, tRNAs etc. Small RNAs mapping to the stem in 
close proximity to the loop are designated as either 5’  or 3’  ‘miRNAs’  depending on 
the arm of the stem to which they map.  
 
In addition to identifying the exact sequence of miRNAs derived from predicted pre-
miRNA stems, sequencing can also supply additional levels of relevant information. 
For example, depending on the depth of coverage and expression levels of the 
transcripts themselves, it is often the case that many more small RNAs (other than 
miRNAs) will map to the same pre-miRNA, although the miRNAs will be the most 
abundant. IsomiRs associated with each miRNA (lesser abundant variations of the 
miRNAs display varying degrees of 5’  and 3’  terminal heterogeneity) can also be 
detected. Additional pre-miRNA-derived transcripts may also be observed mapping 
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to the stem immediately adjacent to the miRNAs, these are referred to as microRNA-
offset-RNAs (moRNAs) and are a separate functional class of small RNA distinct 
from miRNAs (Shi et al., 2009). If miRNAs are identified from both arms of the pre-
miRNA, this allows the prediction of the intermediate mature-miRNA-duplex 
structure, which should have characteristic 3’  overhangs. Quantitative information 
regarding the frequency of each transcript in the data is also quite useful and allows 
designation of major form/minor form strands from a given pre-miRNA among other 
things.  
 
All of these additional layers of information beyond simply identifying the method 
mature miRNA sequences themselves are very important. They help distinguish 
between miRNAs and other small transcripts in the sequencing data and are 
especially relevant to the process of identifying novel non-conserved miRNAs from 
such data. For this, it is important to also take into account the features of all the 
small RNAs that have mapped to pre-miRNAs and also the features of the pre-
miRNA themselves as a whole. With this in mind, recent studies have aimed to 
define suitable criteria for assessing such features in order to aid the correct 
interpretation of miRNA and non-miRNA signals in deep sequencing data (Chiang et 
al., 2010; Friedländer et al., 2008; Hendrix et al., 2010). As a result, a general 
consensus has started to materialize. These were summarized by Kozomara and 
Griffiths-Jones (2011): 
 
 
1. Putative miRNAs must occur multiple times in the data (typically read counts 
of 10-20 are used) and ideally should be found in more than one experiment. 
 
2. Putative miRNAs should map to regions that are predicted to give rise to 
stable pre-miRNA-like secondary structures (ideally this would also 
incorporate the use of information about predicted pre-miRNAs from de novo 
prediction methods and pre-miRNA classifiers). Reads mapping to many 
regions in the genome should be eliminated. 
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3. Putative miRNAs should not overlap with any other RNA species such as 
mRNAs, rRNAs, tRNAs etc as it is difficult to prove that they do not 
represent degradation fragments from such transcripts. 
 
4. IsomiRs of miRNAs may display heterogeneity on both ends relative to the 
start and end positions of miRNAs although their 5’  ends should display 
significantly less heterogeneity. 
 
5. Ideally both 5’  and 3’  arm miRNAs should be identified from a predicted 
hairpin and should form a mature-miRNA-duplex that displays the 
appropriate 3’  overhangs. 
  
In addition to the points mentioned above, Kozomara and Griffiths-Jones (2011) 
highlighted the fact that alignment signatures of miRNAs mapping to pre-miRNAs 
are distinctly different from that of non-miRNA small RNAs mapping to other parts 
of the genome. This is because pre-miRNAs are cleaved up in a very specific manner 
by RNase III enzymes Dicer and Drosha. This results in reads mapping to the pre-
miRNA sequence in a “ stack-like”  pattern, with each stack representing a distinct 
type of small RNA derived from processing of the pre-miRNA i.e. 5’  and 3’ miRNAs 
and associated isomiRs (and 5’  moRNA and/or 3’ moRNAs if present), with little or 
no reads mapping to the loop. In addition more pronounced 3’  end heterogeneity 
should be apparent in such alignment profiles. By contrast, small RNA reads that 
represent random degradation products from larger transcripts are more likely to map 
to genomes in the form of overlapping reads offset across the entire length of the 
degraded transcript due to the fact that their degradation is an entirely random 
process (Figure 1.12) 
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Figure 1.12 Examples of miRNA-like and non-miRNA-like alignment signatures 
(a) miRNA-like alignment signature (b) non-miRNA-like alignment signature 
 
 
Deep sequencing generates large amount of data, for example each flow cell from an 
Illumina genome analyser will produce ~25 million reads. While deep sequencing is 
a very useful tool, analysing such data for the presence of signals associated with 
novel non-conserved miRNAs is an enormous task in the context of eukaryotic 
organisms in contrast to viral genomes, which are much more manageable. Due to 
this, researchers have found it necessary to develop automated methods to “ mine”  
deep sequencing data for novel non-conserved miRNAs. In recent years several 
algorithms have been developed to address this problem. They all start off by 
assessing the genomic locus of mapped small RNAs for the presence of pre-miRNA 
like hairpins. They differ however in the methods they use to classify small RNAs as 
being genuine miRNAs or not. They work in similar ways to de novo prediction 
methods (discussed earlier) but in this case the algorithms only assess sequences 
flanking loci that have small RNAs mapping to them. Some also cross-reference 
these small RNAs with known mature miRNAs and pre-miRNAs in order to infer the 
existence of new evolutionarily conserved miRNAs, or known miRNAs from the 
organism in question. Details of several automated miRNA identification methods 
are given in Table 1.7. 
 
(b) 
(a) 
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Table 1.7 List of methods for the automated identification of miRNAs from deep sequencing 
data
Method Approach Reference 
MiRDeep  See below 
Friedländer et al. 
(2008) Updated to 
miRDeep2 by 
Friedländer et al. 
(2012)   
miRExpress 
Aligns reads to known miRNAs from same 
organism (i.e. identifying known miRNAs) and 
miRNAs form other organisms (i.e. identifying or 
novel conserved miRNAs) 
Wang et al. 
(2009) 
Mireap See below 
No publication 
associated with its 
development. First 
used by Zhang et al 
(2009). Wang et al, 
(2011) referred to it 
as “developed” by 
them. Always 
referenced as  
http://sourceforge.net
/projects/Mireap/ 
(2013) 
MIReNA Uses combinatorial rules to identify pre-miRNAs from mapped reads.  
Mathelier and 
Carbone (2010) 
miRTRAP 
Takes into account features of miRNA  
biogenesis. In addition, it takes into account the 
prevalence of small RNAs from anti-sense loci 
on the basis that some miRNAs will have either 
perfectly matched antisense RNAs, or none, but 
never offset antisense small RNAs. It also takes 
into account reads from flanking loci, as the 
presence of moRNAs can support miRNA 
predictions in some genomes (in particular 
Caenorhabditis elegans). 
Hendrix et al.(2010) 
mirTools 
Classifies small RNA reads from deep 
sequencing as known miRNAs, ncRNA, mRNA, 
genomic repeats, annotates known miRNAs 
present, predicts new miRNAs using miRDeep 
core algorithm. Very useful for well-annotated 
genomes.  
Zhu et al., 
(2010a) 
DSAP 
Web based tool. Filters out reads derived from 
non-miRNA known ncRNA and miRNAs Allows 
comparative miRNA expression analysis and 
cross species comparative analysis. Clustered 
sequences (possible miRNAs and isomiRs) that 
do not match to ncRNA or known miRNAs can 
be downloaded and analysed further elsewhere.   
(Huang et al., 2010) 
miRanalyzer 
Finds novel miRNAs by first filtering reads 
through MirBase and RefSeq. Then maps 
remaining reads to genome, checks for pre-
miRNAs and used Random Forest model to 
predict probability of candidates being real 
miRNAs. Also takes into account evidence from 
multiple experiments to build consensus on 
miRNA and pre-miRNA annotation. 
Hackenberg et al., 
(2011) 
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These kinds of programs differ slightly in their approach and performance in terms of 
identifying known and novel miRNAs from deep sequencing data. The performances 
of several of these programs have been directly compared following analysis of the 
same datasets (Li et al., 2012). The programs included in this comparison study 
included miRDeep, Mireap, MIReNA, miRTRAP, miRanalyser, miRExpress, DSAP 
and mirTools. Overall it was found that Mireap and miRDeep were the most suitable 
for detection of novel miRNA signals in sequencing data from vertebrates (Li et al., 
2012). 
 
The miRDeep core algorithm was designed to accurately identify miRNAs within 
deep sequencing data. It looks for stacks of reads (miRNAs and isomiRs) mapping to 
the same genomic loci and excises the flanking sequence for further analysis. 
MiRDeep employs a probabilistic model of miRNA biogenesis to assess miRNA 
candidates. It takes into account read frequency, the positions occupied by small 
RNAs on predicted pre-miRNAs and pre-miRNA secondary structure. Firstly it 
recognises that miRNA alignment signatures should take the form of a stack-like 
pattern and that all small RNAs derived from genuine pre-miRNAs need to fall 
within one of these stacks (it tolerates a small amount of deviation from this model 
due to expected inconsistencies in miRNA processing). It takes into account features 
of pre-miRNA structure such as the extent of base-pairing between the mature and 
star miRNAs. In a similar way to MiPred (Jiang et al., 2007) it also assess the 
statistical significance of the MFE displayed by the pre-miRNAs by assigning a p-
value of randomisation to it. If candidate miRNA genes do not fit the model they are 
discarded and remaining sites are scored based in their overall consistency with the 
model. In addition, MiRDeep also estimates the false positive rate by carrying out 
statistical analysis of the classifications made by the mirDeep core algorithm. A new 
improved version of miRDeep, called miRDeep2 has also recently been developed 
(Friedländer et al., 2012). One of the improvements includes the recognition that 
micro-RNA-offset RNAs (moRNAs) may also cause extra stacks in the alignment 
signature if present. Steps have been taken to ensure that their presence does not 
interfere with the way that the algorithm defines the boundaries of potential pre-
miRNAs which was initially based on scanning for 1-3 stacks of reads mapped to the 
genome (i.e. 5’  and 3’  miRNA and possible loop). Specifically the improvement 
stops the occurrence of asymmetrically excised pre-miRNA sequences that were a 
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consequence of moRNAs not being taken into account (having not been discovered 
at the time) in the initial model. It is important to note that miRDeep does not 
identify moRNAs; it just ensures that they do not interfere with appropriate sequence 
excision if present. More information on small improvements to on the first version 
of MiRDeep are available in Friedländer et al. (2012).  
 
Mireap is also designed to look for novel miRNA signals within data from deep 
sequencing. Although it performed quite well in this respect when compared to other 
programs there is no information available as to how it was developed or how it 
works (Li et al., 2012). Despite this, it has a proven track record and has been used in 
many other studies since it was first used by Zhang et al (2009) 
 
An important factor in novel miRNA annotation is read frequency. Where miRNA 
enriched samples are used, it is expected that the most abundant reads in such 
samples are miRNAs. Therefore if transcripts map to predicted pre-miRNAs in a 
miRNA-like pattern the presence of high read counts (or read counts over 
background levels) strongly support annotation of these genes as miRNAs (Cullen, 
2011; Kozomara and Griffiths-Jones, 2011). Although the qualitative and 
quantitative data from deep sequencing is ideal for identifying novel miRNAs, deep 
sequencing has a tendency to suffer from enzymatic bias (Hafner et al., 2011; 
Sorefan et al., 2012). This is mainly due to the fact that sample preparation involves 
a series of enzymatic steps, each introducing its own bias towards or against specific 
transcripts depending on sequence content and resulting in over- or under 
representation respectively, in the sequencing data. As small RNA abundance is an 
important aspect of miRNA identification in sequencing data it is important that 
quantitative observations from deep sequencing experiments are verified using 
methods that are more quantitatively reliable (e.g. RT-qPCR) or are free from 
enzymatic bias (e.g. DNA microarray hybridization). 
 
1.7.2.3 DNA microarray hybridization 
DNA microarray hybridization is a very useful high throughput approach to analyse 
gene expression. There are two varieties of arrays, spotted and oligonucleotide. 
Spotted arrays are made by first synthesising oligonucleotides or cDNAs 
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complementary to target transcripts followed by their deposition or “ spotting”  onto 
the array surface. In the case of oligonucleotide arrays, cDNA probes are synthesised 
in-situ on the array surface. (Pease et al.(1994) and Nuwaysir et al.(2002)). 
Hybridizations with oligonucleotide arrays are much more sensitive and for this 
reason were used in this study (see diagram of oligonucleotide array and detection 
process in Figure 1.13). In studies on gene expression, samples can consist of cDNA 
(RNA samples reverse-transcribed for labelling purposes or in order to make them 
more stable), amplified cDNA or aRNA (amplified RNA) generated through in vitro 
transcription from cDNA due to the incorporation of a T7 promoter into the PolyT 
RT primers. Labelling can be done through the direct incorporation of labelled 
nucleotides during cDNA or aRNA preparation. Alternatively, the incorporation of 
modified nucleotides amenable to subsequent labelling is also a popular method (Do 
and Choi, 2007). Labels are usually cyanine dyes such as Cy3 and Cy5. Cy3 
fluorescence occurs in the yellow-green spectrum (emission peak ~570 nm) and Cy5 
fluorescence occurs in the red spectrum (emission peak ~670nm).  
 
DNA microarrays are an effective and sensitive tool for high throughput expression 
profiling of miRNAs (Baskerville and Bartel, 2005; Liu et al., 2004; Miska et al., 
2004; Thomson et al., 2004)  as well as miRNA discovery (Barad et al., 2004; 
Bentwich et al., 2005) including viral miRNA discovery (Grundhoff et al., 2006; Yao 
et al., 2012). The general sample preparation methods mentioned above work well 
for mRNA analysis, however they are not directly applicable to miRNAs due to the 
latter’ s small size and lack of a common tag (such as a polyA tail). This has been 
overcome through ligation of 3’  adaptors containing T7 promoters to miRNAs 
(Barad et al., 2004) allowing RT and subsequent generation of labelled 
complementary RNA (cRNA). Methods involving direct enzymatic labelling of 
miRNAs have also been developed (Shingara et al., 2005).  
 
When using DNA microarrays to detect miRNAs, it is best to use RNA that is 
enriched for miRNAs i.e. RNA <200nt in size (Barad et al., 2004; Bentwich et al., 
2005). This enrichment is necessary because miRNAs make up a very small 
percentage of total RNA (Masotti et al., 2009), and using such samples allows 
definitive distinguishing of miRNA signals from background. This is particularly 
important where novel non-conserved miRNA exist as their expression levels are 
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unknown and may be low. In such experiments probes are usually designed on the 
basis of non-conserved pre-miRNA predictions (Bentwich et al., 2005; Grundhoff et 
al., 2006). As pre-miRNAs are readily processed by cellular miRNA processing 
systems, fully intact pre-miRNAs can often be in extremely low abundance and it has 
been shown that DNA microarray hybridization is not a suitable method for detecting 
such transcripts even where samples were enriched for both miRNA and pre-
miRNAs (Barad et al., 2004; Grundhoff et al., 2006). Conversely, the smaller fully 
processed mature miRNAs derived from these pre-miRNAs can accumulate in higher 
levels once incorporated into the RISC and are therefore much more abundant and 
more readily detectable on arrays. For this reason, where novel non-conserved pre-
miRNAs are predicted and investigated by array analysis, probes are always 
designed to detect theoretical mature miRNAs derived from them, thus they are 
simply complementary to the stems of predicted pre-miRNAs (Bentwich et al., 2005; 
Grundhoff et al., 2006; Sullivan and Grundhoff, 2007). VMir is an example of a 
program that is used both to predict pre-miRNAs in viral genomes and also to design 
appropriate array probes in this manner as a means of facilitating high throughput 
experimental evaluation of predictions (Grundhoff et al., 2006). Importantly it 
designs control probes for such experiments and also analyses exported raw 
fluorescence data from subsequent experiments.  
 
Pre-miRNAs will generally not contribute to signals from such probes and so in 
some cases RNA within the pre-miRNA size range is even excluded in order to 
prepare samples that are specifically enriched for miRNAs. In fact, samples 
consisting of RNA <40 nt in size (Shingara et al., 2005) or even RNA exclusively 
within the miRNA size range of 17-25 nt (Grundhoff et al., 2006; Sullivan and 
Grundhoff, 2007) are best for use in miRNA expression analysis and/or miRNA 
discovery using arrays.  
 
Modifying RNA samples through enzymatic means prior to analysis will introduce 
certain biases into the results obtained, especially if PCR is involved. However 
sometimes this is a necessary part of the preparation process e.g. where sample 
quantity is limited (Livesey, 2003). If the latter is not an issue, enzymatic bias can be 
avoided by direct labelling of RNA (not aRNA or cRNA) through chemical methods 
where dyes are covalently attached to nucleotides (Wiegant et al., 1999). This 
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approach is more straightforward and flexible as it is applicable to both mRNA and 
miRNA. If enzymes can be avoided then array hybridization presents us with an 
ideal high throughput way to verify quantitative information generated by other 
methods that may suffer from enzymatic bias, such as deep sequencing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13 The DNA microarray hybridization process 
Labelled RNA/cDNA/aRNA is in red, labels are in green and oligonucleotide probes are in blue 
 
1.7.2.4 Northern blotting 
Although a less sensitive and lower throughput technique when compared to deep 
sequencing or DNA microarray hybridization, northern blotting remains one of the 
best ways to conclusively demonstrate the presence of novel miRNAs in a biological 
sample. This is due to the fact that it reveals the size of all RNA transcripts 
containing the target miRNA sequence across all RNA size ranges. Detection of bone 
fide miRNAs through northern blotting potentially allows the detection of two other 
distinct transcripts associated with miRNAs, namely the pre-miRNA and the pri-
miRNA. All of these thee transcripts may be detected simultaneously in the same 
sample and appear as three discrete bands, in their expected size ranges. Typically it 
is not possible to estimate the size of the pri-miRNA on the same gel as the miRNA 
and pre-miRNA (as the gels used are designed to resolve lower molecular weight 
RNA) although it is possible to compare the size of pre-miRNA and miRNA bands 
to their predicted sizes. The miRNA should be detected as a band in the 17-25 nt size 
range and the pre-miRNA should be typically in the 50-100 nt size range. 
Importantly, the presence of discrete bands in the absence of smearing indicates that 
the small RNAs being targeted are not the result of random degradation of larger 
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RNA molecules. Sometimes the miRNA will be detected alone in the absence of pre-
miRNAs or pri-miRNAs. Sometimes, somewhat counterintuitive to what would be 
expected, it is also possible to detect pre-miRNAs in the absence of miRNAs (Cui et 
al., 2006; Munson and Burch, 2012). Also in addition to the ~22 nt miRNA it is 
sometimes possible to detect additional  bands (within the 17-25nt range), 
representing highly abundant isomiRs of the miRNA (Cai et al., 2005). 
 
1.8 MiRNA Target prediction 
MiRNA target prediction is a useful way of inferring miRNA function and often acts 
as a basis for laboratory studies. The basic requirement of a potential target site is 
that it has a perfect complementary match to the seed region. Although looking for 
seed pairing is important, this criterion is not stringent enough, and on its own results 
in a high rate of false positives. Based on the characteristics of experimentally 
verified miRNA target sites, it has become apparent that it is necessary to also take 
into account other subtle criteria in order to improve target site prediction. These 
criteria relate to both the target sites themselves and surrounding sequence and 
include features such as seed pairing stability, 3’  pairing contribution (pattern of base 
pairing outside the seed), local AU content, target site abundance and even position 
in within a 3’  UTR (Garcia et al., 2011). Assessing potential target sites using these 
additional criteria is key to improving predictions and to help distinguish genuine 
miRNA target sites from background noise. Most miRNA target site prediction 
methods now take such additional features into account for this purpose and details 
of several of these methods are outlined in Table 1.8. 
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Table 1.8 List of miRNA target prediction methods 
 
Method Approach Reference 
DIANA-microT 
Slides a window along 3’ UTRs, at 1 nt 
increments; in each window it calculates the 
stability of miRNA binding (allowing 
mismatches) and compares it to the stability 
of a perfectly complementary sequence. It 
searches for miRNA/mRNA duplexes with 
canonical structure (i.e. 7-9 nt match in 5’ 
miRNA, 6 nt match to seed, central bulge and 
supplementary pairing at the 3’ in miRNA) It 
also estimates signal-to-noise ratio based on 
randomized miRNA sequences, give a 
probability score to each result and takes into 
account evolutionary conservation of target 
sites.  
Kiriakidou et al. (2004) 
miRanda 
Looks for seed complementarity, seed 
mismatches and gaps. It examines 
miRNA/mRNA duplex stability and the extent 
of compensatory base pairing outside seed 
regions. It adds extra weight to predictions for 
miRNAs with multiple target sites in the same 
3’ UTR. Also takes into account evolutionary 
conservation of target sites. 
John et al. (2004) 
TargetScan See below 
Lewis et al. (2005), 
updated by Grimson et 
al. (2007) and Garcia et 
al. (2011)  
PicTar 
Looks for highly complementary regions in 
highly conserved parts of 3’ UTRs. It 
examines the stability of miRNA/mRNA 
duplexes and scores results using a Hidden 
Markov Model, favouring miRNAs with 
multiple target sites in the same 3’ UTRs and 
takes into account the conservation of target 
sites.   
Krek et al. (2005) 
RNA22 
Unlike other methods RNA22 first locates 
potential miRNA binding sites in 3’ UTRs by 
looking for “hot-spots” that display certain 
patterns and then matches this site to an 
appropriate targeting miRNA and makes 
decisions on appropriate matches based on 
min/max base-paired/in-paired nucleotides in 
potential duplexes and stability. Prediction 
does not rely on conservation.  
Miranda et al. (2006) 
PITA See Below Kertesz et al. (2007) 
 
 
Although many approaches to miRNA target prediction have been developed, the 
high degree of heterogeneity in miRNA/mRNA interactions means that there is no 
perfect model to accurately predict all types of miRNA target sites. However, some 
have been shown to work quite well. TargetScan (Garcia et al., 2011; Grimson et al., 
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2007; Lewis et al., 2005) is a popular “ rule-based”  approach for predicting miRNA 
target sites that also takes into account target site conservation, making it directly 
applicable to finding target sites for eukaryotic miRNAs. Using the web interface, 
the user is restricted to searching for targets to known miRNAs in 3’  UTRs of a small 
variety of model organisms. Custom miRNA (i.e. novel miRNA) target searches can 
also be done, but searches are restricted to 3’  UTRs from the same small range of 
model organisms. This approach is not suited to looking for targets for a high number 
of novel miRNAs in a custom dataset of 3’  UTRs. However the source code for the 
algorithm is freely available allowing complete customisation of the process to suit 
the needs of specific studies. In addition, an analysis can also be done without 
needing to take conservation into account. Overall therefore TargetScan is a flexible 
method that can be applied to wide range of studies. It ranks predicted sites by 
assigning a context score to them based on how well they conform to the ideal 
characteristics of target sites. Experimental evaluation of predictions has shown good 
correlation between context score and protein down-regulation (Baek et al., 2008)  
 
There are two main algorithms in the TargetScan pipeline, namely TargetScan60 and 
TargetScan60-Context-Scores. The output from the former is used as input for the 
latter. TargetScan60 performs a straightforward search for target sites in 3’ UTRs 
based on matches to seed regions. In its simplest form, a match consists of a 
sequence complementary to the six bases of a seed region (bases 2-7). Sites with 
such straightforward seed matches are known as 6-mer sites. Sites complementary to 
bases 2-8 are considered more significant than 6-mer sites and are referred to as 7-
mer-m8 sites. In bone-fide target sites, there seems to be a preference for the 
presence of a conserved adenine on the 3’  end (opposite position 1 on the miRNA), 
sites with straightforward seed matches that also have this feature are called 7-mer-
A1 sites. Furthermore, 7-mer-m8 sites that also have an A at their 3’  ends are known 
as 8-mer-1A sites. Understandably some of these types of target sites perform better 
than others and as such they display the following hierarchy of site efficacy: 8mer-
1A > 7mer-m8 > 7mer-1A > 6mer (Grimson et al., 2007). Six-mer sites are by far the 
least effective and are typically identified by chance more frequently than other types 
of sites. For this reason, TargetScan60 disregards 6-mer sites in searches. The output 
consists of information such as the name, site-type (8mer-1A, 7mer-m8 or 7mer-A1) 
and position of the 3’  UTR containing the possible target site. The output can then be 
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used for a more detailed analysis by another algorithm called TargetScan-Context-
Scores.  
 
The second program in the pipeline is called TargetScan60-Context-Scores. This 
algorithm takes the predicted target sites from TargetScan60 and analyses them 
further based on the stability of the pairing between the miRNA and target site as 
well as taking into account its local sequence context. Sites are given a context score 
and ranked based on their consistency with the characteristics of bone fide miRNA 
target sites. Characteristics that contribute to the context score include.  
 
• Seed-Pairing-Stability (SPS): There is a correlation between greater SPS and 
target site efficacy and this is taken into account when ranking potential 
target sites (Garcia et al., 2011).  
 
• 3’  Pairing Contribution: Additional contributions to overall miRNA-target 
stability are made through base pairing outside the seed region. There is a 
pattern to this type of base pairing. It has a tendency to be contiguous, 
uninterrupted by bulges, wobbles or mismatches. It also seems to mainly 
involve bases at positions 13–16 on the miRNA in particular. In fact, pairing 
at these positions is found to be more important for efficacy than pairing 
anywhere else in the 3’  end of the miRNA, (Grimson et al., 2007). Base 
pairing at the 3’  end can supplement SPS or compensate for weak SPS. When 
scoring predictions TargetScan60-Context-Scores looks specifically for these 
kinds of patterns of base pairing at the 3’  end of miRNAs. 
 
• Local AU content: There is a strong preference for high AU content in 
sequences immediately flanking the miRNA target site with this high AU 
content tailing off ~30 nt upstream and downstream of the target site 
(Grimson et al., 2007) 
 
• Position in 3’  UTR: Target sites tend to distributed in a specific pattern within 
3’  UTRs with most known target sites clustered at both ends of 3’  UTRs 
rather than in the centre (Hon and Zhang, 2007). Despite the fact that many 
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target sites can be predicted in the centres of 3’  UTRs, sites occurring near 
the beginning (excluding the first 15 nt) or near the end of 3’  UTRs are 
generally much more effective and therefore score higher (Grimson et al., 
2007).  
 
• Target Abundance (TA): This is the number of times that the same target site 
occurs in other 3’  UTRs. The lower the TA the better, as miRNAs will not be 
spread as thinly between many target transcripts which may reduce their 
overall efficacy. This is subjective of course, considering differences in (and 
fluctuations of) miRNA expression levels (Garcia et al., 2011).  
 
• Seed match type: Site type also contributes to the score based on the 
following order of efficacy -8mer-1A > 7mer-m8 > 7mer-A1 
 
The output from TargetScan60-Context-Scores consists of a summary of each target 
site in terms of how is scores with regard to the characteristics described above. The 
sum of all of these scores is called the context+ score with a lower value here 
meaning a better quality match. 
 
Although TargetScan looks for many important attributes when predicting potential 
miRNA target sites allowing it to make high quality predictions, sometimes high 
confidence target sites do not have the expected mRNA knockdown efficacy when 
tested experimentally while other lower ranked sites might perform better. This is 
often due to target site accessibility (or lack thereof). This is because 3’  UTRs are 
capable of forming complex RNA secondary structures. Sometimes the target site 
can be incorporated into a stable secondary structure, or sometimes if not then the 
formation of complex structures surrounding the target can physically prevent the 
RISC from accessing the site. Another method of miRNA target prediction known as 
PITA addresses this problem by taking target site accessibility into account . It works 
by initially identifying target sites based on seed region matches. It does this by 
simply looking for 6-8 nt matches starting from position 2 on the miRNA (base-pair 
wobbles are allowed as an option). Once a target site is identified the secondary 
structures that it may form (and secondary structures of regions 70 nt upstream and 
downstream) are then predicted and the minimum free energies of these structures 
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are calculated. The minimum free energy of the miRNA-target site base pairing is 
also calculated. The algorithm then compares the potential energy lost by opening 
these secondary structures (GOpen) to the potential energy gained by binding of the 
miRNA to the target site instead (GDuplex). This is done by calculating GDuplex-
GOpen and the difference is referred to as G. If this value is still negative then 
there is more energy to be gained by miRNA-target base pairing and thus this is the 
more energetically favourable outcome, see Figure 1.14 below. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14 Principles behind miRNA target prediction using PITA 
Diagram illustrating the transition between unbound miRNA/mRNA duplex and bound 
miRNA/mRNA duplex. The free energy gained from this transition is calculated using the equation 
shown in the middle. Diagram taken from (Kertesz et al., 2007) 
 
The PITA output consists of a summary of each predicted target site including co-
ordinates, minimum free energies of structures formed, target-miRNA pairing and 
G. The lower the G the more energetically favourable the miRNA-target 
interaction is compared to the formation or persistence of structures at or around the 
target site. If a miRNA has several target sites on the same 3’  UTR, PITA calculates 
the overall miRNA-UTR interaction score for that site. The overall miRNA-UTR 
interaction score is equal to as G if a miRNA targets only one site on a given 3’  
UTR. 
 
1.9 Aims of this study 
In recent years viral miRNAs have been shown be important regulators of both host 
and viral genes during both lytic and latent infections (Kincaid and Sullivan, 2012) . 
In particular, they have been found to be expressed by some members of the 
Herpesviridae family. Current evidence suggests that the presence of miRNA-coding 
genes in some family members may be due to their distinct biological characteristics 
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(Section 1.6.1.2). Although a distantly related grouping, members of the 
Alloherpesviridae family display many of the same biological characteristics as the 
Herpesviridae (Section 1.3). Thus, it is likely that they also encode miRNAs of their 
own. Based on the general lack of miRNA conservation among viruses, any such 
miRNA-coding sequences are also likely to be non-conserved, although they may 
have analogous functions (Section 1.5). Interestingly, it is equally possible that they 
have completely different functions and act in different ways to promote and/or 
control various stages of the viral life cycle. In light of this, a study to identify 
miRNAs encoded by members of the Alloherpesviridae family is therefore justified 
and may help further our understanding of the biology of these viruses. 
 
CyHV-3 is a highly pathogenic member of the Alloherpesviridae. Its ability to 
establish latent infections in response to non-permissive temperatures has been well- 
documented, although the characterisation of the molecular basis of CyHV-3 latency 
is still in its infancy (Section 1.4.10.). Due to their strong association with latency in 
other HVs, the identification of CyHV-3-encoded miRNAs might provide useful 
insights into how CyHV-3 modulates viral and/or host gene expression during 
latency. It is likely that such transcripts would also have roles during lytic infections, 
thus also furthering our understanding of the molecular basis of CyHV-3 infections 
in general.  Knowledge of CyHV-3 transcripts expressed during latency may enable 
the development of more sensitive and suitable diagnostic methods to identify latent 
carriers (Section 1.4.10.6).  
 
The first step towards this is the identification of CyHV-3-encoded miRNAs and 
hence this was the main aim of this study. The primary samples used here to identify 
CyHV-3 miRNAs consisted of RNA prepared from in vitro lytic infections, 
facilitating the identification of miRNAs expressed during the virus production cycle 
and that may also remain expressed during latency (as is the case with most other HV 
miRNAs). 
 
First, the presence of pre-miRNA-coding sequences were predicted following 
analysis of the CyHV-3 genome, thus providing a theoretical basis for the study. 
These predictions were then experimentally evaluated using various methods to 
identify and characterise the candidate CyHV-3 miRNAs. These methods included 
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•To measure the relative levels of CyHV-3 miRNAs in samples used for deep sequencing and to compare to read count 
data 
•To assess expression of CyHV-3 miRNAs over the course of an in vitro lytic infection 
•To confirm that the same miRNAs are expressed during lytic infections in vivo  
•To test for the expression the same miRNAs in tissues of long term survivors (i.e. possible latent carriers)   
In silico analysis: Prediction of CyHV-3 encoded pre-miRNAs 
Sequencing of 17-25 nt RNA from in vitro lytic infections 
DNA Microarray Hybridization analysis 
Northern Blotting 
Real-Time Stem-Loop RT-PCR 
• Identification of small RNAs mapping to predicted CyHV-3 pre-miRNAs 
• Identification of high probability pre-miRNAs 
• Targeting of miRNAs derived from high and low probability CyHV-3 pre-miRNA candidates using 
miRNA enriched and non miRNA size fractions in order to identify and eliminate small RNAs likely to 
be degradation products of larger transcripts rather than miRNAs 
• To verify the abundance of small RNAs in the absence of potential enzymatic bias 
Northern blotting of the most abundant miRNAs in order to show characteristic miRNA signature  
(i.e. discrete bands representing mature miRNA, pre-miRNA and pri-miRNA) 
Identification of pre-miRNA 
conservation in other CyHVs  
Prediction of 
miRNA targets in 
CyHV-3 genome  
Identification of seed region 
conservation with host and 
other viral miRNAs 
  
deep sequencing, DNA microarray hybridization, northern blotting and reverse 
transcription real-time PCR (RT-qPCR). The end goal of this study was to use RT-
qPCR to test for the expression of these miRNAs in various tissues from lytically 
infected fish and also in long-term healthy survivors of high mortality outbreaks (i.e. 
fish that are likely to be latent carriers). Finally, CyHV-3 miRNAs were further 
characterized in terms of sequence conservation and potential functions. The 
workflow followed is outlined in Figure 1.15.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15 Outline of the workflow used for the identification and characterisation of CyHV-3 
miRNAs.  
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2 Materials and methods 
2.1 Reagents 
10 bp DNA Ladder (Invitrogen 10821-015) 
10 x Tris/Borate/EDTA (TBE) Buffer (Sigma, 93290-5L) 
10x Tris Acetate-EDTA buffer (Sigma, T8280-1L) 
2.5% Trypsin (Gibco, 15090-046) 
2x Gel loading buffer (Ambion, AM8547) 
40% Acrylamide 19 acryl: 1 bis-acryl (Ambion, AM9022)   
50 mM Magnesium Chloride (Promega)  
5M NaCl (Ambion, AM9760G) 
Acetelated BSA (Promega, R3961) 
Agarose (Sigma, A9539)  
Ammonium persulphate (APS) (Sigma, A3678-100G) 
BigDye® Terminator v3.1 Cycle Sequencing Kit (Life Technologies, 4337455) 
BrightStar® BioDetect™ Kit (Ambion, AM1930)a 
Chloroform (Lab-Scan, A07C11X)  
Custom 5’  Biotin labelled DNA probe (IDT) 
Custom TaqMan Small RNA Assays, (Applied Biosystems, 4440418) 
Deoxynucleotide Triphosphates (dNTPs) 100mM (Promega, U1240)  
Dextran sulfate (Sigma, D8906) 
Dimethyl sulfoxide (DMSO) 99.9% (Sigma, D8418-50ML) 
Distilled Water  
DL-Dithiothreitol (DTT) 100mM (Promega, P1171) 
DyeEx 2.0 Spin Kit (Qiagen, 63204)  
DynaMarker Prestain Marker  for Small RNA Plus (Biodynamics, DM253S) 
Ethidium Bromide 10 mg / mL (Sigma, E1510-10ML) 
ExoSAP-IT (Affymetrix 78250) 
Foetal Bovine Serum, Non-USA origin, sterile-filtered, cell culture tested (Sigma, 
F7524)   
Formamide (Sigma, F9037) 
Gel loading buffer (Sigma, G2526)  
GlutaMAX™-I Supplement, 200 mM (Gibco, 35050-038) 
GoTaq Flexi DNA Polymerase (Promega, M8306) 
Hi-Di Formamide (Applied Biosystems, 4311320) 
IPTG (Sigma, I6758) 
Label IT® miRNA Labeling Kit, Version 2 (Mirus, Bio 9510) 
Linear Acrylamide 5 mg / mL (Ambion, AM9520) 
MBG Water (Sigma, W4502) 
MegaClear Kit (Ambion, AM1908) 
Minimum Essential Medium (MEM) Eagle in Earle’ s BSS, with 2,2g/L NaHCO3, 25 
mM HEPES (1x) (Sigma, M72780)   
miRNeasy Mini Kit (Qiagen, 217004)  
Molecular biology Grade (MBG) Ethanol (Sigma, E7-148-1GA)  
Molecular Biology Grade (MBG) Water (Sigma, W4502) 
Non Essential Amino Acids (100X) (Gibco, 11140-035) 
Penicillin-Streptomycin mixture, 5,000 units of penicillin (base) and 5,000 µg of 
streptomycin (base)/ mL (Gibco,15070-063) 
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pGEM®-T Easy Vector System II (Promega, M8306) 
Phosphate buffered saline tablets (BR0014G, Oxoid) 
Phusion High-Fidelity DNA Polymerase 2 U/ µL (Finnzymes, F-530S) 
Polyethylene glycol (PEG) solution, 8,000, ~50% (Sigma, 83271-100ML-F) 
QIAzol Lysis Reagent  (Qiagen, 79306) 
RNAlater (Ambion, AM7020)  
RNase-Free DNase Set (Qiagen, 79254) 
RNaseZap (Ambion, AM9780) 
RNasin Plus RNase Inhibitor (Promega, N2615)  
RNeasy MinElute Cleanup Kit (Qiagen, 74204)  
Sodium acetate anhydrous (Sigma, S2889)  
SuperScript III RT (Invitrogen, 18080-093) 
T4 RNA Ligase I 10 U / µL (New England Biolabs, 
T4 RNA Ligase II  200 U / µL (New England Biolabs, M0242S)  
TaqMan Universal PCR Master mix (Applied Biosystems, 4364340) 
TaqMan® miRNA Reverse Transcription Kit (Applied Biosystems, 4366596) 
Tetramethylethylenediamine (TEMED) ( Sigma, T7024) 
Tween 20 (Sigma, P9416-100ML) 
Ultra Pure 1 M Tris-HCI, pH 8.0 (Invitrogen, 15568-025)  
Ultra Pure Water 
ULTRAhyb®-Oligo buffer (Ambion, AM8663) 
UltraPure™ 10% SDS Solution (Invitrogen, 
UltraPure™ 10% SDS Solution (Invitrogen, 24730-020) 
UltraPure™ 20X SSC (Invitrogen 15557-044) or UltraPure™ 20X SSPE (Invitrogen, 
15591-043)b 
UltraPure™ 20X SSPE (Invitrogen, 15591-043) 
Urea (Ambion, AM9902) 
Versene 0.2 g/L (Gibco, 15040-033) 
X-Gal (Sigma, B4252) 
 
2.2 Equipment 
0.45 m syringe filter  
0.5 ml thin walled PCR tubes 
1 L Duran Flasks 
1.8 mL Micro-centrifuge tubes 
10 mL Sterile Syringe  
10 x 10 cm vertical gel electrophoresis apparatus  
100 mL Duran Flasks 
1000 mL Corning® 0.22 m vacuum filter system (cellulose acetate membrane) 
(Sigma, CLS430516) 
15-22°C Incubators 
2 L Conical Flask 
2 mL Micro-centrifuge Safe-Lock tubes 
20 mL sterile universals 
-20°C Freezer 
20-gauge needles 
-20ºC Freezer 
4ºC Fridge 
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5 mL pipette 
5 mL sterile syringe  
50 mL Sterile universals 
7 mm stainless steel beads (Qiagen)  
75cm2 Cell Culture Flasks (Sigma, CLS430641-100EA)  
-80ºC Freezer 
ABI PRISM® 310 Genetic Analyzer 
Applied Biosystems 7500 Real-Time PCR System 
Autoclave (Touchclave) 
Balance 
BioLuminizer (CAMAG) 
Blot-box 9,1x6,6cm 3-5ml capacity  (VWR, 700-0249)  
BrightStar®-Plus Positively Charged Nylon Membrane (Ambion, AM10102) 
Cryovials (Nunc) 
Electroblotting module and cassettes 
Electronic sealer 
Fibre Pads 
Fume hood (Chem Flow 2000 Standard)  
Gel Tank, Casts, Combs 
Heating Block 
Laminar Flow Cabinet (Heraeus Hera Safe 1200x650x630) 
Masking Tape 
Microwave Oven 
Nanodrop Spectrometer 
NovaRay Scanner (Alpha Innotech) 
Nucleic acid and nuclease free pipette tips 
Pipeteboy 
Power Supply 
Refrigerated centrifuge (Sorvall Legend RT)  
Rocker  
Rocker Platform 
Sealable Hybridization Bags, Whatman® 20.3 x 25.4 cm  (VWR, 89027-004) 
Sterile forceps 
Sterile scalpel 
Sterile scissors  
Tecan HS 400™ Pro Hybridization Station 
Thermocycler  
TissueLyser (Qiagen)  
UV Transilluminator 
Vacuum Pump and tubing 
Water Bath 
Water purification System (Millipore, Milli-Q plus)   
Weighing Boats 
Whatman 3MM Filter Paper 46 cm x 57cm (VWR, 514-8013) 
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2.3 Cell Culture 
2.3.1 Preparation of cell culture mixtures/solutions 
 
2.3.1.1 Cell Culture Media 
Cell culture media was prepared as per Table 2.1  
 
Table 2.1 Cell vulture media components 
 
Component Volume 
Minimum Essential Medium (MEM) Eagle in Earle’s BSS, with 2,2g/L 
NaHCO3, 25 mM HEPES (1x) 500 mL 
Foetal Bovine Serum, Non-USA origin, sterile-filtered, cell culture 
tested 
50 mL 
Non Essential Amino Acids (100X) 5 mL 
Gibco GlutaMAX™-I Supplement, 200 mM 5 mL 
 
The components were mixed in autoclaved 2 L conical flask. If necessary pH was 
adjusted by eye by adding 0.22 M syringe filtered 1M NaOH or HCl until a neutral 
red colour persisted. The mixture was poured into a 1000 mL 0.22 m vacuum filter 
system and using vacuum pump the mixture to be drawn through the filter into a 
sterile collection flask. Filtered media was incubated at 27°C for 3 days for sterility 
testing, and stored at 4°C immediately before being use 5 mL of Penicillin-
Streptomycin mixture was added to the media to protect against possible bacterial 
contamination post filtration.  Media was kept at 4°C when not in use.  
 
2.3.2 Cells 
Common Carp brain cells were originally obtained from the Collection of Cell Lines 
in Veterinary Medicine (CCLV) at the Friedrich-Loeffler Federal Research Institute 
for Animal Health, Greifswald Germany. They were received on cell passage number 
55 at Cefas Weymouth Laboratory, Weymouth UK where they were maintained 
before being received at the Marine Institute, Galway Ireland on passage number 95.  
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2.3.3 Cell culture protocol 
 
2.3.3.1 Aseptic Technique 
All cell culture work including preparation of mixtures and reagents were prepared in 
a laminar flow cabinet. All internal surfaces of the cabinet, reagent containers and 
equipment were cleaned with 70% EtOH before and after use.  
 
2.3.3.2 Maintenance of Cell Line 
The CCB cell line was maintained in 75cm2 cell culture flasks. Flasks were split 
every 3-4 weeks. Splitting was done in a laminar flow cabinet under aseptic 
conditions. Old media was aspirated off into the waste beaker. Cells were rinsed 
using 5 mL PBS to remove any residual media. PBS was removed and cells were 
trypsinized using 1 mL 0.1% trypsin. Trypsin was deactivated by the addition of 3 
mL cell culture media. Cell clumps were broken up by pipetting. For a 1:4 split, 3 
mL of suspended cells were removed (and either disposed of or used to seed new 
flasks, see Section 2.3.3.3)  24 mL of cell culture media was added to the 1 mL of 
suspended cells remaining in the flask. Flasks were put at 27°C for 24 hours to (give 
the cells a temporary growth boost) and were subsequently maintained at 20°C until 
split again.  
2.3.3.3 Seeding new cell culture flasks (Up-Scaling cell stocks)  
Of the 3 mL of suspended cells removed from flasks during splitting, 1 mL was 
added to 3 new flasks and 24 mL of cell culture media was added to each flask. 
Flasks were put at 27°C for 24 hours to (give the cells a temporary growth boost) and 
were subsequently maintained at 20°C until split again.  
 
2.4 Viral Culture 
 
2.4.1 Virus 
CyHV-3 used in this study was an isolate referred to as H361 supplied by Cefas 
Weymouth Laboratory, Weymouth, UK. It was received at passage 3 in the form of 
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an infected Common Carp Brain cell culture. The infected cell culture was received 
at the Marine Institute at 5 days post infection (dpi) and subsequently kept at 22°C 
until 17 d.p.i. when extensive cytopatic effects (CPE) could be observed. At this 
point viral supernatant was collected and stored. 
 
2.4.2 Viral culture protocol 
Aliquots of viral supernatant were taken from storage at -80°C and thawed out on 
ice. 250-500 L of viral supernatant was used to inoculate 1 day old flasks of CCB 
cells (~75% confluent after 24 hours at 27°C). Once inoculated, flasks were rocked 
gently to disperse the virus throughout the cell culture media. To establish a lytic 
infection, inoculated flasks were kept at 22°C until CPE appeared at ~7-12 d.p.i. 
(Figure 2.1).  
  
2.4.3 Viral Supernatant collection 
Once widespread CPE was visible within infected cultures the media was taken off 
and placed in a 20 mL sterile universal tube. This was spun down at 200 x g for 10 
min at 4°C in order to pellet any suspended cells and cellular debris. The supernatant 
was drawn up into a 10 mL sterile syringe and filtered through a 0.45 m syringe 
filter into a new 20 mL sterile universal. The supernatant was split into 1 mL aliquots 
in 1.8 mL cryovial tubes and stored at -80°C. These were used as sources of more 
infectious virus for subsequent viral culture. 
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(a) 
(b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 An example of the Cytopatic Effects (CPE) caused by CyHV-3 during an in vitro lytic 
infection. 
(a) Example of healthy monolayer of CCB cells (b) example of widespread CPE characterized by the 
vacuolation and rounding up of cells and the formation plaques as large patches of the monolayer 
dethatch from the flask surface. 
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2.5 RNA Preparation 
 
2.5.1 Preparation of RNA extraction mixtures/solutions 
 
2.5.1.1 3 M Sodium Acetate 
To prepare this, 24.61 g of NaOAc anhydrous was added to 100 mL MBG water and 
allowed to dissolve at RT.   
 
2.5.1.2 10 mM Tris-HCl 
To prepare this, 500 µL 1 M Tris-HCl was added to 49.5 mL MBG Water 
 
2.5.2 RNA Preparation from biological matrices  
 
2.5.2.1 Sample Lysis 
 
 Cells 
Cells were trypsinized and media was added as outlined in Section 2.3.3.2. The cell 
suspension was transferred to a 20 mL sterile universal and cells were pelleted by 
centrifuging at 300 x g for 5 min. Supernatant was aspirated off and residual media 
was removed by washing pellet with 3 mL PBS. PBS was replaced with 700 µL 
QIAzol Lysis Reagent and the pellet was broken up by pipetting. The lysate was 
homogenised by passing it through a 20-gauge needle several times using a 5 mL 
syringe (this was done 4-5 times or until the lysate became less viscous).  
 
 Stabilized tissue 
25 mg portions were excised from RNAlater stabilised tissue samples using a sterile 
disposable scalpel and forceps and placed in sterile 2 mL Safe-Lock micro centrifuge 
tubes. 700 µL QIAzol Lysis Reagent and one autoclaved 7 mm stainless steel were 
added to each sample. To homogenize samples they were shook at a 20 Hz for 2 min 
in the Qiagen TissueLyser. 
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2.5.2.2 Phase separation  
Lysed samples were transferred to 1.8 mL micro-centrifuge tube and left at room 
temperature for 5 min. 140 µL of chloroform was added, the mixture was shook 
vigorously to mix well and left at room temperature for 3 min and centrifuged at 
12000 x g at 4ºC for 15 min. This separated the sample into 3 phases. The upper 
aqueous layer was transferred to new micro-centrifuge tubes. The aqueous layer 
should have a volume of ~ 350 µL, however in this study, in order to avoid 
disturbing the lower phases only 300 µL was taken and brought forward to RNA 
extraction.  
 
2.5.2.3 RNA extraction  
Four hundred and fifty microlitres (1.5 volumes) of 100% EtOH was added to the 
aqueous layer and mixed thoroughly. 700 µL of the sample was pipetted into an 
RNeasy Mini spin column and this was centrifuged at 8000 x g for 15 s at, the flow 
through was discarded and the collection tube was reused. This was repeated until 
the entire sample had gone through the column. 700 µL Buffer RWT was added to 
the column and it was centrifuged at 8000 x g for 15 s, the flow through was 
discarded and the collection tube was reused. 500 µL Buffer RPE was added to the 
column and it was centrifuged at 8000 x g for 15 s. The flow through was discarded 
and the collection tube was reused. This step was repeated again but spun for 2 min 
the second time and the flow through and collection tube was discarded. The column 
was placed in a new collection tube and spun at 20,000 x g for 1 min, to remove 
traces of Buffer RPE. The column was transferred to a 1.8 mL micro-centrifuge tube 
and 50 µL 10 mM Tris-HCl was added to the column. This was incubated at room 
temperature for 1 min and total RNA was eluted by centrifuging at 8000 x g for 1 
min. 
 
 
 
2.5.3 RNA size fractionation 
The pre-stained RNA marker was seperated in a polyacrylamide gel as outlined in 
Section 2.6.2. This marker contains bands of 20, 30, 40, 50, 75 and 100 bps in length. 
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Sterile forceps and scalpels used for gel excision were pre-soaked in RNaseZap and 
rinsed in MBG water before use. Gel sections containing the size fraction of interest 
were identified and excised using the pre-stained marker in the adjacent lane as a 
guide.  
 
2.5.4 RNA extraction from polyacrylamide gels 
The excised gel sections were placed in a 1.8 mL microcentrifuge tube containing 1 
mL of 1 M NaCl. The gel was shredded up in solution using a scissors (pre-soaked in 
RNaseZap and rinsed in MBG water before use). Once the mixture reached a slurry-
like consistency it was pipetted into a 15 mL sterile universal containing 9 mL of 1 
M NaCl. To elute RNA from the gel fragments, this mixture was incubated on a 
rocker for 8 hours (or overnight) at 4ºC. The Eluted RNA was separated from the gel 
debris by centrifuging it at for 5 min at 2,000 x g. The supernatant was transferred to 
a 50 mL sterile universal. This contained most of the RNA and was placed at 4ºC for 
later use. In order to elute the remaining traces of RNA from the gel debris, 2 mL 1 
M NaCl was added to the remaining gel pellet. This was left rocking at room 
temperature for 1 hour and centrifuged. The supernatant was collected and added to 
the supernatant collected earlier. In order to precipitate the RNA 1.5 µL of 5 mg ⁄ml 
linear acrylamide and 18 mL 100% MBG EtOH (final concentration of 60%) was 
added with thorough vortexing after each addition. The mixture was put through a 
MegaClear column and the precipitated RNA was captured on the RNA binding 
filter. As the MegaClear column had a capacity of ~500 µL and the sample volume 
was 30 mL it was more practical to draw the mixture through the column using a 
vacuum rather than a series of centrifugation steps. A vacuum extraction apparatus 
was constructed by removing a plunger from a 5 mL syringe and replacing it with a 
MegaClear column which forms a seal. Tubing was fed through a whole created in 
the bottom of a 15 mL universal; this was attached to the needle holder on the 
syringe barrel, which was placed into the 15 mL universal allowing it to act as a 
holder for the apparatus allowing it to be placed on a standard tube rack. The other 
end of the tubing was attached to a vacuum, allowing flow through to be pumped 
into a separate waste container, see Figure 2.2. The sample was applied to the 
column slowly using a 5 mL pipette. After the entire mixture was drawn through, an 
additional 4 mL of 80% MBG EtOH was also drawn through to wash the column. 
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To Waste 
Vacuum 
Pump 
5 mL 
Syringe 
Barrel 
MegaClear 
Column 
30 mL 
Sample 
15 mL 
universal 
The column was placed in 1.5 mL centrifuge tube, 500 µL of 80% MBG EtOH was 
added and it was centrifuged at 5,000 x g for 1 min. The flow through was discarded. 
This was centrifuged at 10,000 x g for 1 min to remove traces of EtOH.  The column 
was put in a new collection tube and 50 µL of 10 mM Tris-HCl (heated to 95ºC) was 
applied to the filter. This was incubated at room temperature for 2 min and 
centrifuged at 10,000 x g for 1 min. This elution step was repeated again to give a 
total elution volume of ~100 µL. The large elution volume was necessary to ensure 
that the entire filter was properly wetted.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Diagram of vacuum extraction apparatus 
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2.5.4.1 Ethanol Precipitation and Concentration of RNA 
The volume of purified RNA sample were made up to ~100 µL (if not already at this 
volume) using 10 mM Tris-HCl. The following components were added to the 
samples in this order with thorough vortexing in after each addition: 11 µL of 3 M 
NaOAc, 1 µL of 5 mg/ mL Linear Acrylamide and 333 µL 100 % MBG EtOH. 
Samples were incubated at - 80ºC for 1.5 hours or kept there at this point for long 
term storage. For subsequent re-suspension, samples were removed from storage at -
80ºC and immediately centrifuged at 20,000 x g for 30 min at 4ºC. The supernatant 
was removed and the pellets were rinsed with 1 mL 80 % MBG EtOH by inverting 
the tube several times and centrifuged again at 16,000 x g for 10 min at 4ºC. All 
supernatant was removed and remaining of EtOH were eliminated by leaving the 
tube open to air dry at room temperature for 5-10 min. RNA pellets were 
resuspended in the desired volume of 10mM Tris- HCl.  
2.6 Polyacrylamide Gel Electrophoresis (PAGE) 
 
2.6.1 Preparation of mixtures/solutions for PAGE  
 
2.6.1.1 10% APS 
5 g of APS was dissolved in 50 mL MBG water in a 50 ml universal. This was stored 
at 4ºC until needed. 
 
2.6.1.2 1 x TBE Buffer 
100 mL of 10 X TBE was diluted with 900 mL distilled water in a 1 L Duran flask. 
This was stored at room temperature until needed. 
 
2.6.1.3 7 M Urea-15% acrylamide mixture  
The following components were added to a 50 mL sterile universal in a fume-hood  
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Table 2.2 7 M Urea-15% acrylamide mixture components  
 
Component Amount Final Conc. 
Urea 5.88  g* 6.93 M 
10 x TBE 1.4 mL 1 x 
40% Acrylamide 5.2 mL 14.9% 
MBG Water 2.7 mL N / A 
*The volume of the 5.88 g of urea accounted for ~5.7 mL, bringing the total volume to ~14 mL.  
 
The urea was dissolved by placing the mixture in a 45ºC water bath for ~15-20 min. 
Once the urea was dissolved the mixture was split up into 7 mL aliquots and stored at 
4ºC until needed. 
 
2.6.2 PAGE protocol  
The vertical gel casting apparatus was assembled, ensuring that a proper seal was 
created at the bottom. In a fume-hood, 14 µL TEMED and 35 µL 10% APS was 
added to 7mL of the 7 M Urea-15% acrylamide mixture, with thorough vortexing in 
between each addition. This was immediately added to the gel casting apparatus and 
a comb was added. This required ~5 mL of urea-acrylamide mixture. The remainder 
of the gel mixture was used as an indicator for complete polymerisation. Once 
complete, the gel was placed in the gel tank, the inner buffer was chamber was filled 
with 1 x TBE and the comb was removed. The wells were flushed out with 1 x TBE 
using a syringe.1 x TBE buffer was poured into the buffer chamber of the gel tank 
(typically until just past the bottom of the gel). Gels were pre-run at 200 V for 30 
min. Samples were thawed on ice and 1 volume of 2x gel loading buffer was added. 
The samples were heated to 95ºC for 5 min and put on ice for 1 min. Typically 5 µL 
of pre-stained miRNA marker was used along side samples (if applicable), this did 
not require the addition of 2x loading buffer but was also heated and cooled in the 
same fashion as the samples. Wells were flushed out again with 1 x TBE using a 
syringe. Up to 20 µL of sample was slowly added to each well. Gels were run at 200 
V for 60-90 minutes.  
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2.7 Preparation of Deep-Sequencing Library 
The strategy used for library preparation in this study was adapted from the Illumina 
Small RNA v1.5 protocol. The modified in-house strategy took longer to execute but 
it was significantly lower in cost as it circumvented the need to purchase an 
expensive library preparation kit from Illumina. The main difference was the use of a 
different 3’  adapter. For this, a relatively in-expensive pre-adenylated 3’  adaptor 
(IDT small RNA cloning linker 1) was used. As this adaptor did not have the same 
sequence as the Illumina 3’  adaptor, the appropriate 3’  adaptor sequences 
(compatible with Illumina flow cell primers during Illumina sequencing) were added 
in after the IDT pre-adenylated adapter by incorporating them into the PCR primers, 
see Figure 2.3 and Figure 2.4. In addition, PAGE purification between ligation steps 
and RT combined with using lower amounts of adaptor resulted in cleaner 
sequencing libraries that did not require agarose gel purification prior to sequencing. 
This resulted in slightly longer products than those of conventional Illumina small 
RNA sequencing libraries although this posed no compatibility issues with the 
downstream sequencing process. Illumina sequencing was carried out by TrinSeq, 
the TCD Genome Sequencing Laboratory based in Institute of Molecular Medicine, 
St James’  Hospital Dublin. 
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2.7.1 Adaptors and primers  
Adaptors and primers were synthesized by IDT (Table 2.3) 
 
 
Table 2.3 Details of adaptors and primers used in deep-sequencing library preparation  
 
Name Type Sequence 
3’ Adaptor DNA 5’ /5rApp /CTGTAGGCACCATCAAT/3ddC/ 3’ * 
5’ Adaptor RNA 5’ GUUCAGAGUUCUACAGUCCGACGAUC 3’ 
Reverse 
Transcription 
Primer 
DNA 5’ ATTGATGGTGCCTACAG 3’ 
Forward 
Primer DNA 5’ AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 3’ 
Reverse 
Primer DNA 5’CAAGCAGAAGACGGCATACGAATTGATGGTGCCTACAG 3’  
5’pTag 
Forward 
primer     
DNA 5’ GCTATGACCATGATTACGCCAA 3’ 
3’pTag 
Reverse 
primer      
DNA 5’ TGTAAAACGACGGCCAGTGAA 3’  
*3’  Adaptor terminal modifications:/5rApp/ = 5’  Adenylation containing a pyrophosphate linkage. 
This acts as substrate for T4 RNA Ligase II in the absence of ATP. /3ddC/ = 3’  dideoxy-Cytosine 
(ddC) base. This blocks ligation on this end. 
 
2.7.2 Preparation of mixtures/solutions 
 
2.7.2.1 Adaptors 
Lyophilized adaptors were first centrifuged at 5000 x g for 1 min to ensure all 
adaptors were removed from the sides of the tube. A master stock was prepared by 
re-suspending adaptors to a concentration of 0.1mM using 10mM Tris-HCl. Working 
stocks of 6.6 pmol / µL were prepared from these by diluting them 1/15 in 10mM 
Tris-HCl. Adaptor stocks were stored at -80 ºC.  
 
2.7.2.2 Primers 
Lyophilized adaptors were first centrifuged at 5000 x g for 1 min to ensure all 
adaptors were removed from the sides of the tube. A master stock was prepared by 
re-suspending these using 10mM Tris-HCl to a concentration of 1 mM. Working 
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Small RNA insert (DNA) 5’ 
3’ 
Small RNA insert 5’ 
3’ 
3’ 
5’ 
5’ 
 5’ RNA Adaptor Small RNA insert (DNA) 5’ 
Illumina 3’ RNA Adapter1Sequence  
5’ Adaptor 
3’ Adaptor (IDT Small RNA cloning Linker 1) 
RT Primer 
Adaptor Attachment 
Reverse Transcription 
PCR and incorporation of Illumina flow cell oligo sequences using fusion primers 
3’ TTACTATGCCGCTGGTGGCT 5’ 
Should hybridize to Illumina flow cell 
oligo A with sequence:  
5’ AATGATACGGCGACCACCGA 3’ 
5’ TCGTATGCCGTCTTCTGCTTG 3’ 
Should hybridize to Illumina flow cell 
oligo B with sequence:  
3’ AGCATACGGCAGAAGACGAAC 5’ 
Final DNA library product for Deep Sequencing 
Deep Sequencing 
Illumina Small RNA PCR Primer 2 
 5’ RNA Adaptor 
3’ 
5’ 
Small RNA insert (DNA) 5’ 
3’ 
3’ 
5’ 
3’ 
5’ 
5' /5rApp/CTGTAGGCACCATCAAT/3ddC/ 3’ 
Illumina Small RNA Sequencing Primer 
5’ CGACAGGTTCAGAGTTCTACAGTCCGACGATC3’ 
Short RNA read run (40 nt) 
(Exact same 
terminal 
modifications 
as Illumina v1.5 
3’ Adaptor) 
 3’ RNA Adaptor  
 3’ RNA Adaptor  
stocks of 10 pmol / µL were prepared from these by diluting them 1/100 in 10mM 
Tris-HCl. These were stored at -20ºC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Summary of in-house small RNA deep-sequencing library preparation
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2.7.2.3 3’ Ligation Reaction mix 
This was made up in a 0.5 mL thin walled PCR tube immediately before use. 
 
Table 2.4  Details of 3’ ligation reaction mix 
 
Component Stock Conc. Volume Final Conc. (in 20 µL) 
T4 Ligase 2 200 U / µL 1 µL 10 U / µL 
T4 Ligase II Buffer 10x 2 µL 1x 
MgCl2 50mM 1.6 µL 4mM 
DMSO 100% v/v 2 µL 10% v/v 
PEG 8000 50% 2.9 µL 7.25% v/v 
RNasin 40 U/ µL 1 µL 1 U / µL 
Total 10.5 µL 
 
2.7.2.4 5’ Ligation Reaction mix 
This was made up in a 0.5 mL thin walled PCR tube immediately before use 
 
Table 2.5 Details of 5’ ligation reaction mix 
 
Component Stock Conc. Volume Final Conc. (in 20 µL) 
T4 Ligase 1 20 U/ µL 1 µL 1 U / µL 
T4 Ligase I Buffer 10x 2 µL 1x  
DMSO 100% v/v 2 µL 10% v/v 
PEG 8000 50% 4.5 µL 11.25% v/v 
RNasin 40 U / µL 1 µL 2 U / µL 
Total 10.5 µL 
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2.7.2.5 Library Reverse transcription (RT) reaction mix 
This was made up in a 0.5 mL thin walled PCR tube and stored at -20ºC until needed 
 
 
Table 2.6 Details of library preparation RT reaction mix 
 
 Component Stock Conc.  Volume Final Conc. (in 20 µL) 
dNTPs 10 mM 1 µL  1 mM 
SuperScript III RT  200 U / µL 1 µL  20 U / µL 
SS III RT Buffer 5x  4 µL 1x 
DTT 0.1 M 1 µL 0.05 M 
RNasin 40 U/ µL 1 µL 2 U / µL 
Total 8 µL 
 
2.7.2.6 Library amplification PCR master mix   
This was prepared in a 0.5 mL thin walled PCR tube and stored at -20ºC until 
needed. 
 
Table 2.7 Details of library amplification PCR master mix 
 
  Component Stock Conc. Volume Final Conc. (in 50 µL) 
5X Phusion HF Buffer 5x 10 µL 1x 
Forward Primer 10uM 1 µL 0.2uM 
Reverse Primer 10uM 1 µL 0.2uM 
DNTPs 25mM 0.5 µL 250uM 
Phusion DNA Polymerase 2 U / µL 0.5 µL 0.02 U / µL 
Total 13 µL 
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2.7.2.7 Library validation PCR master mix 
This was prepared in a 0.5 mL thin walled PCR tube and stored at -20ºC until 
needed. 
 
Table 2.8 Details of library amplification PCR master mix 
 
  Component Stock Conc. Volume Final Conc. (in 50 µL) 
5X Green GoTaq® Flexi Buffer 5x 10 µL 1x 
MgCl2 25 mM 5 µL 2.5 
dNTPs 25 mM 0.5 µL 1.25 
Forward Primer  10 µM 1 µL 0.2 pMol / µL 
Reverse Primer 10 µM 1 µL 0.2 pMol / µL 
GoTaq Flexi DNA Polymerase 5 U / µL 0.25 µL 0.025 U / µL 
MBG H2O N/A 29.75 µL N/A 
Total 47.5 µL 
 
2.7.2.8 1 X TAE Buffer 
One Litre of 10x TAE Buffer was added to 9 L of distilled water in a dispenser and 
kept at room temperature.  
   
2.7.2.9  Agarose Gels 
Immediately before use, either 1.2 g (2%) or 2.4 g (4%) of agarose was added to 
60ml 1x TAE buffer and heated in a microwave until the agarose was fully dissolved. 
In a fume hood, 3 µL of 10 mg / mL ethidium bromide was added to the gel and 
mixed well by swirling.  
 
2.7.2.10 DNA Ladders 
There were 2 sizes of DNA ladder used in this study, 10bp and 100bp. These were all 
supplied by Invitrogen and come in a concentration of 1 µg/µl and each tube 
contained 50 µL. Ready to use tock solutions of all DNA ladders were prepared by 
adding 160 µL 6x gel loading dye and 790 µL 1x TAE Buffer. Ladders were stored 
at at -20ºC.  
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2.7.2.11 50 mg/mL X-Gal 
To prepare this, 500 mg of X-Gal was dissolved in 10 ml distilled water in a Duran 
flask. This was wrapped in thin foil and stored at 20°C. 
 
2.7.2.12 100 mM IPTG 
To prepare this, 238 mg of IPTG was dissolved in 10 ml distilled water and stored at 
-20°C. 
2.7.2.13 Ligation reaction mix 
This was prepared immediately before use.  
 
 
Table 2.9 Ligation reaction mix 
 
Component Stock Conc. Volume Final Conc. (in 20 µL) 
2X Rapid Ligation Buffer 2x 5 µL 1x  
pGEM®-T Easy Vector 50 ng / µL  1 µL 5 ng / µL 
Library validation PCR product N/A 3 µL N/A 
T4 DNA Ligase  3 Weiss units/ l 1 µL 0.3 Weiss units/ l 
Total 10 µL 
 
2.7.2.14 Colony PCR mix 
This was prepared in a 0.5 mL thin walled PCR tube and stored at -20ºC until 
needed. 
 
  Component Stock Conc. Volume Final Conc. (in 50 µL) 
5X Green GoTaq® Flexi Buffer 5x 10 µL 1x 
MgCl2 25 mM 5 µL 2.5 
dNTPs 25 mM 0.5 µL 1.25 
5’pTag Forward primer     10 µM 1 µL 0.2uM 
3’pTag Reverse primer      10 µM 1 µL 0.2uM 
GoTaq Flexi DNA Polymerase 5 U / µL 0.25 µL 0.025 U / µL 
MBG H2O N/A 32.25. µL N/A 
Total 50 µL 
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2.7.2.15 Dye terminator PCR mix 
 
The dye terminator PCR mix was prepared immediately before use as per Table 2.10. 
 
 
Table 2.10 Dye terminator PCR mix 
 
  Component Stock Conc. Volume Final Conc. (in 50 µL) 
BigDye Terminator v3. Reaction mix 5x 4 µL 1x 
BigDye Terminator v3.1 Buffer (5X) 5x 4 µL 1x 
5’pTAG Forward primer     10 µM 4µL 0.2uM 
MBG H2O N/A 4. µL N/A 
Total 16 µL 
 
2.7.3 RNA library preparation protocol  
 
2.7.3.1 17-25 nt RNA size fractionation 
Size fractionation and subsequent gel extraction of 17-25 nt RNA was carried out as 
per Section 2.5.3 and 2.5.4. For this particular application the gel was run at 200 V 
for 60 min. A section of gel was excised from the sample lane that corresponded to 
half way between the 20 and 30 nt bands and the same distance again below the 20 nt 
marker on the pre-stained RNA marker in the adjacent lane. Extracted RNA was 
concentrated by EtOH precipitation and resuspended (as per section 2.5.4.1) in a 
volume of 9.5 µL 10mM Tris HCl. In order to see if RNA size fractionation was 
successful before proceeding with adaptor ligation, 1.5 µL of the RNA sample was 
used to measure the RNA quantity on a Nanodrop spectrometer. Libraries were 
prepared from 2 different infections i) 400 ng 17-25 nt RNA from cells infected with 
a 1 mL of 2.7x 104 TCID50 / mL H361 isolate (18 d.p.i.) at and ii) 72 ng from a 17-25 
nt RNA from cells infected with 1 mL of 5x 105 TCID50 / mL N076 isolate (14 d.p.i.) 
(less RNA in N076 sample as it was extracted from a 25cm2 flask compared to 75 
cm2 flask for the H361 isolate). 
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2.7.3.2 3’ Adaptor Ligation 
The remaining 8 µL of concentrated RNA was mixed with 1.5 µL of 3’  adaptor 
working stock. The RNA was denatured by heating to 70ºC for 2 min, put on ice for 
1 min and added to a thawed 3’  ligation reaction. The reaction was incubated at 22ºC 
for 2 hours. The ligation product was separated from unused adaptors and RNA by 
size fractionation. The gel was ran at 200 V for 90 min. The ligation products were 
expected to be ~34-42 nt in length, therefore section of gel was excised from the 
sample lane that corresponded to little under half way between the 30 and 40 nt 
bands and little over the 40 nt band on the pre-stained RNA marker in the adjacent 
lane. Ligation products were extracted from the gel slice and concentrated, 
resuspended in volume of 9.5 µL 10mM Tris HCl. In order to check if 3’  ligation, 
and gel extraction was successful before proceeding with 5’  adaptor ligation, 1.5 µL 
of the RNA sample was used to measure the RNA quantity on a Nanodrop 
spectrometer.  
 
2.7.3.3 5’ Adaptor Ligation 
The remaining 8 µL of concentrated 3’  ligation product ligated to the 5’  adaptor in 
the same manner as above, using the 5’  adaptor ligation mix, which was incubated at 
37ºC for 1 hour. The 5’  ligation products were expected to be ~60-68 nt in length, 
therefore a section of gel was excised from the sample lane that corresponded to 
between the 60 and 75 nt bands on the pre-stained RNA marker in the adjacent lane. 
The product was extracted and checked as per Section 2.7.3.2. 
 
2.7.3.4 Reverse Transcription 
The remaining 8 µL of concentrated 5’  ligation product was mixed with 1 µL of RT 
primer working stock and 3 µL MBG water. This was denatured by heating to 70ºC 
for 2 minutes, put on ice for 1 min and added to an RT mix. This was heated on a 
thermocycler at 55ºC for 90 min followed by 70ºC for 15 min and held at 4ºC. 
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2.7.3.5 Amplification of sequencing library by PCR 
All 20 µL of the RT reaction was added to a library amplification PCR master mix, 
and 17 µL of MBG water. This was placed in a thermocycler and subjected to the 
following cycling conditions: 1 cycle of 98ºC for 30 sec, 12 cycles of 98ºC for 10 
sec, 60ºC for 30 sec, and 72ºC for 15 sec followed by a final extensions step of 72ºC 
for 10 min (the amount of cycles was kept to minimum in order to keep amplification 
bias to minimum). 
 
2.7.4 Validation of amplified sequencing library 
It was important that no non-specific products were generated in sequencing library 
preparation. The final dsDNA product should be 104-113 bp in length. This was 
verified by agarose gel electrophoresis. The library itself was not run on gels, in-
order to conserve it. Instead, the quality of the library was assessed indirectly by 
using 2.5 µL of it as template for another PCR reaction. This involved using the 
same primers with a non-high fidelity DNA polymerase (Taq) that also introduced 
TA overhangs. The introduction A-overhangs also facilitated downstream TA 
cloning of the PCR products for more in dept validation of the library. 
   
2.7.4.1 Gel electrophoresis  
For this PCR 2.5 µL of dsDNA library was added to the library-validation-PCR-
master mix. This was placed in a thermocycler and subjected to the following cycling 
conditions. 1 cycle of 94ºC for 5 min, 15 cycles of 95ºC for 1min, 55ºC for 1 min and 
72ºC for 1 min followed by a final extension step of 72ºC for 10 min (In this PCR the 
amount of cycles was kept to minimum primarily in order to avoid the generation of 
non-specific products due to over-cycling). For gel electrophoresis, the ends of a gel 
cast were sealed with masking tape, 4% agarose gel was poured into it and a comb of 
appropriates size was put in place. Once set, the masking tape was removed and the 
gel it was placed in a gel tank which was filled with 1x TAE buffer until the gel was 
fully submerged. The comb was removed and 10 µL of PCR product (mixed with 2 
µL of 6x gel loading buffer). One lane was loaded with 10 µL DNA ladder. The gels 
were run at 110 V for 60 min and visualized using a UV transilluminator and a CCD 
camera.  
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2.7.4.2 Cloning  
A ligation reaction as set up as per Table 2.9, components were mixed by pipetting. 
This was incubated for 1 hour 22ºC kept at 4ºC overnight for maximum efficiency.  
Ligation reaction was centrifuged and 2 µl was added to a new microcentrifuge tube 
on ice. JM109 High Efficiency Competent Cells (a component of the pGEM®-T 
Easy Vector System II kit) were removed from storage at -80ºC and thawed in ice for 
5 min. These were gently mixed (by flicking the tube) and 50 l of cells were added 
to the 2 µl ligation product. This was gently mixed (by flicking the tube) and left on 
ice for 20 min. Cells were heat shocked by placing them in a water bath at 42°C for 
45 – 50 sec and returned to ice for 2 min. Cells were removed from ice and 950 l 
room temperature LB medium was added. Cells were incubated for 1.5 hours at 37°C 
with shaking (~150rpm). LB-ampicillin plates were dried 37°C for 10 minutes after 
which 100 l of 100 mM IPTG and 20 l of 50 mg/ml X-Gal were spread onto them. 
Plates were warmed at 37°C for 30 min to allow absorption of IPTG. Cells were 
removed from incubation and 100 l of culture was spread onto /ampicillin/IPTG/X-
Gal plate. These were incubated overnight (16 – 24 hours) at 37°C. DNA from white 
colonies (cells carrying plasmids with inserts from the sequencing library) was 
transferred to PCR reactions by using a sterile loop to gently touch the edges of the 
colonies followed by vigorously mixing the loop in a colony-PCR-mix.  This was 
subjected to the following cycling conditions: 1 cycle of 96ºC for 10 min, 30 cycles 
of 94ºC for 1min, 37ºC for 1 min and 72ºC for 1 min followed by a final extension 
step of 72ºC for 10 min. These PCR products were ran on 2% agarose gels as per 
section 2.7.4.1. Colony-PCRs showing PCR products of 312-320 bp in size (104-112 
insert plus a total of 208 nt of flanking pGEM®-T Easy Vector sequence) were 
selected for dye-terminator sequencing.  
   
2.7.4.3 Dye terminator sequencing 
In order to clean up colony PCR reactions before dye terminator sequencing, 4 l of 
ExoSAP-IT was added to 10 l of positive colony PCR product. This was incubated 
at 37°C for 15 min (degrading remaining primers and nucleotides) followed by 
incubation at 80°C for 15 min to inactivate ExoSAP-IT. Four micro-liters of cleaned 
up colony PCR product was added to dye-terminator PCR mix. This was subjected to 
the following reaction conditions: 25 cycles of 96ºC for 30 sec, 45ºC for 15 sec and 
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60ºC for 1 min followed by a final extension step of 72ºC for 10 min. In order to 
remove un-incorporated dye terminators from dye terminator PCRs before 
sequencing they were cleaned up using the DyeEx 2.0 Spin Kit. Columns were 
prepared by gently vortexing them (to re-suspend the resin), opening the cap a 
quarter turn and snapping the bottom closure. Empty columns were centrifuged for 
3min at 750 x g. they were placed in collection tubes and 20 l of dye terminator 
PCR product was slowly added to the centre of the gel bed surface. These were 
centrifuged for 3min at 750 x g. The collection tubes containing purified samples 
were incubated at 80ºC for 30 min in order to dry the sample. Samples were 
resuspended in 12.5 l Hi-Di Formamide, heated to 90ºC for 2 mins and vortexed 
well before being applied to the ABI PRISM 310 Genetic Analyzer sample tray.  
 
2.8 Array Hybridization 
 
2.8.1 Probe Design 
Probes were designed using the probe design tool in VMir. These were designed to 
detect proposed and theoretical mature miRNAs derived from the 5’  and 3’  arms of 
2914 predicted pre-miRNAs These included both high and low probability pre-
miRNA candidates from manual analysis of the deep-sequencing results and 
predicted pre-miRNAs that did not feature in the results at all.  
2.8.2 Controls  
 
2.8.2.1 Control Probes 
Each miRNA-probe was included in duplicate and control probes were also designed 
 
 
Mismatch probes:  
Each miRNA-probe had an associated mismatch control containing one mismatch 
with its target every 5 nt. This allowed estimation of non-specific signal occurring as 
a result of cross hybridization due to sequence similarity (Figure 2.5).  
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Scrambled controls: 
Each miRNA-probe had an associated scrambled control generated by random 
shuffling of probe sequence. (Figure 2.5). 
  
Flanking controls 
Probes targeting sequences (30 nt in length) flanking the target regions (25 nt 
upstream of the 5’  arm target and 25 nt downstream of the 3’  arm target) were also 
included on the array. These controls were not part of the predicted miRNA target 
sequence and were intended to account for non-specific signals caused by 
hybridization of small degradation products of larger transcripts which overlap 
predicted pre-miRNA loci. If such overlapping degradation products hybridized to 
probes targeting putative miRNAs they would also hybridize to the associated 
flanking controls to the same extent. (Figure 2.5). 
 
2.8.2.2 Positive Control targets 
Probes were also designed to detect positive control targets. Positive control probes 
also had associated mismatch and scrambled controls. These are described below. 
 
• Endogenous controls: 
Probes targeting highly expressed Cyprinus carpio (host) miRNAs from deep 
sequencing were also included as endogenous controls. These acted as a 
control for labelling and acted as an indicator of the quality of the miRNA 
enriched RNA samples used.  
 
• Exogenous spike-in control: 
All labelling reactions were spiked with a defined amount of synthetic 
miRNA. This consisted of an RNA oligo with sequence 
GUGCUCACUCUCUUCUGUCG, based on the Arabidopsis thaliana 
miRNA ath-miR156g (MirBase Ac. MIMAT0001012). This acted as a 
positive control for the labelling reaction and hybridization and for all 
samples regardless of whether they contained miRNAs or not. 
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Figure 2.5 Illustration of probe design showing control-probe targets   
On top: linear sequence of predicted pre-miRNA. On bottom: Secondary structure of predicted pre-
miRNA 
 
2.8.2.3 Types of samples used 
 
• S1: CyHV-3 positive miRNA enriched 
This sample consisted of 17-25 nt RNA from CyHV-3 infected CCB cells. 
Probes targeting CyHV-3 miRNAs should show positive signals in this 
sample. 
 
• S2: CyHV-3 positive non-miRNA 
This sample consisted of 26-35 nt RNA from the same CyHV-3 infected 
CCB cells as sample 1. This RNA was derived from the sample used in deep 
sequencing except it consists of small RNA just outside the RNA size range. 
Probes targeting genuine miRNAs should not also show signals in this 
sample.  
 
• S3: CyHV-3 Negative miRNA enriched sample  
This sample consisted of 17-25 nt RNA from non-infected CCB cells. Probes 
targeting genuine CyHV-3 miRNAs should not also show signals in this 
sample, in this way it acted as an extra negative control allowing us to 
identify NSH to host RNA.  
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2.8.3 Preparation of array hybridization mixtures/solutions 
 
2.8.3.1 Exogenous spike-in control  
The exogenous spike-in control, consisting of an RNA oligo with sequence 
GUGCUCACUCUCUUCUGUCG, based on the Arabidopsis thaliana miRNA ath-
miR156g (MirBase Ac. MIMAT0001012), was synthesized by IDT. A master stock 
was prepared by re-suspending lyophilised the pellet to a concentration of 1 nmol/ 
µL (i.e. 1 µL per nmol present) using 10mM Tris-HCl. This was diluted to 10-7 to 
make a working stock of 100 amol/ µL (or ~7 pg / µL). This was split up into 5 µL 
aliquots and stored at -80°C. 
  
2.8.3.2 Label IT Reagent 
Label IT Reagent arrived as dried pellet and was resuspended before use by adding 
22 µL Reconstitution Solution (supplied Label IT® miRNA Labeling Kit, Version 
2). This was mixed by vortexing and centrifuged to ensure all solution was collected 
at the bottom of the tube. 
 
2.8.3.3 Labelling reaction mixture 
This was prepared immediately before use. Components were added in order as they 
appear in Table 2.11 in accordance with the Label IT® miRNA Labeling Kit Version 
2 protocol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  116 
Table 2.11 Labelling reaction mix 
 
 Component Stock Conc. Volume 
Final 
Conc.  
MBG H2O N/A 33 µL N/A 
Labelling Buffer M 10x 10 µL 1x  
RNA sample (~400ng brought to 35 µL in 10mM 
Tris HCl) ~11 ng/ µL 35 µL ~4 ng / µL 
Exogenous-Spike-in control 100 amol/ µL 2 µL 2 amol/ µL 
Label IT® Reagent 25x 20 µL 5x* 
Total 100 µL 
*The final concentration of Label IT® Reagent was increased to 5x (which was optional according to 
the Label IT® miRNA Labeling Kit, Version 2 protocol). This results in maximum labelling density 
and was done to reduce the possibility of false negatives that may occur if some target transcripts were 
present in very low levels. 
 
2.8.3.4 50% w/v dextran sulphate 
50% w/v dextran sulphate working stock was prepared by adding 0.5g dextran 
sulphate to 1000 µL MBG H2O. Due to the highly viscous consistency this could not 
be adequately mixed by vortexing. Instead the mixture was adequately mixed by 
placing the micro-centrifuge tube the TissueLyser and shaking it at a 20 Hz for 2 
min. Bubbles were removed by centrifugation. This was stored at room temperature 
until needed. 
 
2.8.3.5 Hybridization buffer mix 
This was prepared immediately before use and mixed by vortexing (Table 2.12). 
 
Table 2.12 Hybridization buffer mix 
 
 Component Stock Conc. Volume Final Conc.  
SSPE N/A 17.5 µL  N/A 
Formamide 100% 28 µL 20x  
Tween-20 1% 1.4 µL 0.01% 
Acetylated BSA 1 mg / ml 1.4 µL 0.01 mg / mL 
Dextran Sulphate 50% w/v 18.5 µL ~6.5% w/v  
SDS 10% w/v 28 µL 2% 
Labelled RNA (~400ng eluted in 45 µL Elution buffer) ~8.9 ng / µL 44.2 µL ~2.69 ng / µL 
Total 140 µL 
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2.8.3.6 Wash buffers 
Wash buffers were made up in sufficient enough volumes to allow for a flow rate of 
11 mL / min during washing steps when using the Tecan HS 400™ Pro 
Hybridization Station. Once prepared, they were stored at room temperature. Wash 
buffers were prepared as per Table 2.13 
 
Table 2.13 Array wash buffer details 
 
Wash buffer 1 
2x SSPE 0.1% SDS (Low Stringency) 
Component Volume 
20x SSPE 100 mL 
10% SDS 10 mL  
H2O 890 mL 
Wash buffer 2 
1x SSPE (Intermediate Stringency) 
Component Volume 
20x SSPE 50 mL 
H2O 950 mL 
Wash buffer 3 
0.1x SSPE (High Stringency) 
Component Volume 
20x SSPE 5 mL 
H2O 995 mL 
 
 
2.8.4 RNA Labelling and purification 
RNA was size fractionated as per Section 2.5.3. Approximately 400ng RNA was 
selected from each sample and made up to a volume of 35 µL in 10mM Tris HCl. 
This was stored at - 20°C until labelling. The labelling reaction mixture (including 
RNA sample) was prepared as per Section 2.8.3.3. This was incubated for 1.5 hours 
at 37°C. The labelling reaction was stopped by adding 10 µL 10x Stop Reagent and 
briefly stored on ice until purification. Samples were prepared for purification by 
adding 10 L Column Binding Buffer and 250 µL 100 % MBG EtOH and mixed by 
vortexing. Samples were added to purification columns and centrifuged at 11, 000 x 
g for 30 sec. The flow through was discarded and 600 L Wash buffer was added to 
the column and it was centrifuged at 11, 000 x g for 30 sec. The flow through was 
discarded and 200 L Wash buffer was added to the column and it was centrifuged at 
11, 000 x g for 2 min. The column was transferred to a 1.8 mL eppendorf tube and 45 
  118 
L Elution buffer was applied to the membrane and it was centrifuged at 11, 000 x g 
for 1 min. The purified labelled RNA was stored at -20°C until used for array 
hybridization.  
 
2.8.5 Array Hybridization, washing and drying  
The Tecan HS 400™ Pro Hybridization Station was prepared by running the wash 
program which involved pumping MBG H2O through all channels and chambers in 
the system. Each wash buffer flask was assigned and connected to a different flow 
channel, this information and the experiment conditions were programmed into the 
hybridization station. The experimental conditions are given in Table 2.14 
 
Table 2.14 Array hybridization and washing conditions 
 
Hybridization program 
Duration Temperature Agitation Extra settings 
14 hours 42°C Medium High viscosity mode “on” 
Slide washing and Drying program 
Wash buffer Temperature Duration 
Wash Buffer 1 (Channel 1) 30°C 5 min 
Wash Buffer 2 (Channel 2) 22°C 5 min 
Wash Buffer 3 (Channel 3) 22°C 2 min 
N2 Drying RT 5 min 
 
The hybridization buffer (including labelled RNA) was prepared as per Section 
2.8.3.5. This was heated to 65°C for 5 mins and kept on ice for 5 mins. The arrays 
were placed in the Tecan 400 hybridization chamber with the array side (same side 
as barcode) facing up. The chamber was closed and sealed. The hybridization, 
washing and drying programs were executed. After system initialization, the samples 
were injected into the hybridization chambers (when prompted by the display) and 
the hybridization program commenced automatically followed by washing and 
drying programs. 
 
2.8.6 Array Scanning and acquisition of fluorescence data 
Arrays were scanned using NovaRay Scanner (Alpha Innotech). Arrays were placed 
on the slide tray with the barcode facing up and at the flat end of the slide holder 
(this resulted in the arrays being scanned in the correct orientation). Using the visual 
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preview mode, the scanning area, focus settings were manually defined for each 
scan. All arrays were scanned using an 8 sec exposure and resolution of 5 m. The 
resulting images were analyzed using the ArrayVision software package v8.0. To 
facilitate this, the GAL file (GenePix Array List file) sent with the arrays was 
imported into ArrayVision. This contained information on the layout and identity of 
each feature on the array allowing each feature to be correctly identified and 
analyzed. The results were exported as a tab delimited text files consisting of probe 
names in one column with florescence intensity data in the other.  
 
2.8.7 Analysis of fluorescence data 
 
2.8.7.1 Identification of miRNA-like signals 
 
The results files were imported into VMir for automated analysis of the data for 
identification of miRNA-like signals. Each probe targeting a miRNA on the 5’ or 3’  
arm of a predicted pre-miRNA had its own associated control probes and in turn each 
predicted pre-miRNA loci had its own flanking controls. Separate probes targeting 
miRNAs from the same pre-miRNA and their associated control probes were 
automatically recognized based on the nomenclature system used allowing them to 
be analysed together to give an overall score for each predicted pre-miRNA. 
 
VMir first calculated the median intensity of all of these control probes in order to 
estimate the background. Only probes with intensities that rose above this minimum 
background level were considered for further analysis by VMir. Each miRNA-probe 
was present in duplicate; if the signals from these probes were above the background 
level their mean was calculated. If any of the associated controls for these individual 
probes were also above background-levels, this indicated that at least some of the 
signal for the miRNA-probes may be attributed to non-specific hybridization (NSH). 
The extent to which the control probes were above background was used for the 
estimation of the degree of NSH taking place. As a result the amount by which the 
control was above background (i.e. control intensity minus background) was 
subtracted from the mean of the miRNA-probe replicates. The resulting value was 
referred to as the “ corrected-value”  for the miRNA-probe. Flanking controls that 
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were above background were treated in the same way, but unlike scrambled and 
mismatch controls, they were not specific to individual 5’  or 3’  arm miRNA-probes 
but instead act as controls for the pre-miRNA loci as a whole and as such, even 
though they were not replicates of each other, their values (i.e. intensity – minus 
minimum background) were always averaged before subtraction from mean miRNA-
probe values. All fluorescence data was analysed in this fashion except in the case of 
samples consisting 26-35 nt CyHV-3 RNA and 17-25 nt CCB, where the flanking 
probes were ignored in order to avoid possible under-estimation of miRNA-probe 
signals from such samples. For each probe it was only the control type with the 
highest value that was used for correction. The corrected-value of the best 
performing miRNA-probe for each pre-miRNA hairpin (either 5’  or 3’  arm probe) 
was used to represent the value for that predicted pre-miRNA. Only corrected-values 
that were still above background were considered positive by VMir.  
 
In this study, all corrected-values from VMir were expressed as a multiple of the 
background. This was referred to as the “ relative-value”  (RV). RVs from VMir that 
were higher than background were not immediately taken as positive. Separate cut-
off values were established for each hybridization. To establish these cut-offs, the 
level of variability in the intensities of the control probes was established by 
calculating the average absolute-deviation from the background (i.e. background 
previously estimated by VMir using the median intensity of the same control probes). 
Cut-off values were defined as 1 absolute deviation above the background-level. In 
this study only pre-miRNAs with RVs that were above the established cut-off values 
for their respective hybridizations were considered positive. Positive signals from the 
Sample 1 (17-25 nt CyHV-3 RNA) were deemed to be potentially attributed to 
CyHV-3 miRNAs if they showed no corresponding positive signals from Samples 2 
(26-35 nt CyHV-3 RNA) and 3 (17-25 nt CCB RNA). The processes involved in 
analysis of fluorescence data are outlined in Figure 2.6 
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Analysis of fluorescence data 
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Figure 2.6 Outline of processes involved in analysis of fluorescence data 
 
 
2.8.7.2 Investigation of new provisional pre-miRNA candidates. 
Pre-miRNAs, outside of the 21 pre-miRNA candidates identified in deep sequencing, 
were classified as new provisional pre-miRNA candidates and were further 
investigated by searching the deep sequencing data for any low frequency transcripts 
(read counts <10) that mapped to them. This was done using SeqMap in a similar 
manner to the process outlined in Section 2.14.1 and all alignment signatures were 
assessed as per Section 2.14.3.4.  
 
2.9 Northern Blotting 
 
2.9.1  Samples  
Total RNA from CyHV-3 N076 in vitro lytic infections (separate infection to what 
was used in deep sequencing) and non-infected CCB cells was extracted as per 
Section 2.5.2. Polyacrylamide gels were ran (200V for 60 mins) as per Section 2.6. 
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Each gel contained 2 lanes of RNA from infected cells and 2 from non-infected cells 
(Figure 1.1.9.1) with 10 µg RNA in each. RNA was electroblotted onto nylon 
membranes as per Section 2.9.2. After cross-linking, nylon membranes were split 
into 2 pieces and each was probed separately for CyHV-3 putative miRNAs and 
Cyprinus carpio let-7a respectively. The gel loading layout and work flow are 
illustrated in Figure 1.1.9.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7 PAGE sample layout and workflow for electroblotting    
 
 
2.9.2 Electroblotting 
 
Before electroblotting, 2x fibre pads, 2x sheets of filter paper, a nylon membrane and 
the gels were soaked (15-30 sec) in 0.5x TBE Buffer. These were used to assemble a 
gel-sandwich in an open electro blotting cassette, see Figure 2.8. Once assembled, 
the electroblotting cassette was closed, locked and placed in the electroblotting 
module in the gel tank. The gel tank was filled up to the mark maximum with 1x 
TBE buffer, and electroblotting was carried out using 400 mA for 30 mins. This was 
enough time to remove all of the RNA, and loading dye from the gel. Cross-linking 
was done by baking membranes in an oven at 80oC for 4 hours. If not being used 
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immediately the blotted membrane was placed in a 50ml sterile universal tube (rolled 
up, not overlapping, sample side facing the inwards) and stored at -20oC.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8 Diagram of gel sandwich assembly 
 
 
2.9.3 Probes 
Probes targeting the CyHV-3 putative miRNAs were synthesized by IDT. In 
addition, as a loading control Cyprinus carpio Let-7a miRNA was also targeted. All 
probes were 5’  biotin-labelled; see probe sequences in Table 2.15. 
 
 
 
Table 2.15 List of probe sequences  
 
Assay Name Probe Sequence 
CyHV-3 MR5057 3’ miRNA 5’ TCGTCGACAGCGGCCGCAATTT 3’  
CyHV-3 MD11776 3’ miRNA 5’ GCCAACACCCTCACGCAGGCCT 3’  
CyHV-3 MD1111 3’ miRNA 5’ACCACAACAGACTGAGACCATCCT 3’ 
CyHV-3 MD1111 5’ miRNA 5’ TGATGATGATGAGCCTGCTGCT 3’ 
CyHV-3 MR5075 3’ miRNA 5’ CCTTGCAGTTGATACTAGCACCGT 3’ 
Cyprinus carpio Let-7a miRNA 5’ AACTATACAACCTACTACCTCA 3’ 
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2.9.4 Preparation of mixtures/solutions for hybridization washing and 
detection 
 
2.9.4.1 Biotin labelled probes 
Lyophilized probe was first centrifuged at 5000 x g for 1 min to ensure all probe was 
removed from the sides of the tube. Each probe was then resuspended to a final 
concentration of 1 nmol / µL using 10mM Tris-HCl and stored at – 20oC.  
 
2.9.4.2 Pre-hybridization buffer 
ULTRAhyb®-Oligo buffer was removed from storage at 4oC and preheated at in a 
water bath 68oC for at least 30 mins immediately before use to get rid of any 
precipitants. 
 
2.9.4.3 Diluted probe for hybridization 
Immediately before use, 1 µL of probe (1 nmol/µL) was diluted in 1 mL pre-heated 
ULTRAhyb-Oligo buffer and mixed well by pipetting.  
 
2.9.4.4 Low Stringency Wash Buffer 
If precipitation was present it was removed by heating to 37oC until precipitants 
dissolved. There were 3 washing steps in total. Each washing step required 20 mL of 
Low Stringency Wash Buffer. 3x 50 mL universals containing 20 mL of Low 
Stringency Wash Buffer were prepared. Two of these were cooled to room 
temperature (~22oC) and one was kept in a water bath at 37oC.  
 
2.9.4.5 1x Wash buffer (for detection) 
The 5X stock solution of Wash Buffer was pre-heated at 37oC for 15-20 mins (varied 
depending on volume) or until precipitants dissolved. There were 5 wash steps in 
total. Each wash step required 20 mL of 1x Wash Buffer. 5x 50 mL universals each 
containing 20 mL of 1x Wash Buffer were prepared by diluting 4 ml Wash Buffer in 
16 mL distilled water. This was prepared as needed and not stored. 
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2.9.4.6 Blocking Buffer 
The 1X Blocking Buffer was pre-heated at 37oC for 15-20 mins (varied depending on 
volume) or until precipitants dissolved There were 4 blocking steps in total. Each 
blocking step required 20 mL of 1x Blocking Buffer. 4x 50 mL universals each 
containing 20 mL of 1x Blocking Buffer were prepared. Buffer was cooled to room 
temperature before use.  
 
2.9.4.7 Diluted Streptavidin linked Alkaline Phosphatase (Strep-AP) 
1 µL of Streptavidin linked Alkaline Phosphatase was diluted in 10 mL Blocking 
Buffer and mixed well by vortexing. This was prepared as needed and not stored. 
 
2.9.4.8 1x Assay Buffer 
There were 2 wash steps with Assay Buffer in total. Each wash step required 20 mL 
of 1x Assay Buffer. 2 x 50 mL universals each containing 20 mL 1x Assay Buffer 
were prepared by diluting 2 ml 10x Assay Buffer in 18 mL distilled water. This was 
prepared as needed and not stored. 
 
2.9.4.9 CDP-Star (Substrate) 
This was removed from storage at 4oC and 5 mL was dispensed 10 mins before use 
allowing it to heat to RT. This was stored in the dark until used.  
 
2.9.5 Hybridization and washing 
A blotted membrane was removed from storage at -20oC, placed in blot-box (9.1x 66 
cm). For pre-hybridization, 9 ml pre-heated ULTRAhyb®-Oligo buffer was added. 
The buffer was thoroughly washed over all areas of the membrane manually and the 
blot-box was placed on a rocking platform and incubated at 37oC for 30min. The pre-
hybridized membrane was removed from the 37oC incubator and 1 ml diluted probe 
was quickly added using a pipette. This was immediately mixed manually by 
washing the buffer over membrane several times. The blot-box was placed back on a 
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rocking platform and incubated at 37oC for 8-12 hours. After hybridization the 
membrane was put in a new blot-box and incubated for 5 min with 20 mL Low 
Stringency Wash Buffer at room temperature on a rocking platform. This was 
repeated again in a new blot-box (blot-box from hybridization rinsed out with 
distilled water) and a 3rd time in another new blot-box for 2min at 37oC using Low 
Stringency Wash Buffer pre-heated to 37oC.  
 
2.9.6 Chemiluminescent Detection 
This was done using components from the BrightStar® BioDetect™ Kit (Ambion, 
AM1930) All incubation steps in the detection protocol took place on a rocking 
platform at room temperature. The blot-box was changed and washed with distilled 
water between all incubations. Buffers were only used once and disposed of after 
each incubation step. The details of each incubation step are given in Table 2.16 
 
Table 2.16 Details of incubation steps involved in northern blotting probe detection procedure. 
 
Incubation Step Description  Buffer Duration 
1 Wash-Step 1 1x Wash buffer 5 min 
2 Wash-Step 2 1x Wash buffer 5 min 
3 Blocking-Step 1 Blocking Buffer 5 min 
4 Blocking-Step 2 Blocking Buffer 5 min 
5 Blocking-Step 3 Blocking Buffer 30 min 
6 Strep-AP Incubation Diluted Strep-AP 30 min 
7 Blocking-Step 4 Blocking Buffer 10 min 
8 Wash-Step 3 1 x Wash Buffer 10 min 
9 Wash-Step 4 1 x Wash Buffer 10 min 
10 Wash-Step 5 1 x Wash Buffer 10 min 
11 Reaction Prep 1 1x Assay Buffer 2 min 
12 Reaction Prep 2 1x Assay Buffer 2 min 
13 Substrate Addition CDP-Star 5 min 
 
After incubation step 13, the membrane was lightly blotted on filter paper without 
letting the membrane dry (to get rid of excess CDP-Star). The membrane was placed 
in translucent hybridization folder which was then heat sealed using an electronic 
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(a) 
(b) 
sealer. Chemiluminescent signals were visualised and recorded electronically on a 
BioLuminizer (CAMAG), using 10 minute exposures.  
 
2.10 Stem-loop RT-qPCR 
 
Due to their short lengths (~17-25 nt), TaqMan RT-PCR analysis of miRNAs 
involves a slightly different approach known as Stem-loop RT-qPCR. This was a two 
step process, see both steps outlined in Figure 2.9.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9 Stem-loop RT-qPCR process 
(a) RT Step: A portion of the RT-primer not specific for the target miRNA forms a stem-loop 
secondary structure. The presence of this structure prevents the primer from annealing to any larger 
transcripts containing the same target sequence, as a result in can only anneal to the mature miRNA 
during the RT step. (b) Real-time PCR: Due to the higher temperatures in the PCR stage the stem-loop 
denatures. This creates enough space for two small primers and a probe (with one of the primers 
targeting the denatured stem-loop sequence) allowing TaqMan PCR to be carried out.   
     
 
  128 
2.10.1 Primers and probes 
Custom probes were designed by submitting target mature miRNA sequences to the 
Custom TaqMan Small RNA assay Design Tool in the Applied Biosystems website 
(https://www5.appliedbiosystems.com/tools/smallrna/). The appropriate primers and 
probes were designed using this online tool however due to the proprietary design 
process used the sequences of these primer and probes were not disclosed. A list of 
mature miRNA target sequences are displayed in Table 2.17. 
 
Table 2.17 List of CyHV-3 miRNA sequences targeted by Stem-loop RT-qPCR 
 
Assay Name Small RNA target Sequence 
MR5057 3’ miRNA 5’ AAAUUGCGGCCGCUGUCGACGA 3’  
MD11776 3’miRNA 5’ AGGCCUGCGUGAGGGUGUUGGC 3’  
MD1111 3’miRNA 5’ AGGAUGGUCUCAGUCUGUUGUGGU 3’ 
MD1111 5’ miRNA 5’ AGCAGCAGGCUCAUCAUCAUCA 3’ 
MR5075 3’  miRNA 5’ ACGGUGCUAGUAUCAACUGCAAGG 3’ 
MR5075 5’ miRNA 5’ UUGUAGUUGGUACAACUGCCUGC 3’ 
MD11410 5’ miRNA 5’ ACGCGUAGGCCGUGUCCACCUC 3’ 
MD9812 5’ miRNA 5’ AGGCCGUCGGCCUUCAUGAUG 3’ 
 
 
The host miRNA Let-7a (5’  UGAGGUAGUAGGUUGUAUAGUU 3’ ) was present 
at similarly high levels in sequencing experiments. It was therefore used as both an 
endogenous positive control and a reference gene. As the sequence was found to be 
highly conserved across most eukaryotic organisms and exactly the same as human 
Let-7a, it was not necessary to purchase a custom assay to detect this target as a pre-
existing human let-7a assay was already available to for purchase. 
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2.10.2 Preparation mixtures/solutions for Stem-loop RT-qPCR 
 
2.10.2.1 Reverse transcription (RT) Reaction Mix 
This was scaled up as required and stored at -20ºC until needed. 
 
Table 2.18 RT reaction mix components 
 
Component Stock Conc. Volume Final Conc. (in 15 µL) 
dNTPs 100mM 0.15 µL 1 mM 
MultiScribe™ RT 50 U/ L 1 µL 3.33 U/ L 
RT Buffer 10x 1.5 µL 1 x 
RNase Inhibitor 20 U/ L 0.19 µL 0.25 U/ L 
MBG H2O N/A 0.16 µL N/A 
Total 3 µL 
 
2.10.2.2 Stem-loop-RT-Primer preparation 
This was scaled up as required and stored at -20ºC until needed. 0.1 x primers were 
used with in vitro samples and 1x primers were used to test in vivo samples (see 
Section 5.1 for reasoning).  
 
Table 2.19 RT primer preparation using 1x or 0.1x final concentration of RT Primer) 
 
Component Stock Conc. Volume Final Conc. (in 15 µL) 
5x RT Primer* 5x  3/0.3 µL 1/0.1x 
MBG H2O N/A 8/10.7 µL N/A 
Total 11 µL 
*Where possible, RT reactions were multiplexed, thus several primers were added to this mix and 
H2O volumes were adjusted accordingly 
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2.10.2.3 PCR-Reaction-Mix (using 1 x or 0.1x final concentration of primer-probe) 
This was scaled up as required and stored at -20ºC until needed. 0.1 x primers were 
used with in vitro samples and 1x primers were used to test in vivo samples (see 
Section 5.1 for reasoning). 
 
 
Table 2.20 Stem-loop RT-qPCR mix 
 
Component Stock Conc. Volume Final Conc. (in 20 µL) 
TaqMan Mix 2x 10 µL 1 x 
20x Primer-Probe  20x 1/0.1 µL  1/0.1x 
cDNA ~ 1.3 µL ~ 
Nuclease Free Water N/A 7.7/8.6 µL N/A 
Total 20 µL 
 
2.10.3 Stem-loop RT-qPCR Protocol 
 
Total RNA was prepared as per section 2.5.2. RNA concentration was measured 
using Nanodrop. RNA samples were thawed on ice, 1 µL was taken from each 
sample and denatured by heating to 70ºC for 5 min in a thin-wall PCR tube and left 
on ice for 1 min. RT-Reaction-mix and RT-Primer were thawed, 3 µL RT reaction 
mix and 11 µL RT-Primer (either 1x or 0.1x) were added to the denatured RNA and 
mixed by pipetting. RT was carried out using following reaction conditions: 30 min 
at 16 °C, 30 min at 42°C and 5 min at 85 °C. The resulting cDNA was either stored 
at -20ºC until required or kept on ice temporarily for immediate use in PCR. PCR-
Reaction-mix (either 1x or 0.1x final primer concentration) was thawed, vortexed 
and 18.7 µL was added to individual sample wells on a 96-well plate followed by 1.3 
µL cDNA. The plate was sealed and centrifuged at 1000 x g for 1 min. PCR was 
carried out on an Applied Biosystems 7500 real-time PCR machine using the 
following PCR conditions: 1 cycle of 2 min at 50°C, 1 cycle of 10 min at 95°C, 40 
cycles of 15 sec at 95°C and 60 sec at 60°C (both extension and annealing were 
carried out at this temperature). 
 
  131 
2.10.4 Analysis of Real-time PCR data 
All PCR data was analysed using either one of the following techniques. Technique 1 
was used where the levels of the same miRNA target were being compared (i.e. 
where taking efficiency into account does not change the relative levels). Technique 
2 was used where levels different miRNAs were being compared (where each assay 
may have a significantly different reaction efficiency).  
 
2.10.4.1 Technique 1 
Results were analysed using the Applied Biosystems 7500 Software (version 2.0.1). 
The assay efficiency was taken to be 100% (i.e.1) and individual Ct values were 
transformed to linear scale expression quantities using Equation 1 and compared to 
each other.   
 
Equation 1: 2-Ct (i.e. (Eff + 1)-Ct (where Eff = % Efficiency) 
 
 
2.10.4.2 Technique 2 
The raw amplification data, normalized to internal passive reference dye ROX (i.e. 
Rn data) was recorded using Applied Biosystems 7500 Software. To calculate the 
PCR efficiency in each individual well, Rn data from each well was exported to an 
Excel file and reformatted as outlined in. Figure 2.10 This reformatted data was 
imported into a program called LinReg PCR version 2013.0 (Ruijter et al., 2009). 
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(a) 
(b) 
 
 
 
Figure 2.10 Reformatting of exported raw Rn values for LinReg-PCR  
(a) Format of Rn data exported from Applied Biosystems 7500 Software (b) Rn data reformatted for 
LinReg PCR. The reformatted data had cycle number in row 1 starting at column 3 with the 
corresponding fluoresce values for each sample at each cycle in the same positions in the rows 
underneath. The sample name was in the format Sample_Name_Assay_Name (Assay Name = 
Amplicon Name in LinReg PCR) 
 
 
In LinReg PCR each amplicon-group was defined based on the value for 
“ Assay_Name”  in the “ Amplicon Groups”  tab. In “ User Settings”  tab, the options for 
excluding samples without amplification and without plateau phases (i.e. negatives) 
were selected. Also efficiency outliners were defined as samples with efficiencies 
that deviate by more that 10% from median efficiency for their respective amplicon 
groups. As a result these outliners were excluded when calculating mean efficiency 
for their respective amplicon-groups. LinReg-PCR also used the amplification data to 
estimate an appropriate fluorescence threshold for each amplicon group and 
indicated Ct values based on group thresholds. Using the mean efficiency (Eff) for all 
samples in each amplicon-group (i.e. each assay), the threshold (Nn) and the Ct value 
(n) for each sample LinReg PCR calculated an arbitrary value (N0) representing the 
initial target molecule copy numbers in a given sample. These calculations were 
based on the Equation 3 which was derived from Equation 2, see equations and 
descriptions in Figure 2.11.  
 
 
 
 Column 1 Column 2 Column 3 Column 4 Column 5 
Row 1 Well Cycle Target Name Rn  
Row 2 A1 1 MD9812 0.107637  
Row 3 A2 2 MD9812 0.109796  
Row 4 A3 3 MD9812 0.109980  
Row 5 A4 4 MD9812 0.110514  
Row 6 A5 5 MD9812 0.110302  
 Column 1 Column 2 Column 3 Column 4 Column 5 
Row 1     1 2 3 
Row 2 Sample 1_Assay_Name   0.10764 0.107637 0.109980 
Row 3 Sample 2_Assay_Name   0.706 0.711646 0.713133 
Row 4 Sample 3_Assay_Name   0.70803 0.711791 0.715243 
Row 5 Sample 4_Assay_Name   0.72205 0.724081 0.726755 
Row 6 Sample 5_Assay_Name  0.70424 0.708158 0.710543 
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Equation 2: Nn = N0*(Eff + 1)n 
 
Equation 3: N0 = Nn*(Eff + 1)-n  
 
 
 
Figure 2.11 Description of Equations used for relative quantification in Stem-loop PCR 
Equation 2 describes the exponential amplification of target molecules by PCR where Nn was an 
arbitrary value (i.e. fluorescence) representing target molecule copy number at cycle n, N0 was an 
arbitrary value representing target molecule copy number at Cycle 0 (i.e. initial target molecule copy 
number in sample), Eff refers to PCR reaction efficiency and n represents the number of cycles. This 
can be rearranged to form Equation 3 which allows N0 to be calculated using values for Nn, Eff and n.  
 
For comparison of separate PCRs derived from a common multiplex RT reaction 
(where multiple RT primers were used in the same RT reaction to compare levels of 
different miRNAs in a single sample) no normalization was required. In such cases, 
the relative levels of different miRNAs were established by directly comparing N0 
values. Where levels of miRNAs were compared between separate samples, the N0 
values for each target miRNA were normalized by dividing them by N0 values for 
the reference gene within the same sample (in this case the reference gene was the 
host gene let-7a). 
 
2.11 Real time PCR 
CyHV-3 and host DNA levels were measures by real time PCR. The assays used for 
this were based on those developed by Gilad et al (2004). 
  
2.11.1 Preparation mixtures/solutions for real time PCR  
 
2.11.1.1 Primers 
Lyophilized primers were first centrifuged at 5000 x g for 1 min to ensure all primers 
were removed from the sides of the tube. A master stock was prepared by re-
suspending primers to a concentration of 1 mM using 10mM Tris-HCl. Working 
stocks of 10 pmol / µL were prepared from these by diluting them 1/100 in 10mM 
Tris-HCl. Primer stocks were stored at -20 ºC.  
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2.11.1.2 Probes 
 
Custom probes were ordered from Applied Biosystems. Working stocks were 
prepared of 10 pmol/ µL were prepared by diluting master stocks 1/10 in 10mM Tris-
HCl. Primer stocks were stored at -20 ºC.  
 
 
Table 2.21 List of CyHV-3 miRNA sequences targeted by Stem-loop RT-qPCR 
 
Target Primer Name Sequence 
KHV86f 5’ GACGCCGGAGACCTTGTG 3’ 
KHV163r 5’ CGGGTTCTTATTTTTGTCCTTGTT 3’ 
CyHV-3 
Genomic 
DNA 
KHV109p FAM 5’CTTCCTCTGCTCGGCGAGCACG 3’ MGB 
KoiGluc162f 5’ ACTGCGAGTGGAGACACATGAT 3’ 
KoiGluc230r 5’ TCAGGTGTGGAGCGGACAT 3’ 
Cyprinus 
carpio 
Genomic 
DNA KoiGluc185p VIC 5’ AAGCCAGTGTCAAAAGCCAGTGTCAA 3’ MGB 
 
2.11.1.3 PCR-Reaction-Mix (using 1 x or 0.1x final concentration of primer-probe) 
This was scaled up as required and stored at -20ºC until needed. 0.1 x primers were 
used with in vitro samples and 1x primers were used to test in vivo samples (see 
Section 5.1 for reasoning). 
 
Table 2.22 Stem-loop RT-qPCR mix 
 
Component Stock Conc. Volume Final Conc. (in 20 µL) 
TaqMan Mix 2x 12.5 µL 1 x 
Forward primer  10 pmol/ µL  1.5 µL  300 nM 
Reverse primer 10 pmol/ µL 1.5 µL 300 nM 
Probe  10 pmol/ µL 0.5 µL 100 nM 
Nuclease Free Water N/A 4 µL N/A 
Total 20 µL 
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2.11.2 Real-time PCR protocol 
PCR-Reaction-mix  was thawed, vortexed and 20 µL was added to individual sample 
wells on a 96-well plate followed by 5 µL of DNA (1000 ng)  The plate was sealed 
and centrifuged at 1000 x g for 1 min. PCR was carried out on an Applied 
Biosystems 7500 real-time PCR machine using the following PCR conditions: 1 
cycle of 2 min at 50°C, 1 cycle of 10 min at 95°C, 40 cycles of 15 sec at 95°C and 60 
sec at 60°C (both extension and annealing were carried out at this temperature). As 
the relative levels of different targets were not being compared, there was no need to 
take reaction efficiency into account. All PCR data was analysed using Technique 
1.() CyHV-3 genomic DNA levels were normalised to host cell DNA levels by 
dividing CyHV-3 linear scale expression values by the corresponding values for 
Cyprinus carpio genomic DNA in the same sample. 
 
2.12  De Novo Prediction of CyHV-3 pre-miRNAs 
 
2.12.1 De Novo prediction of pre-miRNAs in viral genomes 
Pre-miRNAs were predicted in viral genomes using VMir Analyser (v2.3) 
(Grundhoff et al., 2006). Viral genomes analysed included CyHV-3 (DQ657948.1) 
genomes of 6 other herpesviruses known to encode a combined total of 77 pre-
miRNAs (details are available in Supplementary File 3.1 T.1) for viruses and pre-
miRNAs) Each genome was analysed using the same settings; Genome 
Conformation: Linear, Window size: 500, Step size: 10, Minimum HP size: Any, 
Maximum HP size: Any, Min. HP Score: Any. Max. Size Calc.Score: 100, Max. Size 
Assign SHPs: 50, Max. Size Assign RHPs: 50. Results were viewed using VMir 
Viewer (v1.5). 
 
2.12.2 Establishment of filters based on characteristics of known viral 
pre-miRNAs 
VMir pre-miRNA predictions from 6 other herpesviruses genomes known to encode 
pre-miRNAs were screened to see if these known pre-miRNAs were correctly 
predicted in each viral genome. The pre-miRNAs searched for were based on 
sequences listed in miRBase at the time of the study (MirBase release 13). This was 
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done using the “ Find Sequence”  tool in VMir Viewer. Once identified, relevant 
attributes such as size, Relative Window Count (WC) and VMir Score were recorded 
for each correctly predicted pre-miRNA. For each virus, the minimum, maximum 
and average values for these attributes were calculated. These were used to establish 
the values typically displayed by bone-fide herpesvirus pre-miRNAs present in VMir 
output. These were used to establish relevant cut-off values that could be used to 
filter VMir pre-miRNA predictions from the CyHV-3 genome that did not have 
similar characteristics to known viral pre-miRNAs. To aid in identification of the 
optimum cut-off value, the sensitivity of potential cut-off values were estimated by 
calculation the percentage of the correctly predicted pre-miRNAs passing.  
 
2.12.3 Further assessment of miRNAs passing cut-off values 
After imposing the cut-offs values each remaining predicted pre-miRNA was further 
assessed based on genome position, any predictions occurring in ORFs were 
eliminated. This was done by searching for the pre-miRNA sequences in the CyHV-3 
genome map using SeqBuilder. Any predicted pre-miRNAs occurring outside ORFs 
were analysed in more detail using MiPred (see implementation in section 2.14.3.2. 
In addition to MHPs, SHPs were analysed also. Through this analysis each remaining 
predicted pre-miRNA was classified as either a real pre-miRNA, a pseudo pre-
miRNA or not pre-miRNA like at all. 
 
2.13 Mapping small RNA deep sequencing reads to the genome 
Quality filtered reads from deep sequencing were collapsed into a sequence tag file. 
This was a tab delimited text file consisting of a non redundant list of unique reads 
sequenced in one column and their associated read-count in a second column. Before 
mapping reads to the CyHV-3 genome, they were pre-processed. Using Excel, 
sequences containing “ Ns”  were removed using filter tool. Using a formula for 
counting the amount of characters in individual cells, the length of each read was 
compiled and using the sorting function, transcripts with lengths less than 15 
nt or greater than 26nt were removed. Each sequence was given unique ID and read 
count information was also incorporated onto the end of each ID separated by an 
underscore using the concatenate function in Excel. The file was converted to fasta 
using the perl script tabtofasta.pl (see Section 2.19.2 for use) and any remaining 3’  
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adaptor sequences were removed using perl script clip_adapters.pl (see section 2.19.2 
for use of clip_adapters.pl) These reads were mapped to the CyHV-3 genome with 
no mismatches using SeqMap (Jiang and Wong, 2008). It acted as a useful source of 
data for several other aspects of this study and was referred to as the Genome-
SeqMap-Output and is available in Supplementary File 4.1 T.1-T.4. 
 
2.14 Non-automated identification of CyHV-3 pre-miRNAs from 
deep sequencing data 
 
2.14.1 Mapping highly-expressed CyHV-3 derived small RNAs to VMir 
predicted CyHV-3 pre-miRNAs 
Viral transcripts with read counts 10 were retrieved from the Genome-SeqMap-
Output. All highly expressed CyHV-3 derived transcripts were mapped to the 5’  and 
3’  arm sequences of VMir predicted CyHV-3 pre-miRNAs and CyHV-3 ORFs using 
SeqMap (both sets of reverence sequences were first converted to fasta as per Section 
2.13). 
 
2.14.2 Selection of pre-miRNA candidates from mapping data 
The data from the mapping CyHV-3 derived small RNAs to CyHV-3 protein coding 
sequences and predicted pre-miRNA sequences was combined with the Genome-
SeqMap-Output in order to identify highly abundant RNAs, from non-coding regions 
mapping to the arms of predicted pre-miRNAs. For this, the Genome-SeqMap-
Output was separated into reads mapping to forward and reverse strands and both 
groups were sorted in order of 5’ starting position. This allowed easy manual 
identification of large stacks of overlapping reads mapping to the same locus (i.e. 
many reads with similar 5’ start positions offset by ~ +/- 4 nt relative to each other). 
Stacks containing transcripts with read counts 10, mapping to predicted pre-
miRNAs and not mapping to ORFs (all this information was contained within 
separate columns), were selected for further inspection. The pre-miRNA positions of 
the most abundant transcript in a given stack (putative miRNA) were manually 
inspected in VMir Viewer to check if they occurred on the stem adjacent to the 
terminal loop (i.e. roughly consistent with the model of miRNA biogenesis). The pre-
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miRNA sequence was also retrieved from the VMir output and its genomic position 
was checked on the CyHV-3 genome map in SeqBuilder to make sure that none of 
the extended sequence overlapped with protein coding sequences. The sequencing 
data was checked for further stacks or individual transcripts mapping to the other arm 
of the same predicted pre-miRNA being inspected (usually the next/previous 
transcripts in the list as sequencing data was arranged in order of 5’  starting 
position). Other reads with read counts 10, not occurring in stacks but mapping to 
predicted pre-miRNAs outside ORFs were also inspected in the same way. This 
allowed the identification of potential miRNAs (most abundant), isomiRs and 
moRNAs (microRNA-offset-RNAs) from predicted pre-miRNAs. Predicted pre-
miRNAs that were identified as (i) having small RNAs mapped to their 5’  and 3’  
arms adjacent to the terminal loop (including at least one read with a read count 10) 
and (ii) not overlapping with any ORFs were noted as provisional pre-miRNA 
candidates. Only those provisional pre-miRNA candidates that could be identified in 
more than one experiment, due to the same pattern of small RNA mapping (even if 
none of these transcripts had a read count 10 in the second experiment) were 
defined as pre-miRNA candidates. These were subjected to more in dept analysis. 
 
2.14.3 In depth analysis of pre-miRNA candidates 
This was done through the methods outlined below 
 
2.14.3.1 Mature miRNA duplex structure assessment 
The structures of these pre-miRNA candidates were copied (in text form) from VMir 
Viewer and the positions of the proposed 5’  and 3’  miRNAs mapping to their stems 
were highlighted. Once the miRNAs were highlighted, the predicted mature miRNA 
duplex structure was inspected for the presence of 3’  overhangs, a characteristic of 
Drosha and Dicer processing. 
 
2.14.3.2 Pre-miRNA structure assessment 
The structure of each pre-miRNA candidate was also analyzed using two different 
pre-miRNA classifiers, MiPred and CSHMM-Method. MiPred was accessed at 
http://www.bioinf.seu.edu.cn/miRNA/ and CSHMM-Method was accessed at 
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http://web.iitd.ac.in/~sumeet/mirna/. In all cases the sequence analysed was that of 
the most stable version to form within its local sequence context (as predicted by 
VMir) i.e. either the MHPs or SHPs of the predicted pre-miRNA that showed the 
highest absolute-WC and containing the full length putative miRNA sequences. In 
the case of pre-miRNAs also containing candidate moRNAs, the most stable versions 
containing the combined full length miRNA and moRNA sequences were also 
analysed. Through these methods, pre-miRNA candidates were classified either pre-
miRNA-like or non-pre-miRNA-like.  
 
2.14.3.3 Visualisation of mapped CyHV-3 reads and enrichment quantification 
SeqMonk (Version 0.16.0) was used to visualize the Genome-SeqMap-Output 
created in Section 2.13. It accepts genomes in EMBL format only. However, most 
viral genomes (including CyHv-3) were only available in GenBank format. As a 
result the GenBank file for the CyHV-3 genome (DQ6579481.1) was downloaded 
and converted to EMBL using the online tool Readseq 
(http://www.ebi.ac.uk/Tools/sfc/readseq/). Once converted to EMBL, the file was 
saved as a DAT file and placed in the SeqMonk genome directory. The structure of 
the accession line in the EMBL file was also modified so that it could be recognized 
by SeqMonk. This involved introducing 5 additional fields separated by colons. The 
values used for all 6 fields were as follows: 
 
1. Simply the text “ chromosome”    
2. Assembly name/Accession number 
3. Chromosome number (Just referred to as “ Genome”  for CyHV-3) 
4. The starting base of this sequence (normally 1) 
5. The last base of this sequence (normally the sequence length) 
6. The direction of the sequence (should always be 1) 
 
Based on this, the accession line from the CyHV-3 EMBL file was changed as 
outlined below: 
 
  !"!##!!

 #$

%&'%
%'%('%' 
)!*!#!##!!



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The Genome-SeqMap-Output from each experiment containing information for each 
mapped read such as start position, end position, strand (+/-) and chromosome (just 
referred to as “ genome”  for CyHV-3 (corresponding with field 3 in the modified 
accession line of the genome file) was saved as a tab delimited text file for import 
into SeqMonk. To display quantitative information SeqMonk derives read count 
information from the mapped data by counting the amount of rows containing 
identical mapping info (same positions, strand and chromosome). As a result the 
mapped data was first un-collapsed i.e. modified so that each row was repeated, with 
the number of repeats equal to the value in the read count column. The data was 
modified in this way using a script called fastx_uncollapser (see Section 2.19.2 for 
use) by defining the column in each row containing read count values.  
 
2.14.3.4 Inspection of miRNA alignment signatures 
All the candidate pre-miRNA sequences, pre-miRNA linear structures (in dot-
bracket notation) and reads mapped to each candidate pre-miRNA were retrieved and 
consolidated in .txt files. Mapped reads were manually aligned to the pre-miRNA 
sequences and the linear structures. This allowed detailed view of alignment 
signatures to ascertain if they fitted the model of miRNA biogenesis as outlined by 
Kozomara and Griffiths-Jones (2011). 
 
2.14.3.5 IsomiR end heterogeneity assessment 
IsomiRs of putative miRNAs from pre-miRNA candidates that showed miRNA-like 
alignment profiles were assessed in terms of their degree of 5’  and 3’  heterogeneity 
relative to the putative miRNAs themselves. For each putative miRNA, the start and 
end positions of their associated isomiRs (defined as transcripts that had 60% of 
their bases overlapping with the miRNA) were expressed in terms of their distance 
(nt) from the miRNA start and end positions. IsomiRs that were <19nt in length or 
those representing <0.1% of the combined miRNA and isomiR read count (for the 
miRNA in question) were not included in analysis. For each isomiR, the start and 
end positions (relative to miRNA start and end positions) were calculated e.g. taking 
the 5’  end of the miRNA to be 0, and isomiRs with 5’  positions that were 1 nt before 
the miRNA were assigned an offset value of -1 for its 5’  end (absolute values were 
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used in calculations) to indicate the degree of 5’  end heterogeneity. The 3’  ends of all 
isomiRs were assigned offset values in the same manner. The offset-values 
(representing the degree of 5’  and 3’  heterogeneity) for all isomiRs of a given 
miRNA were compared in three ways. The number unique isomiRs showing 5’  and 
3’  end heterogeneity respectively were counted and compared using the “ Unique 3’  
End: 5' End Off-set IsomiR Ratio”  (Ratio-1), where ratios greater than 1 indicated 
that there were more unique isomiRs displaying 3’  end heterogeneity. The overall 
degree of heterogeneity displayed by 5’  and 3’  ends of all unique isomiRs relative to 
the start and end positions of the miRNA was established by calculating the average 
off-set values for both ends of all isomiRs (even if one end was not off-set) and 
comparing them using the “ 3’  End: 5' End Average Absolute Off-set Ratio”  (Ratio-
2), where ratios greater than 1 indicated that there was a greater degree of 3’  end 
heterogeneity. Finally, the overall degree of 5’  and 3’  end processing consistency 
among isomiRs was established by comparing the combined read count of all 
isomiRs offset at the 5’  end to that of all isomiRs offset at the 3’  end using the “ 3’  
End :5' End Processing Consistency Ratio”  (Ratio-3).  
 
2.14.3.6 Identification of high probability pre-miRNA genes 
The results from in-dept analysis of pre-miRNA candidates were used to identify 
high probability pre-miRNAs from the pre-miRNA candidates. This was done on the 
basis of compliance with the pre-miRNA identification criteria outlined below. This 
criteria was based on the criteria outlined by Kozomara and Griffiths-Jones (2011) ( 
described in Section 1.7.2.2) with some additions to improve stringency.  
 
Pre-miRNA identification criteria 
1. At least one of the putative miRNAs from the same precursor must have a 
read-count of 10 or more in at least one infection.  
2. The pre-miRNA candidate must not map to a protein coding region.  
3. The putative miRNAs must be derived from the stems of the pre-miRNA 
candidate hairpin structure in close proximity to loop. 
4. Each putative miRNA must also be accompanied by major/minor strand in 
both infections. 
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5. The same transcript (or close isomiR differing by a maximum of +/- 1nt on 
the 5’  end) must be identified as the putative miRNA (dominant read from a 
given pre-miRNA arm) in both infections.  
6. The pre-miRNA candidate must be classified as a real pre-miRNA by both 
MiPred and CSHMM-Method. 
7. The pre-miRNA candidate structure must have an MFE < -25 kcal/mol. 
8. The proposed mature-miRNA-duplex must display 3’  overhangs (or may 
have a maximum of one blunt end) in both infections. 
9. Alignments of putative miRNAs/moRNAs pre-miRNAs must resemble 
miRNA-like alignment signatures in both infections. 
10. For a given pre-miRNA candidate, the isomiRs of at least one of the putative 
miRNAs must have a Ratio-1 value that is 1 in both infections and a Ratio-3 
value that is 1 in at least one infection.  
11. Reads mapped to pre-miRNA candidate loci must collectively form discrete 
stacks and must be enriched for mapped reads compared to flanking genomic 
regions.  
 
2.15 Automated identification of CyHV-3 pre-miRNAs from deep 
sequencing data 
Due to the benefits of combining output from different methods (as discussed in 
Section 2.14.3.6), two methods for automated identification of novel miRNAs from 
deep sequencing data were used. These were MirDeep2 and Mireap and their use in 
this study is described below 
 
2.15.1 MiRDeep2 
The process of identifying miRNAs using miedeep2.pl involved the used of two 
other programs to prepare the appropriate input files. Although the deep sequencing 
data had already been mapped to the CyHV-3 genome using SeqMap, the mapping 
file used by mirdeep2.pl needed to be in .arf format. Another script called mapper.pl 
generated mapped reads in this format. However, mapper.pl required the reference 
genome to be first broken up into cluster files with a Burrows-Wheeler index. This is 
a form of compression and is necessary in order to keep the memory footprint of the 
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mapping process small when working with large genomes. Memory footprint is not 
an issue when dealing with genomes in size range of herpesviruses, but the genome 
file was still prepared in this way purely for compatibility purposes This was carried 
out using a script called Bowtie. All of these steps are outlined below.  
 
1.  Genome Indexing (using Bowtie): The input file required by Bowtie 
consisted of CyHV-3 (Ac. DQ657948.1) genome in fasta format. Using the 
“ build”  function the genome was indexed into 6 cluster files all recognized by 
a defined common prefix in the file names (see Section 2.19.2 for use of 
Bowtie).These files could now be collectively used as a reference for 
mapper.pl. 
 
2. Mapping (using mapper.pl): Information from the Genome-SeqMap-Output 
generated in Section 2.13 was used to make a tab delimited .txt file with 
CyHV-3 derived reads and read counts in one column and sequences in the 
other, see format below. 
 
 
 
 
This tab delimited text file was converted into fasta using the script 
tabtofasta.pl. The indexed genome clusters generated by Bowtie and the new 
fasta file containing the reads were both used as input by mapper.pl (see 
Section 2.19.2 for use of mapper.pl) which mapped these reads to the CyHv-3 
genome and generated output in .arf format  which could be read by 
mirdeep2.pl . 
 
3. Novel miRNA identification (using mirdeep2.pl): The output .arf file from 
mapper.pl, the fasta file containing the reads and the fasta file originally used 
to generate the indexed genome were used as input for mirdeep2.pl (see 
Section 2.19.2 for use of mirdeep2.pl). The resulting output consisted of pre-
miRNA and miRNA candidates, their scores, read signatures and coverage 
plots.   
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2.15.2 Mireap 
Unlike mirdeep2.pl, Mireap required mapped reads in a basic format. For this, the 
information from the Genome-SeqMap-Output generated in Section 2.13 was used to 
make a tab delimited .txt file with read ID, chromosome (with the value used 
corresponding to the fasta identifier for the reference genome) and genome positions 
see format below. 
 
The information in the Genome-SeqMap-Output was also used to make a tab 
delimited .txt file with CyHV-3 derived reads and read counts in one column 
(separated by an underscore) and sequences in the other, see format below.  
 
This tab delimited text file was converted into fasta using the script tabtofasta.pl Also 
the CyHV-3 genome was also required in fasta format. These 3 files were used as 
input for Mireap (see Section 2.19.2 for use of Mireap). The resulting output 
consisted of pre-miRNA and miRNA candidates and their associated read signatures 
 
2.15.3 Filtering and comparison of results from two automated methods 
Before comparison, results were filtered by elimination of predictions occurring 
ORFs (using genome map in Seqbuilder) and elimination of predictions with no 
corresponding minor strand. Remaining predicted pre-miRNAs from the two 
methods were renamed based on their VMir name (all were also predicted by VMir). 
Predictions that were not common to both MirDeep2 and Mireap were eliminated. 
These were compared to the results obtained from manual identification of miRNAs 
from the deep sequencing data. 
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2.16 Comparison of CyHV-3 seed regions to known host and viral 
miRNA seed regions 
All common carp (Cyprinus Carpio carpio) and viral miRNAs retrieved from 
MiRBase (Release 18) in fasta format. To facilitate manipulation in Excel, this fasta 
file was converted to tab delimited format using fastatotab.pl (see Section 2.19.2 for 
use of fastatotab.pl). In Excel, columns containing miRNA sequences were broken 
up by inserting column breaks between characters 1-2 and 8-9, thus isolating the seed 
sequence (positions 2-8) in a separate column. The remaining parts of the miRNA 
sequences were deleted. This file (now containing miRNA IDs and seed regions in 
two separate columns) was saved as a tab delimited text file and converted back into 
fasta format using tabtofasta.pl (see Section 2.19.2 for use of tabtofasta.pl). The 
CyHV-3 miRNA seed regions were formatted in the same way in a separate fasta 
file. CyHV-3 seed regions mapped to viral and common carp seed regions from 
MiRBase using SeqMap allowing 1 mismatch (see Section 2.19.2 for use of 
SeqMap). MiRNAs with matching seeds were also compared in full length in Excel.  
 
2.17 Search for CyHV-3 miRNA homology in other CyHVs 
All CyHV-3 miRNAs and pre-miRNAs were aligned to CyHV-1 (Ac. JQ815364.1) 
and CyHV-2 (Ac. JQ815363.1) genomes using BLAST. For more specific homology 
searches, genomic regions from other CyHV genomes that were directly orthologous 
to regions containing miRNAs in the CyHV-3 genome were selected. This was done 
by checking if the ORFs occurring opposite all CyHV-3 miRNAs had orthologs in 
either of the other two CyHVs. This was checked by referring to Davison et al. 
(2012), and all ORFs opposite to CyHV-3 high probability pre-miRNAs were found 
to have orthologs in CyHV-2 and CyHV-3 with the exception of ORF-7 (opposite 
MD1111) which had no ortholog in CyHV-1. The sequences of these orthologs in 
other CyHVs were retrieved from GenBank and reverse complemented (using ReCo 
RoKo tool) to obtain the sequence of the non-coding regions from other CyHVs that 
were directly orthologous to the non-coding regions in CyHV-3 that encoded 
miRNAs. CyHV-3 pre-miRNA sequences were aligned to their respective 
orthologous non-coding regions in CyHV-1 and CyHV-2 using BLAST i.e. two 
sequences were aligned using blastn program available online 
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(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&BLAST_PROGRAMS
=megaBlast&PAGE_TYPE=BlastSearch). High quality matches (with E-values 
<1E-8) were aligned to CyHV-3 pre-miRNAs using Multalin 
(http://multalin.toulouse.inra.fr/multalin/). Both of these methods performed the 
same task but BLAST gave more informative statistical output while Multalin gave 
more visually informative output. In essence, the best features of both approaches 
were combined.   
 
2.18 MiRNA Target Prediction 
In this study 2 programs were used to predict miRNA targets for CyHV-3 miRNAs 
in 3’  UTRs of CyHV-3 genes. 
 
2.18.1 Retrieval of 3’ UTR sequences 
CyHV-3 3’  UTR sequences were retrieved from Seqbuilder. As no CyHV-3 3’  UTRs 
were annotated at the time of this study, for practical purposes the 3; UTRs for each 
ORF were defined as the sequence between the stop codons and the nearest 
downstream polyA signal. There are more ORFs than polyA signals in the CyHV-3 
genome. As a consequence, many ORFs occur in the 3’  UTRs of upstream ORFs.  
Where this occurred, the 2 overlapping 3’  UTRs were included in analysis. UTRs 
that also contained ORFs had the names of these ORF(s) were mentioned in their 3’  
UTR names, see example in Figure 2.12. 
 
 
 
 
 
 
 
 
Figure 2.12 Illustration of ORF naming system 
In this diagram, the 3’  UTR for ORF7 overlaps with the 3’ UTR and coding region for ORF8. Hence 
the retrieved 3’  UTR sequence for ORF7 was named ORF_7-8.  
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2.18.2 TargetScan 
 
1. targetscan_60.pl: The file containing the miRNAs for target prediction 
consisted of a tab delimited .txt file with information such as: miRNA ID, 
miRNA sequence (positions 2-8) and species ID (this was only relevant to 
studies taking evolutionary conservation into account, for the purposes of this 
study a value of 1 was used for this field for each miRNA), see format below. 
 
 
 
 
The file consisting of the 3’  UTRs was formatted in a similar way except 
species ID was in the middle column (a value of 1 was used for all 3’  UTRs, 
corresponding to the value used for all miRNAs above), see format below. 
 
 
 
 
These two files were used as input for the script targetscan_60.pl (see Section 
2.19.2 for use of targetscan_60.pl). The output consisted of information such 
as name of 3’  UTR containing possible target site and a description of the site 
type (see Section 1.8 for details). This was used as input for 
targetscan_60_context_scores.pl 
 
2. targetscan_60_context_scores.pl: The output from targetscan_60.pl, the tab 
delimited .txt file containing 3’ UTR sequences and an extra dab delimited .txt 
file containing full length miRNA sequences were used as input for this 
script, see format for this extra file below. Again, the value used for species 
ID was 1, corresponding to what was used in all other input files. 
MirBase_ID was not applicable to this study as none of the miRNA 
sequences that were used were in MirBase.  
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targetscan_60_context_scores.pl was implemented as per see Section 
2.19.2. The output consisted of a summary of each predicted target site in the 
form of a breakdown of to how they scored in terms of their consistency with 
the characteristics of known miRNA target sites. This was all summed up in 
the form of a context+ score. A percentile rank column was also added to the 
output in order to help assess the significance of individual context+ scores.  
 
2.18.3 PITA 
The input for PITA consisted of 2 fasta files containing full length miRNAs and 3’  
UTRs respectively. The analysis was implemented as per Section 2.19.2. A 
percentile rank column was also added to the output in order to help assess the 
significance of specific G scores. 
 
2.18.4 Comparison of TargetScan and PITA results 
The top ranking predicted target sites from both TargetScan and PITA were 
compared. A prediction was considered probable if ranked within the top 10 
TargetScan and PITA predictions for CyHV-3 UTRs.  
 
2.19 Bioinformatics scripts used  
 
2.19.1 General Summary  
The bioinformatics scripts used in this study comprised of mixture of Linux based 
and Windows based scripts, see general details of all scripts used in Table 2.23. For 
convenience Linux was ran (in the form of Ubuntu 12.04 LTS) on a virtual machine 
within Windows XP using Oracle VM virtualBox manager. A shared folder was set 
up as a bridge between the two operating systems. This folder was used to carry out 
all data analysis and as such it was also the default location for all output files as 
allowed easy sharing of input and output data between the two operating systems. 
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Table 2.23 Details of all bioinformatics scripts used in this study 
 
Script Used for Implemented via 
Tabtofasta.pl High throughput formatting Linux terminal 
Fastatotab.pl High throughput formatting Linux terminal 
Clip_adapters.pl High throughput formatting Linux terminal 
fastx_uncollapser High throughput formatting Linux terminal 
seqmap.exe Read Mapping Windows command prompt 
Bowtie Genome-indexing, miRDeep Linux terminal 
mapper.pl Read Mapping, miRDeep Linux terminal 
Mirdeep2.pl Novel miRNA identification Linux terminal 
Mireap.pl Novel miRNA identification Linux terminal 
Targetscan_60.pl miRNA target prediction Windows command prompt 
Targetscan_60_context_scores.pl miRNA target prediction Windows command prompt 
Pita_prediction.pl miRNA target prediction Linux terminal 
 
2.19.2 Implementation of scripts 
In all cases, input files were located in the same directories as the scripts used to 
analyse them. All input files were tab delimited text files (.txt) or fasta files (.fa). No 
spaces were allowed in any file names as this was incompatible with the use of 
command lines to implement analysis. Table 2.24 contains information as to how 
each script was implemented and what specific options were used in this study. 
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Table 2.24 (1/2) Implementation of bioinformatics scripts used in this study 
 
High throughput formatting tools 
Script Usage 
Tabtofasta.pl 8*&!.,8,)!
!),*!,
&-9
#:),*,*!,

Fastatotab.pl *8&!.,*,*!,
&-9
#:),8,)!
!),*!,

Clip_adapters.pl #!,)&!.,),*!,
&*
;<	+2++9#!),),..&* 
fastx_uncollapser *-,.#=##.
.
8#!!")#.=:=!
.,*!,
&-=..,*!,
&-
Mapping tools 
Script Usage 
6
='&>&'(=?!)?>!.,),*!,
&*
!.,"
,*!,
&*
),),..,*!,

7..,,
#$
Seqmap 
Options used: 
 
>: Number of mismatches allowed = 0 
 
7..,,
#$: Output format 
 

&!.,),*!,
&*@#@'@
8?!,..,#.,*!,
,*!-=
#),),A!,
&*=
),),..,*!,
&*
@:
mapper.pl 
(Used with 
miRDeep) 
Options used 
 
=# : input file is fasta format 
 
-' : Removes sequences with lengths >17nt from the reads input 
reads files in case they interfere with miRNA signals 
 
= : Defines name of new reads file with reads >17 removed 
 
=: : progress report 
 
Genome Indexing tools  
Script Usage 
Bowtie 
(Used with 
miRDeep) 
8?!=8.!)!.,"
,*!,
&*
..,#.,*!,
,*!-
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Table 2.24 (2/2) Implementation of bioinformatics scripts used in this study 
 
Automated miRNA identification tools 
Script Usage 

!(&#),),A!,
&*
!.,"
,*!&*

),),..,*!,
&*(9
#,,",*!,
&"
Mirdeep2.pl 
Options used: 

: No list of known miRNAs from genome analysed 
included. 
: No list of known miRNAs from closely related 
species included 
: No list of known pre-miRNAs from genome 
analysed included. 
 
Mireap.pl 
;4!&=!!.,),*!,
&*=


),),*!,
&-=
!.,"
,A!,
&*@
7#!*!),)!#37#!*!),..,*),

MiRNA target prediction tools 
Script Usage 
targetscan_60.pl 
"#,>&
!,),!,*!,
&-
2,!,*!,
&-
"#,>,..,*!,
&- 
targetscan_60_context_scores.pl 
"#,>,#-,#&
*.,"$,
!,!,A!,
&-
2,!,*!,
&-
"#,>,..,*!,
&-
"#,>,#-,#,..,*!,
&-
&7!,)!#!&=.2,!,*!,
&*=

!*.,"$,
!,!,*!&*=*!-
..,*),*!,
,*!-=
 >B >B >
Pita_prediction.pl 
Options used: 
 
=
  >B >B >: This indicated that no mismatches 
were allowed for all lengths of seed region matches (by 
default one GU wobble was allowed in 7nt and 8nt seed 
matches. 
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Prediction of CyHV-3 encoded pre-miRNAs 
Prediction of CyHV-3 miRNAs Prediction of pre-miRNAs from  
6 other viral genomes 
VMir 
Use to characteristics of known pre-
miRNAs to establish relevant cut-off 
values for predicted CyHV-3 miRNAs 
Filter predictions based on established 
cut-off values 
Filter predictions further using pre-
miRNA classifier MiPred 
 
 
3 De Novo Prediction of Pre-miRNA-coding genes on the 
CyHV-3 genome 
In order to search for theoretical evidence to suggest that the CyHV-3 genome could 
encode miRNAs, the genome was analysed using VMir (Grundhoff et al., 2006). 
This predicted all hairpin structures occurring on the genome and scored them in 
Reterms of their consistency with general pre-miRNA structural characteristics. 
Predictions most likely to be genuine were then selected based on the characteristics 
of known viral pre-miRNAs that were correctly predicted by VMir. The strategy 
used in this study is outlined below in Figure 3.1   
 
 
 
 
  
 
 
 
 
  
 
 
 
Figure 3.1 Outline of strategy used for prediction of CyHV-3 pre-miRNAs  
 
3.1 Initial predictions  
 
Each pre-miRNA prediction was represented by a main hairpin (MHP) and shorter 
variations of this MHP referred to as subsiduary hairpins (SHPs) that were predicted 
to form in different analysis windows (described in more detail in Section 1.7.1.1). 
VMir predicted 43,921 MHPs in the CyHV-3 genome. On average each MHP had an 
average of 1.56 associated SHP variations, resulting in a total of 69,084 individual 
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pre-miRNAs when these length variants are also counted. A visual representation of 
these predictions is displayed in Figure 3.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Output from VMir analysis of the CyHV-3 genome 
MHP positions on the forward and reverse strands of the CyHV-3 genome are represented by solid 
blue triangles and green diamonds respectively. Repeated MHPs are represented by open shapes. As 
expected, hairpin structures in the left terminal repeat also occur in the right terminal repeat, hence 
hairpins in the right terminal repeat are denoted here as open shapes. 
 
3.2 Identification of relevant cut-off values for predicted pre-
miRNAs 
In order to establish relevant cut-off values for pre-miRNAs predicted in the CyHV-3 
genome, VMir was also used to predict pre-miRNAs on six other herpesvirus 
genomes known to encode pre-miRNAs. Details of viral genomes analyzed and 
known pre-miRNAs that were predicted in these genomes are available in 
Supplementary File 3.1 T.1. The prediction statistics for each of these six viruses are 
compared to the prediction statistics from CyHV-3 (Table 3.1).  
 
 
 
 
 
 
 
 
Genome Position Direct Terminal Repeat Direct Terminal Repeat 
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Table 3.1 Summary of VMir pre-miRNA predictions and statistics on all viral genomes analysed 
in this study 
Note: The number of known pre-miRNAs from each virus was based on information available from 
miRBase (Release 13) at the start of this study. Several of these viruses have since had more miRNA 
genes identified; up-to-date information is available in Table 1.4. 
 
 
Virus EBV HSV-1 HCMV KSHV MDV-1 MGHV68 Mean CyHV-3 
Genome Size (kb) 184.11 152.26 235.64 137.50 177.87 119.45 167.80 295.00 
Predicted MHPs 27042 23518 34615 19187 23699 16463 24087 43921 
SHPs 43189 36976 54162 30637 36023 25173 37693 69084 
Ave. SHPs Per 
MHP 1.60 1.57 1.56 1.60 1.52 1.53 1.56 1.57 
MHPs per Kb 146.9 154.5 146.9 139.5 133.2 137.8 143.14 148.88 
Pre-miRNAs 
known at time of 
analysis (MirBase 
release 13) 
25 6 11 12 14 9   N/A 
 
 
All 77 known pre-miRNA genes (based on miRBase Release 13) on these six viral 
genomes were successfully predicted by VMir. A summary of the sizes, VMir Scores 
and relative-WC values (referred to as just WC) of all correctly predicted pre-
miRNAs from each virus are shown in Table 3.2. These values are based on the 
MHPs of each predicted pre-miRNA. No correctly predicted pre-miRNA had a score 
lower than 112 and most (55%) were over the average value of 186. Some pre-
miRNAs did have WC values at or close to the lowest possible value of 1, although 
the majority (89%) had WC values >40.  
 
Table 3.2 Characteristics of VMir predicted MHPs corresponding to known pre-miRNAs on the 
other six viral genomes  
  
 Viral genome  EBV  HSV-1 HCMV KSHV MDV-1 MGHV68 
Correctly  predicted of 
known pre-miRNAs 25/25 6/6 11/11 12/12 14/14 9/9 
 Mean 
  
            
  
Min VMir Score 152.2 124 134.3 120.5 191.6 112.3 139.15 
Max VMir Score 233.5 237.3 244.7 267.9 276.3 167.1 237.80 
Mean 196.06 195.25 187.76 188.63 209.00 140.72 186.236 
                
Min MHP length 78 80 66 51 69 47 65.17 
Max MHP length 192 140 181 164 139 93 151.50 
Mean 112.36 105.50 108.73 117.17 101.27 66.56 101.930 
                
Min WC 43 2 38 11 33 1 21.33 
Max WC 49 47 48 48 48 48 48.00 
Mean 45.92 24.00 44.45 40.25 44.64 40.00 39.877 
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3.3 Testing and application of cut-off values 
The information in Table 3.2 was used to establish relevant cut-off values for 
filtering out the least likely CyHV-3 pre-miRNA predictions from Figure 3.2. 
 
3.3.1 Pre-miRNA length cut-off values 
The mean minimum and maximum pre-miRNA lengths displayed by correctly 
predicted pre-miRNAs in the 6 other viruses were 65 bp and 152 bp respectively, as 
shown in Table 3.2. Using these values as a guide, it was decided that low stringency 
cut-offs of 50 bp and 200 bp for minimum and maximum pre-miRNA lengths would 
be applied to pre-miRNA predictions from CyHV-3. These cut-off values were 
slightly outside the values displayed by correctly predicted pre-miRNAs in the six 
other viruses but they were selected in order to avoid eliminating genuine pre-
miRNA predictions that were outliners in terms of minimum and maximum MHP 
size.  
 
3.3.2 WC and VMir Score cut-off testing 
Based on the data presented in Table 3.2, the suitability of combinations of relevant 
cut-offs for WC and VMir Scores were tested. The suitability of each combination of 
cut-off values was assessed based on percentage sensitivity. These results are shown 
in Table 3.3. Using the mean WC and VMir Scores as cut-off values gave the worst 
sensitivity, in theory only allowing the prediction of 49.6% of the 77 correctly 
predicted known pre-miRNAs. Using the mean WC and lowering the VMir score 
cut-off to the mean minimum value improved the sensitivity to 77.9%. Lowering the 
WC to the minimum mean only increased the sensitivity to 81.8%. The fact that 89% 
of correctly predicted pre-miRNAs had WC values over 40 indicated that it may be 
important to use a WC cut-off of 40. This explains why lowering the WC cut-off 
value below 40 did not significantly increase sensitivity. This was also reflected in 
the difference in percentage sensitivity between using mean minimum WC and mean 
VMir Score as cut-offs and vice versa (53.2% vs. 77.9%). Thus, the WC cut-off was 
defined as 40. In order to improve the sensitivity, without reducing the cut-off value 
for WC below the mean, the cut-off value for VMir Score was further reduced to 
112, in line with the lowest score among the correctly predicted pre-miRNAs. This 
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resulted in the best sensitivity of 83.1% (that is to say, these cut-off values still 
allowed the detection of 83% of the 77 known pre-miRNAs on the other 6 viral 
genomes). 
 
Table 3.3 Estimated sensitivity of different combinations of VMir Score and WC cut-off values  
 
Cut-offs used WC Cut-off  
VMir 
Score 
Cut-off  
Estimated %  
Sensitivity 
Predicted CyHV-3 pre-
miRNAs post-filtering 
Mean WC and VMir 
Scores 40 186 49.4 49 
Mean Min WC and 
Mean VMir Score 21 186 53.2 142 
Mean WC and 
Mean Min.VMir 
Score 
40 139 77.9 192 
Mean WC and 
Lowest VMir Score 
in data 
40 112 83.1 303 
Mean Min. WC and 
VMir Scores 21 139 81.8 563 
 
 
Applying any of these combinations of cut-off values to the 43,921 predicted CyHV-
3 pre-miRNAs had the effect of eliminating most of them (Table 3.3). In general, the 
higher the sensitivity, the less predictions were eliminated, suggesting a possible 
reduction in accuracy as sensitivity increased. Despite this, the cut-off values 
displaying the best sensitivity in this case did not also show the least accuracy. Using 
the cut-off values WC: 40, VMir Score: 112 resulted in the highest sensitivity 
(83.1%, as mentioned earlier) and eliminated all but 303 pre-miRNA predictions. By 
contrast, the next most sensitive cut-offs of WC: 21, VMir Score: 139 actually left 
563 predictions. This suggested that using cut-off values of WC: 40, VMir Score: 
112 resulted in more accurate predictions than using WC: 21, VMir Score: 139 
despite also being more sensitive. As a result, these were the cut-off values (WC: 40, 
VMir Score: 112) that were ultimately used to eliminate low probability predictions 
on the CyHV-3 genome. The effect of applying these cut-off values to filter out low 
probability pre-miRNA predictions in the CyHV-3 genome is displayed in Figure 
3.3. The effect of applying the same cut-off values to the VMir predictions from the 
six other viral genomes and comparison to CyHV-3 in this regard are shown in Table 
3.4.   
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Direct Terminal Repeat 
Table 3.4 Summary of VMir pre-miRNA predictions passing established cut-offs values  
 
Filter Applied : Min Score: 112, Min MHP size: 45, Max MHP size 200, Min WC: 40 
Viral Genome EBV HSV HCMV KSHV MDV-1 MGHV-68 Mean CyHV-3 
Predicted pre-miRNAs after 
application of cut-off values 173 195 252 111 143 106 163.33 303 
% Reduction in Predicted MHPs 
due to filter  99.36 99.17 99.27 99.42 99.40 99.36 99.33 99.31 
Filtered MHP sites per Kb post 
filter 0.94 1.28 1.07 0.81 0.80 0.89 0.96 1.03 
Real miRNAs post filter 25/25 2/6 10/11 10/12 10/14 7/9    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 VMir pre-miRNA predictions on the CyHV-3 genome after cut-off values 
MHP positions in the forward and reverse orientations are represented by solid blue triangles and 
green diamonds respectively. Repeated MHPs are represented by open shapes. As expected hairpin 
structures in the left terminal repeat also occur in the right terminal repeat, hence hairpins in the right 
terminal repeat are presented here as open shapes. 
 
3.4 Further assessment of pre-miRNA predictions: 
Any predictions occurring in ORFs were eliminated. This resulted in the elimination 
of 104 predictions. The remaining 199 were structurally analysed using the pre-
miRNA-classifier MiPred. This involved analysis of both MHPs and SHPs as shorter 
versions hairpins of the same hairpin may fold slightly differently or may be more 
stable in the local sequence context (i.e. may have different values for WC). The 
inclusion of SHPs resulted in the analysis of 597 more pre-miRNA structures (i.e. 
length variations of MHPs). Out of a total of 796 predicted pre-miRNAs analysed, 
488 were classified as real pre-miRNAs. In total there were 155 hairpin sites where 
either the MHP or at least 1 SHP was classified as a real pre-miRNA. These results 
are summarized below (Table 3.5). 
 
 
Genome Position Direct Terminal Repeat 
  158 
Table 3.5 Summary of MiPred analysis on VMir predicted CyHV-3 pre-miRNAs 
 
Classification No. of Hairpins Percentage  
Not a pre-miRNA-like 138 17% 
Pseudo pre-miRNA 170 22% 
Real pre-miRNA 488 61% 
155 sites (77%) contain at least 1 “Real” pre-miRNA 
 
4 Experimental evaluation of pre-miRNA predictions  
In order to experimentally evaluate VMir and MiPred CyHV-3 pre-miRNA 
predictions (Section 3), RNA from an in vitro CyHV-3 lytic infection was analysed 
using a variety of methods. CyHV-3 putative miRNAs/pre-miRNAs were initially 
identified by deep sequencing of small RNAs from CyHV-3-infected cells followed 
by identification of highly abundant small RNAs mapping to VMir predicted pre-
miRNAs. In order to verify the RNA size range distribution of these small RNAs and 
to rule out the possibility of over-representation in the deep sequencing data (due to 
potential enzymatic bias) the same RNA was re-tested using array hybridization, 
targeting miRNAs from a range of high and low probability miRNA candidates. 
High probability candidates were also later analysed by northern blotting in order to 
check if they gave bands of sizes that were indicative of genuine miRNAs.  
 
4.1 Deep sequencing of small RNAs from in vitro CyHV-3 infections 
In order to identify small RNAs mapping to predicted pre-miRNAs, high throughput 
Illumina cDNA sequencing was carried out on 17-25 nt RNA from two separate in 
vitro infections of CCB cells using two different CyHV-3 isolates, H361 and N076. 
This approach allowed the detection of putative miRNAs derived from stems of 
predicted pre-miRNAs. Furthermore, sequencing from two different infections 
allowed the assessment of consistency in small RNA profiles between different 
flasks infected with different isolates. This strategy used to identify putative miRNAs 
from pre-miRNA candidates is outlined below in Figure 4.1 
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Sequencing of 17-25nt RNA from 2 different in vitro lytic infections 
Non-automated analysis of data Automated Analysis of data 
Identification of high probability pre-miRNA 
candidates from automated analysis 
In depth analysis or pre-miRNA candidates 
Identification of pre-miRNA candidates with 
highly abundant small RNAs mapped to 
them 
•Mature miRNA duplex structure 
assessment 
•Pre-miRNA structure assessment 
•Enrichment analysis 
•Inspection of alignment signature 
•IsomiR end heterogeneity analysis 
MiRDeep Mireap 
Pre-miRNA candidates 
identified by both methods 
Identification of high probability pre-miRNA 
candidates from non-automated analysis 
Pre-miRNA candidates identified by both approaches 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Outline of workflow for identification of high probability CyHV-3 pre-miRNAs 
through analysis of small RNA deep sequencing data 
 
 
4.1.1 Deep sequencing library validation 
 
4.1.1.1 Quality check of amplified library 
It was important that no non-specific products were present in the deep sequencing 
library. This was verified by agarose gel electrophoresis. Based on the adapter and 
primer sequences using in this study, a successfully prepared sequencing library 
(consisting of amplified dsDNA versions of 17-25 nt ssRNA now flanked by full-
length adaptor sequences) should consist of only dsDNA ranging from 104-112 bp in 
length. The vast majority of these products should be in the 107-109 bp size range on 
the basis that the 17-25 nt samples consisted predominantly of miRNAs which are 
20-22 nt in length. This should be visible on gels as a single strong band with no 
additional (non-specific) products.  
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In the initial optimization of the in-house deep sequencing library preparation 
process (using a modified version of the Illumina Small RNA v1.5 protocol 
described in Section 2.7), 150 pmol of each adaptor was used without PAGE 
purification of 5’  ligation products before the RT step (similar to the Illumina Small 
RNA v1.5 protocol). While this generated the correct product of 107-109 bp in size, 
it also generated much more abundant shorter non-specific products of ~90 bp in 
length. This smaller non-specific product was likely to be amplified adaptor-dimers 
which should be 87 bp in length (Figure 4.2 (a) Lib 1). Repeating this process and 
including PAGE purification of 5’  ligation products before the RT step reduced the 
amount of adaptor-dimers but did not eliminate them (Figure 4.2 (a) Lib 2). It 
became apparent that excess pre-adenylated 3’  adaptors from the 3’  ligation step 
were still present after PAGE purification and were entering the 5’  adapter ligation 
reactions to form adapter-dimers. It is likely that at this stage, adapter-dimers form 
much easier than the intended 5’  ligation product due to the pre-adenylation of the 3’  
adaptor. These shorter products may also be much more efficiently amplified during 
PCR due to their small size and enzymatic bias. This may have been the cause of the 
result shown in Figure 4.2 (a) Lib 1. PAGE purification of 5’  ligation products before 
the RT step went some way towards reducing the amount of adapter-dimers entering 
the RT step, although some of them still persisted (Figure 4.2 (a) Lib 2.). It was 
found that this problem could easily be eliminated by repeating the process used to 
prepare Lib 2 and using less adaptor (10 pmol compared to 150 pmol). This resulted 
in the elimination of adaptor-dimers and a much stronger band representing the 
correct library amplification product. This method was used to successfully prepare 
cDNA libraries from size-selected small RNA from both the H361 and N076 
infections. These amplified libraries (displaying a single band at ~110 bp) are 
displayed in Figure 4.2 (a) and (b). 
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100 bp 
marker Lib 1 10 bp marker 
Lib 2 H361 
Library 
100 bp 
600 bp 
1500 bp 
100 bp 
330 bp 
(a) (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Validation of Deep-sequencing libraries by gel electrophoresis.  
(a) Lib 1 and 2 show additional smaller non-specific-products ~90 bp. H361 library shows the correct 
104-112 bp product (b) N076 library shows the correct 104-112 bp product   
 
4.1.1.2 Assessment of content of amplified libraries 
In order to verify that the libraries were enriched for miRNAs over any other type of 
small RNA, PCR product was cloned into pGEM-T Easy vectors and used to 
transform highly competent E. coli JM109 cells. Dye terminator sequencing was then 
used to analyse inserts in these vectors. In total, 40 clones were sequenced. This 
analysis confirmed the correct assembly of the Illumina-compatible flanking 
sequences. Most of the sequences matched evolutionarily conserved eukaryotic 
miRNAs i.e. novel conserved carp cell miRNAs. This confirmed that the library was 
specifically enriched for miRNAs and suitable for deep sequencing analysis. In 
addition, one putative CyHV-3 miRNA was identified from dye terminator 
sequencing. This was identified on the basis that it mapped to the stem of a predicted 
CyHV-3 pre-miRNA (MR5057). This putative miRNA and its predicted pre-miRNA 
are shown in Figure 4.3.
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Figure 4.3 Identification of a putative CyHV-3 miRNA through dye terminator sequencing of an insert (from amplified cDNA library) cloned into pGEM-T Easy 
Vector  
(a) Structure of predicted pre-miRNA MR5057 (b) Sequence of mature miRNA from 3’  arm of MR5057 (c) Electropherogram with putative miRNA sequence highlighted.
(a) 
(c) 
(b) 
4>	.#.
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4.1.2 Mapping small RNA deep sequencing data to the CyHV-3 genome 
 
Quality filtered and processed reads from deep sequencing were mapped to the 
CyHV-3 genome. This revealed that the vast majority of transcripts sequenced from 
both infections were from the host and that only a small percentage were of viral 
origin (see Table 4.1 and Figure 4.4). In total there were 212,399 and 1,601,110 
CyHV-3 transcripts sequenced from the H361 and N076 infections respectively.  
 
Table 4.1 Overall deep sequencing yields from H361 and N076 infections.   
 
Infection Total Yield (Read Count) CyHV-3 Total Read Count 
CyHV-3 Total Read Count 
as a % of total yield 
H361 12,016,247 212,399 1.77% 
N076 23,903,173 1,601,110 6.70% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 A breakdown of the origin of reads (viral/host) from both infections 
This shows the percentage of transcripts sequenced that were of viral and host origin and specifically 
those of host rRNA origin. The latter give an indication as to the extent of overall RNA degradation.    
H361 Infection 
Other Host Transcripts CyHV-3 Transcripts Degraded Host rRNA Transcripts
11,645,431
96.9% 
212,399 
1.8%
158,417
1.3%
22,207,112 
92.9%
1,601,110
6.7%
94,951 
0.4% 
N076 Infection 
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Coverage plots of the mapped sequencing data are displawed in Figure 4.5. It can be 
seen that the entire genome was well-represented and that overall there was good 
agreement between the two infections both in terms of qualitative and quantitative 
data. In general however, the read counts for individual transcripts from the N076 
infection were significantly higher than the corresponding read counts for the same 
transcripts from the H361 infection. It can also be seen from the quantitative data 
(Figure 4.5) that there are discrete parts of the genome that have many more reads 
mapping to them than other parts. However, in both infections the vast majority of 
transcripts were detected only once i.e. they had a read count of 1, thus the median 
read count from both infections was equal to 1. A breakdown of unique reads and 
frequency ranges from both infections is also shown (Table 1.6 (a) and (b)). Details of 
all individual reads mapping to the CyHV-3 genome including start and end positions, 
length and read counts are displayed in Supplementary File 4.1 T.1-T.4.
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Table 4.2 A breakdown of unique small RNA reads sequenced in terms of frequency ranges 
Numbers of unique transcripts sequenced and their frequencies from (a) the H361 infection and (b) the 
N076 infection 
 
H361 infection 
Total Unique-Transcripts CyHV-3 Unique-Transcripts 
Read count 
range 
Number of 
unique-
transcripts 
Percentage 
of total 
unique-
transcripts 
Read count 
range 
Number of 
CyHV-3 
unique-
transcripts 
Percentage 
of total 
unique-
transcripts 
>999 563 0.16% >999 9 0.003% 
100-999 2424 0.71% 100-999 41 0.012% 
10-99 15033 4.38% 10-99 581 0.169% 
5-9 14411 4.20% 5-9 1032 0.301% 
2-4 55944 16.30% 2-4 6331 1.845% 
1 254799 74.25% 1 22223 6.476% 
Total 
number of 
unique-
transcripts 
343174 100.00% 
Total 
number of 
CyHV-3 
unique-
transcripts 
30217 8.81% 
 
 
N076 infection 
Total Unique-Transcripts CyHV-3 Unique-Transcripts 
Read count 
range 
Number of 
unique 
transcripts 
Percentage 
of total 
unique 
transcripts 
Read count 
range 
Number of 
CyHV-3 
unique 
transcripts 
Percentage 
of total 
unique 
transcripts 
>999 499 0.15% >999 19 0.007% 
100-999 1847 0.54% 100-999 218 0.083% 
10-99 11811 3.44% 10-99 3598 1.374% 
5-9 12038 3.51% 5-9 5033 1.923% 
2-4 44595 12.99% 2-4 4172 1.594% 
1 190998 55.66% 1 59539 22.743% 
Total 
number of 
unique 
transcripts 
261788 100.00% 
Total 
number of 
CyHV-3 
unique 
transcripts 
72579 27.724% 
 
 
The 17-25 nt RNA samples were specifically enriched for miRNAs and therefore 
miRNAs should be among the most abundant transcripts present in the sample. 
Transcripts with read counts 10 were considered significantly more abundant than 
the median read count of 1 and as such, miRNAs were expected to be among this 
subset of highly-expressed transcripts. Such highly-expressed transcripts only 
represented ~2% and ~5% of unique CyHV-3 transcripts identified in the H361 and 
(a) 
(b) 
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N076 infections respectively (Table 4.2 (a) and (b) and Table 4.3). However the 
combined read counts of these highly-expressed transcripts accounted for the vast 
majority of transcripts sequenced from both infections, representing 79.29% and 
93.25% of all transcripts sequenced in the H361 and N076 infections respectively 
(Table 4.3). Unique transcripts were further divided into those mapping to coding-
regions and non-coding regions of the genome. These details are relevant in this study 
because in addition to being of high abundance in these samples, miRNAs are 
expected to be mainly derived from non-coding regions of the genome. Figure 4.6 
shows that highly expressed transcripts mapping to non-coding regions only 
represented a small subset of unique transcripts, ~1% in both infections. However, 
Figure 4.7 shows that the combined read counts of these highly abundant transcripts 
actually constituted the vast majority of CyHV-3 transcripts sequenced in both 
infections. This indicated that these non-protein-coding regions of the CyHV-3 
genome were quite transcriptionally active and that this may have been due to the 
expression of miRNAs. In 17-25 nt size fractionated RNA samples, miRNAs should 
be among a small subset of highly expressed CyHV-3 transcripts from non-coding 
regions. Therefore for the purposes of novel miRNA discovery, transcripts from this 
subset were inspected further. 
 
Table 4.3 Details of highly-expressed unique CyHV-3 transcripts sequenced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infection 
Unique 
CyHV-3  
transcripts 
Highly 
expressed 
unique CyHV-
3 transcripts 
(read counts 
 
   
 
10) 
Percentage of 
unique CyHV-
3 transcripts 
that are 
highly 
expressed 
transcripts  
 
Combined 
read count of 
unique CyHV-
3 high-highly 
transcripts 
 
Percentage of 
total CyHV-3 read 
count  
H361 30,217 631 2.09% 168,421 79.29% 
N076 72,579 3,835 5.28% 1,492,985 93.25% 
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Figure 4.6 A breakdown of the number of highly expressed /low-abundance unique CyHV-3 
transcripts sequenced in terms of their genomic regions. 
High-abundance unique transcripts (  10 reads) mapping to both protein-coding and non-coding 
regions represented a small subset of unique CyHV-3 transcripts. Most unique transcripts were present 
low abundance (<10 reads) and were mapped to protein-coding regions.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3,243 
4.5% 
592 
0.8% 
14,284 
19.7% 
54,460 
75.0% 
H361 Infection 
286 
0.9% 
345 
  1.1% 
10,492
34.7% 
19,094
63.2% 
N076 Infection 
Number of highly-expressed unique transcripts ( 
 
 10 reads) mapping to protein-coding genes 
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 
 10 reads) mapping to non-coding regions 
Number of low-abundance unique transcripts (<10 reads) mapping to non-coding genes 
Number of low-abundance unique transcripts (<10 reads) mapping to protein-coding genes 
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Figure 4.7 A breakdown of the combined read counts of highly-expressed /low-abundance unique 
CyHV-3 transcripts in terms of their genomic regions. 
High-abundance unique transcripts (  10 reads) mapping to non-coding regions account for the vast 
majority of CyHV-3 transcripts sequenced in both samples.   
 
 
 
 
 
 
 
 
 
 
 
 
H361 Infection 
95,118 
5.9% 
1,397,867 
87.3%
84,607 
5.3% 
23,518 
1.5% 
6,884 
3.2%
161,537
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28,330 
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15,648 
7.4% 
N076 Infection 
Combined read count of highly-expressed unique transcripts (

 

10 reads) mapping to protein-coding genes 
Combined read count of highly-expressed unique transcripts ( 
 
 10 reads) mapping to non-coding genes 
Combined read count of low-abundance unique transcripts (<10 reads) mapping to protein-coding genes 
Combined read count of low-abundance unique transcripts (<10 reads) mapping to non-coding genes 
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4.1.3 Non-automated identification of miRNAs from deep sequencing data 
 
4.1.3.1 Initial identification of pre-miRNA candidates 
By mapping CyHV-3 transcripts to CyHV-3 protein-coding sequences and predicted 
pre-miRNA sequences it was possible to identify highly-expressed transcripts (read 
counts 10) mapping to predicted pre-miRNAs occurring in non-coding parts of the 
CyHV-3 genome. These provisional pre-miRNA candidates (i.e. VMir predicted pre-
CyHV-3 miRNAs with sequenced small RNAs mapping to them) were checked for 
the presence of putative miRNAs mapping to both arms and adjacent to the terminal 
loop (only one of which needed to be highly-expressed i.e. a read count 10). In order 
that a provisional pre-miRNA candidate be considered for further analysis, it was 
essential that the same pattern of small RNA mapping was observed in both 
infections. This at least suggested that some of these patterns were caused by a precise 
repeated pattern of miRNA processing from pre-miRNAs as opposed to the random 
degradation of larger non-coding transcripts. This strategy resulted in the 
identification of 21 pre-miRNA candidates (no longer considered provisional 
candidates) for further analysis. Nineteen of these occurred in 4 discrete clusters 
(defined as containing pre-miRNA candidates within 10 kb of each other). Details of 
these pre-miRNA candidates are given in Table 4.4 and their genomic positions can 
be seen in Figure 4.8.   
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Table 4.4 (Part 1/3) List of Pre-miRNA candidates identified on the forward strand of the CyHV-
3 genome (GenBank Ac No. DQ6579481.1) 
The co-ordinates of the pre-miRNA candidates are based on MHPs predicted by VMir 
 
Forward Strand  
Clustered/
non-
clustered 
Pre-miRNA 
candidate 
name 
Start  End VMir Score 
WC 
Relative 
Pre-miRNA candidate sequence 5' 
to 3’ 
MD759 10265 10325 93.9 28 
GGUGUGGGGGCCCAGCAAAGCC
ACGUGCUAGAGGCUGAGGGCAG
GCUGAGGUCCCUGAUUC 
MD773 10531 10574 119.7 1 CGCUUGGGGCUGCCGUCUGCUGUUCCCGAUGGGGCUCUGGUGCG 
MD20185 10754 10812 62.9 15 
GGUUACUCGUAAUGGUUACAUA
UAUUACAUAUAUUACAUAUCAUA
CUAUACGGUUUACU 
MD20189 11006 11054 33.4 1 
UGGUCUUUGGAAGAAACGAAUA
AACAAGCGAUUUAACUUUGGGG
GUCCG 
Forward 
Strand 
Cluster 1 
MD1111 15432 15603 222.9 42 
UCAGCAGUCUCUUGUGGGUCUC
UGUCUGCAGUGGACAUCACCUC
CUCCUCACCAGCAUCAGCAGCA
GGCUCAUCAUCAUCAUCAGAGU
CAGAGAUGAGGAUGGUCUCAGU
CUGUUGUGGUGGUGGUGUGGA
CUUGGCUGCACGGCGCUGCUCA
CGGCUUGCAAGACGGCUGA 
Forward 
Strand 
non-
clustered 
MD9812 133905 134011 224.8 46 
GGCACAGCGUGCGGGCCCUUUC
CGGCAGGCCGUCGGCCUUCAUG
AUGUAGACGCCGGACUCGUCGC
GAAGGUCGACGGCGCCCGGCGA
GCGCGGCCUCACUCCGGCC 
MD11410 154441 154515 141.8 37 
GCCCACCGAGGACGCGUAGGCC
GUGUCCACCUCGUUGAUCUUGG
AGAUGUCCACGGUGUACCCGGC
CUCGGCGGC 
Forward 
Strand 
Cluster 2      
MD11776 159561 159696 210.2 45 
GCCCAGCUGAUCCUUGGACUCU
GGCACGCCGUUGAUACCGGUCA
GCACCCUCCCGUAGAACUUGUC
CACAAAGUUGCAGCAGGCCUGC
GUGAGGGUGUUGGCCGGCACGU
GCUUGUUGGGCGUCCACACGCC
GGGC 
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Table 4.4 (Part 2/3) List of Pre-miRNA candidates identified on the forward strand of the CyHV-
3 genome (GenBank Ac No. DQ6579481.1) 
The co-ordinates of the pre-miRNA candidates are based on MHPs predicted by VMir 
 
Reverse Strand 
Clustered/
non-
clustered 
Pre-miRNA 
candidate 
name 
Start  End VMir Score 
WC 
Relative 
Pre-miRNA candidate sequence 5' 
to 3’ 
MR5057 69618 69677 114.2 2 
GUCGGAGGCAGUGACGGCAAUG
UCGUUUUUAUUCCCGAAAUUGC
GGCCGCUGUCGACGAC 
Reverse 
Strand 
Cluster 1      
MR5075 69875 70015 165.4 47 
GGUUCUUGCUUGGUUGACUGCG
AGGAAGGCAGCACGGGGGUGGG
CGUCUUUGUAGUUGGUACAACU
GCCUGCUUCACGGUGCUAGUAU
CAACUGCAAGGGUGCCCGUUCC
ACUCUUCUCCGCUGGAUCGACC
UUGACGGCC 
Reverse 
Strand 
non-
clustered 
MR6201 84889 84939 123 45 
GACGGCGCUGUGCCAGAAGGGC
UUUUCCAGCGCUUCGAGCGCGU
CGUCGUC 
MR7404 100908 100958 76.3 9 
ACGUUGUGGGGGACGGUUCAGA
UCACCAACGAACCUCCGAUCACA
UUUUGU 
MR7409 100949 101022 115.4 11 
CCGGCGACUCGUGUGGGACGUG
AUGAGCGGCGAGCCCCGCGACG
GCUCGUCCACACACAUCCUCAC
GUUGUGGG 
MR7412 101011 101055 76.5 1 
ACGGCUCGCCUGGGCUCAGAAG
CGGGACUAGGACCGGCGACUCG
U 
MR7418 101072 101119 86.9 18 
CAACCGGCCGCGGACCCUGGUC
CCUCAGACCGGUAGACGUCGCC
GUUG 
Reverse 
Strand 
Cluster 2  
MR7434 101223 101300 172.5 8 
AGGUUGCUCGCCGUCGCCGUCU
CGGCUUGGAGGUACCUGCGGGC
ACGUCGAGACGGACGGCUCGGG
CCAGCGCUGCCU 
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Table 4.4 (Part 3/3) List of Pre-miRNA candidates identified on the forward strand of the CyHV-
3 genome (GenBank Ac No. DQ6579481.1) 
The co-ordinates of the pre-miRNA candidates are based on MHPs predicted by VMir 
 
Reverse Strand 
Clustered/non-
clustered 
Pre-
miRNA 
Name 
Start  End VMir Score 
WC 
Relative 
Pre-miRNA candidate sequence 
5' to 3’ 
MR7440  101364 101508 115.9 12 
UCUCACGCGUGACGGAUGGGU
GUGCGACGGUCGCUGCGACUA
CUCGCCAACCUCCUCACGUCA
GA 
MR7460 101591 101658 144.5 17 
GGGUCAGAGAGACGGCUCACU
CGGUAGGGAGCGUCCGACGUC
GUGCGGGCCACCGUCGCGGG
GACAUGGGUUCGGGUCCCGCC
GCCGAAAGCGAGCUGGAUCCA
UCCCGGUCUUCACCUCGGCCA
AAUGGACUCCGUCUCUCGAUU
GUCGUGACGACUCUGCUACUC
GGGUGCACCGAAAACCUCUAU
GGCCC 
MR7468 101668 101718 33 1 
GGCACAGCGUGCGGGCCCUUU
CCGGCAGGCCGUCGGCCUUCA
UGAUGUAGACGCCGGACUCGU
CGCGAAGGUCGACGGCGCCCG
GCGAGCGCGGCCUCACUCCGG
CC 
MR7471 101717 101781 130.1 42 
GCCCACCGAGGACGCGUAGGC
CGUGUCCACCUCGUUGAUCUU
GGAGAUGUCCACGGUGUACCC
GGCCUCGGCGGC 
Reverse Strand 
Cluster 2 
(Continued)  
MR7476  101817 102009 130.7 37 
GCCCAGCUGAUCCUUGGACUC
UGGCACGCCGUUGAUACCGGU
CAGCACCCUCCCGUAGAACUU
GUCCACAAAGUUGCAGCAGGC
CUGCGUGAGGGUGUUGGCCG
GCACGUGCUUGUUGGGCGUC
CACACGCCGGGC 
 
 
Details of putative miRNAs which were the basis for identification of these pre-
miRNA candidates are given in Table 4.5. It can be seen from the read counts in 
Table 4.5 that some of these are extremely abundant, for example the transcripts 
mapping to pre-miRNA candidates MR5057, MD11776, MD773 and MD1111. In 
particular the putative miRNA from the 3’  arm of MR5057 was very highly 
expressed. It was the most abundant CyHV-3 transcript in both infections accounting 
for 29% and 72% of all CyHV-3 transcripts in the H361 and N076 infections 
respectively. Overall, it was the 35th and 4th most abundant transcript sequenced in 
the H361 and N076 infections respectively, making it even more abundant that 99.9% 
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of host transcripts sequenced in both infections. In addition to miRNAs, 6 pre-
miRNAs were also found to have additional transcripts occurring immediately 
adjacent to a putative miRNA. These are a new class of pre-miRNA derivatives called 
microRNA-offset-RNAs (or moRNAs). Some of these were very highly expressed. 
For example the most abundant putative moRNA detected was the 3’  putative 
moRNA from MD11776 in the N076 infection (3,171 reads). In both infections, the 5’  
putative moRNA from MR5075 was more abundant than the putative miRNA on the 
same arm. Conversely, the putative moRNAs from MD9812 only occurred once in 
both infections. Details of read counts for all putative miRNAs and moRNAs are 
given in Table 4.5 and their positions on their respective candidate pre-miRNA 
secondary structures are shown in Figure 4.10. Overall it can be seen from Table 4.5 
that read counts were generally higher from the N076 infection when compared to the 
H361 infection. These levels are also directly compared in Figure 1.12. It was also 
observed that the dominant isomiRs at some miRNA loci were slightly different from 
one infection to the next. Out of the 42 putative miRNAs, 21 (50%) are represented by 
slightly different isomiRs (putative isomiRs at this stage) in each infection. IsomiRs 
are variants or miRNAs that are slightly different in length and occur due to 
inconsistencies in miRNA processing (Section 1.5.1). Despite this, the majority of 
putative miRNAs (32 of them, or 73.8%) still retained the same 5’  end in both 
infections. Of those that did not share the same 5’  ends, 4 of them (9.5%) were offset 
by just 1 nt and 7 of them (16.7%) were offset by >1nt at their 5’ ends. In addition, for 
one pre-miRNA candidate, MD1111, the major form switched from the miRNA on 
the 3’  arm in the H361 infection to the miRNA on the 5’  arm in the N076 infection.  
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Table 4.5 (Part 1/3) List of putative miRNAs and moRNAs from pre-miRNA candidates and 
their read counts 
 
Pre-miRNA 
candidate 
name 
Arm Infection Sequence 
Same 
isomiR is 
miRNA in 
both 
infections? 
IsomiR 
present in 
both 
infections 
Read 
Count 
H361  22 No 1 5' miRNA  
N076 
No 
 
No 3 
H361  22222 Yes 15 
MD759 
3’ miRNA 
N076 22222
No 
No 70 
H361  2222 No 1 5' miRNA  
N076 22222
No 
No 7 
H361  22222 Yes 53006 
MD773 
3’ miRNA 
N076 22222
Yes 
Yes 7314 
H361  22222222 Yes 36 5' miRNA  
N076 22222222
No. Same 
5’ End Yes 453 
H361  22222222222 No 2 
MD20185 
3’ miRNA 
N076 2222222222
No. 5’ end 
off-set +/- 
1nt No 5 
H361  22222 Yes 107 5' miRNA  
N076 222222
No. Same 
5’ End Yes 950 
H361  22222 Yes 2 
MD20189 
3’ miRNA 
N076 2222
No. Same 
5’ End Yes 9 
H361  2222 Yes 567 5' miRNA  
N076 2222
Yes 
Yes 1055 
H361  222222222 Yes 2711 3’ miRNA 
N076 222222222
Yes 
Yes 72 
H361  2222 No 3 5' moRNA  
N076 2222
No. 5’ end 
off-set +/- 
1nt No 4 
H361  222222 Yes 38 
MD1111 
3’ moRNA 
N076 2222222
No. Same 
5’ End Yes 85 
H361  22222 Yes 23 5' miRNA  
N076 222222
No. Same 
5’ End Yes 7 
H361  22 Yes 1 3’ miRNA 
N076 22
No. Same 
5’ End Yes 5 
H361  2222 Yes 1 5' moRNA  
N076 2222
Yes 
Yes 1 
H361  7 N/A N/A 
MD9812 
3’ moRNA 
N076 22
N/A 
N/A 1 
H361  2222 Yes 10 5' miRNA  
N076 2222
Yes 
Yes 26 
H361  2222 No 4 
MD11410 
3’ miRNA 
N076 2222
No. 5’ end 
off-set +/- 
1nt No 2 
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Table 4.5 (Part 2/3) List of putative miRNAs and moRNAs from pre-miRNA candidates and 
their read counts 
 
Pre-miRNA 
candidate 
name 
Arm Infection Sequence 
Same 
isomiR is 
miRNA in 
both 
infections? 
IsomiR 
present in 
both 
infections 
Read 
Count 
H361  2222 Yes 301 5' miRNA  
N076 2222
Yes 
Yes 1126 
H361  22222 Yes 2114 3’ miRNA 
N076 22222
No. Same 
5’ End Yes 10396 
H361  222222 Yes 18 5' moRNA  
N076 222222
No 
Yes 85 
H361  22222 Yes 60 
MD11776 
3’ moRNA 
N076 22222
Yes 
Yes 3171 
H361  22222 Yes 15 5' miRNA  
N076 22222
Yes 
Yes 149 
H361  2222 Yes 62596 
MR5057 
3’ miRNA 
N076 2222
Yes 
Yes 1166058 
H361  22222222 Yes 12 5' miRNA  
N076 22222222
Yes 
Yes 95 
H361  22222 Yes 125 3’ miRNA 
N076 22222
Yes 
Yes 217 
H361  222 Yes 26 5' moRNA  
N076 222
Yes 
Yes 122 
H361  7 N/A N/A 
MR5075 
3’ moRNA 
N076 7
N/A 
N/A N/A 
H361  222 Yes 2 5' miRNA  
N076 222
No. 5’ end 
off-set +/- 
1nt Yes 6 
H361  2222222 Yes 6 
MR6201 
3’ miRNA 
N076 2222222
Yes 
Yes 22 
H361  22222 Yes 91 5' miRNA  
N076 22222
No. Same 
5’ End Yes 128 
H361  22222 Yes 205 
MR7404 
3’ miRNA 
N076 22222
Yes 
Yes 1033 
H361  22 Yes 124 5' miRNA  
N076 22
Yes 
Yes 973 
H361  2222 No 2 
MR7409 
3’ miRNA 
N076 2222
No. Same 
5’ End No 12 
H361  222 No 1 5' miRNA  
N076 222
No. Same 
5’ End Yes 23 
H361  222 Yes 14 
MR7412 
3’ miRNA 
N076 222
Yes 
Yes 81 
 
 
 
 
 
 
 
  178 
Table 4.5 (Part 3/3) List of putative miRNAs and moRNAs from pre-miRNA candidates and 
their read counts 
 
Pre-miRNA 
candidate 
name 
Arm Infection Sequence 
Same 
isomiR is 
miRNA in 
both 
infections 
IsomiR 
present in 
both 
infections 
Read 
Count 
H361  22 No 2 5' miRNA  
N076 22
No. Same 
5’ End Yes 12 
H361  2222 Yes 66 
MR7418 
3’ miRNA 
N076 2222
Yes 
Yes 130 
H361  2222 Yes 2 5' miRNA  
N076 222222
No 
Yes 14 
H361  2 Yes 56 
MR7434 
3’ miRNA 
N076 2
Yes 
Yes 508 
H361  22 Yes 13 5' miRNA  
N076 22
Yes 
Yes 154 
H361  22222 Yes 15 3’ miRNA 
N076 22222
Yes 
Yes 67 
H361  2222 Yes 38 5' moRNA  
N076 2222
No. 5’ end 
off-set +/- 
1nt Yes 58 
H361  22222 Yes 280 
MR7440 
3’ moRNA 
N076 22222
Yes 
Yes 70 
H361  2222 Yes 5 5' miRNA  
N076 2222
No. 5’ end 
off-set +/- 
1nt Yes 126 
H361  22 Yes 13 
MR7460 
3’ miRNA 
N076 22
Yes 
Yes 46 
H361  222 No 1 5' miRNA  
N076 222
No 
No 86 
H361  2222 No 3 
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4.1.3.2 In depth analysis of pre-miRNA candidates 
Only pre-miRNA candidates were selected for more in depth assessment so as to 
determine the likelihood that these predictions represented genuine pre-miRNAs. This 
involved analysing the characteristics of both the pre-miRNAs themselves and all of 
the small RNAs mapping to their stems in order to ascertain if they conformed to the 
characteristics of bone-fide miRNAs. 
 
4.1.3.3 Mature miRNA duplex structure assessment 
 
During miRNA biogenesis, the processing of miRNAs from pre-miRNAs typically 
results in the formation of mature-miRNA-duplexes with characteristic 3’  overhangs. 
Mature miRNA duplexes were predicted by highlighting the putative miRNA 
sequence’ s pre-miRNA candidate secondary structures. These were inspected for the 
presence of 1-4 nt 3’ end overhangs (or a maximum of one blunt end) in both 
infections. Out of the 21 pre-miRNA candidates, 9 of them (42.9%) were found to 
meet these criteria in both H361and N076 infections. The results of this analysis are 
shown in Figure 4.10. These structures can also be viewed in Supplementary File 4.1 
T.5.  
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Figure 4.10 (Part 1/4) Structures of CyHV-3 pre-miRNA candidates and predicted mature 
miRNA-duplexes, based on putative miRNA sequences 
5’  miRNAs are red, 3’  miRNAs are yellow, 5’  moRNAs in green and 3’  moRNAs in purple.  
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Pre-miRNA 
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Pre-miRNA candidate and mature 
-miRNA-duplex structure from 
H361 infection 
Pre-miRNA candidate and mature 
-miRNA-duplex structure from 
N076 infection 
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3’ miRNA: Blunt 
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Candidate 
Pre-miRNA 
name 
Pre-miRNA candidate and mature 
-miRNA-duplex structure from 
H361 infection 
Pre-miRNA candidate and mature 
-miRNA-duplex structure from 
N076 infection 
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MD11776 
 
 
MD11776 
moRNAs 
 
 
MR5057  
MR5075 
 
MR5075 
moRNAs 
 
MR6201 
 
 
 
Figure 4.10 (Part 2/4) Structures of CyHV-3 pre-miRNA candidates and predicted mature 
miRNA-duplexes, based on putative miRNA sequences 
MiRNAs are red, 3’  miRNAs are yellow, 5’  moRNAs in green and 3’  moRNAs in purple.  
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Candidate 
Pre-miRNA 
name 
Pre-miRNA candidate and mature 
-miRNA-duplex structure from 
H361 infection 
Pre-miRNA candidate and mature 
-miRNA-duplex structure from 
N076 infection 
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Figure 4.10 (Part 3/4) Structures of CyHV-3 pre-miRNA candidates and predicted mature 
miRNA-duplexes, based on putative miRNA sequences  
5’  miRNAs are red, 3’  miRNAs are yellow, 5’  moRNAs in green and 3’  moRNAs in purple.  
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Figure 4.10 (Part 4/4) Structures of CyHV-3 pre-miRNA candidates and predicted mature 
miRNA-duplexes, based on putative miRNA sequences   
5’  miRNAs are red, 3’  miRNAs are yellow, 5’  moRNAs in green and 3’  moRNAs in purple.  
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4.1.3.4 Assessment of Pre-miRNA structures 
Two separate pre-miRNA classifiers, namely MiPred and the CSHMM-Method, were 
used in order to assess the structures of pre-miRNA candidates. These two classifiers 
performed well in performance comparison studies elsewhere (Agarwal et al., 2010; 
Sinha et al., 2009) and were therefore deemed to be most suitable for differentiating 
between pseudo-pre-miRNAs and genuine pre-miRNAs. Details of their performance 
and how they work are outlined in Section 1.7.1.2. In the case of each pre-miRNA 
candidate, it was the most stable version of the hairpin predicted (by VMir) to contain 
the full length miRNAs that was analyzed. This was based on the absolute-WC of the 
predicted MHP and SHPs (if any) from VMir analysis. WC is a measure of the 
stability of a specific hairpin structure within its local sequence context. Predicted 
length-variants with higher absolute WC values are more likely to form stable pre-
miRNAs within the local sequence context than those with lower absolute WC values. 
These were therefore the most relevant variants to analyse for the purposes of pre-
miRNA candidate classification. Where putative moRNAs were identified and where 
these sequences were not included in the most stable SHP (pre-miRNA variant) 
containing the miRNAs, the next most SHP also containing the moRNA sequence was 
also analysed. These longer variants were taken into account because previous studies 
indicated that moRNAs are included as part of the original pre-miRNA structure 
(Bortoluzzi et al., 2012, 2011).  
 
In order for a pre-miRNA to be considered classified as a real pre-miRNA in this 
study, it needed to be classified as real by both methods. In addition, where longer 
variants were also used to account for moRNAs, both variants also needed to be 
classified as real pre-miRNAs by both methods. Fourteen out of the 21 pre-miRNA 
candidates were classified as real pre-miRNAs based on these criteria (Table 4.6). A 
more detailed description of the results including details of sequences used, MiPred 
Prediction Confidence and the CSHMM Prediction likelihood are available in 
Supplementary File 4.1. T.6 
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Table 4.6 CyHV-3 pre-miRNA candidate structural analysis using pre-miRNA classifiers 
The pre-miRNA classifiers used were MiPred and the CSHMM-Method. Relative WC info was also 
included for comparative purposes   
 
Pre-miRNA 
Name 
Absolute 
WC 
Relative 
WC 
MFE 
kcal/Mol 
p-value 
(shuffle 
times:1000) 
MiPred 
Result 
CSHMM 
Result 
Classified as 
Real Pre-miRNA 
by both methods 
MD759 17 28 -28.1 N/A Not Real Not Real No 
MD773 1 1 -17.8 N/A Not Real Not Real No 
MD20185 1 15 -6.4 N/A Not Real Real No 
MD20189 1 1 -7.6 N/A Not Real Not Real No 
MD1111 31 42 -43.6 0.001 Real Real Yes 
MD1111 
 (+ moRNAs) 5 42 -45.4 0.002 Real Real Yes 
MD9812 14 46 -37.2 0.004 Real Real Yes 
MD9812  
(+ moRNAs) 1 46 -56.2 0.044 Real Real Yes 
MD11410 29 37 -33.0 0.002 Real Real Yes 
MD11776 17 45 -40.4 0.002 Real Real Yes 
MD11776 
 (+ moRNAs) 10 45 -57.5 0.002 Real Real Yes 
MR5057 2 2 -26.9 0.004 Real Real Yes 
MR5075 28 47 -40.2 0.001 Real Real Yes 
MR5075 
 (+ moRNAs) 14 47 -58.7 0.001 Real Real Yes 
MR6201 45 45 -27.9 0.005 Real Real Yes 
MR7404 5 9 -27.9 0.012 Real Not Real No 
MR7409 1 11 -27.6 0.015 Real Real Yes 
MR7412 1 1 -15.3 N/A Not Real Not Real No 
MR7418 18 18 -19.9 N/A Not Real Real No 
MR7434 9 8 -38.7 0.106 Not Real Real No 
MR7440 
(+ moRNAs) 3 12 -70.8 N/A Not Real Not Real No 
MR7460 16 17 -29.1 0.014 Real Real Yes 
MR7468 1 1 -16.1 N/A Not Real Not Real No 
MR7471 36 42 -25.1 0.013 Real Real Yes 
MR7476  
(+ moRNAs) 14 37 -95.4 N/A Not Real Real No 
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4.1.3.5 Enrichment quantification of putative CyHV-3 miRNAs 
 
If the miRNA-enriched RNA sample that was sequenced from the CyHV-3 infections 
contained CyHV-3 miRNAs, then the mapping of this sequencing data to the CyHV-3 
genome should reveal high concentrations of unique reads (stacks of miRNAs and 
isomiRs) that map to discrete pre-miRNA loci. Notably, this should be in stark 
contrast to local non-coding genomic regions surrounding these pre-miRNA loci. In 
addition, individual transcripts within these stacks should show much higher read 
counts when compared to transcripts that map to surrounding regions. In this study, 
candidate pre-miRNA loci were inspected for these kinds of characteristics using 
SeqMonk. This facilitated the visual analysis of transcripts that mapped to pre-
miRNA candidate loci and surrounding loci, thus enabling a comparison to be made 
between the two infections. The use of the enrichment-quantification function in 
SeqMonk also facilitated the identification of loci that were specifically enriched in 
terms of read counts relative to surrounding genomic regions. To visualise this 
information, the genome file was first opened and then the mapping data from 
forward and reverse strands of the CyHV-3 genome were imported separately for each 
experiment so that they could be displayed on separate data tracks. The quantitative 
information displayed represented a log2 ratio of the observed base density in the 
region divided by the overall base density on the same data track.  
 
Out of the 21 pre-miRNA candidate loci, six of them were consistent with the 
characteristics outlined above: these were MD1111, MD9812, MD11410, MD11776, 
MR5057 and MR5075, (Figure 4.11 (b)-(f)). All of these are enriched when compared 
to their surrounding genomic regions, with the exception of MD9812 in the N076 
infection. However, even though there is no enrichment in reads mapping to the 
MD9812 locus in the N076 infection it can be seen from the quantitative information 
that read counts for this locus are less depleted than that of the surrounding genomic 
region (Figure 4.11 (c)). Unlike these six pre-miRNA candidates, the remaining 15 
pre-miRNA candidate loci (Figure 4.11(a), (g) and (h)) do not show individual 
discrete stacks of highly expressed transcripts. They are all parts of a continuous (in 
some cases overlapping) stretch of read stacks. None of the remaining fifteen pre-
miRNA loci (Figure 4.11 (a), (g) and (h)) are further enriched in terms of read count 
relative to their surrounding genomic regions. This aspect is more apparent in Figure 
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4.12 where basic read count quantification (rather than enrichment quantification) is 
displayed for these five pre-miRNA candidate loci. Although putative miRNAs from 
MR6201 have comparable read counts to MD9812 and MD11410 (Figure 4.9 and 
Table 4.5), both of these are enriched (Figure 4.11 (c) and (d)) whereas MR6201 is 
not (Figure 4.11 (g)). This is because it is not as enriched relative to other transcripts 
that map to its surrounding genomic region. The ten pre-miRNA candidates in 
Reverse Cluster 2 (Figure 4.8) that are represented in Figure 4.11 (h) and Figure 4.12 
(c) form a large continuous read stack which itself is highly enriched in terms of read 
count when compared to the surrounding genomic region. However the stack consists 
mainly of overlapping reads and there are no clear boundaries between each 
individual pre-miRNA candidate. In addition, regions of this stack that do not 
apparently contain pre-miRNA candidates are equally enriched in terms of read 
counts. Notably it is apparent from Figure 4.11 (a), (g), and (h) and Figure 4.12 that 
all fifteen pre-miRNA candidate loci appear to be located within three theoretical 3’  
UTRs. This is because they are all located between the stop codons and PolyA signals 
for upstream protein-coding genes. In contrast none of the other six pre-miRNA 
candidate loci that show the characteristics of pre-miRNAs occur within any apparent 
3’  UTR.   
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Figure 4.11 Enrichment quantification of CyHV-3 putative miRNAs using SeqMonk 
Reads mapping to the forward strand are shown in red, those mapping to the reverse strand are in blue. 
Protein coding genes and PolyA signals on the forward strand are red; those on the reverse strand are 
blue and indicated using circles. Loci that are enriched in terms of read counts relative to the 
surrounding genomic region appear as positive values (i.e. above the axis) in the quantitative 
information tracks.    
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Figure 4.12 Read count quantification (using SeqMonk) of pre-miRNA candidate loci showing 
non-miRNA-like patterns of read enrichment 
Reads mapping to the forward strand are in red, those mapping to the reverse strand are in blue. Protein 
coding genes and PolyA signals on the forward strand are red; those on the reverse strand are blue and 
indicated using circles. 
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4.1.3.6 Inspection of miRNA alignment signatures 
In order to establish if the small RNAs mapping to pre-miRNA candidates did so in a 
way that was consistent with the model of miRNA biogenesis, the alignment signature 
of each pre-miRNA candidate was assessed. The ideal miRNA alignment signature 
was outlined by Kozomara and Griffiths-Jones (2011) and is discussed in Section 
1.7.2.2 (for an example see Figure 1.12).  
 
In this study, alignment profiles that were either closely or loosely consistent with that 
of pre-miRNAs as described by Kozomara and Griffiths-Jones (2011) were identified 
as having a miRNA-like alignment signature. Seven of the 21 pre-miRNA candidates 
had alignment signatures that were considered miRNA-like (based on the deep 
sequencing data obtained from both infections). Signatures for the 7 miRNA-like and 
14 non-miRNA-like alignments from the H361 and N076 infections are available as 
Supplementary File 4.2. Five of these pre-miRNA candidates (MR5057, MD9812, 
MD11410, MR6201 and MD11776) displayed strong miRNA-like alignment 
signatures. These all contained discrete stacks of reads representing either putative 
miRNAs or moRNAs. Notably, the alignment signature for MD11776 was 
particularly consistent with the ideal miRNA alignment signature. Transcripts were 
observed from five distinct regions of the MD11776 loci representing the 2 miRNAs, 
2 moRNAs and low level terminal loop sequences. The signature observed for 
MD11776 resembles that of a “ five-phased-precursor”  recently described in several 
publications (Berezikov et al., 2011; Bortoluzzi et al., 2012, 2011) (see Figure 4.13). 
  
The alignment profiles for MD1111 and MR5075 were slightly less consistent with 
the ideal miRNA alignment profile compared to other pre-miRNAs (MR5057, 
MD9812, MD11410, MR6201 and MD11776), although they certainly displayed the 
basic features of miRNA-like patterns. Importantly the signatures for MD1111 and 
MR5075 were very different from that of the remaining 14 pre-miRNAs. The 
alignment signatures for the other 14 pre-miRNA candidates consisted of overlapping 
reads offset across the entire pre-miRNA sequence. These signatures are not 
consistent with the model of miRNA biogenesis and are in stark contrast to the 
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(a) 
(b) 
miRNA-like alignment signatures displayed by MD1111, MD9812, MD11410, 
MD11776, MR5057, MR5075 and MR6201 (Supplementary File 4.2)  
 
 
 
 
 
 
 
 
Figure 4.13 “Five-phased precursor” miRNA-like alignment signature displayed by pre-miRNA 
candidate MD11776 
(a) Secondary structure of pre-miRNA candidate MD11776 with miRNA and moRNA reads 
highlighted on the stem (b) Alignment signature of small RNAs to pre-miRNA candidate MD11776. 
This is a good example of a site that displays all of the different types of distinct functional groups that 
are expected to be derived from a single pre-miRNA (miRNAs, moRNAs, terminal loop and associated 
isomers). Based on the read count information, it can be seen that it is the dominant read at each locus 
that is designated as the miRNA/moRNA with the rest designated as isomiRs/ moRNA isomers 
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4.1.3.7 IsomiR end heterogeneity analysis 
Due to the depth of coverage offered by deep sequencing it was possible to detect 
accompanying isomiRs for the putative miRNAs identified. These variants are all off-
set by 1 or more nucleotides on either the 5’  or 3’  ends (or both) relative to the 
putative miRNAs. While heterogeneity can be observed at both ends, isomiRs 
generally tend to display more 3’ end heterogeneity overall. The degree of end 
heterogeneity displayed by both 5’  and 3’  ends of isomiRs of putative miRNAs 
identified in this study were compared. Only putative miRNAs from pre-miRNA 
candidates showing miRNA-like alignment profiles were considered for this. IsomiRs 
from separated infections were analysed separately, resulting in 28 different sets of 
isomiRs being analyzed.  
 
Most unique isomiRs from each putative miRNA were off-set at the 3’  end i.e. most 
values (60.7%) for Ratio-1 were >1 (Table 4.7). Although 32.1% of putative miRNAs 
had similar numbers 5’  offset isomiRs (i.e. values for Ratio-1 were equal to 1), 78% 
of these particular putative miRNAs and 89.3% of total putative miRNAs displayed a 
greater degree of 3’  end heterogeneity among their isomiRs i.e. values for Ratio-2 
were >1 (Table 4.7), meaning that offset values for 3’  ends of unique isomiRs were 
generally higher.   
 
The measure the overall degree of consistency 5’  end processing consistency among 
these isomiRs it was also necessary to take read count into account using Ratio-3. 
This indicated that the isomiRs from 67.9.% of putative miRNAs showed more 5’  end 
processing consistency and that 10.7% showed no significant difference to 3’  end 
processing consistency (Table 4.7).  
 
Overall, the isomiRs of the putative miRNAs from the pre-miRNA candidate 
MD1111 showed the least 5’  end processing consistency (i.e. lowest values for Ratio-
3). The same isomiRs were also the only ones to have values for Ratio-1 and Ratio-2 
that were <1. However, isomiRs from the 5’  arm miRNA of MD1111 did have good 
values for Ratio-2 in both infections and also showed more overall 5’  end consistency 
among isomiRs in the H361 infection (Ratio-3 >1). The results of this analysis are 
summarized in Table 4.7 and displayed in Table 4.8 and the datasets used to calculate 
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these ratios (i.e. offset values for both ends of each individual isomiR) are available in 
Supplementary File 4.3 T.1-T.14. 
 
Table 4.7 Summary of isomiR end heterogeneity analysis 
 
 Ratio-1 Ratio-2 Ratio-3 
More 3’ Arm 
Heterogeneity 60.7% 89.3% 67.9% 
More 5' Arm 
Heterogeneity 7.1% 7.1% 21.4% 
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Table 4.8 (Part 1/4) Analysis of isomiR end heterogeneity for putative miRNAs from CyHV-3 pre-miRNA candidates 
MiRNAs with 3’  End: 5’  End ratios that are <1 are highlighted in bold 
 
Transcripts 

 

19nt representing 

 

0.1% of combined miRNA and isomiR read count from respective strands 
Number of unique isomiRs Average absolute offset (nt) displayed by 
all unique isomiRs 
Read counts of IsomiRs as a % of the 
combined miRNA and isomiR read count 
from respective strands 
Pre-miRNA miRNA Infection miRNA end 
Number of 
unique 
isomiRs 
offset at 
each end 
Unique 3’ End :5' End 
Off-set IsomiR Ratio 
(Ratio-1) 
Should be >1 if there are 
more unique isomiRs 
displaying 3’ end 
heterogeneity  
Average offset 
(nt) at each 
end 
3’ End :5' End Average 
Absolute Off-set Ratio 
(Ratio-2)  
Should be >1 if there is a 
greater degree of  3’ end 
heterogeneity overall  
Read counts 
of isomiRs off-
set at each 
end as a % of 
total read 
count 
3’ End :5' End 
Processing Consistency 
Ratio (Ratio-3) 
Should be >1 if 5' end 
processing is more 
consistent than at the 3’ 
end processing 
5' End  4 0.80 1.36% 
H361 
3’ End 3 
0.75 
1.00 
1.25 
2.54% 
1.88 
5' End 2 1.00 1.58% 
5' Arm  
N076 
3’ End 3 
1.50 
1.50 
1.50 
0.19% 
0.12 
5' End 6 1.80 2.96% 
H361 
3’ End 6 
1.00 
1.10 
0.61 
2.50% 
0.85 
5' End 3 1.60 27.27% 
MD1111 
3’ Arm  
N076 
3’ End 1 
0.33 
0.20 
0.13 
10.00% 
0.37 
5' End  1 0.86 1.69% 
H361 
3’ End 6 
6.00 
3.14 
3.67 
61.02% 
36.00 
5' End 2 1.30 15.38% 
5' Arm  
N076 
3’ End 2 
1.00 
1.50 
1.15 
61.54% 
4.00 
5' End 3 0.50 50.00% 
H361 
3’ End 3 
1.00 
0.50 
1.00 
50.00% 
1.00 
5' End 2 0.40 40.00% 
MD9812 
3’ Arm  
N076 
3’ End 3 
1.50 
0.80 
2.00 
40.00% 
1.00 
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Table 4.8 (Part 2/4) Analysis of isomiR end heterogeneity for putative miRNAs from CyHV-3 pre-miRNA candidates 
MiRNAs with 3’  End: 5’  End ratios that are <1 are highlighted in bold 
 
Transcripts 

 

19nt representing 

 

0.1% of combined miRNA and isomiR read count from respective strands 
Number of unique isomiRs Average absolute offset (nt) displayed by 
all unique isomiRs 
Read counts of IsomiRs as a % of the 
combined miRNA and isomiR read count 
from respective strands 
Pre-miRNA miRNA Infection miRNA end 
Number of 
unique 
isomiRs 
offset at 
each end 
Unique 3’ End :5' End 
Off-set IsomiR Ratio 
(Ratio-1) 
Should be >1 if there are 
more unique isomiRs 
displaying 3’ end 
heterogeneity  
Average offset 
(nt) at each 
end 
3’ End :5' End Average 
Absolute Off-set Ratio 
(Ratio-2)  
Should be >1 if there is a 
greater degree of  3’ end 
heterogeneity overall  
Read counts 
of isomiRs off-
set at each 
end as a % of 
total read 
count 
3’ End :5' End 
Processing Consistency 
Ratio (Ratio-3) 
Should be >1 if 5' end 
processing is more 
consistent than at the 3’ 
end processing 
5' End  1 0.25 5.88% 
H361 
3’ End 2 
2.00 
0.75 
3.00 
35.29% 
6.00 
5' End 6 2.40 29.79% 
5' Arm  
N076 
3’ End 6 
1.00 
3.00 
1.25 
36.17% 
1.21 
5' End 1 2.00 20.00% 
H361 
3’ End 1 
1.00 
3.00 
1.50 
80.00% 
4.00 
5' End 1 0.33 33.33% 
MD11410 
3’ Arm  
N076 
3’ End 2 
2.00 
3.00 
9.00 
66.67% 
2.00 
5' End  7 1.00 46.95% 
H361 
3’ End 11 
1.57 
1.80 
1.80 
45.30% 
0.96 
5' End 4 0.44 40.51% 
5' Arm  
N076 
3’ End 7 
1.43 
1.44 
3.25 
45.61% 
1.13 
5' End 14 1.10 22.68% 
H361 
3’ End 15 
1.07 
1.50 
1.36 
40.71% 
1.80 
5' End 10 0.85 32.17% 
MD11776 
3’ Arm  
N076 
3’ End 10 
1.00 
1.00 
1.18 
33.54% 
1.04 
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Table 4.8 (Part 3/4) Analysis of isomiR end heterogeneity for putative miRNAs from CyHV-3 pre-miRNA candidates 
MiRNAs with 3’  End: 5’  End ratios that are <1 are highlighted in bold 
 
Transcripts 

 

19nt representing 

 

0.1% of combined miRNA and isomiR read count from respective strands 
Number of unique isomiRs Average absolute offset (nt) displayed by 
all unique isomiRs 
Read counts of IsomiRs as a % of the 
combined miRNA and isomiR read count 
from respective strands 
Pre-miRNA miRNA Infection miRNA end 
Number of 
unique 
isomiRs 
offset at 
each end 
Unique 3’ End :5' End 
Off-set IsomiR Ratio 
(Ratio-1) 
Should be >1 if there are 
more unique isomiRs 
displaying 3’ end 
heterogeneity  
Average offset 
(nt) at each 
end 
3’ End :5' End Average 
Absolute Off-set Ratio 
(Ratio-2)  
Should be >1 if there is a 
greater degree of 3’ end 
heterogeneity overall  
Read counts 
of isomiRs off-
set at each 
end as a % of 
total read 
count 
3’ End :5' End 
Processing Consistency 
Ratio (Ratio-3) 
Should be >1 if 5' end 
processing is more 
consistent than at the 3’ 
end processing 
5' End  1 0.25 7.14% 
H361 
3’ End 2 
2.00 
1.25 
5.00 
39.29% 
5.50 
5' End 4 1.00 3.67% 
5' Arm  
N076 
3’ End 7 
1.75 
1.70 
1.70 
54.80% 
14.92 
5' End 2 0.30 1.16% 
H361 
3’ End 5 
2.50 
1.10 
3.67 
20.97% 
18.14 
5' End 4 0.60 1.35% 
MR5057 
3’ Arm  
N076 
3’ End 4 
1.00 
1.00 
1.67 
10.56% 
7.83 
5' End  6 1.80 18.75% 
H361 
3’ End 8 
1.33 
2.50 
1.39 
72.92% 
3.89 
5' End 11 1.50 9.84% 
5' Arm  
N076 
3’ End 13 
1.18 
1.80 
1.20 
45.60% 
4.63 
5' End 12 1.58 42.16% 
H361 
3’ End 15 
1.25 
2.60 
1.65 
40.67% 
0.96 
5' End 16 1.90 49.15% 
MR5075 
3’ Arm  
N076 
3’ End 16 
1.00 
2.50 
1.32 
44.72% 
0.91 
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Table 4.8 (Part 4/4) Results of isomiR end heterogeneity analysis for putative miRNAs from CyHV-3 pre-miRNA candidates 
MiRNAs with 3’  End: 5’  End ratios that are <1 are highlighted in bold 
 
Transcripts 

 

19nt representing 

 

0.1% of combined miRNA and isomiR read count from respective strands 
Number of unique isomiRs Average absolute offset (nt) displayed by 
all unique isomiRs 
Read counts of IsomiRs as a % of the 
combined miRNA and isomiR read count 
from respective strands 
Pre-
miRNA miRNA Infection miRNA end 
Number of 
unique 
isomiRs offset 
at each end 
Unique 3’ End :5' End 
Off-set IsomiR Ratio 
(Ratio-1) 
Should be >1 if there are 
more unique isomiRs 
displaying 3’ end 
heterogeneity  
Average offset 
(nt) at each 
end 
3’ End :5' End Average 
Absolute Off-set Ratio 
(Ratio-2)  
Should be >1 if there is a 
greater degree of  3’ end 
heterogeneity overall  
Read counts 
of isomiRs off-
set at each 
end as a % of 
total read 
count 
3’ End :5' End Processing 
Consistency Ratio (Ratio-
3) 
Should be >1 if 5' end 
processing is more 
consistent than at the 3’ 
end processing 
5' End  1 0.50 20.00% 
H361 
3’ End 3 
3.00 
1.00 
2.00 
60.00% 
3.00 
5' End 12 1.80 61.90% 
5' Arm  
N076 
3’ End 15 
1.25 
2.40 
1.33 
73.81% 
1.19 
5' End 2 0.80 22.22% 
H361 
3’ End 2 
1.00 
1.00 
1.25 
22.22% 
1.00 
5' End 5 1.40 15.15% 
MR6201 
3’ Arm  
N076 
3’ End 6 
1.20 
2.10 
1.50 
30.30% 
2.00 
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4.1.3.8 Identification of high probability pre-miRNA candidates  
By analysing the candidate pre-miRNAs in the manner described above, it was 
possible to identify high probability pre-miRNA candidates that complied with the 
criteria outlined in Section 2.14.3.6. Pre-miRNA candidates that did not comply with 
all of the criteria were eliminated. By default, all pre-miRNA candidates complied 
with points 1-4 as these were the criteria used for their initial identification. The main 
reason for eliminating most pre-miRNA candidates was non-compliance with points 
11, 9, 8 and 6 (in descending order of effectiveness). In total, six out of the 21 pre-
miRNA candidates MD1111, MD9812, MD11410, MD11776, MR5057 and MR5075 
complied with all the pre-miRNA identification criteria outlined earlier (Section 
2.14.3.6). As a result, these six pre-miRNA candidates were considered to be high 
probability CyHV-3 pre-miRNAs. The results of this assessment are summarized in 
Table 4.9  
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Table 4.9 A summary of all CyHV-3 pre-miRNA candidates in terms of compliance with pre-miRNA identification criteria.  
Pre-miRNA candidates that complied with all of the criteria are highlighted in grey 
  
Pre-miRNA 
Name 
1. Highly 
expressed 
small 
RNAs 
2. From non-
coding 
region 
3. Putative 
miRNAs 
adjacent to 
stem 
4. Putative 
major and 
minor form 
detected 
5. MiRNA 
isoform 
stability 
6. Classified 
as real pre-
miRNA 
7. Pre-miRNA 
structure has 
MFE <-20 
kcal/mol 
8. Mature-
miRNA-
duplex  3’ 
overhangs  
9. MiRNA-
like 
alignment 
signature  
10. Greater 
3’ end 
heterogene
ity among 
isomiRs  
11. Discrete, 
read-
enriched 
locus 
Compliance 
with all 
points 
MD759 Yes Yes (3’ UTR) Yes Yes No No Yes No No N/A No No 
MD773 Yes Yes (3’ UTR) Yes Yes No No No No No N/A No No 
MD20185 Yes Yes (3’ UTR) Yes Yes Yes No No No No N/A No No 
MD20189 Yes Yes (3’ UTR) Yes Yes Yes No No No No N/A No No 
MD1111 Yes Yes  Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
MD9812 Yes Yes  Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
MD11410 Yes Yes  Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
MD11776 Yes Yes  Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
MR5057 Yes Yes  Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
MR5075 Yes Yes  Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
MD6201 Yes Yes (3’ UTR) Yes Yes Yes Yes Yes No Yes Yes No No 
MR7404 Yes Yes (3’ UTR) Yes Yes Yes No Yes Yes No N/A No No 
MR7409 Yes Yes (3’ UTR) Yes Yes Yes Yes Yes No No N/A No No 
MR7412 Yes Yes (3’ UTR) Yes Yes Yes No No No No N/A No No 
MR7418 Yes Yes (3’ UTR) Yes Yes Yes No No No No N/A No No 
MR7434 Yes Yes (3’ UTR) Yes Yes No No Yes No No N/A No No 
MR7440 Yes Yes (3’ UTR) Yes Yes Yes No Yes No No N/A No No 
MR7460 Yes Yes (3’ UTR) Yes Yes Yes Yes Yes Yes No N/A No No 
MR7468 Yes Yes (3’ UTR) Yes Yes No No No No No N/A No No 
MR7471 Yes Yes (3’ UTR) Yes Yes No Yes Yes No No N/A No No 
MR7476 Yes Yes (3’ UTR) Yes Yes Yes No Yes No No N/A No No 
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4.1.4 Automated identification of miRNAs from deep sequencing data 
 
In order to support the findings made following non-automated identification of 
miRNAs and to possibly identify additional high probability pre-miRNA candidates, 
the same deep sequencing data was also analysed using two automated methods of 
miRNA identification, namely MirDeep and Mireap. The choice of methods was 
based on the results of a performance comparison study in which these two methods 
were found to be most suitable for predicting novel miRNAs (see section 1.7.2.2 and 
Li et al (2012)). The decision to use both of these methods together was based on 
other findings in the same comparison study by Li et al (2012) which suggested that 
the best practice is to use more than one method to support the classification of 
specific loci as pre-miRNAs 
 
4.1.4.1 Automated identification of CyHV-3 miRNAs using MirDeep and Mireap 
The use of two different automated methods to detect miRNAs from two different 
deep sequencing experiments resulted in 4 sets of results. (Table 4.10, Table 4.11, 
Table 4.12, and Table 4.13). The pre-miRNA sequences, miRNA sequences and 
alignment signatures for these results can be seen in Supplementary File 4.4. All of 
these were then cross-compared in order to identify pre-miRNA candidates that were 
common to multiple sets of results. A summary of the pre-miRNA candidates 
identified and the numbers that were common to different sets of results can be seen 
in Table 4.14. More pre-miRNA candidates were identified by Mireap than by 
miRDeep. This was because Mireap identified many pre-miRNA candidates in the 
absence of a suitable minor form derived from the opposite arm of the pre-miRNA 
candidates. Both methods identified pre-miRNA candidates within protein-coding 
regions. Consistent with the criteria used for non-automated identification of pre-
miRNA candidates, any candidates identified using the automated methods that 
occurred within protein-coding genes and those with no accompanying minor forms 
were eliminated from further analysis. MiRDeep also assigns scores to all pre-miRNA 
candidates that it identifies, allowing ranking in terms of how likely they were to be 
genuine pre-miRNAs. Using miRDeep, the top 6 and top 3 ranked candidates from the 
H361 (Table 4.10) and N076 (Table 4.11) infections respectively were common to 
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both sets of results (ignoring candidates within protein-coding regions, marked in red) 
(summarized in Table 4.15). These pre-miRNA candidates also have the highest read 
counts of all candidates from non-coding regions in their respective infections. Li et 
al. (2012) concluded that it should be possible to identify most genuine pre-miRNAs 
from deep sequencing data by more than one method. Interestingly, the six candidates 
mentioned above were also the only candidates to be independently identified using 
Mireap, with the exception of one pre-miRNA candidate from a protein-coding region 
(Table 4.15). Due to the fact that these six candidates were different from the rest in 
this respect, and on the basis that identification by multiple methods supports pre-
miRNA classification, they were deemed to be high-probability pre-miRNA 
candidates. Furthermore, five of the six were also among those deemed to be high 
probability pre-miRNA candidates from non-automated analysis (Table 4.9). This 
indicated that elimination of candidates not identified by both methods had the effect 
of retaining only high-quality pre-miRNA candidates. Incidentally, inspection of the 
eliminated pre-miRNA candidates revealed that none of them conformed to the pre-
miRNA identification criteria (data not shown; alignment signatures can be seen in 
Supplementary File 4.4). In addition to pre-miRNA candidates that were identified by 
both automated methods, those found in both infections by the one method only are 
shown in Table 4.15. Only one such pre-miRNA candidate (MD11704) was 
identified. MD11704 conformed to all of the pre-miRNA identification criteria from 
Section 2.14.3.6 except Point 1 as the putative miRNAs were not highly expressed 
and did not have read counts 10 in either infection (this candidate is examined in 
more detail, for other reasons, in Section 6.1). Although all of the putative miRNAs 
from all high probability pre-miRNA candidates were present in each infection, not all 
of the pre-miRNA candidates were identified in both infections by the automated 
methods. For example MD11410 was not identified by Mireap in the N076 infection, 
MD9812 was not identified in the N076 infection by miRDeep and both MD1111 and 
MR6201 were only identified in the H361 infection by both methods (Table 4.15). 
Also, it is unclear as to why MR5075, a high probability pre-miRNA candidate from 
non-automated analysis, was not identified at all using the automated methods. 
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Table 4.10 Pre-miRNA candidates predicted by miRDeep from the CyHV-3 H361 infection 
 
Provisional ID 
(assigned by 
miRDeep) 
Equivalent VMir Prediction ID Rank miRDeep2 score 
Total Read 
Count 
(Including 
isomiRs) 
KHVU_4678 MR5057 1 40967 80360 
KHVU_3683 MD11111 2 3523.6 6908 
KHVU_193 MD11111 (repeat) 3 3523.6 6908 
KHVU_2055 MD11776 4 2306.6 4521 
KHVU_6996 MR18527 5 96.2 195 
KHVU_2519 MD14318 6 89.9 181 
KHVU_1710 MD9812 7 28.7 60 
KHVU_4945 MR6545 8 12.2 29 
KHVU_1990 MD11410 9 8.7 21 
KHVU_5500 MD9701 10 7.5 21 
KHVU_4878 MR6201 11 4.9 15 
KHVU_4908 MR6373 12 4.3 12 
KHVU_1288 MD7493 13 3 3 
KHVU_6071 MR13096 14 2.6 58 
KHVU_2189 MD12474 15 2.2 175 
KHVU_4505 MR4130 16 2.2 11 
KHVU_1380 MD7990 17 2.1 77 
KHVU_6794 MR17381 18 0.5 9 
KHVU_3991 MR1328 19 0.4 16 
KHVU_7469 MR1328 (repeat) 20 0.4 16 
KHVU_2367 MD13496 21 0 5 
 
Key Explanation 
  
Previously deemed to be high-probability pre-miRNA candidate from non-automated 
analysis of deep sequencing data  
  
New pre-miRNA candidate from automated analysis of deep sequencing data  
  
Previously deemed to be low probability pre-miRNA candidate from non-automated 
analysis of deep sequencing data  
  
Occurs within protein-coding region (eliminated) 
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Table 4.11 Pre-miRNA candidates predicted by miRDeep from the CyHV-3 N076 infection 
 
Provisional ID (assigned by 
miRDeep) 
Equivalent VMir Prediction 
ID Rank 
miRDeep2 
score 
Total Read 
Count 
(Including 
isomiRs) 
KHVU_5130 MR5057 1 674758.2 1323514 
KHVU_2337 MD11776 2 14677 28785 
KHVU_1442 Not Predicted 3 298.9 593 
KHVU_7440 Not Predicted 4 80.7 164 
KHVU_840 MD4173 5 74 150 
KHVU_6024 MR9635 6 56.8 119 
KHVU_1146 MD5909 7 47.3 98 
KHVU_2258 MD11410 8 22.5 48 
KHVU_6494 MR12001 9 21 46 
KHVU_8115 MR159  10 9 30 
KHVU_4183 MR159 (repeat) 11 9 30 
KHVU_2722 MD13747 12 5.6 16 
KHVU_1084 MD5586 13 2.5 516 
KHVU_7144 MR15193 14 2.4 2 
KHVU_1590 MD7990 15 2.1 155 
KHVU_2930 MD14795 16 1.9 52 
KHVU_8057 MR19774 17 1.9 142 
KHVU_6960 MR14203 18 1.9 9 
KHVU_8040 Not Predicted 19 0 17 
 
Key Explanation 
  
Previously deemed to be high-probability pre-miRNA candidate from non-automated 
analysis of deep sequencing data  
  
New pre-miRNA candidate from automated analysis of deep sequencing data  
  
Occurs within protein-coding region (eliminated) 
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Table 4.12 Pre-miRNA candidates predicted by Mireap from the CyHV-3 H361 infection 
 
Provisional ID 
(assigned by Mireap) 
Equivalent VMir 
Prediction ID 
m0001 MD1111 
m0002 MD3150 
m0003 MD4188 
m0004 MD5234 
m0008 MD8620 
m0009 MD9812 
m0010 Not predicted 
m0011 MD11410 
m0012 MD11704 
m0013 MD11776 
m0015 MD13551 
m0019 MD1111 (repeat) 
m0020 MR1635 
m0021 MR2459 
m0022 MR2741 
m0023 MD2877 
m0024 MR3613 
m0027 MR5057 
m0030 MR5552 
m0031 MR6201 
m0034 MR7191 
m0035 MR7627 
m0042 MR11068 
m0050 MR17129 
m0051 None 
m0053 MR17383 
m0054 MR18408 
m0055 MR19207 
 
Key Explanation 
  
Previously deemed to be high-probability pre-miRNA candidate from non-automated 
analysis of deep sequencing data  
  
New pre-miRNA candidate from automated analysis of deep sequencing data  
  
Previously deemed to be low probability pre-miRNA candidate from non-automated 
analysis of deep sequencing data  
  
Occurs within protein-coding region (eliminated) 
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Table 4.13 Pre-miRNA candidates predicted by Mireap from the CyHV-3 N076 infection 
 
Provisional ID 
(assigned by 
Mireap) 
Equivalent VMir Prediction ID 
M0001 MD8080 
M0002 MD9812 
M0003 MD11704 
M0004 MD11776 
M0007 MD16282 
M0008 Not predicted 
M0009 MR5057 
M0011 MR6853 
M0014 Not predicted 
M0016 Not predicted 
M0018 Not predicted 
M0019 MR15158 
 
Key Explanation 
  
Previously deemed to be high-probability pre-miRNA candidate from non-automated 
analysis of deep sequencing data  
  
New pre-miRNA candidate from automated analysis of deep sequencing data  
  
Occurs within protein-coding region (eliminated) 
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Table 4.14 Summary of results from automated identification of miRNAs from sequencing data 
 
Method miRDeep Mireap 
Infection H361 Infection 
N076 
Infection H361 Infection 
N076 
Infection 
Total Predicted Pre-miRNAs 19  (+ 2repeat) 
18  
(+1 repeat) 
55 (28 have no 
minor form) 
21 (9 have no 
minor form)  
Total number of pre-miRNA 
candidates found in protein-
coding regions 
10 9 
15  
(with minor 
form) 
5  
(with minor 
form) 
Found by both miRDeep and 
Mireap in either infection 1 0 1 0 
Found in both infections by same 
method  1 1 0 0 
Found in different infection by 
different method 0 0 0 0 
Protein-
coding 
regions 
Found in both infections by both 
methods 0 0 0 0 
Total amount of pre-miRNA 
candidates in non-protein-
coding regions 
9 (+2 repeats) 9 (+1 repeat) 
12 (with minor 
form +1 repeat) 
7 
(with minor 
form) 
Found by both miRDeep and 
Mireap in either infection  6 3 6 3 
Found in both infections by same 
method  3 3 4 4 
Found in different infection by 
different method 3 2 3 3 
Found in both infections by both 
methods 2 2 2 2 
Non-
protein-
coding 
regions 
Not found in both infections by 
the same method or in either 
infection by different methods. 
These were all also analysed 
using MiPred and the CSHMM. 
None were classified as real pre-
miRNAs 
3 6 5 3 
 
Table 4.15 Summary of CyHV-3 pre-miRNA candidates from non-coding regions predicted by 
both automated methods or in both infections by the same method. 
 
Set of results that pre-miRNA candidates were 
identified in Predicted 
pre-miRNA 
name 
miRDeep 
H361 
Infection 
miRDeep 
N076 
Infection 
Mireap 
H361 
Infection 
Mireap 
N076 
Infection 
Found by both 
methods 
Found in different  
infections by one 
or both methods 
MR5057  Yes Yes Yes Yes Yes Yes 
MD11776  Yes Yes Yes Yes Yes Yes 
MD11410 Yes Yes Yes No Yes Yes 
MD9812 Yes No Yes Yes Yes Yes 
MD1111 Yes No Yes No Yes No 
MR6201 Yes No Yes No Yes No 
MD11704 No No Yes Yes No Yes 
 
Key Explanation 
  
Previously deemed to be high-probability pre-miRNA candidate from non-automated analysis of 
deep sequencing data  
  
New pre-miRNA candidate from automated analysis of deep sequencing data  
  
Previously deemed to be low probability pre-miRNA candidate from non-automated analysis of 
deep sequencing data  
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4.1.5 Summary -identification of pre-miRNA candidates from deep 
sequencing data 
 
The combined list of high-probability candidates from both non-automated and 
automated analysis gave a total of seven high probability candidates (Table 4.16). 
MR6201 was not deemed to be a high probability candidate following non-automated 
analysis due to non-conformance with points 8 and 11 in the pre-miRNA 
identification criteria and for this reason it was eliminated even though it was 
identified by both automated methods. MR5075 was identified as a high probability 
pre-miRNA following non-automated analysis although it was not identified from the 
same deep sequencing data using the automated methods. Due to its conformance 
with the pre-miRNA identification criteria and because of the fact that other pre-
miRNA candidates identified by both automated methods were not identified in both 
infections (even though they were present in both infections) it was decided to retain 
MR5075 in the final list of high probability pre-miRNA candidates. This resulted in a 
total of six high probability pre-miRNA candidates for further characterisation by 
several other methods (Table 4.16). 
 
Table 4.16 Comparison of high-probability pre-miRNA candidates following non-automated and 
automated analysis of deep sequencing data.  
Those highlighted in dark-grey were classified as the most likely pre-miRNA candidates overall 
following both non-automated and automated analysis of the deep sequencing data  
 
High- probability miRNA candidate in: Pre-miRNA name 
Non-automated approach Automated approach 
MR5057  Yes Yes 
MD11776  Yes Yes 
MD11410 Yes Yes 
MD9812 Yes Yes 
MD1111 Yes Yes 
MR5075 Yes No 
MR6201 No Yes 
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4.2 DNA Microarray analysis 
In order to support the findings made following small RNA deep sequencing (Section 
4.1) the same RNA sample was also analysed by DNA microarray hybridization. 
Size-selected small RNAs, from both miRNA inclusive and non-inclusive size ranges 
were tested to see if probes targeting putative miRNAs from high probability pre-
miRNAs gave positive signals in the miRNA size range only.  This was on the basis 
that mature miRNAs are specifically enriched in the 17-25 nt size range. Also, 
because DNA array hybridization can be carried out in a non-enzymatically biased 
manner, it was also used to test if ‘highly abundant’  small RNAs that were detected 
by deep sequencing were in fact merely over-represented in the data due to enzymatic 
bias. In addition, the high throughput nature of the method facilitated targeting of 
many more theoretical CyHV-3 miRNAs that may have been under represented in the 
deep sequencing data for the same reasons. Endogenous and exogenous positive 
controls were also employed throughout. A work-flow diagram for this is outlined in 
Figure 4.14. 
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Target Selection 
High and low  
likelihood VMir  
predicted pre-miRNA  
candidates identified  
in analysis of deep  
sequencing data   
VMir predicted pre-
miRNA candidates 
not featured in 
analysis of deep  
sequencing data   
Host miRNAs 
(Endogenous 
positive controls). 
Spike in miRNA 
(Exogenous positive 
controls) 
Samples 
S1. CyHV-3 
Positive miRNA 
enriched RNA 
S2. CyHV-3 
Positive non-  
miRNA RNA 
S3. CyHV-3 
Negative miRNA 
enriched RNA 
Hybridization and analysis 
Predicted pre-miRNAs showing positive signals in S1 
and negative in S2&S3 were considered most likely 
to be attributed to CyHV-3 miRNAs. Those not 
previously identified as pre-miRNA candidates in 
analysis of deep sequencing data were considered 
new provisional pre-miRNA candidates 
Deep sequencing data 
searched for low-read-count 
small RNAs mapping to new 
provisional pre-miRNA 
candidates 
DNA Microarray Hybridization 
Hybridization 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Outline of workflow for DNA Microarray hybridization 
 
4.2.1 Positive controls 
Oligonucleotide probes targeting transcripts known to be present or absent in specific 
samples were also included on the array. These controls were included in order to 
confirm that the samples were prepared correctly and fit for purpose. There were two 
types of positive control: endogenous and exogenous. Their detection and absence, 
respectively, in specific samples were ideal indicators of correct RNA size 
fractionation, labelling/purification and overall RNA quality.   
 
4.2.1.1 Endogenous positive controls 
Probes targeting five Cyprinus carpio (host) miRNAs that were identified following 
analysis of deep sequencing data, namely, ccr-miR-143, ccr-miR-21, ccr-miR-22a, 
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ccr-let-7a and ccr-et-7b were included on the array. MiRNAs should only be present 
in the 17-25 nt RNA samples (S1 and S3) and not in the 26-35 nt RNA sample (S2). If 
size fractionation was done correctly, probes for these miRNAs should give positive 
results in S1 and S3 and not in S2. The hybridization intensities for endogenous 
positive control probes in all samples are shown in Table 4.17. In S1 and S3, all 
replicate probes for all miRNA targets display much higher intensities than the 
background for their respective hybridizations and much higher intensities than their 
associated mismatch and scrambled control probes. The intensity values for probes 
targeting ccr-miR-21, ccr-miR-22a, ccr-let-7a and ccr-et-7b are either at saturation 
(showing a maximum value of 65535) or close to saturation. The intensity values for 
probes targeting ccr-miR-143 are not as high but are still significantly over 
background levels. The RVs for all host miRNA targets are all above the cut-off 
values for S1 and S3 respectively. Conversely, for S2, the same probes display lower 
intensity values that are much closer to background levels and none of their respective 
RVs are over the cut-off value for the S2 hybridization.  
 
4.2.1.2 Exogenous Positive controls 
A synthetic miRNA was spiked into all labelling reactions. Twenty-four replicate 
probes targeting this exogenous control were included on the array. As expected, all 
of these probes showed high intensity values. In both S1 and S3 these probes 
displayed intensity values that were either at or close to saturation and had RVs of 
37.7 and 35.9 respectively. While the intensities for these probes in the S2 sample 
were also quite high they were not as high as the corresponding values from S1 and 
S2 resulting in a lower RVs of 14.0. These results are shown in Table 4.18.  
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Table 4.17 Hybridization intensities for endogenous positive control probes in all samples 
 
 Endogenous Positive controls 
 
Probe Type 
S1. H361 17-25 nt 
(Background 1661) 
RV cut-off: 1.8 
S2. H361 26-35 nt 
(Background 1302) 
RV cut-off: 1.6 
S3. CCB 17-25 nt 
(Background 1813) 
RV cut-off: 1.9 
Probe Replicate 1 34873 1562 65535 
Probe Replicate 2 33151 1159 65535 
Probe Replicate 3 32374 1537 65535 
Probe Replicate 4 18272 2770 65535 
Mismatch Control 1 2094 2827 1962 
Mismatch Control 2 1491 1072 2110 
Scrambled Control 1 1778 1668 1836 
ccr-miR-143 
Scrambled Control 2 2118 1997 1416 
 RV 17.8 1.3 36.0 
Probe Replicate 1 65535 3694 65535 
Probe Replicate 2 65535 1202 65535 
Probe Replicate 3 65535 2656 65535 
Probe Replicate 4 65535 3283 65535 
Mismatch Control 1 1241 890 1141 
Mismatch Control 2 1595 1050 1419 
Scrambled Control 1 2047 3103 2541 
ccr-miR-21 
Scrambled Control 2 1596 3098 1178 
 
RV 39.5 1.4 36.1 
Probe Replicate 1 65535 3334 65535 
Probe Replicate 2 65535 2451 65535 
Probe Replicate 3 65535 2439 65535 
Probe Replicate 4 65535 4204 64385 
Mismatch Control 1 2394 2057 2127 
Mismatch Control 2 1951 1398 2437 
Scrambled Control 1 1172 2991 1142 
ccr-miR-22a 
Scrambled Control 2 1167 3002 891 
 
RV 39.3 1.5 35.7 
Probe Replicate 1 65535 1196 65535 
Probe Replicate 2 63437 1204 65535 
Probe Replicate 3 65535 1172 65535 
Probe Replicate 4 65535 1717 65535 
Mismatch Control 1 1420 868 305 
Mismatch Control 2 2270 3268 1934 
Scrambled Control 1 1883 2373 2672 
ccr-let-7a 
Scrambled Control 2 840 949 1765 
 RV 39.1 1.0 35.9 
Probe Replicate 1 65535 1609 65535 
Probe Replicate 2 65535 3493 65535 
Probe Replicate 3 64193 1039 65535 
Probe Replicate 4 59354 902 65535 
Mismatch Control 1 2498 4627 2674 
Mismatch Control 2 2331 1472 997 
Scrambled Control 1 1408 2928 1329 
Scrambled Control 2 1897 2246 2531 
ccr-et-7b 
RV 38.0 1.4 36.1 
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Table 4.18 Hybridization intensities for exogenous positive control probes in all samples 
 
Exogenous Positive Control: Synthetic ath-miR156g spike-in 
Probe 
S1. H361 17-25 nt 
(Background 1661) 
RV cut-off: 1.8 
S2. H361 26-35 nt 
(Background 1302) 
RV cut-off: 1.6 
S3. CCB 17-25 nt 
(Background 1813) 
RV cut-off: 1.9 
Probe Replicate 1 65535 15124 65535 
Probe Replicate 2 65535 18907 65535 
Probe Replicate 3 65535 18176 65535 
Probe Replicate 4 65535 19045 65535 
Probe Replicate 5 64538 20077 65535 
Probe Replicate 6 60049 16909 65535 
Probe Replicate 7 65535 24482 64147 
Probe Replicate 8 65535 14581 65535 
Probe Replicate 9 56062 12409 65535 
Probe Replicate 10 65535 16358 65535 
Probe Replicate 11 65535 20918 65535 
Probe Replicate 12 65535 23303 65535 
Probe Replicate 13 65535 20780 65535 
Probe Replicate 14 65535 13954 65535 
Probe Replicate 15 65535 18211 65535 
Probe Replicate 16 65535 25818 64178 
Probe Replicate 17 65535 16520 65535 
Probe Replicate 18 65535 17377 65535 
Probe Replicate 19 65535 23901 65535 
Probe Replicate 20 65535 23016 65535 
Probe Replicate 21 65535 20919 65535 
Probe Replicate 22 61562 15595 65535 
Probe Replicate 23 65535 17661 65535 
Probe Replicate 24 65535 15858 65535 
Mismatch Control Probe Replicate 1 1982 2824 1247 
Mismatch Control Probe Replicate 2 1160 502 1343 
Mismatch Control Probe Replicate 3 2199 3128 2116 
Mismatch Control Probe Replicate 4 1159 826 1418 
Scrambled Control Probe Replicate 1 1372 482 1830 
Scrambled Control Probe Replicate 2 10425 1539 729 
Scrambled Control Probe Replicate 3 2296 2075 2379 
Scrambled Control Probe Replicate 4 1104 578 1921 
RV 37.7 14.0 35.9 
 
4.2.2 Analysis of twenty-one CyHV-3 pre-miRNA candidates  
In Section 4.1.3.1, twenty-one CyHV-3 pre-miRNA candidates were identified. Six of 
these were deemed to be high probability pre-miRNA candidates. Assuming that these 
are real then small RNAs (putative miRNAs) processed from these pre-miRNAs 
should be specifically enriched in the 17-25 nt RNA and not present in non-miRNA 
size fractions such as that covering 26-35 nt. Conversely, small RNAs mapping to low 
probability pre-miRNA candidates are more likely to be degradation products from 
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larger transcripts, therefore these target sequences should be evenly distributed across 
many RNA size ranges and not specifically enriched in the 17-25 nt size fraction. In 
order to test this assumption and to support the conclusions from Section 4.1, arrays 
containing probes targeting putative miRNAs from these pre-miRNAs were 
hybridized to non-enzymatically labelled RNA from samples S1, S2 and S3 (the latter 
used as a negative control).  
 
Putative miRNAs from four out of the six high probability pre-miRNAs were detected 
in S1. These were detected from both arms of pre-miRNA candidates MR5057 and 
MD11776; putative miRNAs were detected from only one arm of pre-miRNA 
candidates MD1111 and MR5075. There were no significant corresponding signals in 
S2 and S3 for any of these 4 pre-miRNAs, indicating that these target sequences were 
specifically enriched in the miRNA RNA size fraction and that signals in this sample 
were not the result of non-specific hybridization to host small RNAs in the miRNA 
size range. The hybridization intensities and RVs for miRNA probes from these 4 pre-
miRNAs are shown in Table 4.19.  
 
The RVs (in S1) for these pre-miRNAs were then compared to the corresponding read 
counts obtained following deep sequencing analysis of the same sample from the 
H361 infection (see Figure 4.15). As with the deep sequencing data, the putative 
miRNA from the 3’  arm of MR5057 was the most highly expressed putative miRNA 
from these four pre-miRNA candidates. The RVs suggested that there was less of a 
difference in expression levels between the major and minor forms derived from both 
MR5057 and MD11776. Only one miRNA was detected for MD1111 and MR5075. 
Although the read counts from both infections indicated that it was the miRNA from 
the 3’  arm that was the major form derived from pre-miRNA candidate MR5075 
(Table 4.5), only the miRNA from the 5’  arm was detected on the array. In the case of 
MD1111, it was not clear from the deep sequencing data which miRNA was the major 
form as this was different in both infections (Table 4.5) and it was only the 5’  miRNA 
that was detected on the array. The array results for MD1111 and MR5075 are the 
opposite of those obtained from deep sequencing analysis of the same sample (H361) 
with regard to the apparent major forms derived from these precursors, thus it 
suggests that the putative miRNA from the 3’  ends of these pre-miRNA candidates 
was over represented in the sequencing data. 
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Table 4.19 Hybridization intensities for probes targeting the 4 high probability pre-miRNA 
candidates 
The RV for each pre-miRNA represents that of the miRNA (5’  or 3’  arm) with the highest signal 
 
 Probe 
S1. H361 17-25 nt 
(Background 1661) 
RV cut-off: 1.8 
S2. H361 26-35 nt 
(Background 1302) 
RV cut-off: 1.6 
S3. CCB 17-25 nt 
(Background 1813) 
RV cut-off: 1.9 
5' Arm Replicate 1 8056 2457 2089 
5' Arm Replicate 2 7648 1637 1636 
3’ Arm Replicate 1 35107 2849 1135 
3’ Arm Replicate 2 46549 1568 1141 
5' Scrambled Control 1419 2605 3467 
3’ Scrambled Control 1077 1692 1706 
5' Mismatch Control 2494 3200 2726 
3’ Mismatch Control 5399 3400 9507 
5' Flanking control 935 720 1084 
MR5057 
3’ Flanking control 1315 1080 1793 
 RV 22.3 1.0 1.0 
5' Arm Replicate 1 6702 1127 1131 
5' Arm Replicate 2 6150 1261 669 
3’ Arm Replicate 1 14531 1960 2413 
3’ Arm Replicate 2 14535 2055 2665 
5' Scrambled Control 2182 985 1834 
3’ Scrambled Control 6787 1806 9576 
5' Mismatch Control 1723 1854 1992 
3’ Mismatch Control 331 476 1208 
5' Flanking control 1345 1776 1601 
MD11776 
3’ Flanking control 2493 3488 2783 
 RV 5.6 1.2 1.0 
5' Arm Replicate 1 2898 1033 1164 
5' Arm Replicate 2 4095 1704 2554 
3’ Arm Replicate 1 3338 2221 1609 
3’ Arm Replicate 2 3656 1920 1696 
5' Scrambled Control 1862 1389 1322 
3’ Scrambled Control 5250 1132 3772 
5' Mismatch Control 1135 458 1307 
3’ Mismatch Control 2261 2036 1543 
5' Flanking control 845 718 756 
MD1111 
3’ Flanking control 2348 1118 1854 
 RV 2.0 1.0 1.0 
5' Arm Replicate 1 4851 2799 2430 
5' Arm Replicate 2 4247 1015 1928 
3’ Arm Replicate 1 2018 675 1365 
3’ Arm Replicate 2 1660 432 1757 
5' Scrambled Control 1947 988 2127 
3’ Scrambled Control 2038 840 1570 
5' Mismatch Control 2133 2957 2671 
3’ Mismatch Control 1549 682 2082 
5' Flanking control 3233 2038 3189 
MR5075 
3’ Flanking control 1851 616 1528 
 RV 2.2 1.0 1.0 
 
  218 
1
6
11
16
21
MR
50
57
 
5' 
 
MR
50
57
 
3' 
MD
11
77
6 5
' 
 
MD
11
77
6 3
' 
MD
11
11
 
5' 
 
MD
11
11
 
3' 
MR
50
75
 
5' 
 
MR
50
75
 
3' 
miRNA Name
R
V
Array Intensity
(a) 
(b) 
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
MR
50
57
 
5' 
 
MR
50
57
 
3' 
MD
11
77
6 5
' 
 
MD
11
77
6 3
' 
MD
11
11
 
5' 
 
MD
11
11
 
3' 
MR
50
75
 
5' 
 
MR
50
75
 
3' 
miRNA Name
R
e
ad
 
co
u
n
t
Read Counts
62596
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 4.15 (a) RVs for probes targeting putative miRNAs from the four high probability pre-
miRNAs that showed positive signals on DNA microarray hybridization (b) Read counts 
corresponding to miRNAs from the same four pre-miRNAs in the H361 infection.  
 
 
Out of the fifteen low probability pre-miRNA candidates identified in non-automated 
analysis of the deep sequencing data, small RNAs from ten of them were also detected 
in S1. Nine of these also gave positive signals in S2 and one also gave a low signal in 
S3. The RVs for these fifteen low probability candidates and the six high probability 
pre-miRNAs in all three samples are compared in Table 4.20. Interestingly all of the 
pre-miRNAs from Reverse Cluster 2 gave signals in S2, even the three pre-miRNAs 
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(MR7412, MR7418 and MR7440) from this cluster that showed no signals in S1. 
MiRNA probes for these three precursors did display high signals in S1, but high 
signals from corresponding flanking control probes suggested that these miRNA 
probe signals were caused by larger overlapping transcripts. Therefore the signals 
from the miRNA probes were sufficiently corrected for this, eliminating false positive 
signals in S1 for these three pre-miRNAs. All of the other probes in Reverse Cluster 2 
also had high signals (RVs) from flanking probes in S1 but not enough to bring their 
corrected values below the cut-off point for this hybridization. Hence the remaining 
seven pre-miRNAs in the same cluster still scored positive signals in S1.  
 
In summary, miRNA probes for twelve of the fifteen low probability pre-miRNAs 
identified from the non-automated analysis of deep sequencing showed signals in S2 
(26-35 nt RNA, outside the size range of miRNAs, pre-miRNAs and pri-miRNAs). 
These signals are likely to be caused by hybridization to larger RNA degradation 
products containing the same target sequence. In contrast, none of the high probability 
pre-miRNAs showed positive signals in S2. These results are largely what would be 
expected based on the observations from the deep sequencing data, and thus these 
results support the main findings from that experiment. Interestingly, the signals from 
the low probability miRNA candidate MD20189 did give signals that were of a 
similar pattern to those of the high probability pre-miRNA candidates (i.e. positive 
signal in S1 with no corresponding positive signal in S2 or S3), however, due to a 
complete lack of conformance with the pre-miRNA identification criteria earlier 
(Table 4.9), MD20189 it was not considered to be a pre-miRNA. 
 
 
. 
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Table 4.20 DNA microarray analysis of pre-miRNA candidates 
The RV for each pre-miRNA represents that of the miRNA (5’  or 3’  arm) with the highest signal. RVs 
that exceed the cut-off value for a given hybridization are highlighted in bold 
 
S1. H361 17-25 nt S2. H361 26-35nt S3. CCB 17-25 nt 
  
Cut-off: 1.8 times 
Background 
Cut-off: 1.6 times 
Background 
Cut-off: 1.9 times 
Background 
  
Pre-
miRNA 
Compliance 
with miRNA 
identification 
criteria 
RV Percentile Ranka RV 
Percentile 
Ranka RV 
Percentile 
Ranka 
CyHV-3 
miRNA-
like 
Signals 
MD759 No 9.6 98.3 2.4 96.6 1.0 26.4 No 
MD773 No 11.6 98.9 1.9 87.7 1.0 26.4 No 
MD20185 No 1.5 83.5 1.0 19.0 0.9 13.1 No 
MD20189 No 5.1 96.2 1.0 19.0 1.2 78.0 Yes 
MD11410 Yes 0.9 9.5 0.8 5.2 0.6 0.5 No 
MD11776 Yes 5.6 96.8 1.2 61.2 1.0 26.4 Yes 
MD1111 Yes 2.0 89.9 1.0 52.8 1.0 61.7 Yes 
MD9812 Yes 1.0 18.9 1.0 19.0 1.0 26.4 No 
MR5057 Yes 22.3 99.7 1.0 19.0 1.0 26.4 Yes 
MR5075 Yes 2.2 91.1 1.0 19.0 1.0 26.4 Yes 
MR7404 No 11.1 98.7 1.9 91.0 1.6 88.2 No 
MR7409 No 11.2 98.8 6.8 99.2 1.0 26.4 No 
MR7412 No 1.00* 18.9 2.1 94.2 1.1 67.7 No 
MR7418 No 1.00* 18.9 4.7 98.6 1.0 26.4 No 
MR7434 No 4.1 95.3 1.6 84.9 1.0 26.4 No 
MR7440 No 1.00* 18.9 3.5 98.3 1.1 72.4 No 
MR7460 No 6.3 97.3 10.0 99.6 1.0 26.4 No 
MR7468** No 30.5 99.8 6.6 99.1 2.2 92.5 No 
MR7471 No 12.4 98.9 2.7 97.6 1.0 26.4 No 
MR7476 No 15.7 99.2 6.7 99.2 1.0 26.4 No 
MR6201 No 1.5 85.3 1.0 19.0 1.1 65.4 No 
 
*Probes for these actually gave significant values, but high values in the associated flanking control 
probes meant that after correction these were cancelled out. ** Despite correction for non-specific 
hybridization, the positive signals for MR7468 in the CCB cells suggest that some of the signal from 
the 17-25 nt RNA (H361 infection) may be due to non-specific hybridization to host transcripts, but 
this only accounts for a small proportion of the positive signal. 
 
 
MiRNAs should be the most abundant transcripts in the 17-25 nt RNA sample used 
for deep sequencing and thus the pre-miRNA candidates listed in Table 4.20 were 
primarily identified on the basis of them having highly abundant small RNAs 
mapping to them. As these specific sequences could potentially be over-represented in 
the data due to enzymatic bias and because other sequences could be under-
represented for the same reasons, re-analysing the same sample using array 
hybridization provided an ideal way to investigate this possibility in the absence of 
enzymatic bias. These arrays were designed to target high probability and low 
probability miRNA candidates from the deep sequencing experiments and also 
theoretical small RNAs derived from predicted pre-miRNAs that were not represented 
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or were ignored in the sequencing data. The small RNAs derived from the 21 pre-
miRNA candidates in Table 4.20 were among the most abundant identified following 
the sequencing of small RNAs from the H361 infection. In agreement with this, for 
the S1 sample, the percentile ranks for the positive signals (RVs over a cut-off value 
of 1.6) among these twenty-one pre-miRNAs are quite high, ranging from 89.9 to 99.2 
(average of 97.1). This indicated that regardless of whether these small RNAs were 
derived from high or low probability pre-miRNA candidates, in the absence of any 
enzymatic bias, most were still shown to be among the most abundant transcripts 
present in the sample. These percentile rank values refer to their rank among the 
results for all 2,914 other CyHV-3 pre-miRNAs targeted in the same sample.   
 
In total, 318 of these other pre-miRNAs also showed positive signals. However, this 
figure represents the number of positive signals before elimination of positive results 
(positive signals in S3) and elimination of other false positives caused by array 
surface artefacts. It was necessary to eliminate such signals in order to facilitate the 
identification of new provisional pre-miRNA candidates based on array data. Of these 
318 other positive pre-miRNAs, 136 of them were eliminated for having 
corresponding positive signals in S3. The array spots for the remaining 182 positives 
were visually inspected to ensure that they were not caused by array surface artefacts 
(i.e. “ blobs”  caused by dust, salt precipitants etc. which would produce erroneous 
signals). This resulted in the elimination of 111 high but artificial positive signals. 
(spots corresponding to positive signals from S3 were inspected in the same manner 
before elimination). In Table 4.21, the RVs from the remaining 71 positives were 
compared to the RVs of the fourteen positives from the 21 pre-miRNA candidates 
obtained from the sequencing of small RNAs 
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Table 4.21 (Part 1/2) Summary of all positive array signals from S1 that were not attributed to 
CCB transcripts or array surface artefacts 
 
Name RV Genomic region Description Percentile Rank 
MR7468 30.5 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 100 
MR7462 22.6 Non-Coding High signal in 26-35nt RNA 98.8 
MR5057 22.3 Non-Coding High Probability Pre-miRNA from Deep Sequencing 97.6 
MR7476 15.7 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 96.4 
MR12034 14.3 Non-Coding Novel provisional Pre-miRNA Candidate 95.2 
MR7471 12.4 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 94 
MD8620 11.8 Protein-Coding Novel provisional Pre-miRNA Candidate 92.8 
MD773 11.6 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 91.6 
MR7409 11.2 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 90.4 
MR7404 11.1 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 89.2 
MR14980 9.8 Protein-Coding High signal in 26-35nt RNA 88 
MD759 9.6 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 86.9 
MR8901 8.4 Non-Coding High signal in 26-35nt RNA 85.7 
MR7410 8.4 Non-Coding High signal in 26-35nt RNA 84.5 
MD18707 7.5 Non-Coding Novel provisional Pre-miRNA Candidate 83.3 
MR7460 6.3 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 82.1 
MD11776 5.7 Non-Coding High Probability Pre-miRNA from Deep Sequencing 80.9 
MD20189 5.1 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 79.7 
MR5537 4.9 Non-Coding Novel provisional Pre-miRNA Candidate 78.5 
MR8063 4.7 Non-Coding Novel provisional Pre-miRNA Candidate 77.3 
MR15569 4.7 Non-Coding Novel provisional Pre-miRNA Candidate 76.1 
MR9420 4.5 Protein-Coding Novel provisional Pre-miRNA Candidate 75 
MD16363 4.2 Non-Coding Novel provisional Pre-miRNA Candidate 73.8 
MR7434 4.1 Non-Coding Low Probability Pre-miRNA from Deep Sequencing 72.6 
MR5055 3.9 Non-Coding Novel provisional Pre-miRNA Candidate 71.4 
MR11140 3.9 Protein-Coding Novel provisional Pre-miRNA Candidate 70.2 
MR5123 3.8 Non-Coding Novel provisional Pre-miRNA Candidate 69 
MR5420 3.8 Non-Coding High signal in 26-35nt RNA 67.8 
MD8281 3.7 Protein-Coding Novel provisional Pre-miRNA Candidate 66.6 
MD2897 3.3 Protein-Coding Novel provisional Pre-miRNA Candidate 65.4 
MD9074 3.2 Non-Coding Novel provisional Pre-miRNA Candidate 64.2 
MR9157 3.0 Protein-Coding Novel provisional Pre-miRNA Candidate 63 
MR15858 3.0 Non-Coding Novel provisional Pre-miRNA Candidate 61.9 
MD12312 3.0 Non-Coding Novel provisional Pre-miRNA Candidate 60.7 
MD8950 2.8 Non-Coding Novel provisional Pre-miRNA Candidate 59.5 
MR9187 2.8 Protein-Coding Novel provisional Pre-miRNA Candidate 58.3 
MD19009 2.7 Protein-Coding Novel provisional Pre-miRNA Candidate 57.1 
MD11118 2.6 Non-Coding Novel provisional Pre-miRNA Candidate 55.9 
MR5512 2.6 Non-Coding Novel provisional Pre-miRNA Candidate 54.7 
MD8952 2.5 Non-Coding Novel provisional Pre-miRNA Candidate 53.5 
MR6677 2.5 Non-Coding Novel provisional Pre-miRNA Candidate 52.3 
MR13051 2.5 Protein-Coding Novel provisional Pre-miRNA Candidate 51.1 
MD10606 2.5 Protein-Coding Novel provisional Pre-miRNA Candidate 50 
MD4873 2.5 Non-Coding Novel provisional Pre-miRNA Candidate 48.8 
MD718 2.4 Protein-Coding Novel provisional Pre-miRNA Candidate 47.6 
MR9158 2.4 Protein-Coding Novel provisional Pre-miRNA Candidate 46.4 
MD9743 2.3 Non-Coding Novel provisional Pre-miRNA Candidate 45.2 
MD9852 2.3 Non-Coding Novel provisional Pre-miRNA Candidate 44 
MD1559 2.3 Non-Coding Novel provisional Pre-miRNA Candidate 42.8 
 
 
Key Description 
  
Previously deemed to be high probability pre-miRNA candidate following non-automated analysis of deep 
sequencing data. No corresponding signal in 26-35nt. 
  
Previously deemed to be low probability pre-miRNA candidate following non-automated analysis of deep 
sequencing data. Corresponding signal in 26-35nt. Most likely degradation product 
  
Previously deemed to be low probability pre-miRNA candidate following non-automated analysis of deep 
sequencing data. No corresponding signal in 26-35nt 
  VMir Predicted Pre-miRNA. Not identified in deep sequencing. Corresponding signal in 26-35nt 
  
VMir Predicted Pre-miRNA. Not identified in deep sequencing. No corresponding signal in 26-35nt. New 
provisional pre-miRNA candidate 
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Table 4.21 (Part 2/2) Summary of all positive array signals from S1 that were not attributed to 
CCB transcripts or array surface artefacts 
 
Name RV Genomic region Description Percentile Rank 
MD695 2.2 Protein-Coding High signal in 26-35nt RNA 41.6 
MD2718 2.2 Protein-Coding Novel provisional Pre-miRNA Candidate 40.4 
MD18142 2.2 Non-Coding Novel provisional Pre-miRNA Candidate 39.2 
MR5075 2.2 Non-Coding High Probability Pre-miRNA from Deep Sequencing 38 
MR8070 2.2 Non-Coding Novel provisional Pre-miRNA Candidate 36.9 
MR1556 2.2 Non-Coding Novel provisional Pre-miRNA Candidate 35.7 
MR8599 2.1 Non-Coding Novel provisional Pre-miRNA Candidate 34.5 
MR12580 2.1 Non-Coding Novel provisional Pre-miRNA Candidate 33.3 
MD665 2.1 Protein-Coding Novel provisional Pre-miRNA Candidate 32.1 
MR4453 2.1 Protein-Coding Novel provisional Pre-miRNA Candidate 30.9 
MR18968 2.0 Non-Coding Novel provisional Pre-miRNA Candidate 29.7 
MR3949 2.0 Protein-Coding Novel provisional Pre-miRNA Candidate 28.5 
MR16865 2.0 Non-Coding Novel provisional Pre-miRNA Candidate 27.3 
MR10689 2.0 Non-Coding Novel provisional Pre-miRNA Candidate 26.1 
MD1111 2.0 Non-Coding High Probability Pre-miRNA from Deep Sequencing 25 
MR8192 2.0 Non-Coding Novel provisional Pre-miRNA Candidate 23.8 
MD18477 2.0 Non-Coding Novel provisional Pre-miRNA Candidate 22.6 
MR1281 1.9 Protein-Coding Novel provisional Pre-miRNA Candidate 21.4 
MD7271 1.9 Protein-Coding Novel provisional Pre-miRNA Candidate 20.2 
MD16522 1.9 Non-Coding Novel provisional Pre-miRNA Candidate 19 
MD5586 1.9 Protein-Coding Novel provisional Pre-miRNA Candidate 17.8 
MR8069 1.9 Non-Coding Novel provisional Pre-miRNA Candidate 16.6 
MD5645 1.9 Protein-Coding Novel provisional Pre-miRNA Candidate 15.4 
MR17045 1.9 Non-Coding Novel provisional Pre-miRNA Candidate 14.2 
MR3935 1.9 Non-Coding Novel provisional Pre-miRNA Candidate 13 
MR4138 1.9 Non-Coding Novel provisional Pre-miRNA Candidate 11.9 
MD5470 1.9 Protein-Coding Novel provisional Pre-miRNA Candidate 10.7 
MD710 1.9 Protein-Coding Novel provisional Pre-miRNA Candidate 9.5 
MD18849 1.8 Non-Coding Novel provisional Pre-miRNA Candidate 8.3 
MD16282 1.8 Protein-Coding Novel provisional Pre-miRNA Candidate 7.1 
MD9246 1.8 Non-Coding Novel provisional Pre-miRNA Candidate 5.9 
MD18702 1.8 Non-Coding Novel provisional Pre-miRNA Candidate 4.7 
MD11829 1.8 Non-Coding Novel provisional Pre-miRNA Candidate 3.5 
MD9506 1.8 Non-Coding Novel provisional Pre-miRNA Candidate 2.3 
MD6507 1.8 Non-Coding Novel provisional Pre-miRNA Candidate 1.1 
MD3906 1.8 Protein-Coding Novel provisional Pre-miRNA Candidate 0 
 
 
Of the 14 pre-miRNA candidates from sequencing that also gave positive results in 
array hybridization analysis of S1, seven of them feature in the top ten and twelve of 
them feature in the top twenty highest positive signals from array hybridization (Table 
4.21). This indicated that most of them were not just over-represented in the deep 
sequencing data due to enzymatic bias. While many of the pre-miRNA candidates 
(both high and low probability) identified in deep sequencing gave strong signals, it is 
important to note that the signals from MR5075 and MD1111 were ranked 53rd and 
64th respectively out of the 85 positives. 
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4.2.3 Identification and analysis of new provisional CyHV-3 pre-miRNA 
candidates from array hybridization 
The remaining pre-miRNAs showing positive signals were analysed further. Out of 
the 71 signals, six of them were eliminated due to corresponding signals in S2. The 
other 65 pre-miRNAs were deemed to display CyHV-3 miRNA-like signals (i.e. 
positive in S1 and negative in S2 and S3) making them provisional pre-miRNA 
candidates. These candidates were investigated further by searching the sequencing 
data (from both infections) for evidence to support the existence of miRNAs derived 
from these pre-miRNAs i.e. transcripts with low read counts that were potentially 
under represented in the data due to enzymatic bias. Originally such transcripts would 
not have been considered as they were not mapped to predicted pre-miRNAs 
complying with Point 1 of the pre-miRNA identification criteria as applied during 
non-automated analysis (i.e. at least one small RNA from the pre-miRNA needed to 
have a read count >10, in at least 1 infection), however positive signals from probes 
targeting them suggested that their actual expression levels may have been higher. 
Alternatively, these transcripts may have been identified as putative miRNAs by the 
automatic methods, but if the same pre-miRNA candidate was not identified in both 
infections or by both algorithms, these candidates would have been ignored.  
 
The sequencing data revealed that many of these 65 pre-miRNAs showing CyHV-3 
miRNA-like signals did indeed have small RNAs mapping to them. However, other 
than non-compliance with Points 1 and 2 (must be from non-coding region), none of 
them displayed even a moderate compliance with the other points in the list of 
miRNA identification criteria, mainly showing non-compliance with Points 3 (not 
derived from stems), 4, (minor forms not present) and 9 (no miRNA-like signature).  
 
4.2.4 Summary of array hybridization results 
In summary, no new provisional pre-miRNA candidates identified by array analysis 
could be supported by corresponding low level signals from the sequencing data and 
therefore these were not investigated further. All four of the high probability pre-
miRNA candidates (MR5057, MD11776, MD1111 and MR5075) that were detected 
in S1 showed CyHV-3 miRNA-like signals (no corresponding signals in S2 or S3). 
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The two high probability pre-miRNAs that showed no signals (MD9812 and 
MD11410) also displayed the lowest miRNA read counts in deep sequencing and 
therefore these miRNAs may have been beyond the limit of detection for array 
hybridization.  
 
The fourteen pre-miRNA candidates identified in deep sequencing that were also the 
detected in array hybridization had RVs that were generally among the highest of all 
the positives. This indicated that even in the absence of enzymatic bias, the small 
RNAs derived from these pre-mRNA candidates were generally still among the most 
highly expressed transcripts detected in the S1 sample, regardless of whether they 
were from high or low probability candidates. This was largely in-line with the 
observations from the deep sequencing data, indicating they were not over represented 
in the sequencing data due to enzymatic bias. In the cases of the high probability pre-
miRNA candidates MR5057 and MD11776 from deep sequencing, the results from 
array hybridization agreed well with the sequencing data and supported their 
annotation as genuine pre-miRNAs. The results for MD1111 and MR5075 on the 
array differed from the deep sequencing data, in terms of their expression levels and 
the dominant miRNA derived from them, implying the need to investigate this further 
by other methods.  
 
The results from array hybridization supported the elimination of low probability pre-
miRNA candidates from further analysis. This indicated the criteria used to 
distinguish between low and high probability pre-miRNA candidates in the analysis of 
the deep sequencing data was well founded. Therefore the remaining high probability 
pre-miRNA candidates were now referred to as “ pre-miRNAs”  and accordingly 
putative miRNAs derived from them were now referred to as miRNAs 
 
4.3 Northern blotting 
Northern blotting analysis was also carried out in order to support the annotation of 
high probability pre-miRNA candidates as genuine CyHV-3 pre-miRNAs. As with 
DNA array hybridization, probes were designed to target miRNAs derived from the 
stems of selected pre-miRNA candidates. Unlike previous experiments, total RNA 
was used thus allowing the detection of all transcripts containing the same target 
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sequences across all RNA size ranges. The sample in question was from a new in 
vitro lytic infection using the N076 CyHV-3 isolate (separate infection to that used in 
deep sequencing). The miRNAs initially targeted included the major forms (as 
indicated from deep sequencing and array hybridization) from pre-miRNA candidates 
MR5057 and MD11776 and both putative miRNAs from pre-miRNA candidate 
MD1111 (as it was unclear which miRNA was the major form). As northern blotting 
was not as sensitive as deep sequencing or array hybridization, it was only the most 
abundant putative miRNAs that were also detected in array hybridization that were 
selected for investigation by northern blotting, with a view to extending northern 
blotting analysis to additional targets if all initial targets were successfully detected. 
 
No bands were detected when probes for MD11776 or MD1111 were used (data not 
shown). However the MR5057 probe did show positive hybridization signals (Figure 
4.16). Two discrete transcripts were detected, one at ~22 nt and the other at ~56 nt. 
These sizes correspond to the sizes expected for the processed miRNA (22 nt) 
identified by deep sequencing (Section 4.1) and the MR5057 pre-miRNA (56 nt) 
inferred from VMir pre-miRNA structure prediction (Section 3) and the boundaries of 
the 5’  and 3’  arm miRNAs (Section 4.1). Importantly, the same signals were not seen 
in the total RNA from non-infected CCB cells. The detection of the host miRNA ccr-
let-7a in lanes from both infected and non-infected cells confirmed equal loading and 
validated the negative result obtained with the non-infected sample. Higher molecular 
weight signals on the blots may be the result of probe binding to pri-mRNA 
transcripts.  
 
This mature miRNA from MR5057 was shown to be the most highly expressed and 
most readily detectable CyHV-3 miRNA in the RNA deep sequencing and array 
hybridization experiments, and unsurprisingly it was the only CyHV-3 miRNA that 
was detectable by northern blotting Although present in the sample (as later 
confirmed by stem-loop RT-qPCR, data not shown) the levels of the miRNAs from 
pre-miRNA MD11776 and MD1111 were too low to be detected by northern blotting.  
 
MR5057 occurs only 257 bp from MR5075 (based on 5’  start positions) (Table 4.4), 
meaning that both pre-miRNAs may occur on the same pri-miRNA. Their miRNAs 
may be processed at different efficiencies (based on the differences in expression 
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levels) but their pre-miRNAs may be processed at similar rates. It was for this reason 
the same sample was also probed for the 3’  miRNA from MR5075 to see if a pre-
miRNA band could at least be detected, however no signals were detected for this 
target either (results not shown). 
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Figure 4.16 (a) Detection of CyHV-3 pre-miRNA MR5057 (56 nt) and 3’ arm mature miRNA (22 nt) (b) Loading control: detection of host miRNA ccr-let-7a (22 nt)
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5 Diagnostic assay development and application 
 
Stem-loop RT-qPCR assays were developed in order to accurately and sensitively 
measure the relative expression levels of miRNAs (both high and low level) derived 
from all CyHV-3 pre-miRNAs. Stem-loop RT-qPCR is a TaqMan–based assay that is 
specific for mature miRNAs due to the use of a special type of RT primer known as a 
stem-loop RT primer (Chen et al., 2005). The process is explained in Figure 2.9 
Assays were designed to detect the major forms (as determined by sequencing/array 
hybridization) from all 6 CyHV-3 pre-miRNAs. Assays were also designed to detect 
both miRNAs from MD1111 and MR5075 as it was not clear from previous 
experiments which miRNAs were in fact the major forms derived from these pre-
miRNAs.  
 
5.1 Stem Loop RT-qPCR assay testing and optimization  
Before sample testing could begin, experimental parameters such as primer/probe 
concentration and input RNA had to be optimised to see how they affected each assay 
in terms of sensitivity and specificity. The strategy for stem-loop RT-qPCR 
optimization is outlined in Figure 4.14.  
 
 
 
Figure 5.1 Outline of strategy for stem-loop RT-qPCR parameter testing and sample testing 
Real time Stem-loop RT-qPCR 
assay parameter testing 
RT/PCR primer/probe  
and input RNA 
parameter testing  
with in vitro samples 
RNA input 
parameter testing 
with in vivo samples 
Specificity testing 
Selection of appropriate 
parameters and sample 
testing in Section 5.2 
In vitro samples In vivo samples 
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5.1.1 Assay Parameter testing 
Before the assays were used to test experimental samples, the primer and probe 
concentrations were varied in order to establish the most appropriate assay conditions 
for each sample type. An endogenous control assay for the carp miRNA let-7a was 
used as a proxy for all stem-loop RT-qPCR assays (just referred to as RT-qPCR from 
this point onwards). 
 
5.1.1.1 Primer/probe and input RNA parameter testing with in vitro samples 
The performance of RT-qPCR assays was first tested using different final 
concentrations (0.1x and 1x) of RT primer and PCR Primer/Probe mix and different 
input quantities of total RNA from CCB cells (see combinations of parameters used 
with let-7a assay Table 5.1). The resulting Ct values corresponding to each different 
RT primer/PCR Primer-Probe and input RNA combination are shown in Table 5.1. 
These Ct values were compared using Technique 1 (Section 2.10.4.1) and these 
results are shown in Figure 5.2.  
 
Table 5.1 Parameter combinations used for let-7a RT-qPCR testing with in vitro samples 
 
Primer Parameter set RT-Primer PCR-Primer- Probe Input RNA  Result (Ct) 
1 1x 1x 1000 ng 16.37 
1 1x 1x 100 ng 15.40 
1 1x 1x 10 ng 17.22 
2 1x 0.1x 1000 ng 18.77 
2 1x 0.1x 100 ng 17.92 
2 1x 0.1x 10 ng 19.52 
3 0.1x 1x 1000 ng 18.97 
3 0.1x 1x 100 ng 18.81 
3 0.1x 1x 10 ng 20.19 
4 0.1x 0.1x 1000 ng 21.42 
4 0.1x 0.1x 100 ng 20.97 
4 0.1x 0.1x 10 ng 22.54 
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Figure 5.2 Results for primer/probe and input RNA parameter testing with in vitro samples 
 
The strongest signal (i.e. lowest Ct value) was obtained using Primer/Probe parameter 
set 1 (1x RT primer/1x PCR primer-probe) with 100 ng of input total RNA (Figure 
5.3). In addition, Primer/Probe parameter set 1 (1x RT primer/1x PCR primer-probe) 
performed best for all input RNA quantities. Conversely, Primer/Probe perameter set 
4 (0.1x RT primer/0.1x PCR primer-probe) performed the worst for all input RNA 
quantities. In terms of input RNA quantity, the use of 100 ng input RNA gave the 
lowest Ct values with all primer parameter sets. Conversely, the use of 10 ng input 
RNA performed worst with all primer sets. Despite the fact that it performed the 
worst, the use of primer parameter set 4 and in combination with 10 ng input of RNA 
still gave a Ct of 22.54 (Table 5.1) indicating that these parameters were still more 
than adequate to detect the host miRNA ccr-let-7a and therefore also putative CyHV-
3 miRNAs that are expressed at much lower levels.  
 
5.1.1.2 Input RNA quantity testing with in vivo samples 
RNA input testing with in vitro samples indicated that 100 ng RNA consistently gave 
the best results. However, in vivo samples are very different to cell culture-derived 
samples and could possibly contain different amounts or types of inhibitors that could 
persist through RNA extraction, meaning that the RNA input quantities required for 
optimum results with in vivo samples could differ from that of in vitro samples. In 
   Primer/Probe Parameter Set 
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order to test this, 27 RNA samples from four different Cyprinus carpio tissues (brain, 
gill, gut and head-kidney) were tested for host let-7a. The RNA concentrations in 
these samples ranged from 29.3-4415.3 ng/mL and each sample was tested at neat, 
1/10 and 1/100 concentrations. In order to save on consumables, this was tested using 
0.1x RT primer/0.1x PCR primer-probe, which had already been shown to be more 
than adequate (Section 5.1.1.1). Sample details and the resulting Ct values obtained 
following testing are shown in Table 5.2. Samples that had RNA input quantities 
comparable to those tested with in vitro samples in Section 5.1.1.1 are highlighted in 
bold. These Ct values were compared using Technique 1 (Section 2.10.4.1) and the 
results of this comparison are shown in Figure 5.3 
 
Table 5.2 Let-7a RT-qPCR input RNA quantity testing using RNA derived from in vivo samples 
Samples highlighted in bold had RNA input quantities that were comparable to those tested with RNA 
derived from in vitro samples in Section 5.1.1.1 
 
Sample details Results (Ct) 
Sample ID Details 260/280 Neat Input RNA Neat 1/10 1/100 
1 Fish21-1-HK 2 916.5 ng 22.34 21.71 23.64 
2 Fish21-1-GILL 2 824.5 ng 22.50 21.61 24.21 
3 Fish21-1-BRAIN 2 1431.9 ng 20.17 19.47 22.57 
4 Fish21-1-GUT 1.9 624 ng 23.07 22.62 23.64 
5 Fish-4-1-HK 1.8 3890.6 ng 24.97 24.20 25.40 
6 Fish-4-1-GILL 1.5 4415.3 ng 24.28 25.93 26.40 
7 Fish-4-1-BRAIN 1 541 ng 21.05 20.99 23.24 
8 Fish-4-1-GUT 1.5 29.3 ng 24.26 27.41 30.91 
9 Fish-15-1-HK 2 1148.7 ng 22.35 22.39 24.45 
10 Fish-15-1-GILL 2 603.8 ng 21.96 21.66 23.23 
11 Fish-15-1-BRAIN 1.9 1203.4 ng 21.70 21.92 23.85 
12 Fish-15-1-GUT 2 1132.4 ng 23.49 22.42 23.97 
13 Fish-3-1-HK 2 2296.7 ng 22.69 22.54 24.47 
14 Fish-3-1-GILL 2 1178.1 ng 23.66 23.67 23.93 
15 Fish-3-1-BRAIN 2 447.1 ng 20.94 21.29 23.10 
16 Fish-3-1-GUT 2 2058 ng 23.92 24.38 25.03 
17 Fish-16-1-HK 1.7 4130 ng 25.15 24.78 25.21 
18 Fish-16-1-GILL 2 1456.2 ng 24.27 24.56 24.96 
19 Fish-16-1-BRAIN 2 3029.3 ng 21.70 22.03 22.70 
20 Fish-16-1-GUT 1.9 3710.9 ng 25.28 25.75 26.02 
21 Fish11-1-HK 1.9 3629.6 ng 23.88 23.79 24.96 
22 Fish11-1-GILL 1.7 152.2 ng 28.08 26.57 35.93 
23 Fish11-1-BRAIN 2 581.7 ng 22.63 22.52 24.85 
24 Fish11-1-GUT 2 1403.3 ng 23.22 23.36 24.22 
25 Fish-8-1-HK 1.8 3798 ng 26.94 27.93 30.25 
26 Fish-8-2-GILL 1.9 1193.5 ng 27.47 22.73 26.36 
27 Fish-8-3-Brain 1.9 1066.7 ng 23.07 26.76 22.54 
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Figure 5.3 Let-7a RT-qPCR input RNA quantity testing with total RNA prepared from in vivo samples 
RNA samples originating from brain tissue and Fish-21 gave higher signals on average and are marked with * and x respectively   
Input RNA Quantity 
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It was evident from results in Figure 5.3 that there was no clear relationship between 
the neat input RNA quantity and assay performance, nor was there a correlation to 
A260/280 values. This suggested that the performance of the assay with each 
individual sample may be dependent on other factors intrinsic to each individual 
sample such as inhibitors or a matrix effect. On this note there was a correlation 
between Ct value and tissue type. Samples from brain tissue gave lower Ct signals on 
average, compared to other tissues (marked with * in Figure 5.3). In addition organs 
from Fish-21 (marked with x in Figure 5.3) gave higher signals, on average, than 
samples from other fish. The lowest signal obtained for each sample was always the 
1/100 dilution (with the exception of sample 27). The strongest signal for each sample 
was obtained from the Neat or the 1/10 dilution and generally there was not much 
difference between them (Figure 5.3). This was true even for samples that had RNA 
input quantities that were comparable to the quantities used in vitro (section 5.1.1.1; 
marked in bold in Table 5.2) As these were the same samples that were to be tested 
for CyHV-3 miRNAs, these results suggested that it was best to test both Neat and 
1/10 dilutions when carrying out this testing (Section 5.2.2). 
 
5.1.1.3 Specificity testing for CyHV-3 miRNA RT-qPCR assays  
Higher primer levels were seen to result in greater sensitivity (Section 5.1.1.1). Lower 
concentrations such as 0.1x RT primer/0.1x PCR primer-probe were also 
demonstrated to be more than adequate for detecting host (Section 5.1.1.1 ) and 
CyHV-3 miRNAs in vitro (initial testing for CyHV-3 miRNA assays not shown, see 
other results later in Section 5.2.1). However, it was assumed that CyHV-3 target 
transcripts would be present at lower levels in host tissue, and that therefore it was 
preferable to use 1x RT primer/1x PCR primer-probe when testing in vivo samples. If 
the levels of target transcript were low in tissues, very high Ct values would be 
expected (~ 35). Even though it results in more sensitive assays, the use of high 
primer concentrations increases the chances of low-level non-specific signals that 
would also result in high Ct values (~35). In order to identify assays that have a 
tendency (due to their primer sequences) to give low non-specific signals when using 
high primer concentrations, all CyHV-3 miRNA assays were first tested on RNA from 
non-infected CCB cells using high quantities of input RNA (1000 ng) and primer-
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probe (1x). The same tests were also carried out using low amounts of RT primer/1x 
PCR primer-probe (0.1x), which were less likely to result in non-specific signals. The 
results from these specificity tests are to be seen in Table 5.3. 
 
Table 5.3 Ct values for CyHV-3 miRNA assay specificity testing (using high and low primer 
concentrations) 
The assays that showed non-specific signals at higher primer concentrations are highlighted  
 
0.1x-RT/0.1x-PCR (Low) 1x-RT/1x-PCR (High) Assay 
Replicate 1 Replicate 2 Replicate 1 Replicate 2 
MR5057 3’ Negative Negative Negative Negative 
MD11776 3’ Negative Negative Negative Negative 
MD1111 3’ Negative Negative 36.13 36.57 
MD1111 5' Negative Negative 35.27 35.98 
MR5075 3’ Negative Negative Negative Negative 
MR5075 5' Negative Negative Negative Negative 
MD11410 5' Negative Negative 35.32 35.79 
MD9812 5' Negative Negative Negative 36.12 
 
None of the CyHV-3 miRNA assays gave non-specific signals when 0.1x RT 
primer/0.1x PCR primer-probe (low concentration) was used. When 1x RT primer/1x 
PCR primer-probe (high concentration) was used, the assays for MD1111 3’ , 
MD11776, MD11410 and MD9812 showed low-level signals (~35). This may have 
been because some of the primers for these assays have higher GC content and 
therefore have higher affinities for both specific and non-specific targets during the 
annealing step. In order to quickly test this theory, RNA from non-infected CCB cells 
was tested again using 1x RT primer/1x PCR primer-probe (high concentration) at 
60°C (same as before), 65°C and 70°C. As a positive control for each annealing 
temperature RNA from CyHV-3 infected cells was also tested. The inclusion of 
positive controls also provided a way to test the effects of higher annealing 
temperatures on the sensitivity of these assays, which could be used to investigate the 
feasibility of running all assays at high annealing temperatures to avoid non-specific 
signals at higher primer concentrations (the performance of the assay for the host 
miRNA was also tested in this regard). The results of these tests are to be seen in 
Table 5.4.  
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Table 5.4 Ct values for CyHV-3 miRNA assay specificity testing at higher annealing 
temperatures 
The CyHV-3 assays that showed non-specific signals in non-infected CCB RNA are highlighted 
 
Sample Infected Non-infected 
Annealing 
Temperature 60°C 65°C 70°C 60°C 65°C 70°C 
Replicate 1 25.93 Negative Negative 24.13 Negative Negative Host Let-
7a* Replicate 2 25.44 Negative Negative 24.33 Negative Negative 
Replicate 1 15.87 21.2 38.37 Negative Negative Negative MR5057 
Replicate 2 18.44 21.98 36.99 Negative Negative Negative 
Replicate 1 26.97 28.97 Negative Negative Negative Negative MD11776 
Replicate 2 23.36 27.77 Negative Negative Negative Negative 
Replicate 1 22.74 28.86 Negative 32.55 Negative Negative MD1111 3’ 
Replicate 2 22.43 28.99 Negative 28.34 Negative Negative 
Replicate 1 25.52 22.52 33.17 Negative 38.33 Negative MD1111 5' 
Replicate 2 25.82 22.48 34.97 35.65 35.86 Negative 
Replicate 1 25.70 35.12 Negative 36.30 Negative Negative MR5075 5' 
Replicate 2 26.61 34.98 Negative Negative Negative Negative 
Replicate 1 27.72 34.98 Negative Negative Negative Negative MR5075 3’ 
Replicate 2 25.26 32.26 Negative Negative Negative Negative 
Replicate 1 26.88 32.91 Negative 33.86 Negative Negative MD9812 
Replicate 2 26.73 32.97 Negative 35.12 Negative Negative 
Replicate 1 25.96 26.46 37.17 35.72 Negative Negative MD11410 
Replicate 2 25.91 26.43 37.00 36.05 37.04 Negative 
.* Host Let-7a* was test using 0.1x primer/probe.  
 
As with the previous round of testing (Table 5.3) the same four assays gave low levels 
of non-specific signals in non-infected RNA at 60°C, although in this experiment the 
assay for MR5075 5’  also showed similar signals (in one replicate). Using the RNA 
from non-infected cells, only two of these assays (MD11115’  and MD11410) still 
showed positive signals at 65°C and none showed positive signals at 70°C. This 
indicated that the primer/probe sets for MD1111 5’  and MD11410 may have had the 
strongest affinity to non-specific targets. All of the CyHV-3 miRNA targets could be 
detected in the RNA from infected CCB cells at 60°C. All of them could also be 
detected at 65°C although the sensitively was reduced, with the exception of the assay 
for MD1111 5’  which actually improved significantly. The assay for the host miRNA 
gave no signals at this temperature. At 70°C only the assays for MD11115’  and 
MD11410 and MR5057 gave positive signals, although in all cases the sensitively was 
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reduced. This further supports the idea that the primers for MD1111 5’  and MD11410 
have higher affinities for both their specific and non-specific targets. 
 
In conclusion, the use of 1x RT primer/1x PCR primer-probe (high concentration) at 
60°C gave the best sensitivity with all assays. Therefore these are the most suitable 
parameters to use for testing RNA in vivo samples where the CyHV-3 miRNA levels 
may be very low. However, the same parameters were also most likely to give non-
specific signals with five of these assays (MD1111 3’ , MD1111 5’ , MD11410, 
MD9812 and MR5075 5’ ). The same non-specific signals are likely to be seen in 
RNA from tissue samples. If so, such low non-specific signals will be 
indistinguishable from low-level signals from CyHV-3 miRNAs present in the same 
tissues. Thus, due to a tendency to produce non-specific signals these five assays may 
not be suitable for testing for CyHV-3 miRNAs in vivo. In contrast, the assays for 
MR5057, MD11176 and MR5075 3’  do not appear to suffer from these problems. 
These non-specific signals can be easily eliminated by using lower primer 
concentrations (0.1x RT primer/0.1x PCR primer-probe). This does reduce the overall 
assay sensitivity but it is more than adequate for testing samples known to have high 
levels of target transcript i.e. during in vitro lytic infections. Thus, all of these assays 
could be used to detect and compare levels of CyHV-3 miRNA in vitro without any 
specificity problems. 
 
In summary, it was found that it was best to use low primer concentrations (0.1x RT 
primer/0.1x PCR primer-probe) for all assays when testing in vitro (cell culture-
derived) samples and high primer concentrations (1x RT primer/1x PCR primer-
probe) when testing in vivo samples, in which case, the assays for MR5057, 
MD11176 and MR5075 are the most suitable to use. 
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5.2 Sample Testing 
The RT-qPCR assays were first used to verify the relative CyHV-3 miRNA 
expression levels that were observed in the deep sequencing data (which was 
measured as read counts) by using them to re-test one of the RNA samples used (from 
the H361 infection). They were also ideal for comparing the levels observed in deep 
sequencing to the levels observed over the course of a second in vitro lytic infection 
(separate to N076 infection used for deep sequencing and northern blotting) in order 
to establish if the same relative expression levels are typical of this kind of in vitro 
CyHV-3 infection. Lastly RT-qPCR provided most suitable way to test for the same 
miRNAs in vivo. The strategy used for the testing of samples is outlined in Figure 5.4. 
 
Figure 5.4 Outline of strategy used to test samples for CyHV-3 miRNA expression 
 
Selection of appropriate 
parameters and sample 
testing based on results 
from Section 5.1.1 
Analysis of 
CyHV-3 miRNA 
levels in H361  
Infection used 
for sequencing 
Phase 1 (0.1x primer/probe) All samples 
In vitro samples (0.1x primer/probe) In vivo samples 
Analysis of CyHV-3 
miRNA expression 
levels in N076 
infection over a 10 
day period   
Phase 2 (1 x primer/probe) 
Re-testing of all 
tissues from fish 
showing most 
consistent results 
in Phase 1 
Phase 3 (1 x primer/probe) 
Re-testing of 
specific tissues 
giving most 
consistent results 
in Phase 2 (in 
duplicate)  
Sample testing using Stem-loop RT-qPCR 
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5.2.1 Testing of RNA from infected cells (in vitro infections) 
All in vitro samples were tested by RT-qPCR using 0.1x RT-Primer/0.1x PCR primer-
probe concentrations.  
 
5.2.1.1 RT-qPCR analysis of relative CyHV-3 miRNA levels in the RNA used for 
deep sequencing (H361 infection) 
A replicate aliquot of the same RNA sample used for deep sequencing analysis (H361 
in vitro infection) was tested for all CyHV-3 miRNAs. One thousand nanograms of 
total RNA was used in one multiplex RT reaction (containing RT primers for all 
CyHV-3 miRNA targets), followed by separate real-time PCRs for each target. As 
different PCRs could display different PCR efficiencies, the relative levels of each 
target transcript were calculated using Technique 2 (Section 2.10.4.2) and then 
compared to each other (see Table 5.5 and Figure 5.5 (a)). These were also compared 
to the read count levels that were obtained in the RNA deep sequencing experiment 
from the same sample (Table 5.5 and Figure 5.5(b)).  
 
Table 5.5 RT-qPCR measurement of CyHV-3 miRNA levels in RNA prepared following CyHV-3 
H361 infection of CCB cells used previously for small RNA deep sequencing 
The corresponding read counts obtained from the same sample in deep sequencing are also included. 
All of these levels refer to the major form miRNA from each CyHV-3 pre-miRNA unless otherwise 
stated. 
 
Target Replicate Ct Value Efficiency  N0  Mean N0 
Read 
counts 
1 19.84 2.14E-08 MR5057 
2 20.16 1.99 2.65E-08 2.39E-08 62596 
1 24.78 4.51E-09 MD11776 
2 24.97 
1.93 
5.09E-09 
4.80E-09 2114 
1 24.67 1.55E-09 MD1111 5' 
2 24.30 
2.01 
1.52E-09 
1.53E-09 567 
1 24.75 1.74E-09 MD1111 3’ 
2 24.72 
1.94 
2.25E-09 
2.00E-09 2711 
1 25.07 1.05E-09 MR5075 5' 
2 24.85 
1.91 
1.11E-09 
1.08E-09 12 
1 27.92 2.87E-09 MR5075 3’ 
2 27.82 
1.87 
3.31E-09 
3.09E-09 125 
1 27.85 1.70E-09 MD9812 
2 28.00 
1.96 
1.49E-09 
1.60E-09 23 
1 28.58 3.64E-10 MD11410 
2 28.38 
1.92 
3.30E-10 
3.47E-10 10 
  240 
1.E-10
1.E-09
1.E-08
1.E-07
MR
50
57
MD
11
77
6
MD
11
11
 
5'
MD
11
11
 
3'
MR
50
75
 
5'
MR
50
75
 
3'
MD
98
12
MD
11
41
0
Target
N
0 
Va
lu
es
 
(Lo
g)
(a) 
(b) 
1.E+00
1.E+01
1.E+02
1.E+03
1.E+04
1.E+05
1.E+06
MR
50
57
MD
11
77
6
MD
11
11
 
5'
MD
11
11
 
3'
MR
50
75
 
5'
MR
50
75
 
3'
MD
98
12
MD
11
41
0
Transcript
R
e
ad
 
Co
u
n
ts
 
(Lo
g)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Relative levels of CyHV-3 miRNAs in RNA from the H361 infection 
Relative expression levels as measured by (a) stem loop RT-qPCR (error bars represent standard 
deviation) and (b) deep sequencing (read counts). Unless otherwise stated, all of these levels refer to 
the major form miRNA from each CyHV-3 pre-miRNA 
 
 
It can be seen that the low concentration of primer/probe (0.1x) used was sufficient to 
detect all target transcripts, in fact the highest Ct value was 28.58 (Table 5.5). As with 
all previous experiments, the 3’  major form derived from MR5057 was the most 
highly expressed transcript present (Figure 5.5 (a)). The relative levels of all other 
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transcripts targeted generally correlated well with the corresponding read counts 
obtained following deep sequencing of the same sample (Figure 5.5 (a) and (b)). The 
most notable difference between the two experiments is the levels of both miRNAs 
from the pre-miRNA MD1111. The RT-qPCR results indicated that both miRNAs 
were actually present in much lower levels relative to the other targets, indicating that 
it may have been over-represented in deep sequencing data (Figure 5.5 (a) and (b)). 
Interestingly, contrary to the results from DNA microarray hybridization, the RT-
qPCR results are in general agreement with the deep sequencing results in relation to 
the most abundant miRNAs from MD1111 and MR5075, indicating that the miRNA 
from the 3’  arms of both of these pre-miRNAs are indeed the major forms.  
 
5.2.1.2 CyHV-3 miRNA expression over the course of an in vitro infection 
In order to show that the positive signals observed following CyHV-3 infection of 
CCB cells (Section 5.2.1.1) were indeed products of productive viral replication, the 
levels of the CyHV-3 viral miRNAs were measured over the course of an in vitro lytic 
infection, from the point of inoculation to the development of widespread CPE. 
CyHV-3 genomic DNA levels were also measured in the same cells over the same 
period. To do this, 11 replicate 75 cm2 cell culture flasks were prepared by seeding 
them from a common trypsinized CCB cell culture suspension. Ten of these were 
inoculated with CyHV-3 (N076 isolate) and a lytic infection was established. The 
remaining non-inoculated flask was kept under the same conditions, serving as a 
negative control. One flask was taken for total RNA extraction every 24 hours. 
Relative levels were calculated using Technique 2 and normalized to host miRNA 
ccr-let-7a. Details, of the Ct values, efficiencies and other values used to calculate N0 
values are available in Supplementary File 5.1 T.1. CyHV-3 DNA levels from this 
experiment are shown in Figure 5.6 (a) and all CyHV-3 miRNA levels are to be seen 
in Figure 5.6 (b). The results for specific groups of targets are also compared (using 
linear scales) in Figure 5.6 (c)-(f).  
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Figure 5.6 Relative levels of CyHV-3 miRNA levels over the course of lytic infection in vitro 
(a) CyHV-3 DNA levels normalized to CCB cell DNA (b) Relative expression levels of CyHV-3 
miRNA targets (log scale) normalized to host miRNA ccr-let-7a. (c)- (f) Comparative expression levels 
of specific pairings of CyHV-3 miRNA targets (linear scales). 
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The establishment of a CyHV-3 lytic infection resulted in the development of 
widespread CPE at 8-9 d.p.i. (data not shown). The levels of CyHV-3 DNA 
progressively increased from 0-9 d.p.i., indicating that CyHV-3 replication was 
occurring (Figure 5.6 (a)). During the same period there was also a progressive 
increase in the levels of all CyHV-3 miRNAs (Figure 5.6 (b)).  
 
Only three CyHV-3 miRNAs were detectable at 1 d.p.i. (MR5057, MD1111 3’  and 
MD11410). All targets could be detected by 2 d.p.i. (although not all were visible 
with the scale used in Figure 5.6 (b)). At all stages from 2 d.p.i. onwards, MR5057 
was consistently the most abundant target followed by MD11776 and MD1111 3’ .  
Notably, both miRNAs from the MR5075 were present at lower levels throughout the 
infection relative to other targets (Figure 5.6 (b)) compared to in the H361 sample 
(Figure 5.5 (a)). 
 
The difference in expression levels between MR5057 and the next highest target 
MD11776 increased dramatically at 8 and 9 d.p.i. (Figure 5.6 (c)) this corresponded to 
a similar increase in viral DNA levels at the same time point (Figure 5.6 (a)). The 
same trend was observed in the expression levels of all other targets (Figure 5.6 (d)-
(f)) although not as pronounced. In fact, MD11410 only marginally increased from 8-
9 d.p.i. compared to all other targets (Figure 5.6 (d)). The miRNA from the 3’  arms of 
MD1111 and MR5075 were always present at higher levels than the miRNAs from 
the 5’  arms of these pre-miRNAs (Figure 5.6 (e)-(f)) providing conclusive evidence 
that these miRNAs must be the major forms derived these pre-miRNAs. 
 
 
 
 
 
 
 
  246 
5.2.2 Testing of tissues from CyHV-3-infected fish (in vivo infections) 
 
5.2.2.1 Samples tested 
Samples were sourced and prepared by our collaborators at Cefas Laboratories, 
Weymouth, UK. 
 
RNA from tissues of a lytically infected fish 
This fish was originally a survivor of a high mortality CyHV-3 outbreak in a UK lake 
in the summer of 2006. A lytic infection was subsequently reactivated when the fish 
was kept at a permissive temperature. This indicated that other long-term survivors 
from the same outbreak were also likely to be latent carriers. Three samples were 
taken from this fish, these were gill, brain and head-kidney. It was possible that the 
same miRNAs expressed during the in vitro CyHV-3 lytic infection were also present 
in these samples. Hence this fish acted as a positive control for the experiment and 
was referred to as Fish-8. 
 
RNA from tissues of six healthy survivors of a CyHV-3 outbreak  
These six fish were survivors of the same high-mortality CyHV-3 outbreak as Fish-8. 
Hence, it was possible that these fish were also latent carriers. Unlike Fish-8, lytic 
infections were not reactivated in these fish, thus it was possible that they were 
latently infected at the time of sampling. Four samples were taken from each fish, 
these included gill, brain, gut and head-kidney. These six fish were referred to as Fish-
4, -3, -15, -16 -11 and -21.  
Controls 
Positive RT-qPCR controls consisted of RNA from CyHV-3 in vitro lytic infections. 
Negative tissue controls consisted of RNA extracted from gill, brain, gut and head-
kidney of CyHV-3 free carp sampled in lakes within the Republic of Ireland. 
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5.2.2.2 Phase 1: Preliminary Screening of all samples 
All samples were initially tested using 0.1x RT-Primer/0.1x PCR primer-probe 
concentrations in order to see if such RT-qPCR parameters were sufficient to detect 
CyHV-3 miRNAs. Samples were tested at three concentrations: Neat, 1/10 and 1/100 
(the neat concentrations of all samples are given in Table 5.2). This also acted as a 
low-cost way to screen samples, allowing tentative selection of those most likely to 
give positive results, and thus appropriate for retesting using 1x RT-Primer/PCR 
primer-probe concentrations. In this phase, samples were only tested for 3 viral targets 
MR5057, MD11776 and MD1111 3’  (Table 5.6). 
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The positive RT-qPCR and negative tissue controls gave the expected results. The 
assay for MD1111 3’  yielded more positive signals than MR5057 and MD11776 
(Table 5.6). Positive test readings for MD1111 3’  were distributed across samples 
from several different fish, whereas the positives for MR5057 and MD11776 were 
confined to Fish 21 (a possible latent carrier) and Fish 8 (the lytically infected fish). 
Due to the fact that the assay for MD1111 was previously shown to have a tendency 
to give low-level non-specific signals (even if only demonstrated using 1x primer 
concentrations with in vivo samples in Section 5.1.1.3) and because there was no 
discernable pattern to the positives (unlike MR5057 and MD11776), the results from 
MD1111 were ignored. The positive results for MR5057 and MD11776 suggested 
that Fish 21 and Fish 8 (Fish-8 was expected to be positive) were the two fish most 
likely to also test positive when retested using higher RT-qPCR primer concentrations 
in Phase 2, thus all tissues from these fish were selected for further testing. 
 
5.2.2.3 Phase 2: Re-testing of individual fish identified as most likely to give positive 
results 
All organs from individual fish showing the most consistent results in Phase 1 were 
re-tested using the 1x RT-Primer/1x PCR primer-probe formulation which had earlier 
been shown give a more sensitive test. In this phase of testing, all assays were used in 
order to confirm that they (i.e. assays for MD1111 5’ , MD1111 3’  MR5075 5’ , 
MD9812 and MD11410) were not suitable for use due to a tendency to low give non-
specific signals when 1x RT-Primer/1x PCR primer-probe was used. 
 
The positive RT-qPCR and negative tissue controls gave the expected results. The 
majority of samples tested using these five assays gave low-level positive test results 
(66/70) (Table 5.7). This was in stark contrast to the assays for MR5057, MD11776 
and MR5075 3’  (Table 5.7). It is highly likely that the positive results for MD1111 5’ , 
MD1111 3’  MR5075 5’ , MD9812 and MD11410 were indeed false positives. 
Although there was no way to confirm this, it was decided that it was best to ignore 
these results.  
 
Assays for MR5057, MD11776 and MR5075 3’  gave positive test results with tissue 
samples 3, 4, 26 and 27 (Table 5.7). Although the Ct values were high, they were 
  250 
significantly lower than any signals from Phase 1 testing. Thus, these samples were 
selected for re-testing in Phase 3.  
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Table 5.7 Phase 2: Testing of samples from fish that were identified in Phase 1 as being most likely to give positive results using 1x RT-Primer/1x PCR primer-probe 
concentrations 
 
 
 
Key Description 
  Host miRNA assay 
  Using 1x PCR primer-probe, this assay gave low non-specific signals in non-infected CCB cells (Section 5.1)  thus it was likely to also give low-level false positives with tissue samples 
  Using 1x primer-probe this assay gave no low non-specific signals in non-infected CCB cells (Section 5.1)   
 
 
Let-7a MD1111 5’ MD1111 3’ MR5075 5' MD9812 MD11410 MR5057 MD11776 MR5075 3’ 
Description ID number Sample 1/10 Neat 1/10 Neat 1/10 Neat 1/10 Neat 1/10 Neat 1/10 Neat 1/10 Neat 1/10 Neat 1/10 Neat 
1 Fish-21-1-HK 23.39 22.93 32.93 30.88 34.22 33.45 Neg Neg 34.96 33.98 35.98 32.76 Neg Neg Neg Neg Neg Neg 
2 Fish-21-1GILL 23.25 23.08 31.74 30.14 38.59 33.00 36.85 38.14 33.61 33.28 33.71 31.06 Neg Neg Neg Neg Neg Neg 
3 Fish-21-1-BRAIN 21.51 20.95 31.72 30.11 33.74 34.99 38.20 37.06 34.23 33.35 35.94 33.79 Neg Neg Neg Neg Neg 37.13 
Healthy 
Long- 
Term 
Survivor 
4 Fish-21-GUT 24.36 24.02 30.91 29.93 32.72 33.73 37.24 Neg 31.56 32.48 33.96 32.63 34.03 Neg Neg Neg Neg Neg 
25 Fish-8-1-HK 28.35 28.78 31.34 32.69 35.88 31.66 36.86 38.56 32.18 33.87 31.79 32.38 Neg Neg Neg Neg Neg Neg 
26 Fish-8-2-GILL 27.58 27.86 30.65 30.09 34.64 31.03 36.62 35.89 32.59 33.07 31.33 31.24 31.58 32.96 Neg 36.97 37.08 34.66 
Fish with 
Reactivated 
Lytic 
Infection 27 Fish-8-3-Brain 23.72 23.77 30.05 29.57 32.79 32.34 Neg 36.31 32.88 34.04 32.49 32.21 Neg Neg Neg Neg Neg 38.70 
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5.2.2.4 Phase 3: Re-testing of individual tissue samples that were most likely to give 
positive results  
Specific samples showing the most consistent results from Phase 2 were retested in 
duplicate using 1x RT-Primer/PCR primer-probe in order to confirm these results. 
RNA samples were tested at both neat and 1/10 dilutions. Due to possible low-level 
non-specific signals with five of the assays, only assays for MR5057, MD11776 and 
MR5075 3’  were used in Phase 3. The results are shown in Table 5.8 and the relative 
levels of each target are compared in Figure 5.7. The estimated relative levels of these 
targets were compared using Technique 1. The different PCR efficiencies were not 
taken into account as most of the Ct values were low, thus the corresponding 
amplification curves were not suitable for calculating  these with high confidence. 
Relative levels were normalised using the corresponding levels of host miRNA ccr-
let-7a in the same samples (levels based on Ct values in Table 5.7). Only samples 
showing (i) amplification in each duplicate and (ii) an average Ct value that was <35 
were deemed positive. The only positive test results in Phase 3 therefore were 
obtained from samples 4 (from possible latent carrier) and sample 26 (from fish with 
lytic infection). 
 
The positive RT-qPCR and negative tissue controls gave the expected results. At least 
one replicate from each of the 4 samples gave a positive result. Sample 26 tested 
positive for all 3 targets using both dilutions and in all replicates (Table 5.8). This 
sample consisted of RNA from the gill of a fish experiencing a reactivated lytic 
infection. MR5057 was present at the highest levels followed by MD11776 and 
MR5075 and this was the case for both dilutions of sample 26 (Figure 5.7). The 
relative levels of these 3 targets in the in vivo lytic infection corresponded to the 
relative levels for the same targets from in vitro lytic infections (Figure 5.5 (a) Figure 
5.6 (b)). The Ct values associated with MR5057 in Phase 3 were quite low compared 
to all other positives and were the only positive signals from Phase 3 that had Ct 
values <32.  
 
The only other sample to score positives in all replicates was Sample 4, although 
MR5057 was the only assay to test positive in that case. This RNA sample was from 
the gut of a long-term healthy survivor of a previous high mortality CyHV-3 outbreak. 
The levels of these miRNAs in sample 4 and sample 26 are directly compared (not 
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normalised) in Figure 5.7. This result showed that the MR5057 levels are low in 
Sample 4 (possible latent carrier) relative to Sample 26 (lytic infection). When these 
samples are normalised to levels of host miRNA in the same samples (Figure 5.8) the 
levels of MR5057 in Sample 4 are shown to be even lower relative to its level in 
Sample 26.  
 
 
Table 5.8 Phase 3: testing of samples that were identified in Phase 2 as most likely to give 
reproducible positive results using 1x RT-Primer/1x PCR primer-probe. 
 
Description ID  Sample Dilution Replicate MR5057 MD11776 MR5075 
1 Negative Negative Negative 1/10 
2 Negative Negative Negative 
1 Negative Negative Negative 
3 Fish-21-1-BRAIN 
Neat 
2 Negative Negative 37.97 
1 34.46 Negative Negative 1/10 
2 33.88 Negative Negative 
1 34.23 Negative Negative 
Healthy 
Long-Term 
Survivor 
 
4 Fish-21-1-GUT 
Neat 
2 34.79 Negative Negative 
1 30.66 35.02 36.38 1/10 
2 30.52 33.95 37.11 
1 30.45 37.09 34.77 
26 Fish-8-2-GILL 
Neat 
2 29.61 32.38 33.42 
1 Negative Negative Negative 1/10 
2 Negative 37.06 Negative 
1 Negative 36.65 Negative 
Fish with 
Reactivated 
Lytic 
Infection 
27 Fish-8-3-BRAIN 
Neat 
2 Negative Negative Negative 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Samples from long-term healthy survivor Samples from fish with reactivated 
lytic infection 
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Figure 5.7 Comparison of the relative levels of CyHV-3 miRNAs (not normalized) from tissue 
samples tested in Phase 3  
These expression values are based on the average of the duplicates. Error bars represent standard 
deviation between duplicates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 Comparison of the relative levels of CyHV-3 miRNAs (normalized) from tissue 
samples tested in Phase 3 testing 
Expression values are based on the average of the duplicates and were normalized to levels of ccr-let-
7a in the same samples. Error bars represent standard deviation between duplicates 
 
 
6 Investigation into CyHV-3 miRNA sequence conservation 
 
6.1 Identification of potential CyHV-3 pre-miRNA and/or miRNA 
homologues in other CyHV genomes 
MiRNA sequences are generally not conserved between viruses. Viral miRNA 
conservation and/or high sequence similarity is quite rare and to date this has only 
been observed between closely related viruses (Section 1.6.2). The closest related 
viruses to CyHV-3 are CyHV-1 and CyHV-2. Incidentally, these 2 viral genomes 
were recently sequenced and found to contain many homologues of CyHV-3 genes  
and so the possibility that there were homologues of CyHV-3 miRNA genes on these 
genomes was thus investigated.  
Samples from long term healthy survivor Samples from fish with reactivated 
lytic infection 
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BLAST searches were carried out for high probability CyHV-3 pre-miRNAs in the 
other CyHV genomes. This was initially confined to non-coding regions that were 
directly orthologous to non-coding regions of the CyHV-3 genome that encoded pre-
miRNAs. Only two of these CyHV-3 pre-miRNAs showed matches in these regions, 
namely to MD1111 and MD11776 (Table 6.1). The match to MD1111 was only 
partial and only present in CyHV-2, but this match was to the region of the pre-
miRNA coding for the 5’  arm miRNA (Figure 6.1 (a)). Matches to MD11776 were 
found in both CyHV-1 and CyHV-2 and consisted of the entire pre-miRNA sequence 
(Figure 6.1 (b)). 
 
 
 
 
The search was then expanded to include the entire genomes of CyHV-1 and CyHV-
2. This time the E-values for the MD1111 and MD11776 matches described above 
were higher. The highest E-Value in both searches was the partial match to the 
MD1111 pre-miRNA in CyHV-2. This went from 1E-8 in the first BLAST search 
(region-specific) to 2E-6 in the second BLAST search (entire genome) (Table 6.1). 
This served as a basis for establishing a relevant cut-off point for E-Values of 1E-5. In 
the second search (based on the entire genomes of CyHV-1 and CyHV-2) many other 
CyHV-3 pre-miRNAs showed partial matches to short stretches of sequences on 
several parts of the CyHV-2 and CyHV-3 genomes, however none of these matches 
showed E-values  <1E-5.  
 
As a result of the good matches observed to pre-miRNAs MD1111 and MD11776 it 
was deemed relevant to check if there were any other pre-miRNA candidates that 
occurred in the same regions but that had been eliminated in Section 4.1.3 or 4.1.4 due 
to low read counts. This was because any other CyHV-3 pre-miRNA candidates 
occurring in the same region were also likely to show some sequence conservation, 
thus supporting their annotation as pre-miRNAs despite their low read counts. One 
such candidate, MD11704 was found to occur very close to MD11776 (~1 kb). It was 
identified in both infections by Mireap (Section 4.1.4.1) and also complied with most 
of the pre-miRNA identification criteria (details in Supplementary File 6.1 and Table 
6.3 (a)-(f)), but was eliminated due to low read counts. Incidentally BLAST analysis 
revealed a possible homologue to that pre-miRNA candidate in both CyHV-1 and 
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CyHV-2 and both matches had very low E-values (Table 6.1). In addition, the match 
spanned the entire MD11704 pre-miRNA sequence (Figure 6.1 (c)) 
 
With the exception of the first 3 nucleotides, the 5’  miRNA sequence from MD1111 
was perfectly conserved in the candidate CyHV-2 homologue (Figure 6.1 (a)). The 
remainder of the pre-miRNA was not well conserved unlike the general genomic 
location (i.e. ORF7 in CyHV-2). The seed region of the 3’  miRNA sequence in 
MD11776 is conserved in CyHV-1 and CyHV-2 and the remainder of the miRNA is 
also conserved in both viruses with the exception of 2 bases (Figure 6.1 (b)) The 
sequence similarity across the remainder of the pre-miRNA was high (78% for 
CyHV-1 and 87% for CyHV-2). The seed region for the 5’  miRNA from MD11704 
was also conserved in CyHV-1 and CyHV-2 and the remainder of the miRNA was 
also well conserved with 2 and 3 mismatches to CyHV-1 and CyHV-2 respectively. 
As was the case with CyHV-3, the homologues for both MD11776 and MD11704 are 
located in a non-coding region of the genome opposite ORF87 in both CyHV1 and 
CyHV-2.  
 
VMir was also used to predict pre-miRNAs in the CyHV-1 and CyHV-2 genomes 
(described in Section 3). One of the potential CyHV-3 pre-miRNA homologues was 
also predicted by VMir, namely the homologue of MD11776 in the CyHV-2 genome 
and this matched perfectly to the homologue identified through BLAST. In addition 
this predicted pre-miRNA had a high VMir score of 203 and a high relative WC of 39. 
Furthermore, analysis of the predicted pre-miRNA structure using pre-miRNA 
classifiers (as in Section 4.1.3.2) classified this predicted pre-miRNA as a real 
miRNA. Conversely, the same analysis of the equivalent homologue in the CyHV-1 
genome suggested that it was not a real pre-miRNA. None of the other sequences for 
possible pre-miRNA homologues were classed as real pre-miRNAs (Table 6.2)
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Table 6.1 BLAST searches for CyHV-3 pre-miRNA sequence homologues on other CyHV 
genomes 
 
Sequences Aligned Results from first BLAST to orthologous non-coding regions 
Results 
from 
BLAST to 
whole 
genome 
CyHV-3 pre-
miRNA Viral genomic region Score E-Value Identities Gaps E-Value 
MD1111 CyHV-2 non-coding 
region opposite ORF7 44.6 bits(48) 1.00E-08 24/24(100%) 0/24(0%) 2.00E-06 
CyHV-1 non-coding 
region opposite ORF84 MD11410 CyHV-2 non-coding 
region opposite ORF84 
No Significant results 
CyHV-1 non-coding 
region opposite ORF87 104 bits(114) 2.00E-26 95/120(79%) 0/120(0%) 2.00E-24 MD11776 CyHV-2 non-coding 
region opposite ORF87 159 bits(176) 3.00E-43 114/131(87%) 0/131(0%) 2.00E-41 
CyHV-1 non-coding 
region opposite ORF87 69.8 bits(76) 2.00E-16 58/71(82%) 0/71(0%) 2.00E-14 MD11704 CyHV-2 non-coding 
region opposite ORF87 86.0 bits(94) 3.00E-21 65/77(84%) 0/71(0%) 2.00E-19 
CyHV-1 non-coding 
region opposite ORF69 MD9812 CyHV-2 non-coding 
region opposite ORF69 
No Significant results 
CyHV-1 non-coding 
region opposite ORF43 MR5057 CyHV-2 non-coding 
region opposite ORF43 
No Significant results 
CyHV-1 non-coding 
region opposite ORF43 MR5075 CyHV-2 non-coding 
region opposite ORF43 
No Significant results 
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Pre-
miRNA 
Name 
1. 
Highly 
express
ed 
small 
RNAs 
2. From 
non-
coding 
region 
3. 
Putative 
miRNAs 
adjacent 
to stem 
4. Putative 
major and 
minor form 
detected 
5. MiRNA 
isoform 
stability 
6. 
Classifie
d as real 
pre-
miRNA 
7. Pre-
miRNA 
structure 
has MFE 
<-25 
8. Mature-
miRNA-
duplex  3’ 
overhangs  
9. MiRNA-
like 
alignment 
signature  
10. Greater 
3’ end 
heterogene
ity among 
isomiRs * 
11. 
Discrete, 
read-
enriched 
locus 
Complia
nce with 
all points 
MD11704 No Yes  Yes Yes Yes Yes Yes Yes Yes No No No 
Ratio-1* Ratio-2* Ratio-3* Pre-miRNA miRNA  
H361  N076 H361 N076 H361 N076 
5' miRNA No isomiRs 2.0 No isomiRs 1.0 No isomiRs 2.0 MD11704 
3’ miRNA No isomiRs 1.0 No isomiRs 1.0 No isomiRs 1.0 
(f) 
* Very few isomiRs were detected: may 
require a greater number of isomiRs in 
order to carry out meaningful end 
heterogeneity analysis 
(e) 
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6.2 CyHV-3 miRNA seed region conservation 
The seed regions of miRNAs are the primary determinants of miRNA target 
specificity and for this reason seed regions are the most likely regions to be 
conserved between otherwise divergent miRNAs.  MiRNAs sharing the same seed 
regions are likely to target the same mRNA and thus have the same function. In order 
to see if any CyHV-3 miRNAs shared seed regions with any known viral and/or host 
miRNAs, SeqMap was used to compare seed regions from all miRNAs from the six 
high probability pre-miRNAs to all known viral and host seeds (allowing only 1 
mismatch).  
 
6.2.1 CyHV-3 seed region matches to viral miRNAs 
Six miRNAs from five of the CyHV-3 pre-miRNA had either full or partial matches 
(1 mismatch) to seed regions of other viral miRNAs. Two had full seed matches, one 
of these (MD11776 5’ ) had a full match to miRNAs from 4 different viruses (one of 
these viral miRNA is actually conserved between EBV and rLCV). The most 
common matches are to miRNAs from EBV, rLCV and MDV-1 (Table 6.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  262 
Table 6.4 CyHV-3 seed region matches to known viral miRNAs 
Seed regions (2-7) are marked in bold. U/C or G/A bases occurring at equivalent positions on different 
miRNAs are indicated with an “ x” . This is important in this context because despite the differences in 
sequence, the nucleotides at these positions on both miRNAs can in theory still base pair with the 
same nucleotides on what are possibly the same the target sites due to GU-wobbles.   
  
MiRNA  Alignment (Seed regions in bold) 
  44444444
MD1111 3’ 222222222
blv-miR-B5-5p 22222
U/C Bases in both can pair with G in Target Site -----
G/A Bases in both can pair with U in Target Site C-
 
  444444444444
MD1111 3’ 222222222
hhv6b-miR-Ro6-4-5p 2222
U/C Bases in both can pair with G in Target Site ----
G/A Bases in both can pair with U in Target Site 
  444444444
MD11776 3’ 22222
mdv1-miR-M2-3p 2222
U/C Bases in both can pair with G in Target Site C
G/A Bases in both can pair with U in Target Site ---
  4444444
MD11776 5’ 2222
blv-miR-B4-3p 2222222
U/C Bases in both can pair with G in Target Site ---
G/A Bases in both can pair with U in Target Site -
 
  444444444
MD11776 5’ 2222
ebv-miR-BART1-3p 222222
U/C Bases in both can pair with G in Target Site -----
G/A Bases in both can pair with U in Target Site 
 
  444444444444
MD11776 5’ 2222
mdv2-miR-M21-3p 2
U/C Bases in both can pair with G in Target Site -
G/A Bases in both can pair with U in Target Site --
 
  444444444
MD11776 5’ 2222
rlcv-miR-rL1-6-3p 222222
U/C Bases in both can pair with G in Target Site C-
G/A Bases in both can pair with U in Target Site 
 
  44444444
MR5057 3’ 2222
rlcv-miR-rL1-32-3p 2222
U/C Bases in both can pair with G in Target Site C
G/A Bases in both can pair with U in Target Site -----
 
  4444444444
MR5075 3’ 22222
hvsa-miR-HSUR2-5p 22222222
U/C Bases in both can pair with G in Target Site C
G/A Bases in both can pair with U in Target Site -
 
  4444444444
MD9812 5’ 22222
hsv2-miR-H23-5p 222
U/C Bases in both can pair with G in Target Site -
G/A Bases in both can pair with U in Target Site ---
 
  4444444444
MD9812 5’ 22222
mdv1-miR-M12-5p 2222222
U/C Bases in both can pair with G in Target Site C
G/A Bases in both can pair with U in Target Site -
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6.2.2 CyHV-3 seed region matches to host miRNAs 
Three CyHV-3 5’ arm miRNAs (all minor forms) had matches to multiple host 
miRNAs, although many multiple matches were to members of the same miRNA 
families that share the same seed sequence. MR5057 5’  (minor strand) was found to 
have a partial match (1 mismatch) to the seed region of one of the most abundant 
cellular miRNAs ccr-Let-7a and members of its miRNA family including Let-7b, Let 
7g and Let-7i (Table 6.5). In addition it also had matches to positions 8 and 9 on 
these miRNAs. MD1111 5’  had perfect matches (positions 1-7) to mir-103 and mir-
107 (same family) and with mir-457a and mir-457b (same family). MD11776 5’  also 
had perfect matches to miRNAs mir-29a and mir-29b (Table 6.5).  All of these also 
tended to have additional matches outside the seed regions, and interestingly these 
were usually from bases 14-17 (Table 6.5). This is relevant in this context because in 
addition to base pairing between the seed and target site, base pairing outside the 
seed, especially with bases at these positions, can sometimes be important for 
miRNA-target duplex stability (Section 1.8).  
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Table 6.5 CyHV-3 seed region matches to known host miRNAs 
Seed regions (2-7) are marked in bold. U/C or G/A bases occurring at equivalent positions on different 
miRNAs are indicated with an “ x” .  
MiRNA  Alignment (Seed regions in bold) 
  444444444
MR5057 5’ 22222
ccr-let-7a 222222222
U/C Bases in both can pair with G in Target Site C-
G/A Bases in both can pair with U in Target Site --
 
  44444444
MR5057 5’ 22222
ccr-let-7b 222222222
U/C Bases in both can pair with G in Target Site C-
G/A Bases in both can pair with U in Target Site ---
 
  444444444
MR5057 5’ 22222
ccr-let-7g 2222222222
U/C Bases in both can pair with G in Target Site C--
G/A Bases in both can pair with U in Target Site C--
 
  4444444
MR5057 5’ 22222
ccr-let-7i 222222222
U/C Bases in both can pair with G in Target Site C---
G/A Bases in both can pair with U in Target Site --
 
  44444444
MD1111 5’ 2222
ccr-miR-103 22222
U/C Bases in both can pair with G in Target Site -
G/A Bases in both can pair with U in Target Site --
 
  444444444
MD1111 5’ 2222
ccr-miR-107 22222
U/C Bases in both can pair with G in Target Site -
G/A Bases in both can pair with U in Target Site -
 
  4444444444
MD1111 5’ 2222
ccr-miR-214 2
U/C Bases in both can pair with G in Target Site 
G/A Bases in both can pair with U in Target Site C-
 
  4444444444
MD1111 5’ 2222
ccr-miR-457a 2222
U/C Bases in both can pair with G in Target Site --
G/A Bases in both can pair with U in Target Site --
 
  4444444444
MD1111 5’ 2222
ccr-miR-457b 222
U/C Bases in both can pair with G in Target Site -
G/A Bases in both can pair with U in Target Site --
 
  444444444
MD11776 5’ 2222
ccr-miR-29a 2222222
U/C Bases in both can pair with G in Target Site C--
G/A Bases in both can pair with U in Target Site ---
 
  444444444
MD11776 5’ 2222
ccr-miR-29b 22222222
U/C Bases in both can pair with G in Target Site C--
G/A Bases in both can pair with U in Target Site -
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7 CyHV-3 miRNA target prediction 
Viral mRNA target site predictions were made for miRNAs derived from all high 
probability CyHV-3 pre-miRNAs. Target sites were predicted for both major and 
minor form miRNAs as it is possible for both to be functionally active. This process 
involved the use two very different target site prediction methods, TargetScan and 
PITA. The process of miRNA target site prediction used in this study is outlined 
below in Figure 7.1. The target site predictions for MR5057 and MD11776 are 
described in this section. The results for other miRNAs are given in the 
Supplementary File 7.1. 
 
 
 
Figure 7.1 Outline of process involved in CyHV-3 miRNA target site prediction 
 
 
7.1 Predicted CyHV-3 targets for the 5’ arm miRNA from precursor 
MR5057 
 
TargetScan and PITA predicted 45 and 106 potential target sites respectively for this 
miRNA. Details of all these predicted target sites are available in Supplementary File 
7.2 T.1-T.3. The top ranked site from TargetScan was located in the 3’  UTR of 
ORF117. The same site was also the top ranked site by PITA (Table 7.1). The seed 
CyHV-3 miRNA target prediction 
CyHV-3 3’ UTRs retrieved 
TargetScan PITA 
miRNA target predictions based on  
seed match and the characteristics  
of bone fide miRNA target sites 
miRNA target predictions based on  
seed match and target site accessibility 
Comparison of high probability miRNA target 
sites predicted by both methods 
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match is a 8mer-1a site (Figure 7.2) and occurs near the start of the 3’  UTR of 
ORF117, from position 39-46 (Figure 7.3). Bases at positions 9-11, 14-15 and 22 on 
the miRNA are also complementary to the 3’  UTR (Figure 7.2). 
 
Table 7.1 Comparison of highest ranking TargetScan and PITA results for MR5057 5’ miRNA 
target site prediction 
 
MR5057 5' CyHV-3 Targets 
3’ UTR 
Seed 
Match 
Position 
Context Score Rank Total Sites Percentile Best TargetScan 
Prediction 
ORF_116-117 39-46 -0.381 1 45 100 
 G Rank Total Sites Percentile Results for the 
same site 
predicted by PITA 
  
-22.41 1 106 100 
 
<A=''=''2D2222222
4>D4!22222D
 
Figure 7.2 Alignment of MR5057 5’ miRNA to its highest ranking predicted target site in Table 
7.1 
Seed matches are highlighted in red. Other elements of the 8mer-1a target site are highlighted in green 
(nucleotide on target site base pairing to position 8 on miRNA) and purple (A on target site opposite 
position 1 on miRNA). All base pairing between the miRNA and target site are highlighted in bold.  
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Figure 7.3 Genomic location of highest ranking predicted target site for MR5057 5’miRNA 
(from Table 7.1) 
 
7.2 Predicted CyHV-3 targets for the 3’ arm miRNA from precursor 
MR5057 
 
TargetScan and PITA predicted 2 and 22 potential target sites respectively for this 
miRNA (details of all these sites are given in Supplementary File 7.2 T.4-T.6). The 
top ranked site from TargetScan is in the 3’  UTR of ORF123. The same site was also 
the top ranked site by PITA (Table 7.2). The seed match is a 7mer-m8 site and 
occurs at position 22-28 on the 3’  UTR of ORF123. Bases at positions 9, 13, 15 and 
20 on the miRNA are also complementary to the 3’  UTR (Figure 7.4). This 3’  UTR 
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overlaps with the 3’  UTR of the upstream ORF122 (as ORF123 actually occurs in 
the 3’  UTR of ORF122) (Figure 7.5). 
 
Table 7.2 Comparison of highest ranking TargetScan and PITA results for MR5057 3’ miRNA 
target site prediction 
 
 
MR5057 3’ CyHV-3 Targets 
3’ UTR Seed Match 
Position Context Score Rank Total Sites Percentile 
Best TargetScan 
Prediction 
ORF-123  22-28 -0.139 1 2 100 
 G Rank Total Sites Percentile Results for the 
same site 
predicted by PITA 
  
-13.65 1 22 100 
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Figure 7.4 Alignment of MR5057 3’ miRNA to its highest ranking predicted target site in Table 
7.2 
Seed matches are highlighted in red. Other elements of the 7mer-m8 target site are highlighted in 
green (nucleotide on target site base pairing to position 8 on miRNA). All base pairing between the 
miRNA and its target site are highlighted in bold.  
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Figure 7.5 Genomic location of the highest ranking predicted target site for MR5057 3’miRNA 
(from Table 7.2) 
 
7.3 Predicted CyHV-3 targets for the 5’ arm miRNA from precursor 
MD11776  
 
TargetScan and PITA predicted 18 and 81 potential target sites respectively for this 
miRNA (details of these sites are given in Supplementary File 7.2 T.7-T.9). The top 
ranked predicted target site from TargetScan was located in the 3’  UTR of ORF117. 
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The G value for this site, as calculated by PITA  was a positive value, indicating 
that this site was not accessible. The most accessible site as deemed by PITA was in 
the 3’  UTR of ORF 129, which is still within the top 10 ranked predictions from 
TargetScan (Table 7.3). The seed match is 7mer-m8 and occurs near the end of the 3’  
UTR from position 1305-1312. Bases at positions 12, 14, 16, 18-19 and 21-22 on the 
miRNA are also complementary to the 3’  UTR (Figure 7.6) This occurs within the 
coding region of ORF128 (which itself occurs entirely within the 3’  UTR of 
ORF129) (Figure 7.7). 
 
Table 7.3 Comparison of highest ranking TargetScan and PITA results for MD11776 5’ miRNA 
target site prediction 
Due to its high ranking in both sets of results the target site in the 3’  UTR of ORF 128-129 was 
identified as most likely CyHV-3 target site for the MD11776 5’  miRNA 
  
Best TargetScan Prediction  
3’ UTR 
Seed 
Match 
Position 
Context 
Score Rank 
Total 
Sites Percentile Best TargetScan 
Prediction 
ORF 107 29-35 -0.222 1 18 100 
G Rank Total Sites Percentile 
Results for the same 
site predicted by 
PITA 
  
0.62 64 81 21.2 
Best PITA Prediction  
3’ UTR 
Seed 
Match 
Position 
G Rank Total Sites Percentile Best PITA Prediction 
ORF 128-129 1305-1312  -10.37 1 81 100 
Context 
Score Rank 
Total 
Sites Percentile 
Results for the same 
site predicted by 
TargetScan 
  
-0.123 7 18 64.7 
TargetScan Prediction (from 10 top ranked) with best corresponding PITA Prediction   
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Figure 7.6 Alignment of MD11776 5’ miRNA to its most likely CyHV-3 target site (in 3’ UTR of 
ORF 128-129) based on data in Table 7.3  
Seed matches are highlighted in red. Other elements of the 7mer-m8 target site are highlighted in 
green (nucleotide on target site base pairing to position 8 on miRNA). All base pairing between the 
miRNA and its target site are highlighted in bold.  
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Figure 7.7 Genomic location of the most likely CyHV-3 target site for MD11776 5’miRNA based 
on the data in Table 7.3 
 
 
7.4 Predicted CyHV-3 targets for the 3’ arm miRNA from precursor 
MD11776 
 
TargetScan and PITA predicted 63 and 231 potential target sites respectively for this 
miRNA (details of these sites are given in Supplementary File 7.2 T.10-T.11). The 
top ranked site from TargetScan was in the 3’  UTR of ORF84. This was also the 2nd 
highest ranked prediction made by PITA. Conversely the highest ranked site in the 
PITA prediction is outside the top 10 ranked sites in TargetScan (Table 7.4). The 
close correlation between the two methods regarding the target site in ORF84 
indicates that it is a much higher quality prediction. The seed match is an 8mer-1a 
and occurs near the end of the 3’  UTR of ORF87 at position 2291-2298. Bases at 
positions 9, 14-16 and 21 on the miRNA are also complementary to the 3’  UTR. This 
extra base pairing outside the seed region is based on the prediction of an asymmetric 
bulge forming in a miRNA-3’ UTR duplex (Figure 7.8) The 3’  UTR appears to be 
shared with ORF86 and 85 and overlaps with the end of the coding region of ORF84 
(Figure 7.9). 
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Table 7.4 Comparison of highest ranking TargetScan and PITA results for MD11776 3’ miRNA 
target site prediction  
Due to its high ranking in both sets of results the target site in the 3’  UTR of ORF 84-85 was 
identified as the most likely CyHV-3 target site for the MD11776 3’  miRNA. 
 
Best TargetScan Prediction  
3’ UTR 
Seed 
Match 
Position 
Context  
Score Rank 
Total 
Sites 
Percentile  
Rank Best TargetScan 
Prediction 
ORF_84-85 2291-2298 -0.319 1 63 100 
 G Rank Total Sites Percentile 
Results for the same 
site predicted by 
PITA 
  
-24.55 2 231 98.2 
Best PITA Prediction  
3’ UTR 
Seed 
Match 
Position 
 G Rank Total Sites Percentile Best PITA Prediction 
ORF_66-67 365-371 -25.61 1 231 100 
Context 
Score Rank 
Total 
Sites Percentile 
Results for the same 
site predicted by 
PITA 
  
-0.044 17 63 74.1 
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Figure 7.8 Alignment of MD11776 3’ miRNA to its most likely CyHV-3 target site (in the 3’ 
UTR of ORF 84-85); based on data in Table 7.4 
Seed matches are highlighted in red. Other elements of the 8mer-1a target site are highlighted in green 
(nucleotide on target site base pairing to position 8 on miRNA) and purple (A on target site opposite 
position 1 on miRNA). All base pairing between the miRNA and target- site are highlighted in bold. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.9 Genomic location of the most likely Cyhv-3 target site for MD11776 3’miRNA based 
on data from Table 7.4 
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8 Discussion 
The aims of this study were to investigate the miRNA coding potential of CyHV-3. 
This investigation was conducted in a stepwise manner through a series of 
interdependent experiments. Each experiment was designed to closely scrutinize 
observations from the preceding experiment in order to support or oppose tentative 
conclusions that were inferred and to act as the basis for proceeding with further 
investigations. The  results of these experiments are discussed below.  
 
8.1 De Novo Prediction of Pre-miRNAs on the CyHV-3 genome 
Most viral miRNAs are not evolutionarily conserved. Where viral miRNA 
conservation or sequence similarity does occur, it is only confined to a few miRNAs 
in closely related viral species. Therefore successful prediction of novel viral 
miRNAs requires the use of de novo miRNA prediction methods. The principles of 
de novo miRNA prediction (and descriptions of several such methods) are outlined in 
Section 1.7.1.1. VMir was specifically designed for de novo prediction of pre-
miRNAs in viral genomes (Grundhoff et al., 2006) and due to its free availability, 
informative output and successful track record it was chosen for this study. This 
method is outlined in more detail in Section 1.7.1.1 . 
 
In order to distinguish predicted CyHV-3 pre-miRNAs most likely to be genuine 
from background noise, cut-off values were established for the three most relevant 
attributes associated with these predictions which included predicted pre-miRNA 
size, VMir-score and relative window count (WC). It was important that the cut-off 
values used were relevant. Appropriate cut-off values for size range were easily 
established based on the size range of bone-fide pre-miRNAs. However, VMir score 
and WC are attributes that exist entirely within the context of VMir analysis, and 
although it was apparent that the higher these values were, the more “ pre-miRNA-
like”  the prediction was, it was not apparent what lower limit cut-off values should 
be used. To avoid selecting arbitrary cut-off values, other viral genomes known to 
encode bone-fide miRNAs were also analyzed in order to see how known pre-
miRNAs were interpreted in terms of VMir-score and WC, thus facilitating the 
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establishment of relevant cut-off values for these attributes for the CyHV-3 predicted 
pre-miRNAs.  
 
Elimination of candidates based on VMir Score and WC cut-off values resulted in 
elimination of ~99% of predictions, leaving 303 predictions. Further elimination 
based on genomic location (i.e. elimination of those predicted to occur in ORFs) and 
MiPred classification resulted in a final list of 155 predicted CyHV-3 pre-miRNA. 
These results suggested that the CyHV-3 genome contained 155 sites that when 
theoretically transcribed into RNA could give rise to secondary structures that were 
consistent with pre-miRNAs in terms of structure and stability.  
 
The assessment of the CyHV-3 genome in this manner was an important pre-
requisite to experimental work. Although miRNA genes appear to be quite prevalent 
in HVs compared to other kinds of viruses, some HV genomes such as HHV-3 
(VSV), HHV-6, and HHV-7 have in fact been predicted to lack any probable pre-
miRNAs unlike others such as HSV-1, HCMV, EBV, KSHV and MHV68 (Pfeffer et 
al., 2005b). To date there have been no experimental investigations into the existence 
of HHV-7 encoded miRNAs and deep sequencing has failed to detect any HHV-3 
miRNAs (Umbach et al., 2009a). Intriguingly, four pre-miRNAs were reported in 
HHV-6 (Tuddenham et al., 2012) although they are no longer present in the latest 
release of miRBase (Table 1.4). Previous pre-miRNA predictions in these three 
genomes were made using a method referred to as the Pfeffer-SVM-Method, which 
is not publicly available. As expected, the VMir prediction statistics from these three 
genomes (HHV-3, HHV-6 and HHV-7) showed significant differences to those from 
the other 6 viruses known to encode miRNAs. Applying the same cut-off values to 
predictions on these 3 genomes resulted in an average of 0.61 pre-miRNA 
predictions per kbp (data not shown) compared to an average of 0.96 for the six other 
viruses and a value of 1.03 for the CyHV-3 genome (Table 3.4). Importantly, this 
showed that the VMir prediction statistics for the CyHV-3 genome were in line with 
those of the six other viral genomes known to encode pre-miRNAs and that this was 
very different picture from other viral genomes previously predicted not to encode 
pre-miRNAs. Overall, this provided a solid theoretical basis to proceed with 
experimental investigations into the existence of CyHV-3 encoded miRNAs.    
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The cut-off values used allowed the detection of 83.1% of the 77 known miRNAs in 
the other six viral genomes analyzed. Based on the values for the prediction 
attributes for the seven CyHV-3 miRNAs proposed here (Table 8.1), four out of the 
seven were present in the remaining 303 filtered predictions resulting in a sensitivity 
of 57.1% for the CyHV-3 predictions when using these cut-off values (incidentally, 
all seven would have passed the subsequent genomic location and MiPred 
elimination steps). All seven exceeded the VMir-score cut-off value. Two of them, 
MD11410 and MR5057, did not exceed the WC cut-off value. Although MD11410 
was close with a value of 37, the WC value for MR5057 was quite low and in stark 
contrast to the others (the average WC value for these six was 43.5). In spite of this, 
out of the seven proposed miRNAs, MR5057 has the strongest experimental 
evidence in support of its annotation as a pre-miRNA. MD11704 was not in the 
original 303 predictions either due to its unusually large size. In hindsight, there 
should have been no upper limit put on pre-miRNA size. In theory the length of a 
pre-miRNA stem should not make a difference in terms of its ability to as to act as 
substrate for Drosha while still part of the pri-miRNA. If the upper length limit is 
ignored, five of the seven proposed miRNAs would have been predicted, resulting in 
a sensitivity of 71.4% which is closer to the sensitivity that these cut-off values gave 
for the other 77 viral pre-miRNAs (which would remain at 83.1% even after 
removing the upper limit on pre-miRNA size). Overall, the prediction attributes for 
the 7 proposed CyHV-3 pre-miRNAs are very similar to those of the 77 other viral 
pre-miRNAs from the other six viruses (Table 8.1), thus further supporting their 
annotation as genuine pre-miRNAs.  
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Table 8.1 Summary of prediction attributes of seven proposed CyHV-3 pre-miRNAs 
 
Attribute VMir Score WC MHP Size 
Cut-off values >112 >40 45-200 nt 
Pass cut-off values? 
MD1111 229.0 42 172 Yes 
MD9812 224.8 46 107 Yes 
MD11410 141.8 37 75 No (WC too low) 
MD11704 207.0 44 250 No (MHP size too big) 
MD11776 210.2 45 136 Yes 
MR5057 114.2 2 60 No (WC too low) 
MR5075 165.4 47 141 Yes 
Average 184.62 37.6 134.4  
Average for 77 
pre-miRNAs 
from other six 
viruses* 186.23 39.9 101.9  
*Six other viral genomes were EBV, MDV-1, HSV-1, KSHV, MGHV68 and HCMV. Further details 
of the genomes used and predictions are is Supplementary File 3.1. 
 
The CyHV-1 and CyHV-2 genomes had not yet been sequenced when this study 
commenced, thus pre-miRNA prediction was done using VMir. The recent 
sequencing of these two genomes now makes it possible to potentially predict 
additional novel miRNAs that are shared (or at least show some sequence similarity) 
between these two genomes and CyHV-3. Several methods use pair-wise genome 
alignments to improve predictions by identifying predicted pre-miRNAs that display 
stretches of sequence similarity with predicted pre-miRNAs in other genomes (i.e. 
possible conserved miRNAs, seed regions etc.). Such sequence similarities between 
CyHV-1, CyHV-2 and CyHV-3 demonstrated in this study using BLAST (i.e. 
MD1111, MD11776 and MD11704 in CyHV-1 and 2; Section 6). This suggests that 
the use of a de novo pre-miRNA prediction approach that takes into account potential 
low level sequence homology between predicted pre-miRNAs in these viruses may 
result in the identification of novel pre-miRNA candidates. Methods that may be 
suitable to carry out this kind of analysis include EVOfold (Pedersen et al., 2006), 
miRseeker (Lai et al., 2003), MIRFINDER (Bonnet et al., 2004a) 
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8.2 Experimental evaluation of pre-miRNA predictions 
The primary samples used in experiments to identify CyHV-3 encoded miRNAs 
consisted of RNA from in vitro lytic infections. This was because RNA from in vivo 
latent infections was not considered suitable for the identification of novel viral 
miRNAs. This decision was made on the basis that other studies have shown that 
viral miRNAs are hard to detect in latently infected tissues. Typically, not all known 
miRNAs can be detected in such samples. This may be because there are lower 
proportions of infected cells in tissue samples compared to in vitro samples resulting 
in a higher level of host background noise in the sequencing data, and so less viral 
miRNAs would be featured in the data. This means that viral miRNAs that are 
identified in such samples typically have very low read counts compared to in vitro 
infections (Amen and Griffiths, 2011; Umbach et al., 2009b). While deep sequencing 
of small RNAs from latent tissue samples may be suitable for cataloguing the 
presence of known viral miRNAs, due to the high background noise and the possible 
absence of associated low abundance transcripts (i.e. minor forms on opposite arm of 
pre-miRNAs and isomiRs) used to support the presence of novel miRNAs, in vivo 
samples (both lytic and latent) were deemed not suitable for the identification of 
novel viral miRNAs. Due to the fact that higher proportions of cells are infected 
during in vitro infections, RNA from such experiments is more enriched for viral 
transcripts in general, making in vitro infections much more suitable for the 
identification of novel viral miRNAs.  
 
8.2.1 Deep sequencing of small RNAs from in vitro CyHV-3 infections 
In order to initially identify putative CyHV-3 encoded miRNAs, the initial 
experimental stages of this study involved the indirect identification of CyHV-3 pre-
miRNAs. Specifically, this involved analyzing deep sequencing data for small RNAs 
(17-25 nt) that mapped to the CyHV-3 genome in a manner that was consistent with 
the model of miRNA biogenesis. This allowed putative miRNAs to be distinguished 
from non-miRNA transcripts also present in the same samples. Small RNAs were 
sequenced from two different CyHV-3 infections. This was important because unlike 
random degradation products, small RNAs that are generated through relatively 
specific and repeatable processes such as miRNA biogenesis should show more 
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consistency between different infections when compared to random degradation 
products. 
 
The percentage of total reads that were of CyHV-3 origin was ~ 2 and ~ 7% in the 
H361 and N076 infections respectively. While this percentage was quite low in both 
infections, similar results have been observed elsewhere. For example, viral small 
RNAs constituted ~ 2% of reads sequenced from marmoset T-cells infected with 
HVS (Cazalla et al., 2011) and MCMV reads from infected bone marrow 
macrophages represented as little as 0.5% of total reads. However the same study 
with MCMV observed that ~ 30% of transcripts sequenced from mouse embryonic 
fibroblasts infected with MCMV were of viral origin (Buck et al., 2007), 
demonstrating that although lytic infections were established in both cells types, 
differences in experimental conditions can have a significant effect on the proportion 
of viral transcripts present. In addition to cell type, several other parameters such as 
the amount of virus used, temperature, time and medium composition may also have 
effects on the proportion of viral transcripts present in RNA samples. In this regard, 
similar variations were also found between different HCMV in vitro infection 
conditions (Dunn et al., 2005; Pfeffer et al., 2005b). Even though CyHV-3 culture 
conditions were kept constant between the two infections used in this study, both 
flasks were inoculated with significantly different amounts of different isolates, 
comprising 1 mL of 2.7x 104 TCID50 / mL and 1 mL 5.0x 105 TCID50 / mL of the 
H361 and N076 isolates respectivley. Also, RNA was also extracted at different time 
points based on CPE progression. RNA was extracted from cells only when visible 
CPE was widespread in the infected flasks. This was done in order to ensure that 
lytic replication (and hence viral gene transcription) was taking place in the 
maximum amount of cells, thus reducing cellular RNA background noise. However, 
it was reasoned that it was important not to allow CPE to progress too far as 
increased levels of cellular RNA turnover in infected cells (Glaunsinger and Ganem, 
2006) may have the effect of increasing non-miRNA background noise in the 17-25 
nt RNA size range. The N076 infection took place in smaller flask than the H361 
infection (25cm2 vs. 75cm2), therefore viral concentrations in the medium were 
higher by comparison and CPE had progressed to what was deemed to be a 
satisfactory level at an earlier time point post inoculation (14 vs. 18 d.p.i.). In 
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summary it is likely that this different sampling time-point, the different quantities of 
virus used and different isolates used are responsible for the differences in the 
proportion of viral transcripts observed in the deep sequencing data from both of 
these infections. 
 
The 17-25nt RNA samples should have been specifically enriched for miRNAs and 
as expected the majority of the reads, ~ 58 % and ~ 76 % from H361 and N076 
infections respectively, consisted of known host miRNAs. Interestingly a significant 
proportion of the remainder consisted of novel host miRNAs and previously 
undetected minor forms derived from currently known host pre-miRNAs (data not 
shown as it relates to a separate study). This loosely correlated with the proportions 
of reads derived from seven newly discovered CyHV-3 pre-miRNAs, which 
(including associated isomiRs) represented 42% and 85% of all CyHV-3 reads from 
the H361 and N076 isolates respectively.  
 
These seven pre-miRNAs were discovered through a combination of manual 
interpretation of the sequencing data (i.e. non-automated approaches focusing on a 
small subset of highly abundant transcripts mapping to predicted pre-miRNAs in 
non-coding regions) followed by the use of automated methods in interpretation of 
the same data (i.e. analysis of the complete dataset using special algorithms to 
identify CyHV-3 pre-miRNAs). The findings from both of these approaches are 
discussed separately in the following sections.  
 
8.2.2 Non-automated identification of miRNAs from deep sequencing data 
In order for a small RNA to be initially considered as a putative miRNA in this study 
(i) it had to map to a predicted pre-miRNA from a non-coding region, (ii) be 
accompanied by a corresponding major/minor form in both infections and (iii) at 
least one of them had to have a read count >10 in at least one infection. Due to the 
read count criteria, only six of the seven CyHV-3 pre-miRNAs were initially 
identified using the non-automated approach (MD11704 was not). All miRNAs 
identified from these six CyHV-3 pre-miRNAs were present in both infections; 
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however, some were not always the dominant small RNA at these loci i.e. different 
isomiRs of the same miRNAs dominant in both infections. This was the case for 4 
out of the 12 miRNAs from these six CyHV-3 pre-miRNAs. However, this is a 
common observation in deep sequencing miRNA data. Often the dominant miRNAs 
at specific loci are found to differ slightly from the reference miRNA recorded in 
miRBase and are mainly offset at the 3’  end. This was found to be the case with 
miRNAs from several viruses e.g. HCMV (Meshesha et al., 2012),  MGHV (Reese et 
al., 2010), KSHV (Umbach and Cullen, 2010)  HSV-1 (Umbach et al., 2009a) and 
EBV (Chen et al., 2010) and in other organisms (Kuchenbauer et al., 2008; Morin et 
al., 2008; Reid et al., 2008) and may be regulated in a tissue-specific manner 
(Fernandez-Valverde et al., 2010; Lee et al., 2010). Out of the 4 CyHV-3 miRNAs 
that differed between both infections, only one of them differed at the 5’  end (3’ arm 
miRNA from MD11410) and this was only offset by 1 nt. This one case represented 
8% of all CyHV-3 miRNAs. This rate was low relative to that of putative miRNAs 
from other pre-miRNA candidates later determined not to be genuine, in which case 
17% of them were found to have 5’  end variations, the majority of which represented 
cases where the 5’  end differed by >1 nt. This demonstrated that the 5’  ends had 
more of a tendency to remain unchanged among the dominant isomiRs observed in 
both infections compared to other non-miRNA small RNAs present in the same 
samples. This makes sense as the 5’  ends of miRNAs contain the seed regions (from 
positions 2-7) and are important from a functional perspective, therefore this part of 
the miRNA would need to remain relatively unchanged in the dominant isomiRs 
(instead they differ at the 3’  ends). Conversely, for non-miRNA small RNAs most 
likely generated through random degradation, there would be no reason for them to 
display such a bias at their 5’  ends. In this study, if such differences were observed 
between infections, in order to be considered a high probability pre-miRNA, the 
dominant isomiRs (i.e. miRNAs) from both arms were only allowed to differ by a 
maximum of +/- 1nt at the 5’ end (pre-miRNA identification criteria). Although it has 
been shown elsewhere that the dominant isomiRs may differ by up to 4 nt at their 5’  
ends in different infections e.g. the MGHV miRNA mgv-miR-M1-2-3p (Reese et al., 
2010), a maximum allowance of +/- 1nt of a difference was still maintained in this 
study. This may be a slightly conservative approach to novel pre-miRNA 
identification but it did ensure selection of only those pre-miRNA candidates that 
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showed the highest degrees of consistency (in terms of putative miRNA processing) 
between the two infections.  
 
Of the six genuine CyHV-3 pre-miRNAs identified, the mature miRNAs 
representing the major and minor forms were consistent between both infections with 
one exception, the miRNAs from MD1111. In that case the major form switched 
from being the 3’  arm miRNA in the H361 infection to the 5’  arm in the N076 
infection. This “ switching”  between major and minor forms is not uncommon and 
has been shown to occur in other organisms. Such changes may occur at certain 
developmental stages (Jagadeeswaran et al., 2010) and in some cases may also be 
determined by tissue type (Ro et al., 2007). Such switches have also been shown to 
occur at different stages of viral life cycles, for example with MGHV the 3’  arm 
miRNA from the pre-miRNA mgv-mir-M1-2 was shown to be the major form in 
latently infected B cells (Pfeffer et al., 2005b) but switched to the 5’  arm in lytically 
infected fibroblasts  (Reese et al., 2010). The same has also been shown to occur 
between two different lytic infections as demonstrated with HCMV pre-miRNA 
hcmv-miR-UL22A which switched from 5’  arm (Pfeffer et al., 2005b) to the 3’  arm 
(Meshesha et al., 2012). Although such switches in major forms between lytic and 
latent infections may occur as part of overall changes in viral transcription programs 
between the two stages - possibly highlighting different roles for the same pre-
miRNA in each stage - it is difficult to imagine why such shifts would occur within 
the same stages of viral life cycles. However this may be down to experimental 
conditions, it stands to reason that if cellular pre-miRNAs regularly switch major 
forms in different tissue types, the same may also occur when different studies use 
different cell types, which often happens.  
 
Four out of the six genuine CyHV-3 pre-miRNAs identified using this approach were 
also found to have additional transcripts derived from stems of the same pre-
miRNAs adjacent to the proposed miRNAs. This suggested the presence of viral 
moRNAs. These are a recently discovered class of small RNAs originally described 
by Shi et al (2009). Since then evidence has emerged to suggest their presence in 
other organisms (Langenberger et al., 2009) and interestingly in several other HVs 
such as HSV-1, HSV-2 (Jurak et al., 2010), KSHV (Lin et al., 2010), HCMV 
(Meshesha et al., 2012), RRV (Umbach et al., 2010), PRV (Wu et al., 2012) and 
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AHV-1 (Yao et al., 2012). In fact some small RNAs originally identified as viral 
miRNAs have been re-classified as pre-miRNAs due to their positions in stems. 
Examples of these  former PRV (Wu et al., 2012) and RRV (Umbach et al., 2010) 
miRNAs. Based on its position on the BoHV-1 pre-miRNA bhv1-mir-B2 (Glazov et 
al., 2010), the currently annotated “ 5’  miRNA”  the may be more correctly described 
as a moRNA, however, this has not been acknowledged in any literature to date. In 
most cases the 3’  ends of the 5’  moRNAs and the 5’  ends of the 3’  moRNAs occur 
immediately adjacent to the mRNAs on the same arms of the pre-miRNA (Figure 
4.10) suggesting that both classes of small RNA arise from a common pre-miRNA 
cleavage event (Berezikov et al., 2011; Bortoluzzi et al., 2012; Shi et al., 2009). It is 
not clear whether the latter is carried out by Drosha or Dicer. Some studies have 
suggested that either enzyme can process moRNAs from pre-miRNA and that this 
may depend on the cell type as exemplified by a model suggested for the biogenesis 
of PRV moRNAs (Wu et al., 2012). Some moRNAs have been shown to span 
annotated Drosha cleavage sites and overlap with miRNAs by up to 8 nt suggesting 
that some moRNAs may arise from non-canonical Drosha cleavage followed by 
mutually exclusive miRNA or moRNA processing from the same pre-miRNAs 
(Bortoluzzi et al., 2012). The 3’  arm moRNA from MD1111 overlaps the adjacent 
miRNA by 1 nt and may be processed in this fashion. 
 
Even though the samples sequenced were significantly enriched for CyHV-3 
miRNAs, 58% and 15 % CyHV-3 transcripts from non-coding regions in the H361 
and N076 infections respectively did not represent miRNAs or isomiRs. In particular 
there were significant numbers of highly enriched CyHV-3 small RNAs that mapped 
to predicted pre-miRNAs in 3’  UTRs. Although viral miRNAs have been found to 
occur in the 3’  UTRs of other viruses such as KSHV (Cai et al., 2005) and MCHV 
(Buck et al., 2007), none of these CyHV-3 transcripts from 3’  UTRs were found to 
be miRNAs. This demonstrates that although the identification of highly abundant 
small RNAs mapping to predicted pre-miRNAs in non-coding regions is a good 
starting point for identifying novel miRNA genes in deep sequencing data, it is 
important to examine other features of pre-miRNA candidates in more detail in order 
to find further evidence to support their annotation as pre-miRNAs.  
 
  281 
The structural characteristics of pre-miRNAs are quite important. It is these 
characteristics that distinguish them from random hairpins and allows them to act as 
substrates for Drosha and Dicer (Han et al., 2006; Tsutsumi et al., 2011). In order to 
classify the VMir predicted CyHV-3 pre-miRNA structure as either pre-miRNA-like 
or not they were all analyzed by MiPred and the CSHMM-Method. In almost all 
cases there were several variations of each pre-miRNA, all differing in stem length 
and absolute WC value. The longest variant was referred to as the MHP and any 
shorter variants were referred to as SHPs. Different variants of the same pre-miRNA 
can be classified differently by pre-miRNA classifiers such as MiPred. This was 
evident after further assessment of VMir predictions in Section 3.4 (Supplementary 
File 3.1 T.10). It was important therefore that the most relevant variant was analysed. 
Naturally, the selection process focused on variants that were most likely to form 
stable hairpin structures. Generally shorter variants had higher absolute WCs, 
meaning that they had more of a tendency to form in many more analysis windows 
than longer variants, indicating that they were more stable within the local sequence 
context. This does not relate to structural stability (MFE) which was generally much 
lower (indicating greater stability) for longer pre-miRNA variants. However, high 
structural stability displayed by longer variants was not as relevant if there was less 
of a chance of them forming in the local sequence context (i.e. as they had a 
tendency to have lower absolute WCs). It was important that the local sequence 
context was taken into account, even though there is currently no information on the 
pri-miRNA sequences for any CyHV-3 pre-miRNAs, such flanking sequences will 
almost certainly be present alongside the pre-miRNA on the pri-miRNA transcript. 
Therefore it was best to analyse the variant that was more likely to form within this 
local sequence context. Hence, for each pre-miRNA candidate, it was the most stable 
variant (in terms of absolute WC) containing the full-length miRNAs that was 
analyzed. Although longer pre-miRNAs are more thermodynamically stable, for all 
high-probability CyHV-3 pre-miRNA candidates these shorter variants were still 
found to have low MFE values (<-25 kcal/mol) that were also found to be 
statistically significant (p <0.05) by MiPred (Table 4.6 and Supplementary File 4.1 
T.5). In addition the same CyHV-3 pre-miRNAs were found to have local contiguous 
structure-sequence composition that was consistent with that of bone-fide pre-
miRNAs by both MiPred and the CSHMM-Method, (these methods are outlined in 
Section 1.7.1.2). 
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In cases where pre-miRNAs were also predicted to give rise to moRNAs, the most 
stable variant (in terms of absolute-WC) also containing full length moRNAs was 
analysed. This was on the basis that if these are genuine moRNAs, these longer 
predicted pre-miRNA candidate variants (containing these additional moRNA 
sequences) should inevitably exist at some stage of the miRNA biogenesis process. 
Indeed two different variants of the same pre-miRNA (normal and longer versions 
containing unprocessed moRNAs) have been detected by northern blotting (Wu et 
al., 2012). If this is the case, these longer variants would also be expected to be 
classified as “ real pre-miRNAs”  by pre-miRNA classifiers on the basis that they 
should be recognised by components involved in the miRNA biogenesis process. 
(Bortoluzzi et al., 2012). It is possible that such longer variants act as substrates for 
either Drosha or Dicer some stage at least for initiation of miRNA biogenesis if not 
for the purposes of moRNA processing. For this reason it was deemed that the 
analysis of longer variants was relevant, where applicable. Moreover this may even 
be a more accurate representation of the pre-miRNA structure, or represent a 
temporary intermediate form. Interestingly, additional analysis of longer variants of 
high probability CyHV-3 pre-miRNAs also gave the same results as shorter variants 
(i.e. all were classified as real pre-miRNAs by both methods with low and 
statistically significant MFE). By contrast, 73% of other pre-miRNA candidates later 
deemed not to be genuine pre-miRNAs were not classified as pre-miRNAs by both 
methods.  
 
Processing of pre-miRNAs by Drosha and Dicer typically results in a mature miRNA 
duplex with a 2 nt 3’  overhang. This is characteristic of the activities of all RNase III 
enzymes (Ji, 2008). In order to see if the putative miRNAs from pre-miRNA 
candidates conformed to this characteristic, all the predicted miRNA duplexes were 
assessed by simply highlighting their positions on the predicted pre-miRNA 
structure. However because of the fact that the most dominant isomiR on each arm is 
designated as the mature miRNA, this creates a small problem when assessing 
miRNA duplex structures. 
 
All miRNAs and isomiRs are initially part of a miRNA duplex with 2 nt 3’  end 
overhangs. However, if a particular small RNA is identified as the dominant isomiR 
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(i.e. miRNA) on one arm of a given pre-miRNA, this does not necessarily mean that 
its original partner strand will be detected as the dominant isomiR mapping to the 
opposite arm of the pre-miRNA (in the sequencing data). Instead the dominant 
isomiR on the opposite arm may originate from a subset of duplexes that were 
cleaved at slightly different positions (i.e. isomiRs of the miRNA). This could be 
down to several reasons, such as differences in efficiency of RISC incorporation (i.e. 
there may be a preference for some isomiRs over others) quantitative inaccuracies 
intrinsic to deep sequencing (i.e. a bias for some sequences over others). Thus, 
inspection of the predicted mature miRNA duplex structure by highlighting the 
positions of dominant isomiRs in the pre-miRNA structure (as used in this study) 
may not always show a mature miRNA duplex with 2 nt 3’  overhangs. This will only 
occur if the isomiRs designated as the mature miRNAs (i.e. dominant isomiRs) on 
both strands are actually generated by the exact same cutting events. Therefore, to 
allow for this, predicted miRNA duplexes were instead assessed for the presence of 
1-4 nt 3’  overhangs. This allowed for small deviations from the model of miRNA 
biogenesis while still allowing the identification of a strong bias towards the 
presence of overhangs on the 3’  ends. In order for a pre-miRNA to be considered a 
likely pre-miRNA in this study, bias towards the presence of 3’  overhangs had to be 
observed in both infections (one blunt end was allowed but no 5’  overhangs). All of 
the miRNA duplexes from the six CyHV-3 pre-miRNAs met these criteria; in 
contrast, only 20% of the other pre-miRNA candidates that were later determined not 
to be genuine also met these criteria.  
 
Based on miRNA duplexes, the ends of all six CyHV-3 pre-miRNA hairpins 
displayed 3’  overhangs on both ends with the exception of MR5075 which 
consistently displayed onle blunt end in both infections (Figure 4.10). Interestingly 
the 3’  end of the 5’  miRNA and 5’  end of the 3’  miRNA (i.e. the Dicer cleavage 
sites) are actually situated on the loop (both overlap the loop by 1 nt) as opposed to 
the stem of the pre-miRNA. This could represent a non-canonical cleavage site for 
Dicer resulting in non-canonical processing. In addition, there are other examples of 
annotated pre-miRNAs in miRBase with mature miRNA duplexes that are predicted 
to have blunt ends, for example in HSV-1 the pre-miRNA hsv1-mir-H5 (Jurak et al., 
2010), indicating that there are precedents for this phenomenon.   
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In addition to mature miRNAs, the fact that deep sequencing facilitated the 
comprehensive profiling of other less abundant small RNAs derived from these 
predicted pre-miRNAs (i.e. isomiRs and other pre-miRNA derivatives such as 
moRNAs) was also quite important and very useful in terms of novel pre-miRNA 
identification. This is because it is the characteristics of these additional transcripts 
that provide the additional information that can be used to either support or oppose 
the annotation of identified pre-miRNA candidates as being genuine or not.  
 
 
Unlike small RNAs that represent random degradation products from mRNA 
transcripts, small RNAs derived from miRNA or moRNA biogenesis are generated 
from specific cleavage events. This is reflected in their alignment signatures (Figure 
1.12 (a)). This “ miRNA-like”  alignment signature was noted elsewhere to act as an 
important way to support high confidence miRNA annotation (Kozomara and 
Griffiths-Jones, 2011).  In fact in the present study this was the most effective way of 
differentiating between CyHV-3 pre-miRNAs and pre-miRNA candidates that were 
later deemed not to be genuine. Inspection of signatures showed that all of the six 
genuine CyHV-3 pre-miRNAs showed this kind of signature, but only one (7%) of 
the other fifteen pre-miRNA candidates did. Although this is something that is quite 
important and useful, in most other studies concerned with novel viral miRNA 
identification, the alignment signatures of small RNAs to viral pre-miRNAs were 
either not commented on at all or not provided. Notable exceptions to this trend are 
studies published by Zhu et al (2010b) and Wu et al (2012). 
 
By its nature, the kind of pattern described by Kozomara and Griffiths-Jones (2011) 
is hard to define precisely. In addition, these kinds of alignment signatures will vary 
for different pre-miRNAs or even for the same pre-miRNA from different samples. 
In some situations, trying to describe a given alignment pattern as either “ like”  or 
“ unlike”  what is recommended in the reference above can be subjective, although 
this was not the case for all alignments in this study. Seven of the twenty-one pre-
miRNA candidates had alignment signatures that were distinctly miRNA-like. This 
included all of the six genuine pre-miRNA candidates. However the signatures for 
MD1111 and MR5075 deviated to a small degree from the “ ideal”  signatures 
(Supplementary File 4.2). The signature for MD1111 was quite elongated. Individual 
  285 
stacks representing miRNAs and moRNAs are not as well defined due to some 
overlap between transcripts in the miRNA and moRNA stacks (overlaps were 
confined to low abundance isomiRs/moRNA isomers). In the alignment signature for 
MR5075 the stacks representing the miRNAs and moRNAs are more clearly defined 
than those of MD1111 (as they are higher) however again there is a similar overlap 
between the 5’ moRNA and 5’  miRNA stacks. There is also overlap between some 
low abundance isomiRs in both miRNA stacks with these overlaps spanning the 
terminal loop sequence. In the signatures for both MD1111 and MR5075 there are 
also additional low level transcripts mapping to the pre-miRNA candidates on the 5’  
side of the 5’  moRNAs. It is possible that these just represent degradation fragments 
of the pre-miRNA or even the original primary transcript. However, overall 
alignment signatures for both MD1111 and MR5075 were still considered miRNA-
like due to the fact that instances of moRNAs overlapping miRNAs (by up to 8 nt) 
and additional transcripts adjacent to moRNAs have been observed elsewhere on 
bone-fide pre-miRNAs (Bortoluzzi et al., 2012; Zhang et al., 2010). 
 
Two out of the six CyHV-3 pre-miRNAs (MD1111 and MD11776) also showed 
additional low count reads mapping to the terminal loop. It is possible that this may 
simply represent pre-miRNA degraded fragments of the pre-miRNA loop and thus 
more likely to be present in the data as consequence of shear depth of coverage rather 
than being of any biological relevance. It may also be argued that detection of loop 
fragments helps infer the existence of a complete stem-loop structure (Friedländer et 
al., 2008). Pre-miRNA loop fragments have been identified at low level before from 
other viral pre-miRNAs, for example in KSHV (Umbach and Cullen, 2010). 
Strangely and quite counter intuitively, sometimes these loop fragments can actually 
be more abundant than the mature miRNAs derived from the same pre-miRNA, for 
example in PRV (Wu et al., 2012). Mature miRNAs accumulate to higher levels than 
pre-miRNA fragments due to incorporation into RISC (protecting them from 
immediate degradation). The high level of loop fragments in the case of PRV 
suggested that it may also be incorporated into the RISC. Indeed it has been 
demonstrated elsewhere that such events do occur, and that some pre-miRNAs can 
give rise to three distinct types of functional miRNAs: major form, minor form and 
the newly described “ loop-miR”  (Winter et al., 2013).  
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In recent years it has become apparent that isomiRs tend to display more much more 
3’  end heterogeneity compared to 5’  end heterogeneity (Ruby et al., 2007). More 
than likely, most isomiRs retain the same functions as the miRNA as the seed regions 
remain unaltered and indeed this may be the very reason why there is a strong bias 
towards 3’  end heterogeneity. Viral isomiRs also tend show this characteristic and 
this has been noted in several studies (Chen et al., 2010; Meshesha et al., 2012; Riley 
et al., 2010; Umbach and Cullen, 2010; Wu et al., 2012; Yao et al., 2012; Zhu et al., 
2010b). Although noted, it has generally not been presented in any great detail in any 
publications. Instead these observations are commonly described in terms of 
collective end heterogeneity for all isomiRs recovered during sequencing (Meshesha 
et al., 2012; Umbach and Cullen, 2010), shown for one pre-miRNA (Wu et al., 2012) 
or shown for all without any corresponding values (Amen and Griffiths, 2011; Riley 
et al., 2010; Zhu et al., 2010b). In the present study it was reasoned that it would be 
useful to quantitatively gauge the amount of 5’  and 3’  end heterogeneity displayed by 
isomiRs of each individual miRNA, to establish if there was bias towards 3’  end 
heterogeneity among individual sets of isomiRs for each miRNA. This was done on 
the basis that it could be used as evidence to support the annotation of novel CyHV-3 
miRNAs. IsomiRs representing <0.1% of the combined miRNA and isomiR read 
count (for the miRNA in question) were less likely to be biologically relevant and 
were eliminated from this analysis. In order to avoid the risk of including partially 
degraded isomiRs which could possibly skew the results, transcripts <19nt in length 
were also eliminated from analysis as per Riley et al (2010). Only isomiRs from the 
seven pre-miRNAs showing miRNA-like alignment signatures were analyzed.  
 
Ratio-1 was used in order to compare the number of unique isomiRs in each set that 
displayed 5’  end heterogeneity to the numbers that displayed 3’  heterogeneity. Ratio-
2 was used in order to compare the degree of heterogeneity in 5’  ends to that of the 
3’ ends (in terms of average offsets on each end) for each set of isomiRs. Overall it 
was found that most isomiR sets were composed of isomiRs that were offset at the 
3’ end and in almost all cases the degree 3’  heterogeneity was much more pronounced 
within each isomiR set. This suggested that there was a clear bias towards 3’  end 
heterogeneity within each set of isomiRs. However, even if isomiRs displayed a 
higher degree of 3’  end heterogeneity, it is possible that unique isomiRs displaying 
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5’  end heterogeneity (albeit a lower degree of heterogeneity) could be more 
numerous in read count, meaning that overall more 5’  end processing events deviated 
from the miRNA 5’  end position. In order to investigate this, a third ratio was also 
used in which the read counts of each unique isomiR were taken into consideration. 
(Ratio-3). This showed that 5’  processing was much more consistent within most sets 
of isomiRs. Although some did not show much difference between the two ends in 
this respect. One reason for this may be that in these cases most isomiRs display both 
5’  and 3’  end heterogeneity. Therefore many of the same isomiRs contribute to the 
total read counts for both 5’  and 3’  end heterogeneity. Overall, the use of these ratios 
indicated that the most individual sets of isomiRs were biased towards displaying 
more 3’  end heterogeneity. This is very consistent with the characteristics of isomiRs 
of bone-fide miRNAs which also generally display a greater amount of 3’  end 
heterogeneity. 
 
Unlike the other CyHV-3 pre-miRNAs, the isomiRs from MD1111 were biased 
towards displaying more 5’  end heterogeneity. Although it is more unusual, isomiRs 
of some miRNAs can show more 5’  end heterogeneity, examples of this include 
mmu-mir-341 in mice and hsa-mir-126 in humans (Lee et al., 2010). In addition the 
amount of MD1111 isomiRs that were offset at the 5’  ends generally only 
represented a small percentage of total reads in each infection (median of 2.3 % for 
each miRNA from each infection), indicating that the majority of 5’  end processing 
was consistent, although not as consistent as 3’  end processing.  For other CyHV-3 
miRNAs ~40% total reads showed 5’  heterogeneity (e.g. MD11776 and MR5075), 
however other known miRNAs have been shown to display similarly high 
proportions of 5’  heterogeneity such as the KSHV miRNA miR-K10-3p (Umbach 
and Cullen, 2010). The same study also observed more 3’  heterogeneity in miRNAs 
from the 5’  arms of pre-miRNAs. In such cases the 3’  ends are defined by Dicer 
processing. Interestingly, the results seen for CyHV-3 miRNAs in this study correlate 
with this. Values for Ratio-3 for 5’  miRNAs are on average 2 times higher than the 
same values for 3’  arm miRNAs (for which 3’  ends are processed by Drosha). It is 
important to note that there is an unusually large Ratio-3 value for the 5’  arm miRNA 
from MD9812 in the H361 infection, which could distort these results, however if 
this is eliminated then the average Ratio-3 values for 5’  arms are still marginally 
higher. Overall only one pre-miRNA candidate showed 5’  end heterogeneity in 
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>50% of reads processed from one of its miRNA loci. This was MR6201 which 
turned out to be the only pre-miRNA candidate analyzed that was later deemed not to 
be a genuine pre-miRNA.  
.  
The results from each stage of in depth analysis of the CyHV-3 pre-miRNA 
candidates were compiled and the observed characteristics for each CyHV-3 pre-
miRNA candidate assessed in terms of how they conformed to the characteristics of 
bone-fide pre-miRNAs using the pre-miRNA identification criteria. This systematic 
approach to the identification of miRNA-like characteristics among pre-miRNA 
candidates showed a clear distinction between different candidates. It provided 
significant evidence to support the annotation of six high probability CyHV-3 pre-
miRNAs as bone-fide pre-miRNAs. It also provided a solid experimental basis for 
describing some pre-miRNA candidates as low-probability pre-miRNAs.  
 
Out of the six pre-miRNAs identified here four of them occur as part of two clusters. 
Furthermore the seventh pre-miRNA identified later in this study also occurs in one 
of these three clusters. This means that most of these pre-miRNAs share the same 
pri-miRNAs, although they may be processed at different rates accounting for 
differences in miRNA read counts. This is similar to the distribution patterns of pre-
miRNAs in other viruses. In most viruses these genes are heavily clustered e.g. in 
EBV, KSHV although in some viruses these may be non-clustered e.g. HCMV. 
 
8.2.2.1 Automated identification of miRNAs from deep sequencing data 
The non-automated approach taken to identify CyHV-3 miRNAs focused on pre-
miRNA candidates from non-coding regions with highly abundant putative miRNAs 
(read count >10). However these sequences only represented a small subset of unique 
reads present in the sequencing data from both infections. In order to explore the 
possibility that within the data, there were other CyHV-3 pre-miRNAs that produced 
miRNAs of lower abundance the entire data set was reanalysed using algorithms 
specifically developed to indentify miRNA signals within sequencing data. This also 
allowed the identification of pre-miRNA candidates within protein-coding genes. 
Although such candidates from protein-coding genes were ultimately not considered, 
  289 
this presented an ideal way to verify that they showed a general lack of consistency 
and poor compliance with the characteristics of bone-fide pre-miRNAs thus 
supporting the elimination form analysis in the non-automated approach. 
 
This strategy involved using two different methods to identify pre-miRNAs, namely 
miRDeep and Mireap (Section 4.1.4). Although quite useful, these kinds of methods 
are likely to give a lot of false positives. In addition, different results can be obtained 
from the same data depending on which method is used in analysis. Nonetheless, this 
observation may be used to improve predictions. The results from the comparison 
study carried out by Li et al. (2012) suggested that it was best to combine results 
from different methods to increase accuracy in novel miRNA prediction. They tested 
the performance of multiple methods in a task that involved prediction of known 
miRNAs from the same deep sequencing datasets. While none of the methods were 
able to identify all known miRNAs within each dataset, the vast majority of known 
miRNAs identified by all methods used. Only a very small minority of known 
miRNAs were not found by multiple methods. This indicated that in most cases, 
independent identification of pre-miRNAs by multiple methods acts to support 
predictions. Based on this, it was reasoned here that the best approach to automated 
identification of novel CyHV-3 pre-miRNAs was to carry out this analysis using 
more than one method.  
  
As expected, analysis of the deep sequencing data using both methods mainly 
resulted in false positives. Only six pre-miRNA candidates (a fraction of the total 
number) were independently identified by both automated methods, thus these six 
were deemed the most likely to be genuine. Strikingly, five out of these six 
candidates were also included in the six high probability CyHV-3 pre-miRNAs 
identified earlier using the non-automated approach. This supported the theory that 
elimination of candidates not identified by both methods had the effect of retaining 
high quality pre-miRNA candidates only. This agreement between the automated and 
non-automated approaches indicated that the methods used to distinguish between 
low and high probability pre-miRNAs in both approaches was well-founded.  
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Despite the fact that the automated approaches identified similar amounts of (and in 
some cases more) pre-miRNA candidates in protein-coding regions compared to 
non-coding regions, only one candidate from a protein-coding region was identified 
by both automated methods and only one was found in both infections by the same 
method (Table 4.14). Ignoring the fact that these were from protein-coding regions, 
neither of these two pre-miRNA candidates were classified as “ Real Pre-miRNAs”  
by MiPred or the CSHMM-Method (data not shown). This lack of repeated 
identification by the same automated method (i.e. in both infections) or independent 
identification by different automated methods (in either infection) supports the 
theory that miRNA-signals identified in protein-coding regions are more likely to be 
caused by sporadic background noise rather than genuine miRNAs.  
 
Unlike the non-automated approach, not all of the high probability pre-miRNAs from 
the automated approach were identified in both infections. As all of the miRNAs 
from these pre-miRNAs were still abundant in both infections, the only reason for 
them to be identified in one infection and not in another would be a slight change in 
the alignment signatures. This may be due to the presence or absence of extra 
isomiRs from one infection to the next. Inspection of the alignment signatures for 
such candidates (i.e. those not identified in both infections by the automated 
methods) revealed that while they did change marginally from one infection to the 
next, a miRNA-like alignment signature was still present in both infections. It is 
likely that it is these subtle changes between infections that result in some pre-
miRNAs not being identified in both infections by the automated methods. Both 
miRDeep and Mireap identified more high probability pre-miRNA candidates in the 
H361 infection compared to the N076 infection, suggesting that overall there were 
better miRNA signals in the H361 infection.   
 
MR5075 was the only high probability pre-miRNA identified in the non-automated 
approach that was not identified by either automated method. To investigate if this 
could have been caused by aberrant isomiRs in the alignment signature, such reads 
were removed from the data followed by reanalysis by MiRDeep. However MR5075 
was not identified as a pre-miRNA by MiRDeep regardless of how many aberrant 
isomiRs were removed. During the analysis process miRDeep creates interim data 
for use by different algorithms at different stages of the analysis process. One such 
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interim dataset consists of a list of provisional pre-miRNA candidate sequences 
excised from the genome based on stacks of reads mapping to them. The sequence 
for MR5075 (or at least a variation of it) was found within the interim datasets for 
both infections, indicating that MR5075 was indeed initially identified as a pre-
miRNA candidate by miRDeep at one stage of the process, but later eliminated for 
some reason.  
 
MiRDeep also scored each pre-miRNA identified, allowing candidates to be ranked 
in terms of how likely they were to be genuine. The miRDeep2 scores associated 
with each pre-miRNA showed an interesting trend. All of the high probability pre-
miRNAs from the non-automated approach that were also identified by MiRDeep 
were also the top ranked candidates from non-coding regions in both infections. This 
refers to their ranking before the elimination of candidates not also identified by 
Mireap, demonstrating further agreement between the non-automated and automated 
approaches. 
 
MirDeep also estimated a signal-to-noise ratio based on the statistical significance of 
scores. As it bases the identification of pre-miRNAs on a combination of structural 
features and small alignment signatures, it works under the assumption that the two 
are explicitly related, i.e. that the unique structural features of pre-miRNAs act as 
substrates of Drosha and Dicer resulting a specific type of cleavage leading to a 
characteristic alignment signature. To test the significance of the relationship 
between the pre-miRNA structure and alignment signature within results, miRDeep 
simulates a null-hypothesis whereby there is no relationship between pre-miRNA 
structure and small RNA alignment signatures. This is done by taking proposed 
miRNAs and isomiR sequences from one precursor and aligning them to another 
precursor selected randomly from the data. Alignments to the new precursor are 
based entirely on position (not sequence) i.e. they are placed in the same positions on 
the new pre-miRNA (relative to the 5’  end). These are termed controls and are 
analysed by the miRDeep core algorithm in the same way as real alignment 
signatures and a new score is given. This is repeated 100 times and the average 
amount of randomly matched pre-miRNA/small RNAs that pass the score cut-off 
points after each of the 100 permutations is taken as the amount of pre-miRNA 
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candidates that are expected to avoid elimination by chance alone (Friedländer et al., 
2008). These control results were used by MiRDeep as a basis to estimate the signal-
to-noise ratio for a range of given score cut-off points (Supplementary File 4.1.4 T.1-
T.2).  
 
In the H361 infection the lowest scoring high probability CyHV-3 pre-miRNA (from 
the non-automated approach) also identified by miRDeep was MD11410 which had a 
score of 8.7. MiRDeep estimated that for pre-miRNAs with scores >8 (i.e. cut-off 
point), the signal-to-noise-ratio should be 3.7. Out of eight pre-miRNA candidates 
identified by miRDeep with scores >8, only five were considered likely represent 
real miRNA signals (on the basis that they were also identified by Mireap and 
classed as high probability candidates in the non-automated approach). The 
remaining three were candidates from protein-coding regions. Taking the latter to be 
noise, this meant that the real signal-to-noise-ratio among candidates with scores >8 
was 1.6 (i.e. 5/3). This suggested that the signal-to-noise ratio was over estimated by 
a factor of 2.3. Testing the signal-to-noise ratio for the N076 infection in the same 
manner revealed a similar degree of overestimation. This suggested that true miRNA 
signals above this cut-off point were statistically lower than expected and that maybe 
some of the eliminated pre-miRNAs (in this case all from protein-coding regions) 
that had significant scores, warranted further investigation. For this reason the 
alignment signatures for these candidates were inspected (Supplementary File 4.1.4 
T.1-T.2) and those showing miRNA-like signatures were further analysed by MiPred 
and the CSHMM-method. However, this analysis revealed that none of these 
candidates were miRNA-like. This observation, combined with the fact that none of 
these particular candidates from non-coding regions were identified in both 
infections or by both automated methods, was considered as conclusive evidence to 
classify these candidates as background noise despite their high scores.  
 
Most pre-miRNAs have low folding energies compared to non-RNA hairpin 
structures (Bonnet et al., 2004b), hence assessment of pre-miRNA candidates in this 
regard is quite important. In a similar way to MiPred (described in Section 1.7.1.2) 
miRDeep also assessed the statistical significance of the folding energies displayed 
by pre-miRNA candidates. While all of the five candidates that were also identified 
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by the non-automated approach were earlier found to have statistically significant 
folding energies by MiPred, conversely most of them were found not to have 
significant folding energies by MiRDeep (Supplementary File 4.1.4 T.1-T.2). This 
was a very significant discrepancy between the two methods that required further 
investigation. Closer examination of the two methods revealed that while both 
methods used the exact same algorithm, Randfold (Workman and Krogh, 1999), to 
assess the significance of folding energy, the approach used in each case was slightly 
different. Both methods randomly shuffle the pre-miRNA sequence 1000 times, to 
assess the distribution of folding energies. The difference however is that miRDeep 
uses simple mononucleotide shuffling (Friedländer et al., 2008), whereas MiPred 
uses dinucleotide shuffling (Jiang et al., 2007) for this analysis. Workman and Krogh 
(1999) found that dinucleotide shuffling is more relevant in this context as the 
stability of the RNA secondary structures depends dinucleotide stacking energies. 
Thus it was concluded that MiPred provided more valid conclusions regarding the 
statistical significance of pre-miRNA stability and hence the equivalent results from 
MiRDeep were ignored.     
 
8.2.3 Summary of the identification of pre-miRNA candidates from deep 
sequencing data 
The results from automated and non-automated approaches to the analysis of 
sequencing data were largely in agreement with each other regarding the most likely 
CyHV-3 pre-miRNAs. This indicated that the elimination of candidates through (i) in 
depth analysis of pre-miRNA candidates in the non-automated approach and (ii) 
elimination of pre-miRNAs not identified by both methods used taking the 
automated approach, were the best ways to filter results from each respective 
approach used. Overall combining the two approaches resulted in the identification 
of seven high probability CyHV-3 pre-miRNAs.  
 
In both cases pre-miRNA candidates occurring in protein-coding regions were not 
considered. Generally miRNAs do not occur within such regions, thus ignoring 
unique reads that mapped to protein-coding regions ensured that the identification of 
to pre-miRNAs using the non-automated approach was confined to genomic regions 
most likely to encode miRNAs. Also, because the majority of unique reads mapped 
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to protein-coding regions in both infections, it was rather impractical to identify all 
possible pre-miRNA candidates in these regions using non-automated approaches, 
even if most unique reads could be ignored for having read counts <10. However this 
could be more easily done using the automated methods, although, as expected this 
revealed no high probability candidates from protein-coding-regions, indicating that 
it was correct to ignore them in non-automated analysis. This does not rule out the 
possibility that CyHV-3 does encode pre-miRNAs within coding regions, and it is 
known that other viruses such as HCMV (Buck et al., 2007) and KSHV (Cai et al., 
2005) encode pre-miRNAs within coding regions. In such cases the same molecule 
can act as both an mRNA and a pri-miRNA resulting in two different possible fates 
for the same molecule. In some cases the miRNA may be inefficiently processed 
from the mRNA allowing most of the mRNA to be transported to the cytoplasm 
before Drosha cleavage (Cai et al., 2005). However identifying miRNA signals from 
protein-coding regions in deep sequencing data from is much more difficult and 
especially so if the mRNA in question is highly expressed. Numerous random 
mRNA degradation products interfere with the interpretation of important signals in 
data beyond the miRNAs themselves, such as the alignment signature. This may be 
especially relevant during lytic infections, when viral transcription and RNA 
turnover levels increase. As exemplified by this study, for the same reasons it is 
difficult to assess the alignment signatures of pre-miRNA candidates occurring in 3’  
UTRs. Despite this, it is still unlikely that many other candidates were genuine pre-
miRNAs due to a general lack of conformance with other characteristics of pre-
miRNAs. Notably out of 15 of these candidates occurring in 3’  UTRs, many of them 
did have MFE values <-25 kcal/mol and for those that did, none (with the exception 
of MR6201) were considered statistically significant by MiPred. 
 
It is likely that increased levels of RNA turnover during the lytic infection 
significantly contributed to the amount of non-miRNA background noise in the 
sequencing data. Other studies have not commented in any detail on the measures 
taken to identify viral miRNAs from background noise in such samples, and if 
CyHV-3 miRNAs were identified based on the same criteria used in other studies it 
would have resulted in many more pre-miRNA candidates, with many of them not 
actually being genuine miRNAs. Some studies have even proposed the existence of 
pre-miRNAs in the absence of minor forms and isomiRs or even if the major forms 
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have extremely low read counts, are not detected in multiple sequencing experiments 
and subsequently not detected by PCR (Glazov et al., 2010). However it is possible 
that there may be low levels of background noise observed in these studies, and that 
the majority of the few viral transcripts detected might map to a handful of predicted 
pre-miRNAs. This may especially be the case where viral miRNAs are identified in 
latently infected cell lines where most genes expressed during lytic infections are 
inactivated with the exception of miRNAs. This may also explain why many other 
studies on viral miRNA identification to not involve deep sequencing from multiple 
infections, however it is something that is not explicitly clear from the literature. By 
contrast, the stringent criteria used for identifying pre-miRNAs in this study made for 
a considerably more conservative approach towards pre-miRNA identification, but it 
was nonetheless necessary to ensure that only genuine pre-miRNAs were identified. 
 
Although the results from the automated and non-automated approaches were quite 
similar, both methods had their advantages and disadvantages. The automated 
approach allowed the identification of one additional CyHV-3 pre-miRNA, namely 
MD11704. This pre-miRNA was not considered in the non-automated approach due 
to the fact that its miRNA read counts were too low. However the non-automated 
approach did allow the identification of MR5075, which was not identified using the 
automated approach. The in-depth analysis carried out on the miRNA candidates in 
the non-automated approach allowed the elimination of MR6201 despite the fact that 
is was detected by both automated methods, demonstrating that overall the non-
automated approach was more effective at distinguishing between low and high 
probability pre-miRNA candidates. Overall the results from both approaches 
complemented each other quite well. The use of both in unison was ultimately better 
than the use of one approach alone, resulting in the identification of seven high 
probability CyHV-3 pre-miRNAs rather than six (i.e. had either method been used 
alone). Although more labour intensive, the non-automated approach had much more 
accuracy and was probably best for this reason. Importantly this approach facilitated 
the identification of moRNAs, something that was not possible with the automated 
approach.  
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The discovery of CyHV-3 encoded moRNAs was not anticipated but it is a very 
interesting aside. Although their biogenesis is intricately connected with that of 
miRNAs and sometimes they can be even more abundant than them, it was only 
recently with the advent of deep sequencing, that the presence of moRNAs was fully 
appreciated. However they are still far from understood. Somewhat surprisingly, 
their abundance is not linked to whether they occur adjacent to the major form or 
minor form miRNA on the pre-miRNA. In fact moRNAs processed from the from 5’  
arm of the pre-miRNAs are generally more dominant in samples (Taft et al., 2010; 
Umbach et al., 2010). This suggests that while their biogenesis may indeed by linked 
to miRNAs, the rates of processing are not necessarily interdependent and may be 
independently regulated. The CyHV-3 miRNAs identified in this study showed no 
clear dominance of moRNAs from one arm over the other (two with 5’  and two with 
dominant 3’  arm moRNAs)   
 
The levels of moRNAs present in samples do not generally correlate with the levels 
of mature miRNAs processed from the same pre-miRNAs (Berezikov et al., 2011). 
In some cases moRNAs have been shown to be present at much lower levels than 
miRNAs from the same pre-miRNAs, as with KSHV (Umbach and Cullen, 2010), 
RRV (Umbach et al., 2010) and in other organisms (Berezikov et al., 2011; 
Langenberger et al., 2009). In other cases some have been found to be more 
prevalent than miRNAs from the same pre-miRNA, as demonstrated in HSV-2 
(Jurak et al., 2010). This dominance of either moRNAs or miRNAs from the same 
pre-miRNA can also fluctuate depending on the circumstances, for example, such 
fluctuations were observed at different developmental stages (Shi et al., 2009). It is 
possible that the dominant classes of small RNAs from viral pre-miRNAs could 
fluctuate in the same manner under different experimental conditions. Experimental 
conditions that result in the absence of detectable miRNAs and the dominance of 
moRNAs may explain why some viral moRNAs were originally classified as 
miRNAs. In the case of the CyHV-3 moRNAs that were discovered in this study, all 
of them were significantly less abundant than miRNAs from the same pre-miRNAs 
although some were more abundant than their adjacent miRNAs for example the 5’  
moRNA from MR5075 and the 3’  moRNA from MD1111 (but only in one 
infection).     
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The functions of moRNAs are still unknown. Unlike miRNAs it appears that they 
localise in the nucleus rather than in the cytoplasm (Taft et al., 2010). Despite this, 
one study did demonstrate that moRNAs may be incorporated into the RISC 
(Umbach et al 2010). In that study, the expression of the RRV moRNA moR-rR1-3-
5p correlated with a 3-fold down regulation of a reporter gene containing a fully 
complementary artificial target site. Its effect on the reporter gene was moderate 
compared to the miRNA processed from the same pre-miRNA in the same cells. 
However, it did demonstrate that moRNAs may be incorporated into the RISC but 
possibly at a lower level. While these findings are interesting, observations made 
elsewhere indicating that moRNAs accumulate in the nucleus (Taft et al., 2010) 
suggest that they may not always be incorporated into the RISC. Ultimately, the role 
of this new class of small RNAs is currently unclear and requires more investigation.   
 
Much of the in depth assessment of the miRNA signals in the non-automated 
approach was based on quantitative information. It was an important part of the 
assessment of small RNAs (putative miRNAs and isomiRs) to determine if they 
collectively displayed fundamental miRNA-like attributes. For example, quantitative 
information was central to the identification of the major and minor forms derived 
from each pre-miRNA, and the dominant isomiRs in each infection. This of course 
had knock-on effects on the nature of the predicted mature miRNA duplexes and 
assessment of 5’  end processing consistency (using Ratio-3). More importantly, it 
was the quantitative data that was primarily used to identify CyHV-3 miRNAs as 
transcripts that were distinct from background noise i.e. they were required to have 
had a read counts 10. It is clear reliable quantitative information is vital in order to 
carry out valid analyses of this nature. 
 
It is important to acknowledge that although deep sequencing is a useful tool it does 
suffer from enzymatic bias, which may cause some sequences to be over-represented 
or under-represented in the data. This occurs as sample preparation involves a series 
of enzymatic steps (i.e. 3’  adapter ligation, 5’  adapter ligation, RT and PCR) and 
biases introduced at each step can have a cumulative effect. It has been shown that 
the ligation steps in particular can be the source of considerable bias which varies 
depending on the combination of enzymes and adapter sequences used (Hafner et al., 
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2011; Sorefan et al., 2012). Sample preparation can even suffer from gel extraction 
bias (Quail et al., 2008). In addition it has been shown that results will vary 
significantly due to protocols used in library preparation (Linsen et al., 2009; 
Toedling et al., 2012). In fact, as a result of widespread use of the Illumina sample 
preparation protocol, the majority of sequences present in miRBase are strongly 
biased towards sequences that are preferred by the Illumina adapters (Sorefan et al., 
2012).  
 
There is ample evidence of this happening following deep sequencing of miRNAs 
and this most often becomes apparent when miRNA expression is also analysed 
using non-enzymatic methods or methods that offer more quantitative precision. For 
example transcripts with low read counts can sometimes be easily detected by 
northern blotting while others with much higher read counts show faint signals 
(Reese et al., 2010) and the same observations have also been made when using PCR 
to verify miRNA expression levels (Meshesha et al., 2012).  
 
The potential for sequencing bias is something that needs to be considered in studies 
such as the one described here. As highlighted earlier quantitative information is 
central to miRNA identification from deep sequencing data, in fact automated 
methods for miRNA identification such as miRDeep attach a lot of weight to 
significantly high read counts when making scoring predictions (Friedländer et al., 
2008). Under controlled experimental conditions it has been shown that bias alone 
will cause many transcripts to display dramatically higher than expected read counts. 
For example Sorefan et al (2012) found that >50,000 different transcripts that were 
expected to appear only once in a specific dataset actually appeared more than 10 
times. In theory it is possible some small RNAs detected in this study (especially at 
levels close to the cut-off of 10) could have been over-represented. Therefore it was 
important to take the quantitative information obtained from deep sequencing as a 
rough guide only until the levels of these small RNAs were verified using 
appropriate additional methods. For these reasons, the most likely CyHV-3 miRNAs 
identified here were investigated further in order to verify their presence in infected 
cells and to estimated their relative expression levels.  
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8.3 DNA Microarray Analysis 
 
MiRNAs should be the most abundant transcripts in the 17-25 nt RNA sample used 
for deep sequencing and thus these pre-miRNA candidates identified in the non-
automated approach were primarily identified on the basis of highly abundant small 
RNAs mapping to them. As these specific sequences could potentially be over-
represented in the data due to enzymatic bias and because other sequences could be 
under-represented for the same reasons, analysing the same sample using array 
hybridization provided an ideal way to investigate this possibility. Probes were 
designed to detect putative miRNAs from all high and low probability pre-miRNA 
candidates. In theory it was possible that miRNAs from other VMir predicted pre-
miRNAs were not present or ignored due to under representation of small RNAs 
mapping to them. For this reason, additional probes designed to detect theoretical 
miRNAs from the highest scoring pre-miRNAs predicted by VMir were included on 
the array. 
 
If the read counts observed in deep sequencing were not the result of over 
representation, regardless of whether these small RNAs are from high or low 
probability pre-miRNA candidates, probes targeting those identified as the most 
abundant transcripts should nonetheless show the highest signals in array 
hybridization using the same sample. This was found to be the case for most of the 
15 low probability and 2 high probability pre-miRNAs in the data, indicating that 
these were actually among the most abundant transcripts in the sample, as previously 
indicated by the deep sequencing data.  
 
In addition, the majority (12/15) of low probability pre-miRNAs identified following 
non-automated analysis gave signals using the S2 as hybridization probe (26-35 nt 
RNA from the H361 infection). This supported the conclusions from seep 
sequencing that these were likely to be degradation products from larger non-miRNA 
transcripts. More specifically, these were all likely to be degraded fragments from 3’  
UTRs to which they mapped. Therefore as expected, other fragments of the same 3’  
UTRs containing the same target sequences were detectable in other RNA size 
ranges with the same probes. 
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In agreement with the deep sequencing data, the highest signals seen among the high 
probability candidates were from MR5057 and MD11776. In both cases the signals 
from the major and minor strands were also in agreement with the deep sequencing 
data. The read counts for the 3’  miRNA from MD1111 were at similar levels to the 
3’  miRNA from MD11776 (in fact higher), which was not detected on the array. This 
suggests that (i) this was over-represented in the deep sequencing data and (ii) it was 
the 5’  arm that was the major form expressed in the H361 infection. The results for 
MR5075 also suggested that contrary to the deep sequencing data, it was the 5’  arm 
miRNA that was the major form of this pre-miRNA.  
 
The two remaining, high probability candidates identified by the non-automated 
approach had much lower read counts in the sequencing data, suggesting their levels 
were beyond the limits of detection in array hybridization.  
 
A cut-off point had to be established in order to distinguish significant from non-
significant results. RVs above background were not immediately taken as positive 
either. A lower limit cut-off for RVs was first established for each hybridization. 
Therefore for a signal to be considered positive in a given hybridization its RV must 
also have been above the cut-off value for that hybridization. The cut-off values used 
in this study were based on the level of variability in the signals for the control 
probes used to estimate background, which was established by calculating their 
average absolute deviation from this background level. The cut-off values were then 
defined as one average absolute deviation above these background levels. Hence, 
pre-miRNAs with RVs that were greater than these cut-off values (even after 
correction) were considered positive.  
 
Using cut-off values based on the intrinsic variability within the dataset is similar to 
the approach used by Grundhoff et al (2006), except in that case the cut-off values 
were 1.5-1.75 standard deviations above the background. In this study to detect 
CyHV-3 miRNAs, the cut-offs were based on the average absolute deviation instead 
of the standard deviation. This was because this is a more robust statistic that is less 
sensitive to being distorted by major outliners. This is because when calculating the 
standard deviation, the differences are squared, so outliners are weighted more 
heavily. This is not a problem when using the absolute deviation and therefore it is 
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better suited to the analysis of data such as this where outliners (mainly caused by 
artefacts on the array surface) are likely to be encountered, thus avoiding over-
estimation of the true level of variability. The cut-off values were defined as one 
average absolute deviation above background so as to avoid imposing higher 
arbitrary cut-off values. (i.e. 1.5 absolute deviations above background or higher). At 
the very least, RVs that were greater than one absolute standard deviation above this 
cut-off value (even after correction) were seen to give signals that were higher than 
the intrinsic level of variation present in the data and therefore significantly different 
from background levels. However, further investigation of the discrepancies between 
the array and deep sequencing suggested that this cut-off may have been too low.  
 
As highlighted earlier it was only the highest level miRNAs from deep-sequencing 
that were (i) also detected at the highest level on the array and (ii) in agreement with 
the deep sequencing data regarding major and minor forms. The low level signals 
from MD1111 and MR5075 that were not in agreement with the deep sequencing 
results were investigated further by re-analyzing the same sample by RT-qPCR, 
targeting both miRNAs (5’  and 3’  arm miRNAs) from these two pre-miRNAs. The 
results from RT-qPCR were in agreement with the sequencing data showing that the 
miRNAs from the 3’  arms of MD1111 and MR5075 were the major forms derived 
from these pre-miRNAs in this infection. Thus, the observation of low-level signals 
from the 5’  arms of both of these pre-miRNAs in the absence of positive signals from 
the 3’  arms was not a true reflection of the levels of target present. However, 
somewhat in agreement with array hybridization the RT-qPCR results also indicated 
that the miRNA from the 3’  arm of MD1111 was over-represented in the sequencing 
data to begin with and was actually present at a much lower level than MD11776, 
confirming why there was no signal from the probe targeting this miRNA. These RT-
qPCR results are discussed in more detail later.    
  
Although the signals from the probes targeting the 5’  arm miRNAs from MD1111 
and MR5075 were both above the cut-off point, the fact that they were both also 
relatively low suggests that these signals may just have been due to background 
noise. The establishment of a cut-off value was supposed to eliminate such 
background noise, however in hindsight this may have been set too low. This may 
also explain why there were also so many apparent signals for novel provisional 
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miRNA candidates for which there was no corresponding evidence in the deep 
sequencing data.  
 
In conclusion, DNA microarray hybridization using miRNA-containing and non-
miRNA-containing size fractions proved to be a very useful high throughput method 
of distinguishing between miRNA and non-miRNA small RNAs. However the 
experimental conditions used here only resulted in the detection of highly expressed 
miRNAs such as those from MR5057, MD11776 and all highly expressed host 
miRNAs. The methodology used was simply not sensitive enough for low-level 
miRNA detection.  The use of molecular crowding agents such as dextran sulphate in 
hybridization buffers dramatically increases the sensitivity of array hybridizations 
(Ku et al., 2004). Indeed, the inclusion of dextran sulphate in the hybridization buffer 
(final conc. 6.5% w/v) in this experiment did allow the detection both major and 
minor forms derived from two CyHV-3 miRNAs, which is in stark contrast to similar 
earlier hybridizations carried out in the absence of dextran sulphate (data not shown). 
It is possible that increasing the levels of dextran sulphate and/or input RNA probe 
might improve the sensitivity in such an experiment. It may also be useful to 
combine this approach with a higher more stringent cut-off point in order to 
adequately eliminate background noise. Overall it can be concluded that the highest 
level miRNAs identified in deep sequencing were not over-represented due to an 
experimental bias and that most high level non-miRNA small RNAs were indeed 
degraded RNA.  
 
8.4 Northern blotting 
The detection of discrete miRNA signals using northern blotting is probably the ideal 
way to prove the existence of proposed miRNAs. This is because it can be used to 
simultaneously detect and display all of the transcripts that contain the target 
sequence. However northern blotting is not as sensitive as deep sequencing or array 
hybridization. The mature miRNA from MR5057 was shown to be the most highly 
expressed and most readily detectable CyHV-3 miRNA in the deep sequencing and 
array hybridization experiments and unsurprisingly it was the only one that was 
detectable by northern blotting. The specific signals obtained for MR5057 are 
characteristic of miRNAs and corresponded perfectly with results from VMir, deep 
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sequencing (pre-miRNA and miRNA length) and array hybridization (RNA size 
range distribution). These observations are enough to confirm that MR5057 is a 
genuine CyHV-3 encoded pre-miRNA. 
 
The high read counts and array signals, suggest that this miRNA it is efficiently 
processed by Dicer. The pre-miRNA nonetheless does accumulate in sufficiently 
high levels to remain detectable by northern blotting. This may be due to (i) high 
levels of pri-miRNA expression, (ii) highly efficient Drosha processing of the pre-
miRNA or (iii) both. Alternatively, Dicer processing of this pre-miRNA may not be 
efficient at all and the high levels of processed mature miRNAs present may simply 
be a consequence of high cellular levels of the MR5057 pre-miRNA. Regardless of 
how efficient the MR5057 pre-miRNA processing is, the results suggested that its 
processing must be more efficient than that of the pre-miRNA for MR5075. Given 
their close proximity to each other on the genome (257 bp separating the two 5’  start 
positions), it is likely that they share the same pri-miRNA, yet a band for the 
MR5075 pre-miRNA could not be detected. The difference in the levels of miRNAs 
derived from these two pre-miRNAs (observed in all other experiments in this study) 
and the relative levels of their pre-miRNAs as observed by northern blotting, implies 
that they must be processed at very different rates however. It is not uncommon for 
this to occur, for example in EBV, despite the fact that that all miRNAs in the BART 
cluster are likely to be transcribed as part of a single pri-miRNA, the levels of these 
miRNAs within cells can differ by as much as 50-fold (Pratt et al., 2009).  
 
Although present in the sample (as later tested by real time RT-qPCR, data not 
shown) the levels of miRNAs from pre-miRNA candidates MD11776,  MD1111 and 
MR5075 were too low to be detected by northern blotting, and ideally should be 
characterised by more sensitive methods. This demonstrates that although useful, 
northern blotting is not always sensitive enough to detect low-level transcripts. Some 
modifications may be enough to enable detection here however. In these 
experiments, 10 g of total RNA was loaded per lane and increasing that amount to 
20-100 g may have led to the detection of miRNAs and possibly pre-miRNAs from 
some of these transcripts. In particular it would be interesting to repeat this with 
MD11776, firstly as it’ s the next most abundant candidate and therefore the most 
likely of the remaining targets to be detectable, and secondly because it may be 
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possible to detect two isoforms of the pre-miRNA i.e. an additional larger version 
containing un-processed moRNAs as has been previously shown for a PRV pre-
miRNA (Wu et al., 2012). 
 
8.5 Diagnostic assay development and use 
Due to the possibility of enzymatic bias in deep sequencing the expression levels of 
CyHV-3 miRNAs needed to be verified by other methods. It was evident from 
previous experiments that many of the miRNAs derived from CyHV-3 pre-miRNAs 
were present at very low levels and that verification of the expression levels for these 
miRNAs required a different more sensitive approach. A sensitive method such as 
RT-qPCR was ideal for this. Due to the small size of miRNAs and the need to avoid 
non-specific signals from pre-miRNAs or pri-miRNAs (which contain the same 
target sequence) or even from genomic DNA, the approach used for detection of 
miRNAs by RT-qPCR is slightly different. This approach is known as Stem-loop 
RT-PCR (Chen et al., 2005) (Figure 2.9) 
 
However, due to the proprietary methods used in primer-design, the primer 
sequences were not disclosed by the manufacturer. In addition the assays themselves 
were very expensive and for this reason they were only purchased in the smallest 
sizes. However reducing the amount of primer/probe used per reaction assay was an 
ideal way to ensure that there was enough to meet the needs of this present study. It 
was important to first assess the effects of this deviation from the manufacturer’ s 
recommendations. As expected using 0.1x primer/probe reduced the sentitivity, but it 
was still more than adequate to detect host and viral miRNAs in vitro. The use of 1x 
CyHV-3 miRNA primer/probe was confined to in vivo samples where it was more 
likely that more sensitivity was needed as a consequence of lower proportions of 
infected/non-infected cells. For some CyHV-3 assays, it was found that the use of 1x 
primer/probe resulted in low level non-specific signals in RNA from negative CCB 
cells (this did not occur using 0.1x primer/probe). Subsequent testing involving 
different annealing temperatures revealed that this may have been due to the 
primer/probe sequence i.e. possibly due to higher GC content. This was something to 
bear in mind when using some of these assays to test for CyHV-3 miRNAs in vivo as 
  305 
low level non-specific signals would be indistinguishable from low level signals 
caused by the presence of low level CyHV-3 miRNAs. 
 
8.6 In vitro sample testing 
 
In order to assess whether the relative levels of CyHV-3 miRNAs observed in deep 
sequencing were caused by enzymatic bias, the same RNA sample was retested using 
RT-qPCR. This retest showed that the relative levels observed in deep sequencing 
were more or less accurate except for the miRNAs from MD1111 which may have 
been over represented due to enzymatic bias. This also revealed that the major/minor 
form designation from deep sequencing was correct. Interestingly, sequencing from 
the N076 experiment showed that the level for the miRNAs from MD1111 was 
greatly reduced, compared to most other miRNAs, although it also showed that the 
major form had switched. If these sequencing results from the N076 infection are 
taken to be reasonably accurate (as exemplified by the RT-qPCR results in the H361 
infection) and assuming no additional bias was introduced in the second experiment 
(i.e. on the basis of the same sequence content in both infections with respect to 
adaptors and small RNAs present and the same methodology), it is plausible that 
there was a shift in major/minor form in this infection. It would have been interesting 
to also test RNA from the same N076 infection by RT-pPCR, although this was not 
possible as there was no more of that particular sample remaining.  
 
The measurement of CyHV-3 miRNA expression over the course of an in vitro lytic 
infection (using RNA from a new infection with the N076 isolate) showed that the 
rise in their expression levels directly correlated with the rise in viral DNA levels 
over the same time period, thus definitively linking these positive signals for CyHV-
3 miRNAs to viral replication. The increase in the expression levels over the course 
of the infection is presumably linked to an overall increase in the levels of viral 
transcripts as more cells become infected. This experiment also showed that the 
relative expression levels observed in the previous experiments (i.e. deep sequencing 
using the H361 isolate) were indeed typical of this kind of CyHV-3 in vitro infection 
regardless of what isolate was used. MR5057 and MD11776 are consistently 
expressed at the highest levels as determined by RT-qPCR. For this reason it makes 
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sense that these were the only ones detected on the array, and why MR5057 was the 
only one detected by northern blotting. In agreement with the deep sequencing and 
RT-qPCR data for the H361 infection, the 3’  mRNAs from MR5075 and MD1111 
were consistently found to be the major forms derived from these pre-miRNAs at all 
time points over the course of the in vitro infection using the N076 isolate. These 
were the only pre-miRNAs to have both major and minor forms targeted by RT-
qPCR. The fact that the miRNAs from the 3’  arms were always present in higher 
levels compared to those from the 5’  arms suggests that this type of expression 
pattern must arise from a precise, repeated process rather than random RNA 
degradation. Thus, these observations support the annotation of MD1111 and 
MR5075 as genuine pre-miRNAs.  
 
8.7 In vivo sample testing 
 
While in vitro infections are very useful for studying viruses, naturally they are not 
fully representative of the situation in vivo, where many additional factors may come 
into play. Most notably, elements of the immune system are absent. This may be 
significant, as sometimes the nature of viral interaction with the immune response 
can have profound effects on the behaviour of a virus in vivo as described in Section 
1.2.2. For this reason it was important to investigate whether or not the same 
miRNAs were expressed during a lytic in vivo infection and if the relative expression 
levels were similar to what was observed in vitro. To do this it was necessary to use 
RNA from lytically infected tissue. Due to possible non-specific signals from five 
out of the eight CyHV-3 miRNA assays ultimately only three CyHV-3 miRNAs 
were targeted in Phase 3, namely the assays targeting the major forms derived from 
MR5057, MD11776 and MR5075. Out of the three samples from this fish only the 
gill gave positive results. All three targets were detected. As somewhat expected the 
levels of CyHV-3 miRNA were low compared to the levels in vitro. Interestingly, 
although low by comparison, the relative levels of these 3 miRNAs did mirror the 
relative levels of the same miRNAs in vitro. This confirmed that at least three of the 
CyHV-3 miRNAs identified the lytic infections in vitro are also expressed in vivo. It 
is unclear why the same miRNAs did not show positive signals in the brain or 
kidney. This is especially surprising in the case of the kidney as CyHV-3 replicates 
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most efficiently in this organ (Pikarsky et al., 2004). One reason is that the levels 
were beyond the limit of detection. While the levels of the positive signals in the gill 
were quite low, it does not necessarily mean that the expression levels were low and 
could in fact be a consequence of low level virus in this tissue (or at least in the 
section taken for RNA sampling). On this note it would be interesting to have 
extracted both RNA and DNA from the same homogenate, thus allowing this to be 
investigated. However, only extracted RNA samples were available for this study.  
 
The lytic infection in Fish-8 was actually a reactivated lytic infection. The fish was a 
long-term survivor of a previous high mortality outbreak in a lake in the UK. As 
expected introduction to a permissive water temperature resulted in the reactivation 
of a lytic infection, demonstrating that this fish was indeed a latent carrier. This 
suggested that other fish from the same lake that were also survivors of the same 
outbreak may also have been latent carriers. As miRNAs in other HVs are usually 
also expressed during latency, it is possible that CyHV-3 encoded miRNAs are also 
expressed at this stage. For reasons described earlier (Section 1.4.10.6) these may be 
more detectable than low levels of viral DNA during latency and therefore more 
ideal as diagnostic targets for the diagnosis of latent infections. In order to explore 
this possibility, six additional fish that were long-term survivors of the same outbreak 
as Fish-8 were also tested for CyHV-3 miRNAs. RNA from gill, gut, brain and 
kidney samples were tested from these fish. The only samples that were selected for 
Phase-3 testing were the brain and gut samples from Fish-21. The gut samples 
showed positive signals for MR5057 in both sample dilutions. Although the positive 
signals were quite consistent they were very low. If this fish was latently infected the 
result suggested that the CyHV-3 miRNAs targeted were not readily detectable and 
that there could be other CyHV-3 miRNAs that were expressed at higher levels 
during latency. However this was just a quick exploratory experiment using a small 
sample size. Crucially the fish that were used were not definitively shown to be 
latently infected. It was possible that the positive signal represents low level 
reactivation. The only way to definitively confirm that specific fish are latent carriers 
is to reactivate a lytic infection. Unfortunately, once reactivation occurs the same fish 
are no longer useful subjects for the study of latency.  
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There are other ways to approach such an experiment however. Recent findings 
indicate that testing leucocytes may in fact be the most reliable and sensitive way to 
detect latent CyHV-3 (Eide et al., 2011a, 2011b; Xu et al., 2013). This also presents a 
way to carry out non-lethal sampling from potential latent carriers before confirming 
latency through reactivation. Blood sampled from fish confirmed to have been latent 
carriers (at the time of sampling) would be ideal test material for use in an 
investigation into CyHV-3 miRNA expression during latency. In addition DNA 
could also be extracted from the same samples allowing a direct comparison between 
the levels of viral DNA and RNA present, thus offering an ideal way to evaluate the 
potential benefits of targeting latency associated miRNAs instead of genomic DNA. 
 
8.8 Investigation into CyHV-3 miRNA sequence conservation 
 
8.8.1 Identification of potential CyHV-3 pre-miRNA and/or miRNA 
homologues in other CyHV genomes 
 
Viral miRNA conservation and/or high sequence similarity is quite rare and to date, 
this has only been observed between closely related viruses. For this reason the 
CyHV-1 and CyHV-2 genomes were searched for sequences that were homologous 
to CyHV-3 pre-miRNAs. BLAST searches revealed significant matches to three 
CyHV-3 pre-miRNA sequences in these two other viruses. The pre-miRNAs in 
question were MD1111, MD11776 and MD11704 (only considered a genuine 
CyHV-3 pre-miRNA at this point in the study). Interestingly, these were all located 
in orthologous non-coding regions of these three viral genomes.  
 
As highlighted in Section 1.6.2, it was possible that if there was some pre-miRNA 
sequence conservation between these viruses, it would be mainly confined to the 
regions of the pre-miRNA encoding the mature miRNAs. Indeed in all three such 
cases found for CyHV-3 pre-miRNAs the highest sequence similarity was in the 
regions encoding the mature miRNAs. In fact for MD1111, the only sequence 
similarity was to the region encoding the 5’  miRNA. In addition this match was only 
in the CyHV-2 genome. Unlike all other CyHV-3 miRNAs, there are no non-coding 
regions in the CyHV-1 genome that are orthologous to the non-coding region 
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encoding MD1111 in the CyHV-3 genome. This is not unusual as there are several 
other genes present in the CyHV-3 and CyHV-2 genomes that are also absent in the 
CyHV-1 genome (Davison et al., 2012).  
 
Matches for the other CyHV-3 pre-miRNAs were more widespread across the pre-
miRNA sequences although the regions showing the highest similarity were those 
encoding the mature miRNAs, namely the 3’  arm miRNA for MD11776 and the 5’  
arm miRNA for MD11704. The regions encoding the MD11776 moRNAs did not 
show the same levels of sequence similarity indicating that it is possible that the 
miRNA sequences are under more selective pressure. If these are genuine miRNA 
orthologues in these three viruses, then it would make sense were it to be the seed 
regions that were most conserved and indeed this is the case with the 3’  arm miRNA 
for MD11776 and the 5’  arm miRNA for MD11704 with their respective seed 
regions being perfectly conserved. The least conserved seed region is that of the 5’  
arm miRNA for MD1111 5’  which showed two mismatches to the CyHV-2 genome 
(all other cases of sequence differences in seed regions show a maximum of one 
mismatch with each virus). Such differences in the seed regions may suggest that 
while there may be an evolutionary relationship between these miRNA sequences, 
the may nonetheless have divergent functions or that their targets may also have 
diverged.  
 
Notably all of these CyHV-3 pre-miRNAs and potential homologues are found in 
non-coding regions opposite the same orthologous protein-coding genes in all 
viruses. While it is interesting that these pre-miRNA sequences may be conserved 
due to some functional importance it is also possible that it is in fact the protein-
coding gene on the opposite DNA strand that is under selective pressure. However, 
the remaining four CyHV-3 pre-miRNAs also occur in non-coding regions opposite 
orthologous protein-coding genes but do not show any signs of conservation. This 
suggests that it is possible that the sequence similarities observed for MD1111, 
MD11776 and MD11704 may not have simply been a consequence of their genomic 
location. 
 
The only potential CyHV-3 pre-miRNA homologue in CyHV-1 and CyHV-2 that 
was also independently predicted by VMir was the MD11776 homologue in CyHV-
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2. This had both a high VMir score and a high WC value in addition to being the 
only potential CyHV-3 pre-miRNA homologue to be classified as a pre-miRNA by 
MiPred and the CSHMM-Method. None of the other potential CyHV-3 pre-miRNA 
homologue sequences were deemed to fold into pre-miRNA-like structures, possibly 
due to differences in sequence.  
 
Although the potential MD11776 homologue in CyHV-2 does form a pre-miRNA 
stem-loop structure, this does not automatically mean that the miRNA is functionally 
active. The pre-miRNA secondary structure is an extremely important factor in 
determining the efficiency with which a pre-miRNAs are processed by Dicer and 
Drosha, or if they are even processed at all. Even small mutations in pre-miRNA 
sequences in different strains of the same viruses can render pre-miRNAs 
functionally inactive. Several mutations in the KSHV pre-miRNA kshv-mir-K9 of 
the strain persistently infecting BC-3 cells has rendered this gene inactive compared 
to the same gene in the KSHV strain infecting BS-1 cells (Kuchenbauer et al., 2008). 
Strikingly a single point mutation in the EBV pre-miRNA BHRF1-3 in the Raji 
strain has disrupted pre-miRNA structure enough to inhibit its maturation (Pratt et 
al., 2009). 
 
8.8.2 CyHV-3 seed region matches to viral miRNAs 
 
The seed regions of miRNAs are the primary determinants of function, thus miRNAs 
from different viruses that share the same seed sequence may also have conserved 
target sites on orthologous genes. CyHV-3 miRNA seed regions were compared to 
seed regions from other known viral miRNAs as a way of identifying other miRNAs 
that carry out the same functions during infections. The most common matches were 
to miRNAs from EBV, rLCV and MDV-1. These are also viruses with some of the 
greatest complements of known miRNAs (68 in rLCV, 44 in EBV and 26 in MDV-
1), so statistically there is a greater likelihood that matches to miRNAs from these 
viruses are due to chance, although it may not necessarily be the case. Interestingly 
two miRNAs (full match to MD11776 5’ and partial to MD1111 3’ ) had matches to 
seed regions from two BLV miRNAs. BLV has a low number of miRNAs (8 known) 
and it does seem that a match to two of these is less likely to occur by chance. 
Moreover it is not a member of the order Herpesvirales; it is a member of the 
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Retroviridae family. This does seem quite unusual, although CyHV-3 has already 
been shown to have a very unusual genome, in that it contains several genes e.g. 
(TmpK and B22R-like genes) not found in any other herpesviruses but instead genes 
that are strongly associated with phylogenetically distant viruses, in particular 
members of Poxviridae, Iridoviridae families and it also has proteins that show 
significant similarity to proteins from African swine fever virus (Ilouze et al., 2006).  
The phylogenic process behind the formation of this unusual genome is not clear, 
however it does present a plausible theory that CyHV-3 may also have also acquired 
miRNA genes from other distantly related viruses outside the order Herpesvirales. 
On the other hand, the presence of the same seed sequences does not necessarily 
mean that there is any evolutionary relationship between any of these miRNAs. 
Instead it may occur as a result of convergent evolution.  
 
Regardless of the reasons behind the observed similarities in seed regions, it is 
possible miRNAs with the same seeds have orthologous functions. Therefore, as 
roles for these other viral miRNAs are elucidated this may provide insights into the 
possible roles of these CyHV-3 miRNAs that possess the same seed regions. 
Interestingly the BLV miRNA blv-miR-B4-3p (with identical seed region to 
MD11776 5’  miRNA) down-regulates the tumor suppressor gene HBP1. This 
function was originally proposed due to the seed region sequence similarity with the 
host oncogenic miRNA miR-29a (Kincaid et al., 2012), demonstrating that viral 
miRNAs that share seed regions with host miRNAs may also have similar functions, 
allowing the virus to tap into host miRNA regulatory networks. Similarly miRNAs 
from other oncogenic viruses such as MDV-1 and KSHV encode orthologues of 
miR-155. (Boss et al., 2011; Zhao et al., 2011). As the MD11776 5’  arm miRNA has 
an identical seed region with that of the Cyprinus carpio miR-29a and it too may 
have the same function as its host cell’ s orthologue. However as CyHV-3 is not an 
oncogenic virus, it is not clear how down regulating an orthologous tumor suppressor 
gene would be an advantage to CyHV-3, although it is possible that Cyprinus carpio 
miR-29a (and hence the MD11776 5’  arm miRNA) carries out a different function 
(the same may be said for the host protein). Furthermore, under the experimental 
conditions used in this study, MD11776 5’  arm miRNA was shown to be the minor 
form derived from this pre-miRNA and would not expected to be present in 
physiologically relevant levels during a lytic infection.  
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8.9 CyHV-3 miRNA target prediction 
 
The high levels of some of the CyHV-3 miRNAs may indicate that they have 
significant biological roles during in vitro infections.  The final part of this study was 
concerned with the prediction of targets for some of these miRNAs. It is mostly the 
major form that is thought to be the biologically active miRNA form of the duplex. 
However, this is not always true. The minor form is still always incorporated into the 
RISC at lower levels and sometimes it is present at physiologically relevant levels 
depending on the miRNA genes in question (Okamura et al., 2008). Alternatively 
both strands may accumulate to similar levels (Kim et al., 2009) and the major/minor 
form can switch depending on the circumstances (Jagadeeswaran et al., 2010; Reese 
et al., 2010; Ro et al., 2007). For these reasons it was decided to investigate possible 
viral mRNA targets for both the major and minor forms derived from CyHV-3 pre-
miRNAs. Target site prediction was carried out for all CyHV-3 miRNAs 
(Supplementary File 7.1), but it was only the predictions for miRNAs from MR5057 
and MD11776 that were evaluated in more detail (Section 7). This was because 
MR5057 and MD11776 had the most evidence to support their annotation as genuine 
pre-miRNAs. 
 
MiRNAs generally target the 3’  UTRs of mRNAs. In rare cases target sites can be 
found within ORFs (and even 5’  UTRs). Both of these pre-miRNAs occur opposite 
protein-coding genes, thus these are obvious potential targets for these miRNAs and 
they also were also deemed to be high probability targets by PITA and TargetScan 
(results not shown). Target sites that map to within ORFs are generally not as 
functionally active as target sites in 3’  UTRs however and this is believed to be 
mainly due to interference from translation (Grimson et al., 2007; Gu et al., 2009; 
Lin and Ganem, 2011).  
 
Predicting target sites in 3’  UTRs based on complementary matches the miRNA seed 
regions not so straightforward. There are other subtle criteria that need to be taken 
into account. This is important as miRNA target prediction by its nature gives lots of 
false positives, but looking for these additional criteria provides an ideal way to 
distinguish high-quality miRNA target predictions from background noise (Section 
1.8). Two very different approaches, TargetScan and PITA were used for miRNA 
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prediction (Section 7). While TargetScan takes into account many characteristics of 
target sites, it does not address target site accessibility. Conversely PITA bases its 
ranking entirely on target site accessibility and acts as a way to also check 
TargetScan predictions for target site accessibility, thus further improving the quality 
of the results. 
 
TargetScan and PITA were in complete agreement regarding the most likely target 
sites for the miRNAs from MR5057. For the 5’  miRNA from MR5057, the 3’  UTR 
from ORF117 was predicted to be the most likely target site by both methods. The 
site itself occurs near the start of the 3’  UTR for ORF117 (Figure 7.3). This 3’  UTR 
also contains ORF116 (hence the 3’  UTR referred to as ORF_116-117 in the 
analysis). This target site is possibly in the 5’  UTR of ORF116, inferring that the 
miRNA may not have any real effect on the expression of ORF116 (as target sites 
that occur outside 3’  UTRs are generally less efficient).  
 
The most likely target site for the 3’  miRNA from MR5057 was predicted to be the 
3’  UTR of ORF122 /ORF123. In fact it was the only target site identified by 
TargetScan. It occurs near the start of the 3’  UTR ORF123 which overlaps with the 
end of the 3’ UTR of ORF122 (Figure 7.5). The location of this target site (i.e. in the 
3’  UTR of both ORFs) suggests that the miRNA could potentially regulate both of 
these transcripts. 
 
Both target sites for miRNAs from MD11776 occur in 3’  UTRs that also overlap 
with ORFs (Figure 7.7 and Figure 7.9). MiRNA target sites do not usually occur 
within ORFs, but this may be simply unavoidable in viral genomes where a lot of 
gene overlap occurs due to limitations on space. A target site for the KSHV miRNA 
hshv-miR-K5 also occurs in a similar genomic context (Lin and Ganem, 2011). 
However it is important to note that overlapping genes may not necessarily share the 
same primary RNA transcripts but instead may be under the control of different 
promoters. Therefore the target site may sometimes be transcribed as part of a UTR 
and as part of an ORF at other times, depending on which promoter is active. If this 
is the case with the CyHV-3 target sites for MD11776 miRNAs, then miRNA 
repression of the gene upstream of the UTR should not be subject to interference 
from the process of translation. The genes upstream from this the target site for 
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MD11776 3’  are ORFs 87 (early gene), 85 (late gene) and 86 (late gene), however 
there are no details available as to their functions. The gene upstream of the target 
site for MD11776 is ORF129 (early gene) and its function is also unknown.  
 
In contrast there is more information available on the function of the genes targeted 
by the miRNAs from MR5057. The 5’  miRNA target site is in the 3’  UTR of 
ORF117. The encoded protein is predicted to have a hydrophobic region (Aoki et al., 
2007) that is likely to represent a transmembrane domain, hence it may form part of 
the viral envelope. Also it was recently identified as an early gene (Ilouze et al., 
2012a). ORF123, one of the candidate targets for the MR5057 3’  miRNA has been 
identified as a deoxyuridine triphosphatase (Aoki et al., 2007) and therefore likely to 
be involved in nucleic acid metabolism and part of the viral DNA replication 
process. It was also identified as a viron protein (Michel et al., 2010b) also found in 
other herpesviruses such as HCMV (Varnum et al., 2004) and RRV (O’ Connor and 
Kedes, 2006) and recently identified as an early gene (Ilouze et al., 2012a).  
 
As the protein encoded by the early gene ORF117 may be incorporated into the viral 
envelope it is possible that the continuous expression of this protein is surplus to 
requirement once viral maturation is complete. However due to the fact that it is 
predicted to be targeted by the 5’  miRNA (minor form) from MR5057, it is possible 
that this miRNA has no real effect on the expression of this gene unless the levels of 
this miRNA are caused to increase under other circumstances.  
 
Deoxyuridine triphosphatase is involved in nucleic acid metabolism -specifically the 
processing of dUTP to dUMP, the precursor for thymine nucleotides. Therefore it is 
likely that the expression of ORF123 (in particular) is excess to requirement once 
viral genomic replication is complete. It is tempting to speculate that the transcription 
of the MR5057 pri-miRNA may be regulated in a temporal manner ensuring that 
there are sufficiently high levels of the 3’  miRNA from MR5057 processed to down-
regulate expression of ORF123 once it is no longer required. Therefore this miRNA 
may contribute to a dynamic and collective process that ensures correct temporal 
progression of viral gene expression during lytic infections.  
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CyHV-3 miRNAs can also target host miRNAs, and ideally carp 3’  UTRs should 
also be assessed for possible CyHV-3 miRNA target sites. Unfortunately at the time 
of this study there was no compiled list of carp 3’  UTRs available. However, there 
was a list of 18,233 3’ UTRs for the related species Danio rerio (zebrafish) available 
from the UTR sequence database (utrdb.ba.itb.cnr.it/). As these two genomes show a 
high degree of similarity (based on initial data from the carp genome project) (Xu et 
al., 2011), these zebrafish 3’  UTRs were used to as a proxy for Carp 3’  UTRs in 
CyHV-3 miRNA target prediction with the initial aim of identifying high-likelihood 
predictions in the zebrafish genome and then searching for their conservation in the 
carp genome once the latter became sufficiently annotated. While significant 
progress has been made towards this in recent years (Henkel et al., 2012; Zhang et 
al., 2011a), it was not sufficiently annotated for these purposes before the end of this 
study. Therefore target site predictions in zebrafish 3’  UTRs could not be checked 
for conservation in the corresponding carp 3’  UTRs.   
 
In is interesting that two very different approaches to miRNA target prediction gave 
identical results regarding the most likely CyHV-3 mRNA targets for the miRNAs 
from MR5057. The target sites that were found to conform most closely to the 
characteristics of bone-fide target sites using TargetScan were also the same sites that 
were found to be the most accessible using PITA. This is in agreement with the idea 
that genomes will tend to evolve in a way that ensures that important miRNA target 
sites remain physically accessible and available for base pairing with RISC bound 
miRNAs. These results regarding target prediction provide a solid basis for further 
experimental investigation. 
9 Conclusion 
 
This study has gathered experimental evidence to propose the existence of at least 
seven CyHV-3 encoded pre-miRNAs. All of these proposed pre-miRNAs were 
initially predicted to exist as part of the initial analysis of the CyHV-3 genome in 
order to determine its pre-miRNA coding potential prior to the commencement of 
experimental investigation. All of the pre-miRNAs and small RNAs (miRNAs and 
associated isomiRs) that map to these precursors display explicit indicative 
characteristics of genuine pre-miRNAs and miRNAs such as alignment signature, 
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miRNA duplex, stable pre-miRNA and specific enrichment in miRNA enriched 
samples. They also possess more subtle miRNA-like characteristics such as a general 
bias towards more 3’  end heterogeneity among isomiRs and tendency to form 
discrete regions of read enrichment upon visualization of mapped data. Importantly 
all of these characteristics were shown to be consistent over two separate infections 
using two different CyHV-3 isolates.    
  
The 3’  miRNA from MR5057 was shown in all experiments to be the most abundant 
CyHV-3 miRNA and was the only miRNA detected by northern blotting providing 
conclusive evidence that MR5057 is a genuine pre-miRNA. Only miRNAs from 
MR5057 and MD11776 were detected by array hybridization. Even though miRNAs 
from MD11776 could not be detected by northern blotting, array hybridization 
showed that like the host miRNAs and the miRNAs from MR5057, the miRNAs 
from MD11776 were specifically enriched in the miRNA enriched sample only and 
not in the non-RNA sample from the same infection, indicating that this proposed 
pre-miRNA is more than likely genuine. Of all the CyHV-3 pre-miRNAs, MD11776 
also showed the most signs of sequence and genomic location conservation in the 
two other CyHVs and in one of these (CyHV-2) it was the only potential homologue 
that was also likely to give rise to a functional pre-miRNA. The fact that this gene 
shows signs of conservation, in particular the region containing the major form 
miRNA, suggests that it has an important function as a miRNA, further supporting its 
annotation as a genuine pre-miRNA.   
 
The miRNAs from the five remaining pre-mRNAs were present at low levels, 
therefore in addition to strong evidence from deep sequencing, miRNAs from these 
pre-miRNAs could only be detected through RT-qPCR, except for MD11704 which 
was not targeted by RT-qPCR. The fact that the expression levels of the major and 
minor forms derived from MD1111 and MR5075 were found to show consistency 
(i.e. that the major form was always present at higher levels), strongly supports the 
annotation of MD1111 and MR5075 as genuine miRNAs. Overall the use of RT-
qPCR for relative quantification of CyHV-3 miRNA expression levels revealed a 
consistent expression profile for these CyHV-3 miRNAs during lytic infections both 
in vitro and in vivo, suggesting their expression is subject to specific underlying 
regulatory process. As similar expression profiles were found for these miRNAs in 
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vitro and in vivo it is highly likely that this profile would also be observed during 
lytic infections and across a broad range of experimental conditions.   
 
In conclusion MR5057 is a genuine CyHV-3 encoded pre-miRNA. Based in the 
evidence gathered in this study, the six remaining proposed CyHV-3 pre-miRNAs 
are more than likely also genuine pre-miRNAs. Due to the fact that the miRNAs 
from MD11776 were the only other CyHV-3 miRNAs also detected by array 
hybridization, ultimately there is more evidence to indicate that these small RNAs 
are specifically enriched in the 17-25 nt RNA size range. Therefore out of the six 
remaining proposed pre-miRNAs, MD11776 is the most likely to be a genuine pre-
miRNA. The detection of all of these transcripts by northern blotting would have 
been sufficient to confirm that they are in fact genuine miRNAs. The failure to detect 
any CyHV-3 miRNAs by northern blotting, other than the most abundant one, 
suggests that this was purely due to the sensitivity of the method. As discussed 
earlier, it may be possible to detect miRNAs at lower levels by repeating northern 
blotting using increased quantities of RNA. Due to their strong association with 
latency in other viruses, CyHV-3 miRNAs represent possible diagnostic markers for 
latent infections. The small exploratory experiment carried out at the end of this 
study, using samples from healthy fish, may not have been adequate enough to fully 
evaluate the potential usefulness of CyHV-3 encoded miRNAs in this context. As 
discussed earlier, for several reasons, carrying out a similar experiment using RNA 
samples from leucocytes may be a more suitable approach and may provide more 
clear cut answers in relation to the expression of these miRNAs during latency in 
vivo. 
  
In accordance with the nomenclature system in use in miRBase the official names 
that have been suggested for the CyHV-3 pre-miRNAs identified in this study are 
shown in Table 9.1.   
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Table 9.1 Official names suggested for all CyHV-3 pre-miRNAs identified in this study 
The names are based on the nomenclature used in miRBase. Pre-miRNAs are numbered based on their 
position on the CyHV3 genome (KHV-U strain Ac. DQ657948.1) Mature miRNAs take the same 
name as the pre-miRNA they are derived from except -mir is changed to –miR and the name ends 
with either -5p or -3p depending on depending on whether the miRNA id derived from the 5’  or 3’  
arm.  
 
Names used in this study Proposed names in accordance with 
miRBase miRNA nomenclature system 
MD1111 CyHV3-mir-1 
MD9812 CyHV3-mir-2 
MD11410 CyHV3-mir-3 
MD11704 CyHV3-mir-4 
MD11776 CyHV3-mir-5 
MR5057 CyHV3-mir-6 
MR5075 CyHV3-mir-7 
 
 
MiRNAs are important players in post-transcriptional regulation and are vital for 
many fundamental cellular processes in almost all eukaryotic organisms. Their 
unique characteristics also make them ideal tools for viruses, providing a genetically 
economic way to modulate both viral and host gene expression without stimulating 
an immune response. As with miRNAs from other viruses, it is likely that the CyHV-
3 miRNAs identified in this study have specific functions during lytic infections. 
This may be particularly true of the miRNAs that are consistently highly expressed 
such as the 3’  miRNA from MR5057 (CyHV3-miR-6-3p). In addition, a target for 
CyHV3-miR-6-3p was tentatively predicted at the end of this study giving a solid 
theoretical basis with which to proceed with further characterisation of this miRNA 
in terms of its function. 
 
Although the functions of moRNAs are not yet known the additional discovery that 
CyHV-3 encodes moRNAs is intriguing. Together, the identification of both CyHV-
3 encoded miRNAs and moRNAs opens up new lines of inquiry into the molecular 
basis of CyHV-3 infections. The detection of latent carriers will continue to play a 
key role in monitoring (and possibly controlling) the spread of this virus in many 
regions and the diagnostic potential of CyHV-3 encoded miRNAs in this context, can 
now be thoroughly evaluated. Furthermore, the identification of potential CyHV-3 
pre-miRNA homologues in CyHV-1 and CyHV-2 provides interesting openings for 
investigations on the existence of miRNAs encoded by these viruses and other 
members of the Alloherpesviridae family.  
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